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DIRECTOR'S REPORT
When I first came to Cold Spring Harbor, in June of 1969, it was to a laboratory that was very
different in character than it is today. The physical plant was dilapidated and only one building -
Demerec - was usable as a year-round laboratory. McClintock -in those days called the Animal
House -had that special air of stagnation found only in empty Victorian structures: Its musty rooms
and silent corridors echoed to a visitor's footsteps like an abandoned railroad station. The lower
floor of James was a grubby warren of unusably small spaces divided from one another by a series
of partitions that effectively insulated workers in the building from any contact with one another;
the upper floor swayed precariously, empty for all but three brief weeks of summer. Delbriick -
then named Davenport- buzzed with bacteriophages in June and July. But come the fall, its water
pipes were drained, its windows were shuttered, and the building hunkered down into the hillside
for the cold winter. On the site of the present Hershey office building was a set of greenhouses,
their cracked and grimy windows serving more effectively to screen out the sunlight than to provide
protection to a few long-forgotten plants whose only source of nourishment seemed to be the still-
strong smell of garden loam.
The grounds were disorderly and delightful with cover, vibrant with birds and animals. For four
months of the year, Bungtown Road was little more than a leafless tunnel for the bitter north wind,
but in early spring it softened into a narrow culvert whose flowered walls were a mass of head-
high brambles and rhododendrons. In late evening, with the light slanting at a certain angle, it
was easy to believe that this was the perfect setting for a Wagnerian opera, so overpowering was
the combination of color and perfume to the senses. Of all the changes at the Laboratory, it is only
the loss of those intense evenings that I regret.
Today, the vines have been tamed, the trees nursed back to health, and much of the ground has
been cleared into open spaces and planted with grass. So, whereas it was difficult previously to
obtain a clear view of the harbor, now the water is always in plain sight, and the land is inviting to
the casual walker. As our grounds have changed over the years from bucolic to pastoral, so the
individual buildings have been transformed from their rustic decay into highly functional labora-
tories and spacious offices. There is now the pleasure of doing science in a cultivated setting in
well-equipped laboratories. It is this restoration of old buildings, together with the planning and
siting of new, that has been a major interest of Jim Watson. Remarkably, he has been able to guide
the Laboratory through a period of explosive growth and massive renovation without compromis-
ing the basic beauty of the land or the style of the science. His absence from the Laboratory for a
sabbatical year in London gives me the opportunity to thank him on behalf of the staff for creating
an environment so stimulating to the intellect and beautiful to the eye.
This year has seen the completion of a major
new addition to Demerec Laboratory - chiefly
to make room for the scientists associated with
our joint program with Exxon Research and
Engineering. The upper floor therefore houses
units working on site-directed mutagenesis and
prokaryotic genetics. On the lower floor, we
have been at last able to achieve our ambition
of a protein chemistry laboratory equipped to
the best modern standards. Much more signif-
icant than our physical expansion, however, has
been the infusion of new people into our sci-
entific community: Doug Youvan from Berke-
ley and Mark Zoller from Vancouver, who have
come here to work on site-directed mutagene-
sis; Pablo Scolnick, from the University of
Chicago, who will continue his genetic analy-
sis of the nif genes of Rhodopseudomonas;
Steve Hinton from Purdue and Dan Lundell
from Berkeley, who are studying molybde-
num-iron centers in metalloenzymes; and,
most recently, Clive Slaughter, an English ex-
patriate who brings not only much-needed ex-
pertise in protein chemistry, but also a long-
standing interest in mammalian cell genetics.
Despite our intensive building program, we
continue to work in very crowded conditions -
nowhere more so than in James Laboratory. It
is therefore welcome news that the long-
awaited extension to this building will be com-
pleted by midsummer of 1984. Funded in part
by grants from the National Cancer Institute,
the Pew Memorial Trust, the Fannie Rippel
Foundation, and the Robertson Research Fund,
the building will provide year-round space for
the growing efforts of Ed Harlow's group to
develop monoclonal antibodies against tumor-
specific antigens and proteins coded by viral
oncogenes.
Late in 1983, the renovations were com-
pleted to Urey Cottage, which has now become
the home of our Publications Department. For
the first time in its 50-year existence this
building, perched on the hillside above James
Laboratory, has achieved a state of elegance.
Originally a small summer house and then an
uncomfortable and draughty year-round resi-
dence, Urey now provides a splendid series of
offices for Nancy Ford and her staff. The ren-
ovations were carried out with the efficiency
and skill that have become the hallmark of our
Buildings and Grounds Department under the
direction of Jack Richards. For some reason,
the laboratory buildings at Cold Spring Harbor
seem to suffer disasters -from floods to fire -
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at an extraordinary rate. That we survive at all
is entirely due to the work of Jack and his de-
partment. Working often under great pressure,
they are infinitely cheerful and never-failingly
helpful.
Dominant among our building plans for the
immediate future is the new auditorium, to be
sited on the west side of Bungtown Road op-
posite our existing Bush Lecture Hall. The fi-
nal drawings by Moore, Grover, and Harper
show a post-modernist structure whose archi-
tectural strength should rival the sophistication
of the work presented at our annual symposia
and summer meetings. Inevitably, since last
year's annual report was written, the estimated
costs of the building have risen (now to $3.3
million), and consequently, we have been
forced to delay construction for several
months. However, the building contract is fi-
nally to be signed within the next four weeks
(before May 1, 1984), and we still have some
hope that the building may be completed in
time for next year's 50th Symposium. That the
new auditorium will be realized is in large part
due to the extraordinary generosity of benefac-
tors in our local community. Year after year,
the members of the Long Island Biological As-
sociation, under the continually inspired lead-
ership of their Chairman Ed Pulling, raise very
substantial sums of money to help the Labora-
tory achieve specific goals; 1983 was an espe-
cially successful year in that LIBA exceeded its
own fund-raising target and has now pledged
to contribute at least $500,000 toward the new
auditorium. The magnitude of this gift makes
us realize once again how fortunate we are to
be surrounded by a community that is so sup-
portive of our goals and so responsive to our
needs.
A major part of the remaining money re-
quired to build the auditorium has been donated
by a single family -again one of our neigh-
bors. Although they wish for the time being to
remain anonymous, we nevertheless want to
take this opportunity to thank them for their
magnificent gift of one million dollars. We
hope that we shall soon be able to acknowledge
this generosity in a more open and fitting way.
+ +
The subject of the 1983 Symposium was Mo-
lecular Neurobiology. The opening address was
given by Max Cowan, who set the high intel-
lectual plane that was to be the standard for the
subsequent seven days. Eric Kandel provided a
most perceptive and balanced summary of the
91 papers that were presented. He, like many
others, is optimistic about the benefits that a
fusion of molecular biology and neurobiology
may bring. To my mind such benefits still lie
several years away - certainly the papers given
at the Symposium were far more neurobiolog-
ical in nature than molecular. I came away with
the impression that molecular biology can do
much to help define the structural properties
of particular proteins that until now have been
recognized on the basis of their electrophysio-
logical behavior. Genes coding for several of
the neurochemical receptor and channel pro-
teins have already been cloned and expressed;
others will rapidly follow. These studies will
surely lead to a thorough understanding of the
structure and function of such molecules and
thence to an appreciation of one of the major
properties that set nerve cells apart from other
differentiated cells in the body. However,
whether molecular biology can be as illumi-
nating about the formation and selection of the
complex neural networks that characterize the
higher workings of the brain is a question that
this Symposium left unresolved.
4.
Our commitment to plant molecular biology
has been greatly strengthened during the year.
First, the Laboratory has successfully con-
cluded negotiations with the Nature Conser-
vancy to purchase approximately 12 acres of
land at Uplands Farm, a former dairy farm lo-
cated about half a mile from the Laboratory.
During the summer of 1983, Barbara Mc-
Clintock and Steve Dellaporta used the exist-
ing greenhouses and a large field at Uplands to
carry out a series of genetic experiments with
corn. With the purchase of the land, we will
now be able to carry out our longer-term plans
to convert the old brick garage at Uplands into
laboratories and offices for six to eight scien-
tists, and to expand and renovate the green-
houses.
Our immediate aim is to assemble a research
group that will be as influential during the next
ten years of plant molecular biology as our tu-
mor virologists have been during the last de-
cade. Central to this goal are the scientists pres-
ently working in Delbriick Laboratory. Two of
them - Steve Dellaporta and Russell Malm-
berg - have been devoting all their efforts to
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plants for some time; several others, notably
Jim Hicks and Jeff Strathern, have started
smaller-scale projects with plants while con-
tinuing their long-standing involvement with
yeast. During the last year, this group applied
to the National Science Foundation for funds
to renovate and equip the Uplands Farm facil-
ity. The grant of $691,000 which they were
awarded - the largest ever given by the Na-
tional Science Foundation for plant research-
will allow us without delay to begin the expan-
sion that is essential to the future success of the
project.
Ambitious though our plans are, their scale
is small compared with the magnitude of the in-
tellectual problems that plants pose. It is a ma-
jor concern, therefore, that the prospects re-
main bleak for secure, long-term funding of
basic research into the biology of plants. Al-
though agencies such as the National Science
Foundation and the Departments of Energy and
Agriculture have established programs on a
small scale, the funds made available so far
cannot fuel sufficient grants to have an impact
on such a large area of science. Most people
would agree that the major source of public
funds for basic research on plants should be
the Department of Agriculture. Although there
are some indications that the Department of
Agriculture, in response to increasing pressure
from Congress, is willing to dispense a larger
fraction of its research budget through a com-
petitive granting system, it still seems likely
that insufficient funds will be available from
governmental sources for several years to
come. We cannot wait that long. During the
next year, therefore, we will need to attract
support from both private individuals and large
corporations who can more clearly see the eco-
nomic and social benefits that will flow from
research in this area.
It seems slightly incongruous that we should
be worried about funds for plant research in
the same year that Barbara McClintock was
awarded a Nobel prize for her work on mov-
able genetic elements in maize. This was an
event that gave many forms of pleasure, be-
cause the award itself was so clearly deserved
and yet so long overdue; because the work was
prophetic and individual rather than, as is more
common these days, the efforts of an anony-
mous group; and most of all, because it was a
victory of radical thought over scientific or-
thodoxy. Barbara McClintock changed the way
we think about genetics and evolution, and it is
not often that intellectual revolutionaries are
honored by the establishment.
A more pleasant revolutionary than Barbara
would be hard to find. On the sunny, fall day
on which the award was announced, she han-
dled the celebrations and press conferences and
television interviews with great grace and wit.
She made sure that the day became an occasion
from which all of us could draw delight and
could share in her success.
+ + +
The year brought sudden sadness as well as
great pleasure. Ahmad Bukhari's death in No-
vember left emptiness in many forms -the loss
of a friend and counsellor and the unresolved
cadences of his interrupted science. Those of
us who had known Ahmad since his arrival
here in those bright early days had seen him
mature scientifically in synchrony with the
Laboratory. The stages of his scientific life -
from postdoctoral fellow to staff investigator
to tenured faculty- therefore seemed to mark
the growth rings of Cold Spring Harbor itself.
His death made us feel both bereft and vulner-
able.
Ahmad himself would have been impatient
curious things and derived too much joy from
clever ideas to tolerate sadness for long. All of
us, however, continue sorely to miss his vital-
ity and intelligence.
In recent years, there has been a great diversi-
fication of science at Cold Spring Harbor. For
a period of 25 years following the Second
World War, the work of the Laboratory was
concerned almost exclusively with the genetic
behavior of a small number of prokaryotic or-
ganisms, chiefly Escherichia coli and its tem-
perate bacteriophages. In those days, there
seemed to be no sensible direction from which
molecular biologists might attack eukaryotic
organisms; in any case, work on prokaryotes
was taken to be prophetic and certainly was too
exciting to abandon in favor of the slower eu-
karyotes. So it was not until 1968 that serious
work began here on mammalian cells, al-
though Phil Marcus and Gordon Sato had for
several years previously taught an excellent
summer course on animal viruses and cells.
The choice of systems available in those days
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was extremely limited. The safest of a bad
bunch seemed to be animal viruses, since they
provided the only homogeneous pieces of eu-
karyotic DNA then available to the molecular
biologist. So we started working on them hop-
ing that we might be able to confirm that the
truths previously discovered in prokaryotes
really were universal.
Of course, our preconceptions about eukary-
otes fortunately were wrong. But our esprit as
a Laboratory in those early years was not
merely the reflection of an excitement gener-
ated by the unexpected results that eukaryotes
provided, but also had to do with the way we
organized ourselves to attack the problems at
hand. Virtually all of the Laboratory was then
working on one aspect or another of gene or-
ganization and expression in adenoviruses and
SV40. Although each individual group might
bring different ideas and techniques to bear on
the various aspects of this problem, there was
a strong sense of shared purpose that came nat-
urally from the fact that much of our scientific
attention was focused toward a common end.
If the science in retrospect seems highly de-
scriptive, it was nevertheless exhilarating at the
time.
How long such a group effort could have re-
hard to say. Before very
long, however, two scientific events occurred
that led to its premature dissolution: the dis-
covery of splicing and the advent of molecular
cloning. The intellectual ferment caused by the
first of these and the technical facility granted
by the second combined to form forces for
change that we were unable to resist. Sud-
denly, any eukaryotic gene became as interest-
ing and amenable to structural analysis as viral
genomes had been just a short time previously.
Freed from the confines of technical limita-
tions we, like many other laboratories, began
to spread laterally into many other systems.
This urge to diversify led us to study the wealth
of topics that are discussed in the body of this
annual report.
My guess is that the tendency to radiate out-
ward into other systems soon will come to an
end. Should it continue, we would have less
and less to say to one another aside from the
latest technical tricks in molecular cloning.
And in any case, it now seems unlikely that we
will be able easily to achieve a satisfactory un-
derstanding of more than a small fraction of
the systems currently under study. We are in
an era in which large numbers of genes are
identified each year, isolated from the organ-
ism of choice, and quickly reduced to their
component DNA sequences. In time, wild-type
and mutant versions of many of these genes
will be inserted into the appropriate vectors
and expressed in the parental organism. This
area of detailed structural and functional anal-
ysis of individual genes -the Great Middle
Ground of molecular biology -will undoubt-
edly continue to yield huge quantities of valu-
able information for many years to come. Ma-
jor among the foreseeable benefits is a
thorough analysis of the structure of eukary-
otic regulatory elements, particularly pro-
moters and enhancers. This is likely to lead to
an understanding of the mechanisms that de-
termine tissue-specific expression of mamma-
lian genes. We can also expect over a longer
term to learn a great deal about the evolution
of gene families and to decipher the rules that
determine the relationship between the do-
mains of proteins and the location of introns
within the corresponding genes.
In the excitement of finding out all that we
need to know about the organization of eukary-
otic genes, it is sobering to remember the lim-
itations of the techniques that are currently so
dominant. Even when the Great Middle
Ground has been completely explored, we will
know comparatively little about the proteins
that are coded by those genes we have mapped.
Unfortunately, the sequence of nucleotides in a
gene presently makes no predictions about the
tertiary structure or function of the corre-
sponding protein. Not even the power and ele-
gance of site-directed mutagenesis can com-
pletely solve this problem. For example, the
gene coding for SV40 large T antigen has been
under intensive study for some 20 years; its
complete nucleotide sequence is known and its
transcriptional pattern has been established.
Hardly a single base pair of the gene has been
left unmutated, and the biological properties of
most of the resulting mutants have been cata-
loged. Molecular biologists can fairly claim to
have carried out the best possible analysis of
the gene. Yet I am sure none of them would
believe that they have anything but the most
superficial understanding of the structure and
function of the T-antigen protein itself. We will
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soon arrive at a similar situation with many
other mammalian genes.
Because there is not likely to be a general
solution to this paradox for several years to
come, there is at present little choice but to
determine individually the structure of each of
the proteins in which we are interested. To
what level of resolution we pursue each protein
is an open question, although to my mind,
nothing short of the atomic level will be satis-
factory in the last analysis. While the idea of
bringing large numbers of proteins to the point
where we can derive their structures by X-ray
crystallography is clearly far beyond our
current capacity, it now seems imperative that
we do so, at least for those proteins in which
we already have considerable intellectual in-
vestment. At Cold Spring Harbor, the natural
choice would include proteins such as those
encoded by the ras-gene family, early region 1
of adenoviruses, and SV40 large T antigen.
Our desire to work effectively on the chemistry
of these proteins may well prompt a partial re-
turn to the sort of group effort that was so pro-
ductive previously. However, the Laboratory is
now much larger than it was ten years ago and
it is inconceivable that we could, or would wish
to, return to an essentially monolithic system.
Clearly, we need to find a balanced position
that will allow us quickly to develop critical
mass in areas new to us, such as protein chem-
istry and protein structure, without unneces-
sarily sacrificing the catholic nature of the top-
ics now under study here.
+ +
During this year as Acting Director, I have
drawn help and encouragement from many
sources. I owe particular thanks to three groups
of people: to the scientific staff, who have been
uncommonly tolerant and supportive; to Bill
Udry and his administrative staff, who have
been unfailingly cooperative and innovative;
and finally, to the Board of Trustees of the
Laboratory, whose counsel, both individual
and collective, has been excellently wise.
March 18, 1984 Joe Sambrook
Ahmad Iqbal Bukhari
1943-1983
On November 19, 1983, Dr. Ahmad Bukhari died suddenly of a heart attack. Dr. Bukhari came
to Cold Spring Harbor Laboratory in 1970 as a postdoctoral fellow. In 1972 he was appointed
to the staff and conducted research involving genetic rearrangements of the bacteriophage
Mu.
A native of Pakistan, he entered the University of Karachi at age 15 and earned his master's
degree by age 20. He came to the U.S. in 1964 as a Fulbright Hays scholar at Brown University
and received his Ph.D. in 1970 from the University of Colorado.
Although a U.S. citizen, Dr. Bukhari maintained scientific liasons with Pakistan and other
third-world countries. He served as an advisor to the United Nations International Develop-
ment Organization and helped to establish an International Center for Genetic Engineering
and Biotechnology, whose aim is to increase the flow of biotechnology to developing coun-
tries. He was also a scientific advisor to UNESCO and played a key role in establishing a
national biotechnology center for Pakistan.
His friends and colleagues respected him as an outstanding scientist and humanitarian. They
also enjoyed his enthusiasm for sports and games. Dr. Bukhari was Captain of the Laboratory's
cricket team and was a challenging player at tennis and chess. An avid reader of poetry, he
found an outlet for his own creative talents in writing short stories.
Through his work, personality, and philosophy, Dr. Bukhari enhanced the lives of the sci-
entists, students, and co-workers with whom he interacted. He is survived by his wife Chris-
tine, and two children, Yousaf Ali and Jaffer Ahmad.
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DEPARTMENTAL
REPORTS
Recto: Carnegie Library. Designed as a laboratory in 1905, this building now houses the Library, Marketing
Department, Book Store, and Office of Information Services.
ADMINISTRATION
As discussed in this year's Director's Report, we
have managed to protect the Laboratory's charming
environment in the face of rapid changes and
growth. This has certainly pleased our neighbors,
and the small community structure thus maintained
we believe has allowed ideas to move quickly and
easily throughout the organization. In a similar
vein, we have also eschewed a highly formalized
bureaucracy. While both these policies result in a
certain inefficiency, they also make it possible for
us to respond flexibly and rapidly.
Continuing growth is, however, leading us in the
administrative sense to rely less on the spoken word
and memory and move towards the embryonic stir-
rings of memos, forms and "guidelines." And as
frustrations build over the lack of a place to put
one's car, or a desk for a new secretary, or a needed
computer attachment, we are beginning to accept
that planning may be more than a "bugaboo" or an
infringement on academic freedom. Thus, in 1983,
we began, under the leadership of a special com-
mittee of our Board of Trustees, a detailed analysis
of the Laboratory's infrastructure of physical and
personnel resources and of the directions in which
our research potentially might lead us. While the
"business" considerations will be of continuing im-
portance for our guidance in the future, the studies
most interestingly provided the framework for a
dramatic expression of consensus by the Board for
a serious commitment to plant genetics.
The studies also provided us with the opportunity
to present our future plans to a combined meeting
of the officials of the Village of Laurel Hollow.
Once again, we received their expression of appre-
ciation and support.
As we faced the necessity of upgrading our sup-
port facilities, the major expressions of which are
the new auditorium and the new additions to James
and Demerec, we sought out more creative financ-
ing arrangements which would relieve some of the
strain on our capital and operating funds. With the
cooperation of the Nassau County Industrial Devel-
opment Agency, we received approval for an $8
million dollar development bond issue which was
immediately subscribed. The funds derived at low,
tax exempt rates of interest will be of immense ben-
efit to the Laboratory's building program and by
costing far less than otherwise possible, will result
in substantial savings to the Laboratory.
+ +
As the Laboratory, and indeed the academic re-
search community in general, continued to explore
its relationships with industry, the question moved
from the basic challenges of "should we" to "how
do we best" handle such relationships. These in-
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clude financial support of our ongoing research
projects, equity and consultant arrangements be-
tween individual scientists and commercial firms,
collaborative projects, and licensing. Again a spe-
cial committee of our Board of Trustees was ap-
pointed to investigate these questions. As its study
progressed, a consensus developed that it is indeed
in the Laboratory's interest, which is reinforced by
federal government policy, to encourage the trans-
fer of findings from our basic research to the gen-
eral public and that many times a variety of rela-
tionships with commercial organizations is the best
or only way to accomplish that objective. Accord-
ingly, during 1983, the Laboratory licensed its dis-
coveries and know-how in the two-dimensional gel
techniques developed by Dr. James Garrels to a new
corporation beginning operations on Long Island
(Protein Databases, Inc.). The company hopes to
develop these basic techniques to the extent needed
to make them viable as a clinical diagnostic tool of
major importance.
We also licensed the H-ras oncogene isolated in
Mike Wigler's lab to the Actagen Corporation of
New Haven, Connecticut. We are now conducting
negotiations with a number of firms for use of the
various ras oncogenes as potential probes for the
diagnosis of cancer.
The year's end marked the completion of a col-
laborative research project among the Laboratory,
Baxter-Travenol, and Genetics Institute. The proj-
ect successfully obtained, by recombinant DNA
techniques, a plasminogen activator substance of
human origin which may be useful as a therapeutic
medicine for treating thromboembolism in humans.
The Wellcome Foundation in Great Britain has now
taken over the project and will endeavor to scale-
up the process of making the substance and will do
the testing and experiments necessary to bring it to
the public at the earliest possible time.
Retiring from our Board after completing the six-
year limit in our By-Laws were Charles Cantor, In-
stitutional Trustee from Columbia University,
where he was Professor of Biology, who provided
us much appreciated advice on both scientific and
administrative matters, and Walter Frank, Jr.,
whose keen insight on financial markets served us
so well while he was a member of the Finance and
Investment Committees. We accepted the resigna-
tion of John Carr after his move to Washington,
D.C., to head the Grumman Corporation office,
which removed him from the possibility of contin-
uing his invaluable help in a variety of administra-
tive areas.
Dr. Eric Kandel, University Professor at Colum-
bia University Medical Center, was elected as an
Institutional Trustee, making even more official his
long-time association with the Laboratory.
Mr. Taggart Whipple, partner in the law firm of
Davis, Polk, and Wardwell, and John Klingenstein,
partner in Wertheim Company, were newly elected
as Individual Trustees.
After an extensive search to fill the post of Person-
nel Director, we found an ideal replacement in Bill
Putnam who brought to us many years of successful
experience in personnel management, most re-
cently at the Celanese Corporation.
We were also greatly pleased to appoint Susan
Schultz as Grants Manager. Susan had previously
served for two years as Grants Assistant and her
great helpfulness and most pleasing personality are
well-known to the staff.
+ +
Two festive occasions, which were orchestrated by
David Micklos, highlighted our otherwise too in-
tensive summer of 1983. In June, the lawn at Air-
slie, under the direction of Elizabeth Watson, was
bedecked in splendor for an Appreciation Dinner at
which over 200 friends and neighbors honored the
combined forty years of service to the Laboratory
by Walter Hines Page and Edward Pulling. For
twenty-five years Mr. Page has served on the Boards
of the Long Island Biological Association and of
the Laboratory, mostly as President or Chairman.
Mr. Pulling has for the past fifteen years been
Chairman of the Long Island Biological Associa-
tion and a member of the Board of Trustees of the
Laboratory.
Edward Pulling
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Margaret M. Heckler, Secretary of Health and Human Services
In September, the Laboratory joined the Ameri-
can Cancer Society in a tribute to Mary Lasker for
her contribution to the advancement of scientific
research on the causes and cure of cancer. In con-
junction with a Laboratory conference on "The
Cancer Cell," which was dedicated to Mrs. Lasker,
a dinner was held in her honor at the Piping Rock
Club. Speakers included Secretary of Health and
Human Services, the Honorable Margaret Heckler;
Director of the National Institutes of Health, Vin-
cent DeVita, Jr.; President of the American Cancer
Society, Lane Adams; and Chairman of the Na-
tional Advisory Cancer Council, Benno Schmidt.
J. Michael Bishop was Master of Ceremonies and
Jim Watson welcomed the guests. Unfortunately,
an untimely illness prevented Mrs. Lasker's attend-
ance, but the speeches, so laudatory to her activi-
ties, were recorded and presented to her.
William R. Udry
Walter H. Page
INFORMATION SERVICES
The Information Services Department was created
in 1983 to perform three major functions: (1) public
relations, (2) fundraising for special projects, and
(3) media relations.
In the broadest sense, the department seeks to ex-
plain the Laboratory to various interest groups. To-
ward this end, two publications were initiated in
1983. A multipurpose brochure, "Cold Spring Har-
bor Laboratory: At the Horizon of Molecular Biol-
ogy," explains the history and current research ef-
forts of the Laboratory in language understandable
to educated laymen. "Harbor Transcript" is a quar-
terly internal newsletter designed to keep employ-
ees up-to-date on current events at the Laboratory.
During the year, the department coordinated sev-
eral special events held in conjunction with the
Long Island Biological Association (LIBA). Also,
an educational outreach program was begun to pro-
vide tours and presentations for school and civic
groups.
The department coordinated successful efforts to
find funding for the Undergraduate Research
Training Program and the Neurobiology Training
Program. A major grant was also secured from the
Rippel Foundation to help purchase equipment for
the Monoclonal Antibody Extension to James Lab-
oratory.
A long-standing objective to formalize and
strengthen the Laboratory's relationships with
companies that have expertise in genetic engineer-
ing/biotechnology was also realized. In 1983, fif-
teen companies were recruited as charter members
of the 1984 Corporate Sponsor Program- Agrige-
netics Corporation; Biogen, Inc.; CPC Interna-
tional, Inc.; E.I. du Pont de Nemours & Company;
Genentech, Inc.; Genetics Institute; Hoffman-La
Roche, Inc.; Johnson & Johnson; Eli Lilly & Com-
pany; Molecular Genetics, Inc.; Monsanto Com-
pany; Pall Corporation; Pfizer, Inc.; Schering Cor-
poration; and Upjohn Company.
Throughout the year, an effort was made to keep
media outlets apprised of the activities of the Lab-
oratory. The department acted as liaison to sched-
ule interviews and filming sessions with print and
broadcast journalists. A press conference held the
day of the announcement of the Nobel prize to Bar-
bara McClintock was attended by media represen-
tatives from around the world.
TWELVE YEARS OF LIBRARY SERVICE
The 1972 Annual Report states that the Laborato-
ry's library collection numbered almost 25,000 vol-
umes. Interestingly enough, at the end of 1983 our
collection numbered only 25,895. In 1973, approx-
imately 360 journal titles comprising 10,800 bound
volumes were placed on permanent loan with The
State University of New York at Stony Brook.
Placements such as this, and a program of contin-
uous weeding, account for the relative stability in
total volume count. This is the only library statistic
that has not significantly increased in the past 12
years.
In the areas of patron services and collection de-
velopment, the story is quite different. In these 12
years there has been a 75 % increase in journal sub-
scriptions; the addition of two branch libraries, one
for Neurobiology, the other for the Banbury Cen-
ter; the processing of 2100 bound books and jour-
nals per year; and the addition of several computer-
based systems for business application and for ac-
cess to highly sophisticated scientific information
networks. All of this has contributed to the 161 %
increase in materials being received.
Patron services, including manual and comput-
erized scientific searches, ready reference, interli-
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David Micklos
brary loan, circulation, archives, and photocopy-
ing, have increased an overall 246 % to meet the
needs of the 183 % increase in the Laboratory's
staff.
In 1972, a staff of two provided access to a stand-
ard card catalog of books, 261 subscriptions, and
ten tedious manual searches from two complicated
scientific sources for 56 scientists. Today, 5.5 staff
members provide services that range from highly
technical on-line literature searches using over 170
databases covering all disciplines, through citation
verification for grant applications and our Publi-
cations Department, to the acquisition of obscure
historical materials for 165 scientists.
These sizeable increases in the numbers of pa-
trons, materials, and personnel make space the ma-
jor priority of the library's long-range planning. It
is essential to look at both renovation of the present
facility and off-grounds storage to provide ade-
quate reader facilities. We look with pleasure to the
completion in 1985 of the new auditorium which
will allow our present tenants, the computer center,
Information Services, and audio-visual services, a
place of their own.
Susan Gensel
PUBLICATIONS
In 1983 I began my 11th year at the Laboratory and
it was an exciting year indeed. Most exciting was
the move of the Publications offices to Urey cot-
tage, which was completely renovated and enlarged
to meet the needs of the editorial, production, and
order fulfillment functions. In 1983 we also saw our
all-time best-seller, Molecular Cloning, reach cu-
mulative sales of more than 22,500 copies. This was
not an unmixed blessing, however, since the unex-
pected continuing strong demand for this title ne-
cessitated three rapid reprintings during the year.
Net sales of all publications for 1983 were almost
$1,600,000 (with more than 35,000 units sold),
giving us a year second only to 1982 when Molec-
ular Cloning was first released. Among the titles
published in 1983 were: a two-book set on Struc-
tures of DNA as volume 47 of the Symposia; Te-
ratocarcinoma Stem Cells, volume 10 in the series
Cold Spring Harbor Conferences on Cell Prolif-
eration; three monographs -Nucleases, Molecular
Biology of the Yeast Saccharomyces: Metabolism
and Gene Expression, and Lambda II; a collection
of reprint articles entitled Readings in Tumor Virol-
ogy; Muscle Development; and Genetic Maps vol-
ume 2. The Publications Department was also re-
sponsible for the production of two Strain Kits to
accompany the lab manuals Experiments in Molec-
well as the Annual Report and ten different Ab-
stract booklets for the Meetings Program.
Although scheduled to appear in 1983, volume 48
of the Symposia, Molecular Neurobiology, did not
make its appearance until early 1984, due to delays
at the printers. When published, however, it marked
a radical departure in policy, since it appeared si-
multaneously both in paperback and in its tradi-
tional cloth binding. It is still too early to tell
whether our aim of increasing unit sales of the
Symposia to their previously higher levels will be
achieved by offering the volume in the lower-priced
paperback format.
We also began a new series in 1983, Current
Communications in Molecular Biology. This se-
ries, composed of paperback editions of extended
abstracts, makes possible the rapid dissemination
of information exchanged at small meetings fo-
cused on rapidly expanding areas of research. The
first two titles in the series, Plant Infectious Agents
and Enhancers and Eukaryotic Gene Expression,
appeared less than five months after their respec-
tive meetings.
Work begun almost two years ago to establish
codes and procedures to enable direct photocom-
position from our on-grounds computer also yielded
results in 1983 with the publication of Nucleases
and both volumes of our Current Communications
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series. Results to date indicate that savings of
30 -40% on initial composition costs can be at-
tained by keying and coding manuscripts on our
own system. Now with the space available in Urey,
we intend to expand our capabilities in this direc-
tion.
The Urey facility has also made it possible to
provide individual offices for the editors, which has
resulted in a level of efficiency not previously pos-
sible when they shared a communal office. The new
building has allowed computerization not only of
our own typesetting, but also of word processing
and financial and scheduling management, as
planned for implementation in 1984, and the estab-
lishment of a true production group.
With the number of new titles steadily increas-
ing, the importance of our Marketing Department,
headed by Susan Gensel, becomes increasingly ev-
ident. In 1983, the Marketing Department achieved
high visibility for our publications by exhibiting our
titles at five major scientific conferences. They also
prepared eight direct mailings (consisting of some
16 flyers) that reached a total of 306,500 scientists,
libraries, and universities.
Additional exposure is achieved through our on-
grounds bookstore, operated by the Marketing De-
partment. In 1983, bookstore sales amounted to
$84,836 with 2994 books sold. Through both the
bookstore and attendance at conferences, we are
able to gather important information from our cus-
tomers so that we can better serve their needs.
An aggressive program to increase our foreign
sales resulted in 1983 in overseas sales constituting
32 % of our net sales, a 42 % increase over our 19 %
in foreign sales in 1979.
To provide better service to our expanding for-
eign market and our individual customers, Char-
laine Apsel, our Fulfillment Manager, instituted in
1982 services which address their special needs.
The first allows foreign customers to opt for a ship-
ping service which provides 2-4-week airmail de-
livery overseas at less than standard airmail costs.
The second provides our individual customers with
the convenience of having their orders billed to any
of three major credit cards.
Both of these services have greatly increased the
number of shipments made from the Laboratory,
the end result being a 42 % increase in direct ship-
ments in 1983 over 1982. This has sorely strained
our on-grounds storage capacity, and the acquisi-
tion of sufficient local warehousing is just one of
our goals for 1984.
Nancy Ford
RESEARCH
Barbara McClintock
Nobel Prize in Medicine, 1983
MAMMALIAN CELLS
STRUCTURAL STUDIES
This past year of research on the structural and
functional organization of cells focused on molec-
ular details and on integration of cell biological and
biochemical approaches. As we delve deeper into
the individual components responsible for cell ar-
chitecture, we find that we have to return at some
point to the whole cell in order to understand more
fully the functional significance of a given molec-
ular component. More and more, as proteins are
identified as interesting spots on two-dimensional
gels, purified by some appropriate method, used to
elicit antibodies in rabbits and mice, and obtained
in the form of molecular DNA clones, the conver-
sation and ideas turn to attempts to study the pro-
tein as an active part of the living cell. Thus, we
have pressed to advance our capabilities in the mi-
croinjection techniques and the subsequent "micro"
cell biological assays that need to be done follow-
ing injections. These types of experiments, which
bring together virtually all of the various individu-
als working here in the field of cell structure, will
most likely continue to be an important tool for the
foreseeable future.
The QUEST System for Two-
dimensional Gel Analysis
J.I. Garrels
The QUEST software package for two-dimensional
gel analysis has been further developed for the
PDP-11/60 computer by the addition of several new
matching programs. Matching of patterns contain-
ing up to 1500 spots is now completely automatic,
and very little manual editing or checking of the
matched patterns is required.
A typical experiment will generate about 40 gels,
representing ten samples run on four different types
of two-dimensional gels (differing in pH ranges and
slab-gel concentrations). Each gel is exposed to
film three times (on the average) to detect the full
range of spot intensities. Each film pattern is
scanned into the computer, and spot detection and
integration take place automatically. To match the
group of ten gels of a given pH range and acrylam-
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ide concentration to their respective standard, the
following protocol is now used.
One of the darkest films is selected as a model
for the experiment. The model is matched carefully
to the standard pattern. (The standard is the collec-
tion of all spots detected so far on this type of gel.
The broad pH range, 10 % standard currently con-
tains over 2600 spots.) The match of the model to
the standard is done by automatic procedures sim-
ilar to those described below, and the accuracy of
this match is carefully checked by interactive
graphics. Next, each of the other dark films is
matched first to the model and then to the standard,
by completely automatic procedures.
Three automatic steps are involved in the match
of a typical film to a standard. The first step is the
selection of landmark matches between the film and
the model. (Until recently, this was done manually.)
The second step is the automatic match of the film
to the model. The automatic matching process be-
gins at the landmark spots and uses spot-neighbor
relationships to match the rest of the pattern. Be-
cause the spots of the model have standard spot
numbers (through its match to the standard), the
spots of each film can also be assigned standard
spot numbers as they are matched to the model. In
the third step of automatic matching, each spot hav-
ing a standard spot number becomes a landmark to
initiate a complete match to the standard. In this
match, any spots on the film that were not present
in the model have a chance to be assigned a stand-
ard spot number by direct match to the standard.
Matching the spots of a film to those of a previous
matched (model) film from the same experiment is
much more accurate than matching directly to the
standard. Patterns from the same experiment are
usually quite similar, whereas the standard pattern
is a much more complicated distribution of spots
derived from many experiments.
When all the dark films have been matched by the
above procedure, a cross-matching program is run
to improve the match quality further. Each film of
the group is automatically matched to each other
film of the group (using spots with identical stand-
ard spot numbers as landmarks), and the results are
checked for internal consistency. If, during the
above matching procedures, any spots have failed
to match or have been matched incorrectly due to
gel distortion, the error will usually be corrected
by the cross-match. Discrepancies that cannot be
conclusively resolved by the automatic program are
flagged for operator inspection. Usually fewer than
10 out of 1000 spots are flagged, and not all of these
are actually in error.
After the darkest films have been matched, the
next lightest exposure of each film is matched au-
tomatically. This group does not use one model
film; instead, the darker exposure of each gel serves
as the model for the lighter exposure. The same au-
tomatic procedure, followed by a cross-match, is
used to complete the match of the lighter films. The
very lightest films (used to quantitate actins, tubu-
lins, and a handful of other major proteins) usually
require manual intervention because there are too
few spots for the operation of the automatic pro-
grams.
This procedure is sufficiently accurate that we no
longer need to routinely check and edit each of the
matches. However, all FILMSPOTS (spot descrip-
tion) files and MATCHLIST (match status) files are
preserved so that a graphic display of the match of
any film to another film or to a standard can be
obtained at any future time. Manual editing, or fur-
ther automatic cross-matching, can be used to im-
prove the matches further at a later date, taking into
account new spots that may have been added to the
standard in the meantime.
Rat Protein Data Base
J.I. Garrels, B.R. Franza, Jr.
The gel-analysis software runs around the clock,
processing data from our large backlog of experi-
ments. Quantitative data from each film are
matched to standard patterns, as described in the
preceding report, and the standardized data are en-
tered into the rat protein data base. Part of our data
base consists of background information necessary
for the interpretation of other studies, and part of
it is composed of data from experiments of great
immediate interest. The background part of the data
base that has already been established includes data
from five clones of REF52 cells, data from six
SV40 transformants of REF52 cells selected by fo-
cus formation in monolayer culture, data from
REF52 cells labeled for differing lengths of time,
and data from a large experiment in which normal
REF52 cells and nine virus-transformed REF52 de-
rivatives were each labeled at five time points dur-
ing their growth to confluence. The latter ex-
periment includes data from two of the SV40
transformants selected by focus formation, two
SV40 transformants further selected for growth in
soft agar, and two SV40 transformants yet further
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selected for tumor formation followed by return to
culture. All SV40 transformants were isolated by
McClure et al. (Cold Spring Harbor Conf. Cell
Proliferation 9: 345 [19821). The other lines stud-
ied include a Kirsten murine sarcoma virus (Ki-
MSV) transformant of REF52 (from B. Ozanne,
University of Texas Health Science Center, Dallas)
and two adenovirus-5 (Ad5) transformants of
REF52 (from J. Logan and T. Shenk, SUNY, Stony
Brook). For a typical sample, approximately 1500
proteins are quantitated, matched, and entered into
the data base.
A few general conclusions can be made from the
baseline data already in the system. In independent
clones of REF52 cells, approximately 6% of the
proteins differ in intensity by more than twofold,
compared to approximately 4% when duplicate
samples of the same clone are analyzed. REF52
cells do not change their protein composition rap-
idly during logarithmic growth; samples labeled 1
day apart are as similar as duplicate samples la-
beled on the same day. However, when confluent
cells are compared with rapidly proliferating cells,
approximately 15 % of the proteins are found to dif-
fer by more than twofold in rate of synthesis.
In comparisons of normal and virus-transformed
REF52 cells, we found that the series of focus-se-
lected SV40 transformants are highly reproducible.
The same proteins are altered in each line relative
to the control, although there are differences in the
degree of alteration. Comparison of a typical SV40-
transformed line with normal REF52 cells reveals
that about 20% of the proteins have been altered by
twofold or more, but comparison of SV40-trans-
formed lines with one another reveals that 5-8% of
proteins differ by twofold or more. When the pro-
teins altered due to transformation were compared
with the proteins that differ in proliferating versus
confluent cells, no overall correlation was found.
This statistical comparison does not exclude some
proteins that are induced both in proliferating cells
and in transformed cells, but it does show that a
transformed cell is not just a normal cell held in a
highly proliferative state.
The adenovirus-transformed lines are altered to
a much greater extent relative to REF52 than are
the SV40-transformed lines. More than 30% of the
total proteins are altered by more than twofold in
each of our two adenovirus-transformed lines. In-
terestingly, many of the same proteins are affected
by SV40 and by adenovirus, but the magnitude of
the alteration is greater for adenovirus transforma-
tion.
One of our recent interests has been the proteins
that respond to serum stimulation in normal and
transformed cells. Normal, SV40-transformed, and
Ad5-transformed REF52 cells were held in low
serum until proliferation had stopped (in REF52)
or slowed significantly (in the transformants). Cells
were labeled at several times after the addition of
fresh serum. Data for about 1000 spots have been
quantitated and entered into the data base. Both
early and delayed responses to refeeding have been
identified. One of the most interesting delayed re-
sponses is the protein PCNA (proliferating cell nu-
clear antigen), or cyclin. This protein is identified
on a section of the standard map in Figure 1. Each
of the graphic inserts plots the relative intensities
of PCNA for each sample in one of the experiments
from the data base. (Users of the graphics worksta-
tion can obtain such graphs for every experiment
analyzed and for every spot on the standard map.)
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Figure 1
Display of data-base information for the protein PCNA. A re-
gion of the standard rat-protein map was displayed on the
graphics monitor, and the PCNA spot was selected (at white
cross-hair). Four experiments from the data base were selected
(experiment numbers are at the top of each graph), and the re-
sults for the PCNA spot from each experiment were plotted on
the screen. Each graph shows the relative intensity of the spot
for each of the samples generated in the experiment, normal-
ized so that the highest intensity is at full scale. (Quantitative
data, expressed as spot dpm divided by total incorporated dpm,
are simultaneously displayed on another terminal.) In experi-
ment 435, each sample (A-C) represents a different clone of
normal REF52 cells. In experiment 433, the samples were la-
beled with [35S]methionine for 30 min (A), 2 hr (B), 24 hr (C),
24 hr followed by 2-hr chase (D), and 24 hr followed by 48-hr
chase (E). In experiment 532, normal and transformed REF52
cells were labeled in log phase growth for 2 hr. The samples
are normal REF52 cells (A), focus-selected SV40 transform-
ants (B,E), agar-selected SV40 transformants (C,F), tumor-se-
lected SV40 transformants (D,G), Ki-MSV transformant (H),
and Ad5 transformants (IA. The latter Ad5 transformant does
not produce the E1B 57K viral protein. In experiment 663, nor-
mal REF52 cells (A-C), focus-selected SV40-transformed cells
(D-F), and Ad5-transformed cells (G-I) were deprived of serum
for 60 hr, followed by addition of fresh serum. Samples A, D,
and G represent the serum-deprived cells; samples B, E, and H
represent cells labeled 1 hr after refeeding; and samples C, F,
and / represent cells labeled 21 hr after refeeding. All labelings
were done for 3 hr. Note that the user of the graphics worksta-
tion can obtain such graphs for any experiment in the data base
and for any spot on the standard map. Equipment for recording
the graphic data on instant Polaroid prints and slides is now
available.
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Experiment 663 (Fig. 1, fourth graph) shows the
response of normal cells at 0, 1, and 21 hours after
refeeding (samples A-C), of SV40-transformed
cells at the same time points (samples D-F), and of
Ad5-transformed cells at the same time points
(samples G-I). Other experiments (not shown) con-
firm that PCNA synthesis in normal REF52 cells is
stimulated between 8 and 16 hours after refeeding.
Each of the transformants maintains an elevated
level of PCNA synthesis even during serum depri-
vation, and this level is not further induced by
serum stimulation. The relative levels of PCNA in
this experiment are consistent with the levels found
in experiment 532, in which normal REF52 and the
nine transformed lines were compared (for further
details, see Fig. 1).
Proteins of L6 skeletal-muscle cells have been
analyzed throughout the period of differentiation in
culture. L6 cells labeled for long and short periods
of time have been analyzed to measure turnover
rates, and phosphoprotein patterns have been ob-
tained. A group of proteins, identified as actin-fil-
ament-binding proteins by the monoclonal anti-
body studies of F. Matsumura, S. Yamashiro-
Matsumura, and J. Lin (this section), was found to
be induced during muscle differentiation. Each of
these becomes fully phosphorylated over a period
of 4 hours after synthesis.
Future entries into the rat protein data base will
consist of many more transformed lines, especially
lines or REF52 cells transformed by introduction
of cloned oncogenes (see report by B.R. Franza,
Oncogene Section). New oncogene protein prod-
ucts are being identified as monoclonal antibodies
become available, and the expression and modifi-
cation of each of these proteins will be examined
for each of the transformed lines. Studies of other
cell types, including muscle cells, NRK cells, pri-
mary rat kidney cells (in collaboration with H.E.
Ruley, Tumor Virus Section), and PC12 pheo-
chromocytoma cells (in collaboration with W.
Huse) are extending the data base to more types of
rat cells. We hope in the future to expand the ca-
pacity of our computer facility and to make more
graphic workstations available so that more users
can interact with the protein data bases.
Microfilaments in Normal and
Transformed Cells: Changes in the
Multiple Forms of Tropomyosin
F. Matsumura, J.J.-C. Lin,
S. Yamashiro-Matsumura
As described in last year's annual report, we have
found changes in tropomyosin patterns of microfil-
aments between normal and virus-transformed rat
cultured cells. To examine whether these changes
in tropomyosin patterns are a common phenome-
non with transformation, we have extended similar
studies to human and mouse cells with different
types of transformation. These cells included NIH-
3T3 cells transformed by transfection with tumor
DNA, BALB/c-3T3 cells transformed with chemi-
cal carcinogen or by UV-irradiation, human fibro-
blasts transformed with chemical carcinogen, and
naturally occurring tumor cells from human. Like
the viral transformation of rat cultured cells, we
have found that the level of one or two of the major
tropomyosin forms with a higher molecular weight
is decreased or missing, and the level of one of the
tropomyosin forms with a lower molecular weight
is increased in all types of transformed cells so far
examined. Because the changes in tropomyosin
patterns are well correlated with morphological
transformation, we suggest that differential expres-
sion of tropomyosin forms in microfilaments may
be responsible for the rearrangement of actin ca-
bles in transformed cells.
Molecular Analysis of Microtubule
Components in Normal and
Transformed Cells
S.H. Blose, G. Blose, F. Matsumura
Two important properties of cancer cells are their
ability to grow by cell division and to move in the
invasion of tissue. The microtubule system of the
cytoskeleton is intimately involved in both proper-
ties: (1) It sets up the mitotic spindle apparatus re-
sponsible for the movement of chromosomes into
daughter cells as part of cell growth; (2) microtu-
bule depolymerization has been shown to regulate
the initiation of cellular DNA synthesis; and (3) the
polarity of the system indicates the direction of
movement a cell is taking. Several studies in the
late 1970s investigated the tubulin content (the ma-
jor constituent protein of microtubules) of normal
and transformed cells and found virtually no differ-
ence in the total chemical amount between both
types of cells. However, several studies proposed
that the pool of disassembled tubulin was increased
in transformed cells. The regulation of microtubule
assembly has been attributed in part to the micro-
tubule-associated proteins, MAP-1 (M, = 330,000)
and MAP-2 (M, = 300,000), and a MAP called tau
(four proteins with M, between 50,000 and 68,000).
In addition to these, several new MAPs of cultured
cells with unknown function have been described.
Therefore, the expression, modification, and be-
havior of the MAPs may regulate the microtubule
assembly dynamics that are ultimately linked to
growth and movement. We initiated pilot studies to
isolate the intact microtubule complex from normal
and transformed cells to determine whether any
molecular component of the microtubules such as
the MAPs was altered. We felt that this might lead
to an understanding of what controls the assembly
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and reorganization of the microtubules in response
to transformation.
We have modified a method adapted from Mat-
sumura et al. (J. Biol. Chem. 285: 6636 [19831) in
which a mouse monoclonal IgM antibody that binds
both a- and 13-tubulin subunits, SBMAP-D3 (here
called D3), was used to harvest cellular microtu-
bules. This was selected over the classic method of
purification by reversible temperature-dependent
assembly of microtubules because the concentra-
tion of tubulin in cultured cells was low and micro-
tubules are very labile. After several experiments,
we determined optimal conditions to stabilize cy-
toplasmic microtubules: We found that brief expo-
sure of the cell lysate to the plant antitumor drug
taxol was necessary. Taxol, a drug that stabilizes
microtubules in cells, used in combination with D3
antibody allowed us to remove intact microtubules
from the cytoplasm for subsequent analysis without
prior disassembly.
When a lysate is obtained by gentle disruption of
the cells followed by low-speed spin (12,500g for
15 min) to remove nuclei, large membrane frag-
ments, and insoluble 10-nm filaments, the dis-
persed assembled microtubules will not sediment.
To this supernatant (total protein concentration of
6-8 mg/ml) was added 0.3 volume of D3 mono-
clonal antibody ( -- 7 mg /ml), and the mixture was
incubated 30-45 minutes at 37°C to allow D3 to
aggregate the microtubules. The mixture was spun
at 12,500g for 7 minutes, and the pellet was then
washed three times with Buffer B. The final pellet
was then analyzed by negative-stain electron mi-
croscopy and one- and two-dimensional SDS gel
electrophoresis. Electron microscopy confirmed
that the isolated microtubules were in their native-
assembled state aggregated and decorated with the
antibody (Fig. 2) versus a denatured precipitated
aggregate. The major constituent proteins con-
sisted of a- and 0-tubulin plus several other asso-
ciated proteins (Figs. 3 and 4). Autoradiographs
were made from dried Coomassie-blue-stained two-
dimensional gels, and the a- and 0-tubulin
spots were cut out of gels obtained from the total
lysate and the antibody precipitate. We found that
this method enables us to recover 60-70% of the
cell's tubulin within 2-3 hours from modest num-
bers of cells (as compared with conventional
cycling methods, which recover - 10% in a longer
time from many liters of cells). One of the proteins
that coisolates with the microtubules was the M,
73,000 heat-shock protein (hsp73) (Fig. 4, spot 1).
Approximately 10% of the cell's hsp73 was re-
covered associated with the microtubules. This
protein has been postulated to associate with 10-nm
filaments and/or microtubules, and we propose to
determine whether it is a cross-linking protein. By
counting the radioactive spots, we can quantitate the
amount of putative MAPs that are removed from
the total cell protein. We will use this information
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Figure 2
Electron micrograph of D3-antibody-induced microtubule aggregate from NRK-1570 cells negatively stained with 2%
aqueous uranyl acetate. Arrowheads indicate positions of the antibody (IgM) decorating the microtubules (MT) with a
periodicity of -24 nm. The antibody cross-linked (X) adjacent microtubules.
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Figure 3
One-dimensional SDS gel (11.5% acrylamide; 0.1% bis-acrylamide) stained with Coomassie blue (STAIN),
dried, and exposed as an autoradiogram for 15.5 hr at 20°C. NRK-49F (NRK-1570) cells were grown to
near confluence in three 24.5-cm2 dishes, and cells at the same density in one 100-mm-diameter dish were
metabolically labeled with [35S]methionine (750 ACi [35S]methionine, 16 hr, in 2.5% calf serum and media
lacking methionine). All cells were then combined and processed for rapid isolation of microtubules as
described. (Lane 1) Total cell homogenate. (Lane 2) First pellet (Pt) obtained from the 12,500g spin for
15 min. P, contains the 10-nm filaments (vimentin), the nuclei, and other large sedimentable particles.
(Lane 3) First supernatant (S,) from the low-speed spin. (Lane 4) Material that sediments (12,500g, for
15 min) after the S, is incubated for 30 min at 37°C. Microtubules do not pellet at this stage. (Lane 5)
Supernatant (S1-S) obtained after incubation of SI at 37°C and centrifugation. To S1-S was added the
monoclonal antibody D3 (anti-a/13 tubulin); the mixture was incubated for 40 min at 37°C to aggregate
the microtubules and then centrifuged at 12,500g for 7 min to sediment the antibody-induced aggregated
microtubules (P2) from the supernatant (S2). (Lane 6) P2 after being washed three times each in 5-10
volumes of buffer by suspension and sedimentation. In the stained gel, the heavy (H) and light (L) chains
of D3 (IgM) antibody are seen, as well as a-tubulin (a) and 13-tubulin (b) of the harvested microtubules.
In the corresponding autoradiograph, both tubulin subunits are heavily labeled with [35S]methionine. The
displacement of radioactive peptides occurred due to the unlabeled heavy (H) and light (L) chains. This
P2 is analyzed in lane 6. (Lane 7) Pooled supernatants obtained from the three washes of P2. They contain
very little tubulin. (Lane 8) S2 does not have any remaining antibody. All of the antibody is found in the
P2. (Lanes 9-11) Control in which buffer is substituted for antibody. (Lane 9) Control P2 showing only
trace amounts of the tubulin subunits. (Lane 10) Pooled wash supernatants of the control P2. (Lane II) S2
from the control. (Lanes 1-5, 7, 8, 10, 11) Isovolumetric loads relative to the total homogenate (10 81 per
lane); (lanes 6,9) P2s were suspended in 50 Al of sample buffer, and 10 Al was loaded per lane. Lane S
contains the M, standards expressed as M, x 10-3; actin (M, = 45,000), a-tubulin (M, = 57,000), and (-
tubulin (M, = 54,000) are included as standards.
19
NRK-1569
_1
23
1`31, 1I I4
NRK-1570
2 3 -.1
6o-
410.-
-08
-49
fir- 11,21314
Figure 4
Autoradiographs of two-dimensional gels of D3-antibody-har-
vested microtubules obtained from KNRK cells (NRK-1569) and
NRK-49F cells (NRK-1570) metabolically labeled with
[35S]methionine. Alpha and beta indicate the positions of the
tubulin subunits. Proteins numbered 1-14 (arrowheads) were
found in association with the microtubule complexes. In the
KNRK complex, proteins 1 and 4 were found to be increased;
2, 3, and 5-11 were decreased; and 12-14 were absent when
compared with NRK-49F. Protein 4 was not detected in NRK-
49F. Act indicates the position of actin. Protein 1 is identified
as the heat-shock protein hsp73, and proteins 2 and 3 appear to
be related to mitochondrial protein 24 of Bravo et al. (Cell Biol.
Int. Rep. 5: 93 [1981]). The differences in spot intensities ap-
pear to be related to the cell phenotype and growth character-
istics: NRK-49F cells grow slowly and are flat; KNRK cells
are very round and rapidly proliferate.
as a guide to establish what is an associated protein
versus a contaminant derived from coprecipitation.
For instance, in Figure 4, actin (Act) was found with
the microtubule complexes. Although it is thought
that actin may bind to MAPs such as MAP-1, it is
thought not to be a MAP. The spot was counted and
found to represent approximately 0.26% of the cell's
total actin, indicating a possible contaminant. When
microtubule complexes were compared between
normal NRK (1570) cells and NRK (1569) cells
transformed by Kirsten sarcoma virus, several dif-
ferences in associated proteins were observed. Spot
1, the M, 73,000 heat-shock protein (hsp73), was
elevated in the transformed cells (NRK-1569), and
spot 4 was only observed in the transformant. The
normal cells exhibited several proteins (spots 5-14)
a
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that were expressed in very low amounts in the
transformed cells. We are currently evaluating the
relationship of these proteins to microtubule stabil-
ity and proteins associated with the mitotic spindle.
Purification and Characterization of
Multiple Forms of Tropomyosin in
Normal and Transformed Rat
Cultured Cells
S. Yamashiro-Matsumura, F. Matsumura
Rat cultured cells have five forms of tropomyosin -
TM-1 (M, = 40,000), TM-2 (M, = 36,500), TM-3
(M, = 35,000), TM-4 (M, = 32,400), and TM-5
(M, = 32,000). Of these, three (TM-1, TM-2, and
TM-4) are major tropomyosins (normal-cell tro-
pomyosin) in normal cells, and two (TM-3 and TM-
5) are major tropomyosins (transformed-cell tro-
pomyosin) in transformed cells. We have purified
and partially separated normal- and transformed-
cell tropomyosins to examine whether these multi-
ple forms of tropomyosin play different roles in the
organization of microfilaments between normal and
transformed cells.
By hydroxyapatite column chromatography, a
mixture of multiple forms of tropomyosin was sep-
arated into four fractions, i.e., pure TM-4, pure
TM-5, a mixture of TM-3 and TM-1, and a mixture
of TM-2 and TM-1. Using these fractions, we have
examined some biochemical properties. Like mus-
cle tropomyosin, TM-1, TM-2, and TM-3 had
higher apparent molecular weights on SDS gels and
showed a higher actin affinity ( 105) than that
( 104) of TM-4 and TM-5 with lower molecular
weights. Moreover, polyclonal rabbit antiserum
against smooth-muscle tropomyosin also showed
much higher affinity to high-molecular-weight tro-
pomyosins (TM-1, TM-2, and TM-3) than to low-
molecular-weight tropomyosins (TM-4 and TM-5).
These results suggest that high-molecular-weight
tropomyosins may be similar to muscle tropomyo-
sins. We have also examined whether these five
forms of tropomyosin are homo- or heterodimers.
Although TM-3 did not make an S-S dimer with the
oxidization of cysteine residues, all of the other
forms of tropomyosin were found to form homodi-
mers. Because the formation of homodimers ap-
pears to be more than 90% in each form of tropo-
myosin, it is likely that all five forms of troponi-
yosin are present as homodimers.
Amino acid compositions of these five forms of
tropomyosin were examined. Normal-cell tropomy-
osins (TM-1, TM-2, and TM-4) showed composi-
tions very similar to those of muscle tropomyosins.
Interestingly, however, the amino acid composi-
tions of transformed-cell tropomyosins (TM-3 and
TM-5) are considerably different, although their
amino acid compositions are very similar to each
other. The contents of glutamic acid, lysin, argi-
nine, and leucine residues in transformed-cell tro-
pomyosin were two times less than those in normal-
cell tropomyosin, whereas the contents of serine,
glycine, and phenylalanine in transformed-cell tro-
pomyosin were increased 2-3 times. In spite of
these differences in amino acid compositions, both
normal- and transformed-cell tropomyosins are
recognized with either monoclonal or polyclonal
antibody against tropomyosin, suggesting that these
two types of tropomyosins share a stretch of ho-
mologous sequence.
Tropomyosin Isoforms in Normal and
RSV-transformed CEF Cells
J.J.-C. Lin
We have identified seven polypeptides in chicken
embryo fibroblasts (CEF) as tropomyosins (Lin
et al., J. Cell Biol. 98: 116 [1984]). Of these, spots
1 (M, = 38,000), 2 (M, = 36,500), 3a (M, =
32,800), and 3b (M, = 32,800) were major forms,
whereas spots a (M, = 45,000), b (M, = 43,000),
and c (M, = 38,000) were relatively minor. Spots
3a and 3b, as well as spots 1 and c, had a slight
difference in their pI values. All of these polypep-
tides were found to be associated with microfila-
ments. These tropomyosin isoforms have also been
purified from CEF by the combination of heat
treatment, ammonium sulfate fractionation, and
DEAE chromatography. The purified tropomy-
osins (particularly, 1, 2, and 3) showed different
binding to F-actin under conditions of 100 Mm KC1
and no Mg" . Other biochemical and biophysical
properties of these isoforms of tropomyosin are un-
der investigation.
Using the microfilament isolation method that we
developed (Lin, et al., J. Biol. Chem. 258: 6636
[1983]), we have compared the protein patterns of
the microfilaments from normal and RSV-trans-
formed CEF cells. In addition to the previous find-
ing that tropomyosins 1 and 2 were greatly reduced
in transformed cells (Hendricks and Weintraub,
Proc. Natl. Acad. Sci. 78: 5633 [1981]), we have
found that the relative amount of tropomyosin 3 was
increased. Because of the different actin-binding
properties observed for tropomyosins, the change
in tropomyosin isoform expression may be respon-
sible for the reduction of actin cables and the alter-
ation of cell shape found in transformed cells.
Purification and Characterization of
55K Actin-bundling Protein from
HeLa Cells
S. Yamashiro-Matsumura, F. Matsumura
It is believed that actin-binding proteins regulate
the organization of actin cables in cultured cells.
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However, little is known regarding how actin-bind-
ing proteins organize actin cables in cultured cells
and what role the proteins play in the disorganiza-
tion of actin cables upon cell transformation. As
the first step in addressing these questions, we have
purified some actin-binding proteins using a
method utilizing actin affinity. Briefly, muscle ac-
tin was mixed with the supernatant of HeLa cell
homogenates, and the resultant actin gel was pre-
cipitated by a low-speed centrifugation. The actin
gel was depolymerized, and proteins bound to actin
were separated on a DEAE-cellulose column. By
this simple and rapid method, we could prepare fi-
lamin and a-actinin and a yet unknown actin-bind-
ing protein with a relative molecular weight of
55,000. The 55K protein is a monomer with a na-
tive molecular weight of 55,000. It has a Stokes'
radius of 32 A and a sedimentation coefficient
(S20, of 4.35. The protein bound to actin at a stoi-
chiometry of four actin molecules to one 55K pro-
tein. The protein caused F-actin to aggregate side
by side into bundles as do other F-actin-bundling
proteins such as fimbrin (M, = 68,000) and fascin
(M, = 55,000). Although a proteolytic fragment
of fimbrin had the same molecular weight
(M, = 55,000), the 55K protein did not comigrate
with this proteolytic fragment on two-dimensional
gels. Antiserum against either fimbrin or fascin did
not cross-react with this 55K protein. It is not likely
that the 55K protein is a proteolytic fragment be-
cause the same 55K protein is found in freshly pre-
pared total cell lysates. Further characterization,
including the localization in cultured cells and the
differences between normal and transformed cells,
is in progress.
Production of Monoclonal Antibodies to
Tropomyosin Isoforms
C.-S. Chou, J.L.-C. Lin, J.J.-C. Lin
Multiple forms of tropomyosin have recently been
observed to be present in a single cell type. During
muscle differentiation, tropomyosin switched from
one isoform to another. Moreover, in many trans-
formed cells, tropomyosin isoforms with higher ap-
parent relative molecular weights tended to de-
crease or disappear, whereas another form of
tropomyosin with a lower apparent relative molec-
ular weight was increased. The intracellular local-
ization and functional properties of these tropomy-
osin isoforms are not understood. To address these
questions, we have used in vivo and in vitro im-
munization methods to generate many monoclonal
antibodies (mAbs) against specific isoforms of tro-
pomyosin from chick cells. For example, mAb CL2
reacted strongly with a striated muscle form of tro-
pomyosin, whereas no reactivity or poor reactivity
was detected for the smooth-muscle form or fibro-
blastic form, respectively, of tropomyosin. The
reactivity for the 13 form of skeletal-muscle tro-
pomyosin was threefold stronger than that for the
a form. mAb CH1 recognized both a and 6 forms
of skeletal-muscle tropomyosin equally well but did
not react with either the smooth-muscle or the fi-
broblastic form. mAb CG1, obtained from the fu-
sion with smooth-muscle tropomyosin as immuno-
gen, reacted preferentially to the a form of smooth-
muscle tropomyosin. By Western blot analysis,
CG1 also reacted with CEF tropomyosin; however,
by indirect immunofluorescence, only some popu-
lations of CEF showed staining with this antibody.
The significance of these results is currently under
investigation.
Expression of Tropomyosin in Normal
and Transformed Cells
D. Helfman, Y. Kataoka
Transformation of cells by DNA and RNA tumor
viruses has profound effects on the organization of
the cytoskeleton, including disruption of the micro-
filament organization. However, the molecular,
biochemical, and structural bases for these altera-
tions of the actin cables are poorly understood. Re-
cent studies have suggested that alterations in the
pattern of tropomyosin expression may be involved
in the rearrangement of stress fibers and that this
may be responsible for morphological alterations
seen in transformed cells (see Matsumura and co-
workers, this section). We have begun to study the
nonmuscle (rat embryonic fibroblast) forms of tro-
pomyosin and the genes that encode these proteins.
We have constructed a cDNA expression library of
approximately 100,000 members from rat embry-
onic fibroblast RNA using the plasmid expression
vectors pUC8 and pUC9. Using both an immuno-
logical screening procedure and "P-labeled
cDNAs, we have identified and isolated at least
three different classes of clones. One set of clones
has been identified by hybrid-selection translation
to contain sequences complementary to tropomy-
osin 1 (m.w. 40,000). Overlapping clones contain-
ing the entire coding region and the entire 3'-un-
translated region for tropomyosin 1 have been
identified and are being sequenced to determine the
primary structure of the protein. Northern blot
analysis reveals a transcript of approximately 1.2
kb. Furthermore, this transcript is absent in aden-
ovirus-transformed REF52 cell lines (Ad5D.1A and
Ad5D.4A). These two cell lines were previously
shown not to contain tropomyosin 1 (see Matsu-
mura and co-workers, this section). Thus, it would
appear that transcription of tropomyosin 1 is shut
off in these cells. We are continuing to isolate and
characterize other cDNAs and hope to obtain clones
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to all five forms of fibroblast tropomyosin. The
cloned cDNAs will be used to study the structure
and organization of these genes, as well as their
expression in normal and transformed cells.
Isolation of Cytoskeletal Genes
S. Hughes, J. Feramisco, D. Helfman,
N. Maihle, T. Kost, Y Kataoka, E. Kosik
The long-range goal is to develop a system in which
it is possible to study and to alter the patterns of
expression of gene families that have tissue-spe-
cific gene products (e.g., the cytoskeletal proteins).
We wish to ask questions about the functional dif-
ferences between the various gene family members
expressed in specific cell types. We are developing
retroviral vectors appropriate for use in primary
cell culture and ultimately for use in vivo. Such
vectors will be used to cause the expression of par-
ticular genes in cells (or tissues) where they are not
normally expressed. These experiments can be used
to look for subtle functional differences between
proteins encoded by the various members of a gene
family. In addition, the vectors can be used to ana-
lyze a variety of mutant genes, either naturally oc-
curring or created in vitro, and to test the functions
of recombinant genes made between different
members of particular gene families.
The chicken was chosen as the experimental ani-
mal because chick embryos are a simple and inex-
pensive source of material for the isolation of cell-
type-specific RNA and for the preparation of a
variety of different types of primary cultured cells.
In addition, Rous sarcoma virus appears to offer
significant advantages as a prototype vector for
these experiments. Our efforts have been focused
on two convergent pathways: (1) development of the
retroviral vectors and (2) development of proce-
dures for the rapid identification of genes that ex-
press low to moderate levels of RNA. These tech-
niques have made it a relatively simple procedure
to identify several cytoskeletal genes in the chicken.
Although the analysis of these genes is far from
complete (see below), a reasonable start has been
made.
We believe that sufficient progress has been made
on both projects so that the initial attempts to rein-
troduce specific cytoskeletal genes with the retro-
viral vectors will come in the next 6 months.
We initially screened genomic libraries directly
for cytoskeletal genes, and although we were able
to isolate and identify clones that encode the
chicken fi-actin gene, the protocols are inefficient.
To facilitate the rapid identification of genes, we
have developed a method for the immunological
screening of cDNA expression libraries (Helfman
et al., Proc. Natl. Acad. Sci. 80: 31 [1983]). With
these techniques, cDNA clones from rare to mod-
erately abundant mRNAs may be readily identi-
fied. To test the general utility of the procedures
we use, we have collaborated with several labora-
tories to identify particular cDNA clones. The ini-
tial experiments have been done with a cDNA li-
brary containing approximately 100,000 members
made from chick smooth-muscle mRNA. Two sets
of expression clones from the library have been
characterized by DNA sequence and hybrid selec-
tion-translation.
The first set of cDNA clones that were isolated
specify smooth-muscle tropomyosin. A full-length
cDNA clone (1100 bp) has been completely se-
quenced (Helfman et al., J. Biol. Chem. [in prep.]),
and overlapping genomic clones have been isolated
and partially mapped. Northern analysis reveals
tissue-specific transcripts. The second set of cDNA
clones specify smooth-muscle tropomyosin. A par-
tial cDNA clone has been partially sequenced, and
genomic clones have been isolated but not fully
characterized. Northern analysis reveals tissue-
specific transcripts.
Several other clones have been isolated, usually
as collaborations. These are less well character-
ized, most having only been identified as antibody-
positive clones, and they include a-actinin, 36K
protein (the major src tyrosine phosphorylation tar-
get), myosin light-chain kinase, ATPase,
70K heat-shock protein, and spectrin. To complete
the isolation and characterization of tissue-specific
genes, other cDNA expression libraries are being
prepared and screened. Either complete or in prep-
aration are the following cDNA libraries:
1. Rat fibroblast cDNA library. This library is
complete and has been screened both with DNA
probes and with antibodies to tropomyosin.
2. Chick fibroblast cDNA library. The cDNA has
been prepared, ligated to plasmid, and tested by
transformation on a small scale. The cDNA is
ready for large-scale transformation.
3. Chick striated-muscle cDNA library. The cDNA
has been prepared, ligated to plasmid, and tested
by transformation on a small scale. The cDNA
is ready for a large-scale transformation.
The chicken i3 -actin gene. The nucleotide se-
quence of the chicken 0-actin gene has been deter-
mined. The gene contains five introns: four introns
interrupt the translated region at codons 41/42, 121/
122, 267, and 327/328 and a large intron occurs in
the 5'-untranslated region. The gene has a 97-nu-
cleotide 5'-untranslated region and a 594-nucleo-
tide 3'-untranslated region. A slight heterogeneity
in the position of the poly(A)-addition site exists;
polyadenylation can occur at either of two positions
two nucleotides apart. The gene codes for an
mRNA of 1814 or 1816 nucleotides, excluding the
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poly(A) tail. In contrast to the chick skeletal-mus-
cle actin gene, the 0-actin gene lacks the cysteine
codon between the initiator ATG and the codon for
the aminoterminal amino acid of the mature pro-
tein. In the 5'-flanking DNA, 15 nucleotides down-
stream from the CCAAT sequence, there is a tract
of 25 nucleotides that is highly homologous to the
sequence found in the same region of the rat 0-actin
gene.
a- and 13- Tropomyosin cDNA clones from smooth
muscle. Two cDNA clones for a-tropomyosin
were isolated from a small (-- 10,000 members)
cDNA library prepared from smooth-muscle RNA.
Subsequently, a larger smooth-muscle library
( - 100,000 members) was rescreened for tropomyo-
sin clones with both cDNA and immunological re-
agents. In all cases the cDNA was inserted via
EcoRI and Sall linkers. The order in which the
linkers were added determines the orientation of the
insert; the cDNAs were matched to the expression
plasmids pUC8 and pUC9 such that the cDNA was
appropriately oriented for expression in Esche-
richia coli. The pUC9 portion of the library con-
tained 13 clones that could be detected with the
DNA probe, two of which reacted with anti-tropo-
myosin antisera. The pUC8 portion of the li-
brary contained 39 clones that could be detected
with cDNA and 13 clones that reacted with anti-
tropomyosin antisera. Two of the clones from the
pUC8 library reacted with antisera were not de-
tected with a-tropomyosin cDNA. These two clones
have been shown by hybrization/translation to con-
tain 0-tropomyosin cDNA.
All three clones from the pUC8 library that must
be checked by DNA sequencing have identical 3'
termini. None of these clones contain the poly(A)
tail or the sequence normally associated with poly-
adenylation. The simplest explanation is that there
is a natural Sall at the 3' end of the message for a-
tropomyosin. This would also explain why there are
relatively fewer clones in the pUC9 library and why
only a small percentage of the pUC9 clones can ex-
press a tropomyosin-related protein.
The clones that express a-tropomyosin in E. coli
contain cDNAs that encode anywhere from the car-
boxyterminal third of the gene up to the entire cod-
ing region. When lysates of the clones were ana-
lyzed on SDS-acrylamide gels, the tropomyosin-
related proteins could be seen by staining. Despite
the fact that all the proteins are made from the LacZ
promoter/AUG, there were considerable differ-
ences in the steady-state level of tropomyosin-re-
lated protein present in the lysates. These differ-
ences did not correlate with the sizes of the
fragments. Furthermore, clones that contained dif-
ferent-size cDNAs contained common carboxyter-
minal protein fragments, which are probably pro-
duced by proteolysis.
These observations suggest two things. First, a
reasonable percentage of the clones that contain an
authentic insert can be expected to produce an im-
munologically detectable protein in E. coli; sec-
ond, at least for tropomyosin, certain "domains"
exist that are reasonably stable in E. coli. Since the
cloning protocol in effect scans through the gene,
the immunological screening procedure has a di-
verse set of clones to search through for those that
produce proteins that are relatively stable in E. coli.
The smooth-muscle a-tropomyosin sequence. Two
of the cDNA clones contained the entire a-tropo-
myosin-coding region; one of these clones was
sequenced. Despite the fact that the clone clearly
selects the RNA for a-tropomyosin in hybridiza-
tion/translation experiments, the sequence is much
closer to the rabbit skeletal-muscle 13-tropomyosin
than to rabbit skeletal-muscle a-tropomyosin.
However, the a-13 designation is based on the posi-
tion of migration of SDS-polyacrylamide gels, and
since all three proteins contain 284 amino acids,
the a-a designation may be somewhat arbitrary.
What is more interesting is that the major differ-
ences between the chicken smooth-muscle a-tro-
pomyosin and the rabbit skeletal-muscle a- and /3-
tropomyosins are in the carboxyterminal portion of
the proteins. Skeletal-muscle tropomyosins interact
with troponin in vivo; nonmuscle tropomyosins ap-
parently do not. The site of interaction with tro-
ponin is in the carboxyl terminus of the skeletal-
muscle tropomyosins.
What reinforces the interpretation that these dif-
ferences have functional significance is the obser-
vation that the carboxyterminal portion of the
chicken smooth-muscle a-tropomyosin is closer in
sequence to equine platelet tropomyosin than it is
to either of the skeletal-muscle tropomyosins.
Elevation of Tubulin Levels by
Microinjection Suppresses New
Tubulin Synthesis
J.R. Feramisco [in collaboration with D. W.
Cleveland and M. F. Pittenger, Johns Hopkin,,
University School of Medicine]
Most eukaryotic cells rapidly and specifically de-
press synthesis of a- and /3-tubulin polypeptides in
response to microtubule inhibitors that cause mi-
crotubule depolymerization and presumably in-
crease the intracellular concentration of free sub-
units. Other drugs that interfere with microtubule
function but lead to a decrease in the subunit pool
size have little effect on the rate of new tubulin syn-
thesis. These findings have previously been inter-
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preted to indicate that cultured cells synthesize tub-
ulin constitutively unless the subunit pool rises
above a specified level. At this point an autoregu-
latory control mechanism is triggered that sup-
presses new tubulin synthesis through specific loss
of tubulin mRNAs. That tubulin RNA levels are
dramatically lowered by microtubule depolymeriz-
ing drugs is unquestionably correct; that fluctua-
tions in the depolymerized tubulin pool size are re-
sponsible for altered RNA levels rests, however,
entirely on the presumptive effects of different mi-
crotubule drugs. This caveat is not trivial, as these
drugs induce gross morphological alterations, and
the specificities and detailed mechanisms of action
of such drugs remain poorly understood. To inves-
tigate the effect of altered levels of tubulin subunits
on the rate of new tubulin synthesis in mammalian
cells, we have microinjected purified tubulin sub-
units into cells in culture and analyzed the synthe-
sized proteins. We have found that tubulin synthesis
is rapidly and specifically suppressed by injection
of an amount of tubulin roughly equivalent to
25-50% of the amount initially present in the cell,
thus indicating the presence of a eukaryotic, auto-
regulatory control mechanism that specifies tubu-
lin content in a cultured mammalian cell line.
Role of the Cytoskeleton in Gene
Expression Induced by Heat Shock
W.J. Welch, S.H. Blose, J.R. Feramisco
Although there has been considerable interest and
speculation concerning the function of the cytoskel-
eton in gene expression and signal transduction
into the nucleus, few direct tests of these possible
cytoskeletal functions have been made. We have
used the gene-expression changes induced by heat
shock as one model to examine the necessity (or
lack thereof) of cytoskeletal integrity for appropri-
ate gene switching to occur. As heat shock induces
the synthesis of several discrete mRNAs, which are
translated into readily identifiable protein prod-
ucts, and induces the translocation of one of the
heat-shock proteins into the nucleus and nucleoli,
several different types of effects of the heat-shock
response were tested in these studies. The drugs cy-
tochalasin D and Colcemid were used to disassem-
ble the actin microfilaments or microtubules and to
disrupt the normal, splayed intermediate-filament
structures in living fibroblasts. Combinations of the
drugs, coupled with variations in the time of treat-
ment of the cells with the drugs, allowed for the
individual disruption of the three cytoskeleton net-
works, as well as for the disruption of the three
simultaneously. The cells were subsequently heat-
shocked and analyzed for the induction of the heat-
shock proteins (in quantity, quality, and kinetics)
and for the migration of hsp72 into the nucleus. The
results of these analyses indicated that none of the
cytoskeleton systems were required for the heat-
shock response, nor for the migration of hsp72 into
its appropriate locale in the cell. These results, al-
though very much limited at the moment to the heat-
shock system, pose several interesting questions
concerning the importance of the cytoskeleton in
cellular events other than cell motility, shape, and
adhesion; we are currently examining other gene-
switching systems in this regard.
Toward the Intracellular Localization
and Function of Protein Kinase C
K. Matlack, J.R. Feramisco
The response of cells to external stimuli may some-
times involve the stimulation of intracellular pro-
tein kinases. The last several years have seen the
discovery and characterization of a new type of
widely distributed protein kinase whose properties
suggest that it may play a role in signal transduc-
tion into the cell. This kinase, called protein kinase
C and discovered and first purified by Y. Nishizuka
and co-workers (Kobe University of Medicine, Ja-
pan), is dependent on divalent calcium ion and
phospholipid and is stimulated by diacylglycerol.
Diacylglycerol is not a common constituent of eu-
karyotic membranes. It is present in them only
transiently and is the result of the breakdown of
inositol phospholipids. Inositol phospholipids are
broken down in response to external stimuli, which
can produce either short-term responses or long-
term proliferative effects in the target cells. That
this protein kinase is stimulated by a compound in-
timately involved in signal transduction suggests
that the kinase may be involved either in mediating
the early phases of the cellular response or in mod-
ulating it. The evidence for its mediation of the re-
sponse of platelets to thrombin is good. The recent
discovery of protein kinase C as a receptor for tu-
mor-promoting phorbol esters also suggests that it
may play an important role in the coordination of
cellular activity.
To date, the biochemistry of protein kinase C
leaves unclear how it may function within the cell.
The same molecular species can apparently be iso-
lated from both the particulate and soluble frac-
tions of rat brain, yet detergent is required for the
isolation from the particulate fraction. Treatment
of intact cells with tumor-promoting phorbol esters
results in an increase of the fraction associated with
the plasma membrane. In extracts, this kinase is ca-
pable of phosphorylating perhaps 30 or more pro-
teins. Highly purified protein kinase C can phos-
phorylate several purified proteins at some of the
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same sites at which they are found phosphorylated
in vivo. These proteins include vinculin, myosin
light chain, and the EGF receptor. The myosin light
chain is not known to be closely associated with
membranes.
To clarify the role of protein kinase C, and of
protein kinases in general, in regulating cellular re-
sponses, we would like to determine its distribution
in vivo and to develop a means of specifically in-
hibiting its activity in living cells. We have there-
fore purified protein kinase C and are trying to pro-
duce monoclonal antibodies that inhibit the activity
of the kinase; these will then be used for microin-
jection. By doing this, we hope to be able to impli-
cate the kinase directly in a number of cellular re-
sponses and to begin to get an idea of the part it
may play in cellular responses to external signals.
Detection of Hemopexin (a Heme-
binding Plasma (3-Glycoprotein) in the
Lysosomes of Cultured Cells Using a
Monoclonal Antibody Against
Hemopexin
G.-Y. Cai, J. Suhan, G.A. Blose, S.H. Blose
A mouse monoclonal antibody, SBV22 (IgG1), was
generated against bovine hemopexin, a heme-bind-
ing plasma glycoprotein made by the liver. Western
immunoblot (Fig. 5) analysis demonstrated that
SBV22 recognized the hemopexins found in a va-
riety of mammalian sera, including human serum.
A variety of cultured cells grown in calf serum and
then stained with SBV22 revealed intensely flu-
orescent perinuclear granules. These granules were
coincident with structures that specifically concen-
trated the supravital dye acridine orange, indicat-
ing that hemopexin was concentrated in lysosomes
(Fig. 6). Immunoelectron microscopy using SBV22
confirmed that the hemopexin was contained in the
lysosomes of the perinuclear region as well as the
peripheral cytoplasm (Fig. 7). The lysosomal ac-
cumulation of hemopexin could be enhanced by in-
cubating the cells with chloroquine, a lysosomal
trophic drug. This drug inhibited lysosomal degra-
dation of hemopexin, causing the observed hemo-
pexin accumulation in lysosomes. When the cells
were fed fetal calf serum (10% v/v), no hemopexin
staining was observed, consistent with the fact that
fetal serum has only trace amounts of hemopexin.
These results indicate that the cells in culture can
specifically ingest hemopexin from the ambient
media for lysosome-mediated degradation and is
the first demonstration that hemopexin is taken up
by nonliver cells. This might in part serve as a
source for intracellular iron. Current studies are
directed at determining whether hemopexin uptake
is facilitated by receptor-mediated endocytosis.
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Figure 5
Western immunoblots analyzing the specificity of SBV22 monoclonal antibody (IgGI), an antihemopexin.
(A) Comparison of the binding of SBV22 and a polyclonal rabbit anti-human hemopexin (RAH-Hx) (from
Calbiochem-Behring Corp.) to partially purified calf serum hemopexin (C-Hx), calf serum (C-SER), and
human serum (Hu-SER). SBV22 recognized calf hemopexin as a doublet (-M, = 60,000 and 62,000) in
the partially purified protein (C-Hx) and calf serum (C-SER) and as a single band (-M, = 63,000) in
human serum. The polyclonal anti-human hemopexin (RAH-Hx) on Western blots only detected hemo-
pexin in human serum (Hu-SER). (B) SBV22 was used to probe sera from various mammalian species.
SBV22 bound strongly to hemopexin in C-SER (M, = 60,000 and 62,000), Hu-SER (M, = 63,000), and
mouse serum (Mo-SER, M, = 54,000). It bound weakly to hemopexin in horse serum (Ho-SER,
M, = 62,800) and rabbit serum (Rb-SER, M, = 61,000). It did not detect the protein in fetal calf serum
(Fc-SER) or guinea pig serum (Gp-SER). (STD) Molecular mass standards; (35S-CELLS) [35S]methionine-
labeled cell protein for internal M, standard that is transferred to the blot (BLOT) and exposes the auto-
radiogram.
Figure 7
Immunoelectron micrograph of a BHK-21 cell stained with SBV22 followed by peroxidase-labeled goat
anti-mouse. The lysosomes (Lys) were stained intensely by the peroxidase reaction product, thus confirm-
ing at the ultrastructural level that hemopexin was in the lysosomes. Asterisks mark lysosomes in which
the centers were open, similar to the observations made at the light level by immunofluorescence. (Nu)
Nucleus; (Mit) mitochondria; (MT) microtubules; (ER) endoplasmic reticulum.
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LYSOSOME STAINING OF BHK-21 CELLS WITH SBV221A,a) AND RAH-HPXN(B,b)
Figure 6
Phase (A,B,E) and fluorescent (a,b,C,D) micrographs of BHK-21 cells used to detect the intracellular distribution of
hemopexin. BHK-21 cells grown in nutrient media supplemented with calf serum (containing hemopexin) for 3 days show
that approximately 30-40% of the cells at any one time contain hemopexin as detected by indirect immunofluorescence
using the monoclonal antibody SBV22 (a) or the rabbit polyclonal anti-hemopexin (RAH-HPXN) (b). These antibodies
intensely stained granules in the perinuclear region. The individual granules had an intensely stained outer region with a
hole in the center. Cells supravitally stained with acridine orange (C) were then stained with SBV22 (D). The antibody
staining was coincident with acridine-orange-positive granules, indicating that hemopexin is in lysosomes. (E) Phase mi-
crograph of the same cell in C and D.
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Figure 8
Phase (A ,B) and fluorescence (a ,b) micrographs of gerbil fibroma cells (A ,a) and HeLa cells (B,b) stained
with SBC1. Some nuclei were stained intensely (arrowhead, a) and others were not stained (asterisk, a).
Nucleoli were not stained (arrowhead, b) by SBC1. Fluorescent dots in the cytoplasm are the mitochondria
stained by SBC1. (Nu) Nucleus.
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Figure 9
Fluorescent micrographs of gerbil fibroma cells at various stages of mitosis stained with SBC1. (A) Early
prophase; (B) prophase; (C) prometaphase; (D) metaphase (dotted line indicates the equatorial plate); (E)
anaphase; (F) telophase. Arrowheads indicate the positions of the chromosomes.
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Monoclonal Antibody to DNA
G.-Y. Cai, J. Suhan, G.A. Blose, S.H. Blose
Immunological approaches developed recently in
several laboratories have been used to probe struc-
tural and conformational domains of DNA in vitro.
We have cloned a mouse monoclonal antibody
SBC1 (IgM) that binds DNA. When this antibody
was used to stain cultured cells by immunoflu-
orescence, three patterns were observed: (1) Only
some of the nuclei stained, (2) the mitochondria
were stained in a beaded pattern, and (3) the chro-
mosomes were intensely stained. Nuclear fluores-
cence varied from very intense to absence of stain-
ing; and in the case where the nuclei were stained,
the nucleoli were unstained (Fig. 8). The intensely
stained nuclei appeared to be related to the cell
cycle, since prophase nuclei (Fig. 9) were very in-
tensely stained, as were the chromosomes (Fig. 9).
Immunoelectron microscopy demonstrated that the
antibody stained over both euchromatin and the
heterochromatin next to the nuclear envelope (Fig.
10) but not the nucleolus. In mitotic cells, the chro-
mosomes were also stained (Fig. 11). By light im-
munofluorescence (Fig. 12) and immunoelectron
microscopy (Fig. 13), the antibody stained the mi-
tochondria in a beaded pattern. By solid-phase ra-
dioimmunoassay, the SBC1 antibody bound nick-
translated X DNA (a gift from 0. Fasano, this sec-
tion) and nick-translated p-alpha 176 DNA (a gift
from J. Maclnnes, this section). When SBC1 was
absorbed with total rat liver DNA (a gift from J.
MacInnes), fluorescence staining of the cell's nu-
cleus and mitochondria was abolished. When the
DNA was first digested with DNase and then used
to absorb SBC1, antibody staining was not abol-
ished. When cultured cells were treated with DNase
(0.2 mg/ml, 30 min) prior to staining with SBC1,
the fluorescent staining of both nuclei and mito-
chondria was abolished. These results indicate that
SBC1 was directed against DNA. Current studies
in progress are aimed at determining the specificity
of SBC1 binding to DNA structure/conformation
and sequence. We are also investigating the possi-
bility that the intense nuclear staining is an indica-
tion of DNA synthesis and/or conformational
changes that occur in the S and M phases of the cell
cycle.
Figure 10
Immunoelectron micrograph of a cell stained by SBCI, followed by peroxidase-labeled goat anti-mouse.
The antibody stained the chromatin in the nucleoplasm (single arrowhead) and near the nuclear envelope
(double arrowhead). The nucleoli (n) were not stained.
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Figure 11
Immunoelectron micrograph of a gerbil fibroma cell in metaphase stained with SBC1, followed by per-
oxidase-labeled goat anti-mouse. The chromosomes (Chr) were stained. Arrowhead indicates a stained
mitochondrion.
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Figure 12
Fluorescent (A,B) and phase (C) micrographs of a gerbil fibroma cell stained supravitally with rhodamine
123 (Rh123) and SBC1. The living cell was seen in B and C with rhodamine 123 labeling the living
mitochondria. This cell was then rapidly fixed and stained with SBC1. (A) SBC1 stained the mitochondria
in a beaded pattern. Some translocation of the mitochondria was observed when comparing A with B due
to fixation shrinkage and natural movement of the mitochondria during the time it took to fix. Arrowheads
indicate mitochondria positions.
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Figure 13
Immunoelectron micrograph of a cell stained with SBC I, followed by peroxidase-labeled goat anti-mouse.
The antibody stained discrete regions of the mitochondria (arrowheads).
TRANSPORT AND SECRETION OF EUKARYOTIC
GLYCOPROTEINS
During the past year, we have continued our studies
on the molecular genetics of membrane and secre-
tory proteins. Our two major interests are (1) to
correlate structure with function by identifying and
analyzing the protein domains or epitopes involved
in receptor recognition, enzyme activity, and anti-
genicity and (2) to understand the mechanisms that
determine the route of transport and final destina-
tion of nascent glycoproteins in eukaryotic cells.
Most of our work has involved the hemagglutinin
of influenza virus, whose biosynthesis utilizes host-
cell enzymes and processes for translation, mem-
brane transport, glycosylation, and maturation. The
hemagglutinin provides an ideal system for our
studies because it is the best characterized of all
integral membrane proteins: Its three-dimensional
structure is known, and the location of its major
antigenic sites, the points at which it is glycosyl-
ated, its organization into trimeric structures, and
its orientation with respect to the membrane have
been defined. More recently, we have begun to
study tissue-type plasminogen activator, a serine
protease secreted from human cells. The genes en-
coding both of these glycoproteins have been cloned
and expressed in eukaryotic cells using recombi-
nant vectors. This provides the opportunity to study
the expression of the wild-type genes in a number
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of different cell types and to introduce site-directed
mutations into the cDNAs and analyze the struc-
ture, function, and transport of the altered glyco-
proteins.
Development and Analysis of
Continuous Cell Lines That Express
Influenza Hemagglutinin
J. Sambrook, L. Rogers, M. -J. Gething
In recent years, we have used the hemagglutinin
(HA) of influenza virus as a model to study the bio-
synthesis, modification, and transport of cellular,
integral membrane proteins. The groundwork for
this approach was laid when it was shown that the
cloned gene for HA could be expressed with very
high efficiency in mammalian cells and that the
newly synthesized HA was translocated through the
endoplasmic reticulum to the Golgi apparatus and
then to the cell surface along a route similar to, if
not identical with, that believed to be taken by the
majority of authentic cellular membrane proteins
(Gething and Sambrook, Nature 293: 620 [1981]).
Virtually all of this work has been carried out using
vectors based on SV40 that express extremely large
quantities of HA during the course of a lytic cycle
of viral growth in permissive simian cells. How-
ever, it would also be advantageous to study the
biosynthesis and expression of HA in mammalian
cells that are not destined to die as a consequence
of viral infection.
The first continuous cell lines that were devel-
oped contained the HA gene integrated into the
chromosome of murine LMtk- or human 143tk
cells. The HA gene was introduced into these cells
in a recombinant plasmid containing (1) the 13-lac-
tamase gene, (2) the chicken thymidine kinase (tk)
gene, and (3) the HA gene inserted between the
SV40 early promoter and SV40 early sequences
containing RNA processing signals. tk+ clones were
obtained that expressed up to 105 molecules/cell.
Evidence that HA is expressed at the surfaces of
these cells was provided by H2-restricted lysis of
the cells by Japan HA-specific cytotoxic T lympho-
cytes (CTLs) (Braciale et al., J. Exp. Med. 159:
341 [19841) (in collaboration with T. Braciale,
Washington University, St. Louis). CTLs that occur
in both mice and humans in response to type-A in-
fluenza virus show an unusually high degree of
cross-reactivity for target cells infected with sero-
logically distinct influenza virus strains. We have
shown that the HA molecule, expressed in the ab-
sence of any other influenza virus gene products,
can serve as target antigen for both the subtype-
specific and cross-reactive subpopulations of influ-
enza-specific CTLs. Thus, it is possible that HAs
of different subtypes of type-A influenza carry a
conserved epitope (or epitopes) that is immuno-
dominant for CTL recognition/activation but very
poorly recognized by the humoral response. These
findings now open the way for mapping specific
CTL epitopes on the HA molecule by site-directed
mutagenesis.
To obtain cell lines that constitutively express
higher levels of HA, murine cells (C127, NIH-3T3,
or BALB MME) were transformed with bovine
papilloma virus (BPV)-HA vectors in which the HA
gene was under the control of either the SV40 early
promoter or the murine metallothionein promoter.
Transformed cell lines were obtained that con-
tained 50-200 copies of the BPV-HA genome
maintained extrachromosomally as episomes. The
HA protein is expressed continuously at levels of
up to approximately 107 molecules/cell per 24
hours. The production of HA was higher when the
gene was under the control of the metallothionein
promoter than when the SV40 early promoter was
utilized. The addition of zinc to the medium re-
sulted in an approximately two- to tenfold increase
in expression of HA from the recombinants con-
taining the metallothionein promoter. Cell-surface
expression was demonstrated by indirect immuno-
fluorescence and hemadsorption of guinea pig
erythrocytes to the cell monolayer. These cell lines
combine the advantage of high-level production
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with the convenience of constitutive and continuous
expression.
Signal Sequences Can Be Exchanged
between Eukaryotic Glycoproteins
S. Sharma, J. Brandsma, J. Sambrook,
M. -J. Gething
The precursors of secretory and integral membrane
proteins of eukaryotic cells contain at or near their
amino termini a tract of hydrophobic amino acids
(the signal peptide) that functions in the transloca-
tion of the nascent polypeptide across the lipid bi-
layer of the endoplasmic reticulum. Analyses of
these peptides from a large number of proteins have
revealed a remarkable diversity of amino acid se-
quence, although hydrophobicity is always main-
tained. The question arises as to whether these sig-
nal peptides can be functionally exchanged between
different glycoproteins and, furthermore, whether
the attachment of a signal peptide to a normally in-
tracellular protein can cause its export from the cy-
toplasm.
We have constructed chimeric genes that fuse the
nucleotide sequence coding for the signal peptides
of calf preprochymosin and the env glycoprotein of
Rous sarcoma virus (in collaboration with E.
Hunter, University of Alabama) in front of the se-
quences coding for the hemagglutinin (HA) glyco-
protein of influenza virus. Alternatively, we have
placed the sequence coding for the HA signal in
front of those coding for the env glycoprotein or
for SV40 large T antigen. The chimeric genes were
inserted into recombinant genomes based on SV40
or adenovirus, and the chimeric proteins were ex-
pressed in eukaryotic cells. We have demonstrated
that when the signal peptides are exchanged be-
tween glycoproteins, the chimeric proteins are ef-
ficiently translocated across the endoplasmic retic-
ulum (ER) membrane. Subsequent cleavage of the
signal sequence and transport of the mature protein
to the cell surface appear to depend on how close
to the cleavage site the fusion has been placed and
whether the chimeric protein can fold correctly.
When the HA signal peptide is attached to large T
antigen, the chimeric protein molecules are at
least partially translocated across the ER mem-
brane. The signal sequence is cleaved from these
molecules, which also undergo glycosylation at a
normally cryptic canonical site (Asn153.Arg.Thr).
Recognition Signals for Sorting
Surface Proteins
M. Roth, C. Doyle, M. -J. Gething
Eukaryotic cells maintain a complex, directed flow
of proteins between their various organelles, in-
cluding their surface membranes. The mechanisms
by which cells control this intracellular traffic are
at present poorly understood. Polarized epithelial
cells that maintain two separate apical and basola-
teral surface domains provide a promising system
for the study of cellular sorting mechanisms. These
surface domains, each containing distinct comple-
ments of proteins, are separated by the zonula oc-
cludentes, belts of tight junctions between adjacent
cells that serve as barriers to the diffusion of ma-
cromolecules. Previous work has shown that viral
glycoproteins are concentrated to either the apical
or basolateral surface, domain of such cells (Rodri-
guez-Boulan and Pendergast, Cell 20: 45 [1980];
Roth et al., Cell 33: 435 [1983]).
To determine which topological features of pro-
teins are recognized by cellular sorting mecha-
nisms, we are investigating the surface expression
of cloned glycoprotein genes in polarized epithelial
cells. In the past year, in collaboration with E. Rod-
riguez-Boulan of Cornell Medical School, we have
characterized a polarized cell line that supports the
growth of SV40 expression vectors containing a
cloned gene for the hemagglutinin (HA) of influ-
enza virus. In this cell line, MA104 rhesus kidney
cells, the HA glycoprotein is preferentially ex-
pressed at the apical domain. To determine whether
features of HA important for sorting reside on the
large external domain of the protein or on the trans-
membrane or cytoplasmic domains, we are investi-
gating the expression of a secreted form of HA in
MA104 cells infected with an SV40-HA recombi-
nant virus. We have also constructed several genes
coding for chimeric glycoproteins in which the
transmembrane and/or cytoplasmic domain of HA
has been replaced by that of a different viral gly-
coprotein. These chimeric molecules appear to re-
tain all of the functional activities of wild-type HA
and are efficiently expressed on the cell surface in
MA104 cells. We are in the process of quantitating
the surface location of the wild-type and chimeric
HA molecules using electron microscopy and are
developing an in situ radioimmunoassay for differ-
entiating between apical and basal HA expression.
Expression and Intracellular Transport
of Mutant Hemagglutinins with Altered,
Deleted, or Extended Cytoplasmic
Domains
C. Doyle, M. Roth, M. -J. Gething
Many cell-surface glycoproteins contain at their
carboxyl termini a short stretch of hydrophilic
amino acids that follow a hydrophobic domain
spanning the lipid bilayer of the plasma membrane.
The carboxyterminal hydrophilic region of the in-
fluenza virus hemagglutinin (HA) extends for only
ten amino acids, with four of the final five residues
being absolutely conserved among HA subtypes.
The terminal ten amino acids are likely to be ex-
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posed on the cytoplasmic face of cellular mem-
branes during transport of HA to the cell surface.
This location could allow for specific interactions
between HA and molecules involved in intracellu-
lar transport.
To investigate the possibility that the "cyto-
plasmic tail" contains recognition signals impor-
tant in its transport through the cell, we have mu-
tated portions of the cloned A/Japan/305/57 HA
gene that code for this region of the molecule. Sev-
eral types of altered HA genes were constructed:
(1) a group of mutants in which sequences coding
for the carboxyterminal amino acids were changed
or deleted, (2) two mutants in which the termina-
tion codon was altered and the coding sequences
extended for either 16 or 21 codons, and (3) one mu-
tant in which the sequences coding for the cyto-
plasmic tail of HA is replaced by nucleotides en-
coding the cytoplasmic tail of the envelope glyco-
protein of Rous sarcoma virus. These genes were
inserted into SV40 vectors and expressed in CV-1
cells as mutant HA molecules in which the cyto-
plasmic tail is either altered, truncated, extended,
or changed to that of a different viral glycoprotein.
The rate of biosynthesis and transport, the cellular
localization, and the biological activity of the al-
tered gene products have been analyzed. Several of
the mutants displayed abnormalities in the pathway
of transport from the endoplasmic reticulum (ER)
to the cell surface. The HA mutant whose tail was
extended by 16 amino acids is retarded in the ER
and does not reach the cell surface. Another mutant
whose tail was replaced by 16 nonhomologous
amino acids is blocked in transport from the Golgi
apparatus to the surface. Other mutants are delayed
in reaching the Golgi apparatus after core glycosy-
lation is completed in the ER, although their sub-
sequent transport to the surface appears normal.
However, the mutant in which the conserved amino
acids at the carboxyl terminus have been altered
cannot be distinguished from the wild type in the
kinetics or pathway of transport. We conclude that
although some changes in the cytoplasmic tail
drastically influence cell-surface expression and the
rate of glycoprotein assembly and transport, the
conservation of wild-type sequences coding for this
region of the molecule is not absolutely required
for maturation and efficient expression of a biolog-
ically active HA on the surfaces of infected cells.
Site-directed Mutagenesis of the Fusion
Peptide of Influenza Hemagglutinin
M.-J. Gething, D. York
Enveloped animal viruses enter and infect cells by
a process involving fusion of the viral membrane
with a cellular membrane. In some cases (e.g., Sen-
dai virus), the fusion event occurs at the plasma
membrane; for many other viruses including influ-
enza, entry occurs through the membranes of intra-
cellular vesicles such as endosomes or lysosomes,
where the fusion is triggered by the endogenous low
pH. Fusion is a function of the viral surface glyco-
proteins and occurs at a threshold pH that is char-
acteristic of each viral species and strain. Experi-
mentally, this activity can be manifested as cell-cell
fusion when monolayers of cells displaying these
glycoproteins on their plasma membranes are sub-
jected to transient low pH. We have previously
shown, using cells expressing influenza virus hem-
agglutinin (HA) from a cloned copy of the HA gene
inserted into a recombinant SV40 vector, that the
HA molecule displays fusion activity in the absence
of any other influenza-virus-coded components
(White et al., Nature 300: 658 [1982]). This fusion
activity requires a posttranslational proteolytic cleav-
age of the HA precursor, HA0, into the active form
of the molecule, HA, which consists of two disul-
fide-bonded subunits, HA, and HA2. A new amino
terminus, which has been implicated in the fusion
activity and which becomes exposed at low pH, is
generated on the HA2 subunit. The first ten amino
acids of this aminoterminal "fusion peptide" are
hydrophobic in nature and are highly conserved be-
tween HAs from different influenza virus strains.
To confirm the function of the fusion peptide and
to identify the role of individual amino acids in the
fusion activity, we have used oligonucleotide-di-
rected, site-specific mutagenesis to alter the nu-
cleotide sequence coding for selected residues at
the amino terminus of HA2. Four mutants have been
constructed that contain single base alterations that
result in nonconservative amino acid changes in the
fusion peptide. These changes have included inter-
rupting the hydrophobic stretch with charged amino
acids and extending the hydrophobic sequence to 18
amino acids by replacing a hydrophilic residue. The
altered sequences were used to replace wild-type
sequences in an SV40-HA recombinant vector, and
the mutant HAs were expressed in CV-1 cells. Im-
munofluorescence, red-cell binding, and cell-fu-
sion assays (in collaboration with J. White, Yale
University) have been used to establish the pheno-
types of the mutants. So far we have defined two
positions at which amino acid replacements can
abolish the fusion activity and one position wh re
introduction of a charged residue causes a change
in the pH at which fusion occurs.
Expression of Tissue-type Plasminogen
Activator Using Recombinant
Viral Vectors
M. -J. Gething, D. Hanahan, J. Sambrook
Many normal and abnormal physiological processes
requiring extracellular proteolysis are thought to be
mediated by plasminogen activators (PAs) that
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cleave plasminogen to the active protease plasmin.
These processes generally involve fibrinolysis, tis-
sue remodeling, and cell migration. Two immuno-
logically and biochemically distinct types of PAs
have been identified as urokinase (uPA; found in
urine) and tissue PA (tPA; found in tissue extracts).
tPA is probably the physiological thrombolytic
agent, since it not only binds to and requires fibrin
for its activity, but also is released from the vascu-
lar wall into the blood by stimuli such as physical
exercise, venous occlusion, vasoactive drugs, and a
variety of clinical states. Recently, much attention
has been focused on the role of PAs in tumor for-
mation and metastasis. Levels of PA activity in nu-
merous transformed cell lines are enhanced, com-
pared with levels in normal-cell counterparts. A
recent study suggests that it is the level of tPA rather
than uPA that correlates with the malignancy of hu-
man myeloid leukemic cells (Wilson et al., Blood
61: 568 [1983]).
In collaboration with G. Larsen, R. Kay, R.
Hewick, E. Fritch, G. Brown, and R. Kaufmann
(Genetics Institute) and D. Rifkin (New York Uni-
versity), we have cloned a cDNA copy of the tPA
gene from a human melanoma cell line (Bowes).
Determination of its nucleotide sequence of 2350
by showed that the polypeptide backbone of tPA is
562 amino acids in length, including a hydrophobic
signal sequence of 20-23 amino acids and a hydro-
philic "pro" sequence of 12-15 amino acids. The
mature polypeptide (527 amino acids) has 35 cys-
teine residues capable of forming disulfide link-
ages and four potential glycosylation sites. Varia-
tions in the structure of the oligosaccharide side
chains may account for the two forms of PA that
are secreted from cells and that run as a doublet on
SDS-PAGE (65K and 63K species).
If the full-length tPA clone were inserted into an
SV40 vector between the HpaII and BamHI sites
(as used for HA expression), the resulting recom-
binant genome would be too large to fulfill the size
constraint for packaging into SV40 virions. Con-
sequently, a truncated cDNA containing all of the
coding sequences but lacking the majority of the 3'-
nontranslated sequences was inserted into the SV40
vector, and high-titer recombinant viral stocks were
generated as described for SV40-HA vectors (Ge-
thing and Sambrook, Nature 293: 620 [1981]). At
late times after infection with SV40-PA, simian CV-
1 cells secrete high levels of tPA into the medium
(10 µg /ml of protein; 500 units /ml of fibrinolytic
activity). This corresponds to about 50-fold higher
levels per cell than are produced in the Bowes mel-
anoma cells from which the cDNA was cloned.
Metabolic labeling of infected cells, followed by
immunoprecipitation and SDS-PAGE, indicated
that the tPA protein produced from the recombinant
vector is essentially identical in size to that secreted
from Bowes cells. The tPA cDNA has also been
inserted into a bovine papilloma virus vector under
the control of the murine metallothionein promoter.
Transformation of NIH-3T3 cells with the recom-
binant genome has yielded cloned lines that secrete
high levels of tPA (50 units/ml).
HEAT-SHOCK AND STRESS RESPONSES
A seemingly general and highly conserved re-
sponse to sudden adverse conditions is the so-called
"heat-shock" or "stress" response. It is found
throughout nature at all levels and is minimally
characterized by the induction of a specific and
limited suite of proteins, the "stress proteins" of as
yet undefined function. These proteins are related
to proteins that are expressed under normal condi-
tions and are by several criteria related among evo-
lutionarily distant organisms; the general features
of their induction also appear similar. Interest in
the stress response itself and the functions of these
proteins has grown quite remarkably, as judged
from the number of concerned publications, and
work here at Cold Spring Harbor has largely ad-
dressed two broad aspects of the stress response
displayed by human and mammalian cells: (1) pu-
rification and detailed characterization of the stress
proteins and (2) analysis of the genes that encode
them and the means by which their induction is ef-
fected.
Purification and Characterization of the
Mammalian Stress Proteins
W.J. Welch, G. Binns, J.R. Feramisco
In our efforts to understand the biology of the
stressed cell, we have continued to focus our atten-
tion on the structure, function, and intracellular lo-
cation of the individual stress proteins themselves.
' As we reported last year, approximately half a doz-
en polypeptides (M, = 28,000, 72,000, 73,000,
80,000, 90,000, 100,000, and 110,000) are synthe-
sized at elevated levels in all mammalian cells in-
cubated under certain adverse conditions. Purifi-
cation of the 72K, 73K, 80K, 90K, and 100K
proteins has been accomplished (Welch and Fer-
amisco, J. Biol. Chem. 257: 14949 [1982] and un-
publ.). Currently, we are in the process of purifying
the remaining two proteins, the 28K and 110K spe-
cies. Using cell-fractionation techniques and meta-
bolic labeling studies, we have found that both the
28K and 110K proteins localize, in part, to the nu-
cleus following stress and are heavily phosphoryl-
ated. The 28K stress protein, composed of at least
four related isoforms, may prove to be most inter-
esting since its phosphorylation state appears to be
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affected by a number of other treatments to cells
(in collaboration with B.R. Franza, this section).
As indicated last year, the major induced mammal-
ian heat-shock protein of 72K localizes to the nu-
cleus and nucleolus. The remaining heat-shock
protein to be purified, the 110K protein, similarly
localizes to the nucleolus and appears to corre-
spond to the C-23 nucleolar protein described dur-
ing the past few years by other laboratories. Puri-
fication of both the 28K and 110K proteins is being
accomplished using a combination of cell fraction-
ation and ion-exchange and gel-filtration chroma-
tography.
We are also continuing our efforts in the produc-
tion of both polyclonal and monoclonal antibodies
against the various stress proteins. As reported last
year, polyclonal antibodies specific for the 72K,
80K, 90K, and 100K proteins have been raised and
used to determine their intracellular localization in
the cell (Welch et al., J. Biol. Chem. 258: 7102
[1983]; Welch and Feramisco, J. Biol. Chem. 259:
4501 [1984]). More recently, we have been concen-
trating much effort on the production of mono-
clonal antibodies against all of the stress proteins.
In this context, we have just obtained one mono-
clonal antibody that appears to be specific for the
73K stress protein. Biochemical fractionation, as
well as indirect immunofluorescence analysis, us-
ing this antibody has shown that a portion of the
73K protein is associated with cytoskeletal ele-
ments, specifically microtubules and/or intermedi-
ate filaments (in collaboration with S. Blose, this
section).
Our battery of antibodies against the various
stress proteins is also proving useful in studies
aimed at dissecting the function of the individual
stress proteins. We have begun a systematic study
in which the various antibodies are introduced into
living cells via microinjection, and the effects are
assayed both morphologically and biochemically.
Using this approach, we have found that introduc-
tion into the cell of anti-72K antibodies and subse-
quent heat treatment of the cells results in acceler-
ated cell death. Hence, although it had been estab-
lished previously that the stress proteins collec-
tively afford the cell protection during heat-shock
treatment, this result is suggestive of at least the
72K protein being directly involved in thermal pro-
tection. We are currently examining whether the
anti-72K antibodies injected into the cytoplasm pre-
vent the migration of newly synthesized 72K pro-
tein into the nucleus/nucleolus of the heat-treated
cells.
Comparison of the Stress Response in
Normal and Transformed Cells
W.J. Welch, B.R. Franza, J.R. Feramisco
Although it has long been recognized that trans-
formed cells in vitro, as well as tumorigenic tissue
in vivo, show increased thermal sensitivity as com-
pared with normal cells, the biochemical basis for
this difference is not understood. Consequently, we
have been examining and comparing a number of
properties of the stress response in both normal and
transformed cells grown in vitro. Whereas the
transformed cells do show a typical stress response
at the protein synthetic level, there appear to be dif-
ferences in the location of some of the stress pro-
teins in the transformed cell as compared with their
normal cell counterparts. Specifically, we have
found that although the major induced 72K stress
protein localizes to the nucleus and nucleolus in
normal cells, the protein localizes to only the nu-
cleus and not the nucleolus in the heat-treated
transformed cells. Similarly, the 110K stress pro-
tein, present in the nucleolus of both normal and
transformed cells grown at 37 °C, shows a dimin-
ished nucleolar locale in only the heat-treated
transformed cells. In the case of the 72K protein,
the failure to localize in the nucleolus of the trans-
formed cell appears to reflect differences in the
cells and not in the protein itself. For example, we
have purified the 72K protein from transformed
HeLa cells (which show no nucleolar distribution
of 72K at high temperatures) and conjugated the
protein with the fluorescent tag, rhodamine iso-
thiocyanate. The rhodamine-coupled 72K protein
was then microinjected back into the cytoplasm of
normal rat fibroblasts, SV40-transformed fibro-
blasts, or HeLa cells, and the cells were heat-
treated. Only in the normal cells (and not in the
transformed cells) was the 72K protein observed to
redistribute into the nucleolus. It would appear then
that the state of the cell, be it normal or trans-
formed, somehow exerts an influence on the intra-
cellular distribution of the 72K protein following
heat-shock treatment.
Energy Metabolism and the Stress
Response
W.J. Welch
Over 20 years ago, Ferruccio Ritossa observed that
in addition to heat-shock treatment, a number of
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agents that interfere with oxidative phosphoryla-
tion can similarly induce the heat-shock response.
In the ensuing years, a large variety of treatments,
many of which affect general energy metabolism,
have been shown to be effective inducers of the
heat-shock proteins, prompting us and others to re-
fer to the response in more general terms as the
"stress response." Consequently, I have begun ex-
amining the apparent relationship between cellular
metabolism and the ability of cells to undergo and
survive heat-shock treatment. In this light, we have
shown that the synthesis of three of the stress pro-
teins (80K, 90K, and 100K) can also be affected by
altering the extracellular levels of glucose in the
culture medium of various mammalian cells (Welch
et al., J. Biol. Chem. 258: 7102 [1983]). In addi-
tion, although many of the oxidative phosphoryla-
tion inhibitors apparently induce the stress proteins
in excised Drosophila salivary glands, these same
agents have surprisingly little effect on protein syn-
thesis patterns in mammalian tissue-culture cells.
However, a profound effect is observed when the
mammalian cells are first treated with these inhib-
itors and subsequently heat-treated. In this case, the
cells' ability to synthesize the stress proteins as well
as survive the heat treatment is very much dimin-
ished as compared with heat-treated cells not ex-
posed to the drugs. Similarly, glucose deprivation
of normal cells followed by heat-shock treatment
again results in accelerated cell death. It is also in-
teresting to note that highly glycolytic transformed
cells also deplete their extracellular glucose quite
rapidly and, as mentioned above, show increased
thermal sensitivity. Hence, it appears that by af-
fecting the manner by which cells generate their
energy pools, one can similarly affect their ability
to respond and survive heat-shock treatment. Al-
though these studies are still at a preliminary stage,
it is hoped that this approach may shed light on how
the cells recognize the environmental insult at hand
and how they subsequently react.
Mechanisms of Translational Control in
the Stress Response
G.P. Thomas, D.D. Pascucci, M.B. Mathews
In addition to induced synthesis of the stress pro-
teins, the synthesis of the normal spectrum of cel-
lular polypeptides is markedly depressed, and the
two processes, although separable, are part and
parcel of the response. For our studies on the mech-
anisms involved in stress-protein induction, we have
used as inducer an amino acid analog that is incor-
porated into newly made proteins, resulting in
aberrant polypeptides. It is easily shown that incor-
poration is necessary, and we assume that aberrant
polypeptides are at least the initial signal for induc-
tion in this situation. RNA synthesis is also neces-
sary and there are two requirements: The first, as
could be expected, is for the production of high
levels of the mRNAs for the stress proteins, and the
second is more general in that protein synthesis as
a whole requires continuous synthesis of RNA.
When mRNA production was examined, it was
found that the stress-protein mRNAs are the only
species produced shortly after stress is imposed.
The patterns of protein synthesis also simplify with
time so that the stress proteins become the only
proteins made. Such parallelism could be mechan-
istically based and would result if only newly made
mRNAs were translated.
Although the normal mRNAs are not used for
protein synthesis in stressed cells, they remain in-
tact and are associated with polysomes, the site of
protein synthesis. As RNA does not exist in a naked
state within cells, one means by which mRNAs
could be distinguished is through protein associa-
tions. We have analyzed the distribution of normal
and stress-protein mRNAs in normal and stressed
cells as a function of their density, a measure of the
protein content of structures containing mRNAs.
We have found that polysomes of stressed cells
contain two classes of mRNA-containing particles:
One is the same as the particles found in normal
cells, but the second is found only in the polysomes
of stressed cells. To date, we have characterized this
fraction as follows: (1) It contains a large propor-
tion of the newly synthesized stress-protein mRNA
made over a given period; (2) it contains both of
the subunits that comprise normal ribosomes, lead-
ing us to suspect its functional significance; (3)
mRNAs for three major normal cell proteins can-
not be detected easily in this polysome class, in
contrast to the fraction at normal density; and (4)
the novel peak has a greater ratio of protein to RNA
than has normal polysomal mRNA. We are tempted
to speculate that this second polysome fraction is
the active vehicle of protein synthesis in stressed
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cells, and experiments to prove or disprove such a
hypothesis are under way.
Human Stress-response Protein Genes
G.P. Thomas, D.D. Pascucci
For many of the experiments aimed at monitoring
transcription and translation of both normal and in-
duced genes, specific probes are essential. We have
isolated genomic clones for the two major proteins,
90K and 72K, as well as what appears to be a 72K-
related gene that is expressed under normal growth
conditions yet is not induced by stress. When these
clones are used as probes in genomic DNA blots,
there are many more bands than would be expected
for a single gene; therefore, we presume that there
are families of 90K and 73/72K genes and/or that
these hybridizing species represent pseudogenes.
On the basis of S, protection experiments, the
clones in hand represent expressed copies, rather
than pseudogenes, although nucleotide sequence
determination of the complete genes will presum-
ably be required before we can be sure. Neverthe-
less, they are of utility as probes in the experiments
described above.
The 72K genes are currently being sequenced to
discover common and divergent regions and hope-
fully uncover sequences implicated in inducibility.
The availability of the genes, the proteins, and the
antibodies directed against the proteins will greatly
facilitate direct analyses of the expression of the
genes, particularly of autoregulation, for which
there is circumstantial evidence. In addition,
through comparison with the corresponding stress-
protein genes of other organisms that have been se-
quenced to date, it will provide a measure of the
evolutionary conservation of these gene products
revealed by immunological cross-reactivity.

ONCOGENES
Structure and Activation of
Mammalian ras Genes
K. Shimizu, M. Goldfarb, 0. Fasano,
E. Taparowsky, D. Birnbaum, M. Ruley,
M. Wig ler
DNA-transfer experiments have led to the obser-
vation that many human tumor cells contain genes
capable of the tumorigenic transformation of NIH-
3T3 cells. Most of these so-called "transforming
genes" are members of the ras-gene family, a highly
conserved group of genes that were first identified
by their presence in the Harvey and Kirsten sar-
coma viruses. We have cloned these genes from tu-
mor cells and have been studying their nucleotide
sequences, their intron/exon structures, and the
predicted amino acid sequences of the proteins they
encode. Additionally, we have determined the na-
ture of the mutations that activate the transforming
potential of the normal cellular genes. Further
studies, utilizing techniques of in vitro mutagene-
sis, have provided information about the functional
domains of the ras proteins. Finally, we have been
analyzing the ras proteins synthesized by cells to
understand the complex posttranslational process-
ing events accompanying ras protein maturation.
Structure and activation of human Ki-ras
genes. We have completed the cloning of the hu-
man Ki-ras gene and the sequencing of its coding
regions. This large gene encompasses 45 kbp and
has the potential to encode two ras-gene products,
one of 189 amino acids homologous to the viral Ki-
ras gene, and one of 188 amino acids. These two
proteins can be encoded by mRNA that utilizes
"exon choice": There are two alternate fourth cod-
ing exons. Similarly, the vestige of an "alternate"
fourth coding exon is found in the 3'-untranslated
sequences of the viral Ki-ras gene, suggesting that
the rat Ki-ras gene also has two fourth coding ex-
ons. Except for the alternate fourth coding exon,
the Ha-ras and the Ki-ras genes have a similar in-
tron/exon structure, indicating that they have
evolved from a common spliced ancestral gene.
Exon-shuffling experiments show that when either
alternate fourth coding exon of Ki-ras replaces the
fourth exon of Ha-ras, the resulting chimeric gene
is still functional. Chimeric gene constructions also
show that the Ki-ras gene of Ca lu-1 lung carcinoma
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cells is activated by a single point mutation, result-
ing in the substitution of cysteine for glycine at the
12th amino acid position.
Structure and activation of the human N-ras
gene. We have now completed the cloning and se-
quencing of the N-ras gene. Like the Ha- and Ki-
ras genes, a functional protein of 189 amino acids
is encoded by four coding exons. This gene has the
same exonic structure as the Ha- and Ki-ras genes.
We have found no evidence for an alternate fourth
coding exon. Comparison of the amino acid se-
quences of the three human ras genes reveals a re-
markable sequence conservation: All three are
identical for the first 86 amino acids. Thereafter,
until position 165, they are very similar ( >80 % ho-
mology). After this there is almost complete diver-
gence, in a region we call the variable region, until
again there is homology in the carboxyterminal se-
quence Cys-AAX, where A is an aliphatic amino
acid and X is the terminal amino acid.
Comparison of the N-ras genes of SK-N-SH neu-
roblastoma cells and human placenta indicates that
the former contains a mutation that activates the N-
ras transforming potential. Chimeric gene con-
struction, transformation assays, and nucleic acid
sequence analysis reveal that this is due to a single
point mutation that results in the substitution of ly-
sine for glutamine at the 61st amino acid position.
Position 12 of the transforming and wild-type N-
ras genes is glycine.
Processing of the ras proteins. Analysis of the
predicted amino acid structure of the ras-gene
products suggests that the carboxyterminal variable
domain is the candidate determinant for physio-
logic specificity of the ras proteins. However, it was
shown several years ago that the ras proteins
undergo processing in the carboxyterminal two
thirds of the molecule. This processing is visual-
ized by a marked increase in the electrophoretic
mobility of mature ras protein, suggestive of pro-
tein cleavage at the carboxyl terminus. This puta-
tive cleavage event would remove the variable re-
gion, making it unlikely that it could have more than
a transient function. We therefore prepared two-di-
mensional tryptic cleavage maps of the processed
and unprocessed Ha-ras proteins to resolve this
question. These studies indicate that the processing
event is not the result of proteolytic cleavage and
that the variable region is present on mature pro-
cessed ras proteins. Work is continuing to deter-
mine the nature and location of the processing
event. Preliminary data indicate that the same pro-
cessing event or a similar one occurs when the
mammalian Ha-ras proteins are expressed in yeast
cells (see below).
Activating mutations of the Ha-ras gene. All of the
activating mutations of the ras genes that occur in
vivo appear to be point mutations resulting in amino
acid substitutions at the 12th or 61st codons. There
are at least nine examples of these reported by our
laboratory and others. However, they are not nec-
essarily the only mutations that can activate the
transforming potential of the ras genes. To test this,
we randomly mutagenized a wild-type Ha-ras gene
by the bisulfite method, introducing C -T transi-
tional mutations. By screening the resulting mu-
tants in NIH-3T3 transformation assays and se-
quencing the transforming mutants, we found that
point mutations leading to amino acid substitutions
at positions 13, 59, and 63 can also activate the
transforming potential of the ras genes. Not all mu-
tants are equally effective in transformation. Mu-
tants encoding aspartic acid for glycine at position
13 are perhaps one-fifth as potent as those encoding
valine for glycine at position 12. Mutants encoding
serine for glycine at position 13 are perhaps 1/100
as potent. Mutants encoding threonine for alanine
at position 59 are particularly potent. This is puz-
zling, since both Ha-ras and Ki-ras viral genes have
at least two transforming mutations: one encoding
substitutions at position 12 and one encoding thre-
onine at position 59. Furthermore, it is no longer
clear why only position-12 and position-61 mutants
are found in vivo.
The clustering of activating mutations has two
other important implications. First, these results
suggest that activating mutations disrupt some crit-
ical ras protein function by disrupting protein
structure. We have argued that these mutations oc-
cur about the guanine-nucleotide-binding site of the
ras protein. From this, we have further argued that
activating mutations alter the conformational
changes induced by guanine nucleotide binding.
Second, it may now be easier to screen tumor DNAs
to determine whether they contain activating muta-
tions using methods of hybridization.
Expression of the Human Ha-ras Gene
in Escherichia coli and Yeast
S. Powers, M. Goldfarb, 0. Fasano,
M. Wigler
Biochemical study of the ras proteins requires a
source from which a functional ras protein can be
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purified in abundance. In collaboration with M.
Rosenberg, R. Sweet, and M. Gross at Smith, Kline
and French Laboratories and J. Feramisco and T.
Kamata at Cold Spring Harbor, we have utilized an
efficient X promoter cloned into a pBR322 deriva-
tive to express clones of normal and mutant Ha-ras
cDNAs. Escherichia coli harboring these vectors
express Ha-ras in great abundance. This protein
comigrates with the unprocessed Ha-ras protein
made in animal cells and also efficiently binds
guanine nucleotides. Ha-ras synthesized and puri-
fied from E. coli can now be used to study the ef-
fects of mutation on ras protein structure, to raise
monoclonal antibodies, and to study ras function
by microinjection. Since ras made in E. coli is un-
processed, we have examined the processing of Ha-
ras expressed in yeast. In collaboration with J.
Broach (SUNY, Stony Brook), we constructed a
galactose-inducible expressor of the Ha-ras cDNA.
Saccharomyces cerevisiae containing this vector
can be induced to express an Ha-ras protein that
undergoes a time-dependent processing event sim-
ilar to, but not identical with, the processing events
in animal cells. Thus, yeast expression systems may
be used to purify large amounts of the processed
Ha-ras protein for biochemical studies and also to
study the signals for protein processing.
Yeast ras Genes
S. Powers, T. Kataoka, 0. Fasano,
M. Goldfarb, M. Wigler
Since the ras genes are so well conserved in evolu-
tion, being present even in Drosophila, we looked
for their existence in Saccharomyces cerevisiae, a
simple eukaryotic organism that can be subjected
to powerful genetic analysis. We have found two
homologous genes in yeast by Southern blot analy-
sis, have cloned both from plasmid libraries, and
have completed DNA sequence analysis of the cod-
ing regions. The predicted amino acid sequence was
compared with that of the human ras genes, with
striking results. Both yeast genes show almost 90 %
homology with the first 80-amino-acid positions of
the mammalian ras and 50% homology with the
next 80. Although the yeast ras genes encode much
larger proteins (315 amino acids for yeast RAS1 and
322 amino acids for RAS2), they both terminate
with the sequence Cys-AAX, common to mamma-
lian ras. Thus, there are clear domains of conser-
vation that we think reflect functional domains of
the encoded proteins. Although the two yeast genes
are far closer to each other than to the mammalian
ras, they diverge radically from each other at pre-
cisely the point where the mammalian variable re-
gion begins. We have hypothesized that the first 80
amino acids comprise the effector domain of the
ras proteins and that the variable region forms a
domain that functions as a physiologic receptor.
The availability of powerful genetic tools in yeast
has enabled us to begin a series of experiments
probing the function of yeast ras genes. This work
was carried out with the collaboration of J. Strath-
ern (Yeast Section) and J. Broach (SUNY, Stony
Brook). We have found that yeast cells with a dele-
tion of either yeast RAS1 or RAS2 are viable; dele-
tion of both genes is lethal. By site-directed muta-
genesis, we have introduced the activating valine
for glycine substitution in RAS2 at the position ho-
mologous to the mammalian ras position 12. Cells
containing this mutant have a drastically altered
phenotype: They grow poorly on certain media, are
flocculant, and do not appear to arrest properly in
G,. Diploids with this mutation do not sporulate.
This phenotype is dominant.
These experiments indicate that it will be possi-
ble to do detailed genetic studies of the yeast ras
genes and that they may have cellular functions that
are homologous to their mammalian counterparts.
In particular, failure to arrest properly in G, is a
hallmark of transformed animal cells.
Tumorigenicity Assay for Transforming
Genes
0. Fasano, D. Birnbaum, C. Birchmeier,
L. Edlund, M. Wig ler
All of the transforming genes we have detected in
tumor-cell DNA using the NIH-3T3 focus assay
have been members of the ras-gene family. All of
these genes have had mutations that introduced
structural alterations into the ras proteins. We
therefore suspected that the NIH-3T3 focus assay
was biased in its sensitivity to structurally mutated
ras genes. In collaboration with J. Fogh (Sloan-
Kettering Institute, Rye, New York), we have de-
veloped and applied an alternative assay for trans-
forming genes present in NIH-3T3 cells after DNA
transfer: tumorigenicity in nude mice. NIH-3T3
cells are cotransfected with a selectable marker in
the presence of tumor DNA and then assayed for
tumorigenicity. We found that many more DNAs
are positive in this assay than in the focus assay.
We have identified and cloned three transforming
genes in the DNA of the human breast carcinoma
cell line, MCF-7, which did not induce transformed
foci of NIH-3T3 cells in our hands. One of these
genes is N-ras, and we find N-ras to be amplified
in MCF-7 cells. The other two genes have no ap-
parent relationship to previously known viral or
cellular oncogenes. We have not yet established
whether these human genes are genetically altered
in MCF-7. These results raise anew the question of
the number of potential oncogenes in our genome
and indicate that some (perhaps most) tumor cells
may contain a multiplicity of weakly transforming
genes.
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Cooperation among Oncogenes
D. Birnbaum, L. Edlund, M. Wigler
Recent observations by E. Ruley at Cold Spring
Harbor and H. Land and others at the Massachu-
setts Institute of Technology indicate that certain
oncogenes can cooperate in the morphologic and
tumorigenic transformation of primary embryo
cells. In particular, a mutant ras gene appears to be
insufficient to induce full transformation but re-
quires in addition the presence either of high-level
expression of myc or adenoviral E 1 A or of another
suitable viral gene. We have confirmed these obser-
vations concerning the cooperation of myc and ras
and, in particular, have shown that high-level
expression from a normal human myc gene is suf-
ficient to complement a mutant ras gene in the tu-
morigenic transformation of primary rat embryo fi-
broblasts. As in the work of Land, we observed that
mutant ras alone is sufficient to induce morphol-
ogical changes in primary embryo cells, but that
such cells have only a very limited life span. In-
deed, we observed that primary embryo fibroblasts
containing mutated ras genes have a greatly re-
duced life span compared with normal embryo fi-
broblasts, and we interpret this to mean that, in the
absence of high-level expression of myc function,
mutant ras genes are actually toxic to these primary
cells. We have also tested the cooperation between
myc and various other viral oncogenes using the
primary rat embryo fibroblast transformation sys-
tem. So far, we have observed cooperative interac-
tions between sarc and myc and, surprisingly, none
between myc and a variety of other tyrosine kinases
or between myc and mos. We also observed a co-
operative interaction between myc and fos, an on-
cogene encoding a nuclear protein.
Biochemistry of ras and ras-related
Proteins
F. Tamanoi, M. Walsh, M. Rao
Mutations in ras genes are known that are respon-
sible for the alteration of a normal protein to a form
active in transformation of NIH-3T3 cells. An in-
triguing question is, what biochemical activities are
affected by these mutations? To obtain an answer,
it is necessary to carry out a detailed enzymologi-
cal study, as well as a conformational and crystal-
lographic study, of the protein. One of the most
promising ways to obtain pure ras protein for such
a study is to express the protein in Escherichia coli.
Therefore, during the past year we have concen-
trated on expressing ras protein in E. coli using
various expression vectors.
First, we have attempted to express mammalian
ras protein using the lac promoter. Using a unique
MstI site five nucleotides upstream of ATG, we in-
serted the ras gene downstream from the lac pro-
moter in M 13mp10. The recombinant phage di-
rected the production of a 23K fusion protein that
was immunoprecipitable with a monoclonal anti-
body against the mammalian ras protein. The level
of expression could be increased to 5 -10% of the
total protein by transferring into a pUC vector. The
protein made in E. coli is active in binding GDP.
Recently, a ras expression system that utilizes the
X P, promoter has been constructed by M. Wigler
(this section) in collaboration with M. Rosenberg
(Smith, Kline and French Laboratories) and J. Fera-
amisco. This system has the advantage that an in-
tact protein is expressed. Characterization of this
intact protein is discussed by J. Feramisco et al.
(this section).
Recently, two yeast genes (RAS1 and RAS2) that
exhibit remarkable homology with the mammalian
ras gene have been isolated (see M. Wigler, this
section). To investigate the biochemical activity of
these gene products, we have started to express the
gene products in E. coli. The RAS2 gene contains a
unique HpaI site just upstream of ATG that could
be used to insert the gene into expression vector
pUC. The recombinant plasmid produced two pro-
teins, 46K and 35K, that could be immunoprecipi-
tated by the monoclonal antibody against the mam-
malian ras protein. The relationship between the
two proteins is currently being investigated. With
the RAS1 protein, no restriction sites suitable for
cloning were found around ATG. Therefore, we
have created a SphI restriction site (GCATGC) at
the ATG by a single base change. This was possible
by cloning the RAS1 gene into bacteriophage M13
and by using a synthetic oligonucleotide. Using this
Spit' site, we are inserting the RASI gene into vec-
tors that contain PR or P, promoters of bacterio-
phage X. Our immediate goal is to see whether yeast
ras proteins exhibit any GTP-binding activity and,
if they do, to compare the activities between the
two yeast proteins, as well as to the mammalian
protein.
Yeast provides an attractive system to carry out
biochemical analyses of ras proteins. Powerful
yeast genetics could lead to the identification of
proteins that interact with the ras proteins (see M.
Wigler, this section). These interacting proteins
could be expressed in E. coli to carry out studies
on the protein-protein interaction. Mutation of ras
protein to a form active in transformation might in-
volve alteration of such a protein-protein interac-
tion.
Microinjection of Cloned Genes to
Study the Mechanisms of
Transformation
B.R. Franza, Jr., H. E. Ruley, J.I. Garrels
We are studying the effects of cloned oncogenes in-
troduced into defined populations of cells utilizing
the techniques of microinjection, photomicros-
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copy, and computer analyzable two-dimensional gel
electrophoresis. Initial studies have focused on the
cloned Ha-ras-1 (pT24) transforming gene from the
human bladder carcinoma line T24 (Fasano et al.,
J. Mol. Appl. Genet. 2: 173 [1983]). We found that
this gene will not transform REF52 cells (a rat-em-
bryo-derived line; McClure et al., Cold Spring
Harbor Conf. Cell Proliferation 9: 345 [1982]) un-
less other genes such as the Ad5 E 1 A region are
cointroduced into the cell either by calcium phos-
phate transfection or by microinjection. Despite the
failure of the T24 gene product to transform, it is
abundantly expressed in microinjected REF52 cells.
At 72 hours postinjection, the protein product is
easily detected on two-dimensional gels (Fig. 1);
however, no major alteration of cell morphology is
apparent.
Another cloned oncogene is capable of rapid and
dramatic morphological transformation of REF52
cells. Less than 24 hours after injection of the
cloned c-sis gene-cloned from HUT-102 cells, a T-
cell lymphoblastoid cell line that produces a human
T-cell leukemia virus (Poiesz et al., Proc. Natl.
Acad. Sci. 77: 7415 [1980]), and kindly provided,
as part of an ongoing collaboration, by S. Josephs,
F. Wong-Staal, and R. Gallo (National Cancer In-
stitute) - many cells have changed their morphology
and their growth rate, leading to formation of a fo-
cus within 72 hours of the time the gene was in-
jected (Fig. 2). We are intrigued by the response of
REF52 cells to the c-sis-gene product given the fact
that considerable homology exists between the pro-
tein product of v-sis (the simian sarcoma virus one
gene) and a platelet-derived growth factor (PDGF)
(Deuel et al., Science 221: 1348 [1983]; Doolittle
et al., Science 221: 275 [1983]); and yet PDGF will
not support growth of normal REF52 cells.
We intend to continue such studies as these and
utilize the resolution capacity of the two-dimen-
sional gel and QUEST computer analysis (Garrels
et al., in Two-dimensional Gel Electrophoresis of
Proteins, Academic Press, New York [1984]) of the
protein patterns to begin defining the early events
that occur in changes of protein synthesis and turn-
over as cells respond to the products of genes
known either to transform or to assist in the trans-
formation process.
Production of Monoclonal Antibodies
to the ras Proteins
T. Kamata, C. Fraser, G. Binns, K. Ramirez,
J.R. Feramisco
In a collaborative effort utilizing the human c-Ha-
ras genes cloned in M. Wigler's laboratory, an ef-
ficient protein expression system of M. Rosenberg
and colleagues (at Smith, Kline and Beckman Lab-
oratories), and the combined use of ours and Smith,
Kline and Beckman's protein-purification tech-
niques and facilities, we have obtained homoge-
Figure 1
Expression of pT24 gene in REF52 cells. Subconfluent
REF52 cells were labeled for 2 hr with [35S]methionine, 72
hr after introduction of the pT24 gene by microinjection.
(A) Proteins resolved from control, noninjected cells; (B)
proteins resolved from cells injected with pT24; (C) phase
photomicrograph of pT24-injected cells just prior to prepa-
ration for two-dimensional gel analysis. (Ac) Actin; (Tml)
tropomyosin 1. Arrow indicates the synthesis of the T24 gene
product by the injected cells.
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Figure 2
Morphological transformation of REF52 by the c-sis oncogene. Confluent (stringent condition for inducing transformation)
REF52 cells were injected with the plasmid containing the sis gene (pSMI) and photographed at 24 hr and 72 hr after
microinjection. (A-C) Noninjected controls for each time point. Cells microinjected with the vector minus the c-sis-gene
insert are indistinguishable from noninjected cells at each time point. (D-F) Phase photomicrographs of the pSM1-injected
cells at 0, 24, and 72 hr, respectively. Note that C and Fare photographed at higher magnification.
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neous, biochemically active preparations of several
protein forms of the human ras proto-oncogenes
and oncogenes, including the "activated" c-Ha-ras
product, the "wild-type" c-Ha-ras product, and a
carboxyterminal truncate of the activated c-Ha-ras
protein lacking 19 amino acids.
Using in the first case a readily obtainable ami-
noterminal truncate ( -20 amino acids) as an anti-
gen, we have prepared several hundred mouse hy-
bridoma cell lines secreting antibodies that
recognize the antigen. Of these, approximately
seven have been cloned through soft agar to homo-
geneity. At least five of these cloned lines produce
IgGs that are capable of immunoprecipitating the
ras protein in the presence or absence of denatur-
ants (SDS) and are being characterized as to their
relative specificities toward the other protein mem-
bers of the ras family and to their effects on the
guanine-nucleotide-binding reaction characteristic
of the ras proteins.
In addition, we produced two 18-residue syn-
thetic peptides corresponding to the two aminoter-
minal sequences that differ by one residue between
the activated and proto-oncogenic forms of the hu-
man Ha-ras proteins. Smith, Kline and Beckman
have provided us with a 22-residue peptide that cor-
responds to the carboxyl terminus of the human c-
Ha-ras proteins. All of these peptides will be used
as antigens and, with luck, might provide us with
some very useful antibodies.
Microinjection of the Purified Human
Forms of the Activated and Normal
Cellular ras Proteins into Living Cells
J.R. Feramisco, T. Kamata, G. Binns
As mentioned above, we have made homogeneous
preparations of the full-length forms of the human
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Figure 3
Approximately 30 NRK cells in the center of
the field were each injected with approximately
106 molecules of the human activated Ha-ras
protein (full length) purified after expression in
E. coli. Photographs of the area were taken
right after injection (0 hr) and as indicated in
the frames.
Ha-ras proteins (both the wild-type or proto-onco-
genic form and the activated or oncogenic form),
as well as an activated protein lacking the carboxy-
terminal 20 or 50 amino acids. All of these pro-
teins seem to be "native" and are capable of binding
guanine nucleotides (to at least the 30 % level) by
several different types of assays. M. Gross, S. Yo-
koyama, R. Sweet, M. Rosenberg, and colleagues
(Smith, Kline, and Beckman Laboratories) are in
the process of quantitating the binding properties
of these proteins more exactly.
We have begun studies utilizing these purified
proteins and microinjection into living, normal cells
in order to gain more insight into the function of
the human ras oncogenes. The initial results of
these experiments show some very promising fea-
tures. As shown in Figure 3, within several hours
after injection of the oncogenic form of the human
Ha-ras protein into confluent NRK cells, dramatic
morphological changes in the cells can be detected.
Microinjection of high levels of the normal, proto-
oncogenic form of the ras protein has a slight effect
on the cells, but nothing as obvious as the effect of
the activated protein. The carboxyterminal truncate
of the activated protein appears to have no effect on
the cells. Video time-lapse recording of the cells
after microinjection of the activated ras protein in-
dicated numerous cell divisions and incredibly ac-
tive cell movements such as blebbing and ruffling.
Other experiments indicate that the effect of the ras
protein requires entry into the cells, is temporary,
does not require the presence of serum, and is in-
hibited by cycloheximide or actinomycin D. We are
in the process of trying to understand this effect in
molecular detail.
Is the ras Oncogene Protein a
Component of the Epidermal Growth
Factor Receptor System?
T. Kamata, G. Binns, J. R. Feramisco
A number of human cellular oncogenes have been
identified in part by transfection of DNA from tu-
mor-cell lines and tumor tissues into NIH-3T3 cells.
Several of these oncogenes have been classified as
members of the ras-gene family because of their
relatedness to the viral oncogenes of Harvey (v-Ha-
ras) or Kirsten (v-Ki-ras) murine sarcoma virus
(Ha-MSV or Ki-MSV). The human genes have been
put into at least three classes, c-Ha-ras, c-Ki-ras,
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or c-N-ras, depending on the degree of homology
with v-Ha-ras, v-Ki-ras oncogenes, or the human
cell line of initial description (i.e., neuroblastoma),
respectively. All of the known c-ras oncogenes have
normal or proto-oncogene forms that have only a
single amino acid change from the corresponding
activated oncogene forms. In general, the proteins
encoded by the ras-gene family are approximately
21,000 daltons and are associated with the inner-
surface plasma membrane. The only known bio-
chemical property common to all forms of the ras
proteins is the ability to bind guanine nucleotides.
In the particular case of the v-Ha-ras protein, ap-
parent autophosphorylation on threonine occurs
(both in vivo and in vitro). The guanine-nucleotide-
binding property is most likely an important prop-
erty of the ras proteins, since in a temperature-sen-
sitive viral mutant of the v-Ki-ras gene, the virus is
temperature sensitive for transformation and the v-
Ki-ras protein is temperature sensitive for the
guanine-nucleotide-binding activity. Of the many
alterations in the cellular phenotype associated with
transformation by the ras oncogenes, the one rele-
vant to the present work is the apparent loss of epi-
dermal growth factor (EGF)-binding sites on the
surfaces of the transformed cells. This has been
postulated to occur as a result of either down-reg-
ulation of the receptors or occupancy of the recep-
tors by the alpha-type transforming growth factor
(TGFa), which is produced by the transformed
cells. Because of the similar cellular location of
ras oncogene proteins and the growth factor recep-
tors, and because several other hormone systems
utilize guanine-nucleotide-binding proteins as reg-
ulatory elements (such as the G protein of the ade-
nylate cyclase system), we investigated the possible
relationship of ras oncogene proteins to the EGF
receptors. We have found that the normally low
EGF-binding activity of ras-transformed cell mem-
branes is apparently stimulated by the addition of
guanine nucleotides. By immunoadsorption of the
ras proteins from the membranes, we found that
this effect appears dependent on the presence of the
ras protein. In addition, we have found that the
phosphorylation of the v-Ha-ras protein and the
guanine-nucleotide-binding activity of the v- or
c-Ha-ras proteins in membranes isolated from
transformed cells are stimulated by the addition of
EGF and MgGTP- . Taken together, these results
suggest a role for the ras oncogene protein in the
EGF receptor system, perhaps acting in a manner
similar to the G protein.

TUMOR VIRUSES
PAPILLOMA VIRUSES
Human Papilloma Virus Expression
Vectors
L. T. Chow, A.J. Pelletier, S. Cheng,
R.L. Galli, T.R. Broker
Human papilloma viruses (HPVs) cannot be prop-
agated in cell cultures. Nor do they generally ex-
press mRNA in warts, in organ cultures, or in
transformed, transfected, or infected cell cultures
in amounts sufficient for recovery and molecular
analysis. Accordingly, to determine the structures
of the mRNAs, we have adapted expression vec-
tors that variously include transcriptional enhancer
sequences, surrogate promoters, the SV40 replica-
tion origin (to amplify the DNA and increase gene
dosage), or selectable drug resistances for isolation
of transformed cells. Determination of the mRNA
sequences will be necessary to ascertain how the
open reading frames might be used alone or in
combination after RNA splicing to encode proteins
necessary for cellular transformation, DNA repli-
cation, and virion morphogenesis.
Our studies during the past year have focused
largely on three types of HPVs. HPV-1 causes plan-
tar warts and exhibits relatively prolific replication
and gene expression in highly keratinized tissues.
HPV-6 and HPV-11 are (along with HPV-16 and
HPV-18) the leading causes of viral venereal dis-
eases (condylomas, dysplasias, and, possibly, some
carcinomas), resulting now in more than 1 million
medical visits per year in the United States alone.
HPV-11 also causes laryngeal papillomatosis.
PAPILLOMA VIRUS EXPRESSION VECTOR
We have assembled a vector that consists of a mod-
ified pML2 (pBR322 deleted for the tet resistance
gene and for the "poison" sequences that inhibit
replication in eukaryotes), the SV40 origin of rep-
lication and enhancer sequences, and the promoter
for the Drosophila gene encoding the heat-shock
protein (received from H. Pelham, Medical Re-
search Council, Cambridge, England). Into this
expression vector, the complete HPV-1 and HPV-6b
DNA sequences have been cloned after addition of
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new restriction sites in the noncoding region up-
stream of the E region and downstream from the L
region. In addition, small deletions have been made
(using BAL-31 exonuclease) in the noncoding re-
gion of HPV-1 so that the surrogate heat-shock pro-
moter is at different distances from the E-region
open reading frames. Part of our anticipation is that
possible regulatory sequences in this region that
may result in the normally very low levels of HPV
transcription might be eliminated. Forty hours after
transfection into COS A2 cells and amplification of
the plasmid DNAs, the cells were shocked at 43°C.
The recovered cytoplasmic mRNAs were analyzed
by electron microscopic heteroduplex methods. One
of the clones gave about 100-fold more HPV-1-spe-
cific mRNA than had been observed previously.
Most of the many mRNA species were indeed de-
rived from the Drosophila heat-shock promoter. All
contained one or more splices. The most abundant
species spans the overlapping open translation
frames E4 and the carboxyterminal half of E2 in the
transformation region (Fig. 1); less-abundant spe-
cies extend across the Ll region coding for the ma-
jor capsid protein. Minor species have long leader
sequences that span the E6 and E7 regions or long
main bodies that extend through the El and L2 re-
gions. Other clones were constructed to take advan-
tage of the SV40 early promoter and enhancer.
Transfection of COS cells with such clones pro-
duced less HPV-specific RNA than clones with the
Drosophila heat-shock promoter.
CELLULAR TRANSFORMATION
Transformation of mouse C127 cells with clones
driven by the Drosophila heat-shock promoter.
Mouse C127 cells can be morphologically trans-
formed with cloned bovine and HPV DNAs. The
transformants contain the input DNA in an episo-
mal state. We have attempted to transform C127
cells with a variety of cloned HPV-1 and HPV-6
DNAs, including those containing the Drosophila
heat-shock promoter upstream of the E-coding re-
gion. Transfected cells were generally kept at 37 °C
but were heat-shocked at 42 -43 °C for 1-5 hours
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Figure 1
Electron microscopic mapping of RNA transcripts derived from COS cells transfected with a shuttle-expression vector containing the
D. melanogaster heat-shock promoter, the SV40 replication origin and enhancer region, and a bacterial replication origin and the
ampicillin resistance gene. The HPV-la restriction site and open reading frames are based on the revised DNA sequence of Danos et
al. (EMBO J. 1: 23 [19821; see also Schwarz et al., EMBO J. 2: 2341 [19821). The HPV -1 cloning site near nucleotide 7630 is
indicated by the dashed vertical line adjacent to the RNA 5' ends. Gaps in the RNA structures shown are intervening sequences deleted
from the messages, the two most common of which are indicated by stars. The 3' ends are just beyond AATAAA poly(A) signals
evident in the sequence. El is required from episomal DNA replication, E2/E4 for transformation, and L2 and LI for virion morpho-
genesis.
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every other day. Morphological transformants were
picked after 3 weeks, and these are being grown up
for further characterization as to the state of the
input DNA.
Transformation of Rat 4 cells. HPV-6b DNA se-
quences received from L. Gissman (German Can-
cer Research Center, Heidelberg) were originally
represented in two separate BamHI-EcoRI frag-
ments. These were reassembled at the EcoRI site,
and the entire HPV-6b was recloned in pKO-neo
(constructed by D. Hanahan, Mammalian Cells
Section) from which we deleted the "poison" se-
quences in the pBR322 portion. This recombinant
DNA was then transfected into Rat 4 cells, and col-
onies resistant to the neomycin analog G418 were
obtained. DNA was recovered from clonal isolates
of the transformed cells and characterized. All
clones experienced rearrangements, and the DNA
is integrated. This result is different from what was
observed with BPV-1 cloned into similar vectors
(Matthais et al., EMBO J. 2: 1487 [1983]).
HPV-11, a virus related to HPV-6b, is associated
48
with laryngeal papillomatosis. Cloned HPV-11 se-
quences, also received from Gissman, were re-
moved from the original vector, recloned in a "poi-
son"-minus pK0 vector, and then used to transform
C127 cells. The DNAs from morphological trans-
formants were characterized by Southern blotting,
and the input HPV-11 clone was found to be inte-
grated, similar to the result we obtained with HPV-
6b.
PHYSICAL CHARACTERIZATION OF HPV DNAs
Heteroduplexes were prepared between HPV-6b and
HPV-11 DNAs, and the samples were analyzed
under moderate stringency (30% formamide, 0.1 M
salt, 23°C). The DNAs were paired over 90% of
their lengths, indicating that the homology is at
least 46% in the paired regions. Extensive pairing
persists at higher stringencies (60% formamide),
indicative of more than 73% homology in those re-
gions. On the basis of these electron microscopic
studies, the physical and genetic maps of HPV-6b
and HPV-11 have been aligned.
Genomic Organization of HPV-5
S. Watts, L. T. Chow
Patients with epidermodysplasia verruciformis
(EV) exhibit a rare familial disease characterized
by multiple persistent flat warts. Many distinct
types of HPVs have been isolated from these le-
sions, but thus far only HPV types 5 and 8 have
been associated with the progression of sun-ex-
posed lesions to primary and metastatic squamous
cell carcinomas. Multiple episomal copies of HPV
DNA are present both in the benign warts and in
the primary and metastatic carcinomas, although
carcinomas do not produce detectable viral parti-
cles. We have demonstrated that molecularly cloned
HPV-5 DNA is able to induce morphological trans-
formation of cultured mouse C127 cells and to per-
sist as an episome in these transformed cells (S.
Watts et al., in prep.). Accordingly, we chose to in-
vestigate the functional organization of the HPV-5
genome.
The nucleic acid sequence of HPV-5 DNA has
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not yet been determined. Therefore, to infer the ap-
proximate locations of the functional regions of the
HPV-5 genome, we annealed HPV-5 DNA to HPV -
la DNA, for which the complete DNA sequence
and the organization of open translation frames are
known (Danos et al., EMBO J. 1: 231 [1982]), and
we examined the heteroduplexes by electron mi-
croscopy. Under low-stringency hybridization con-
ditions, partial hybrids were formed between HPV-5
and HPV-1 DNAs in two regions, the major one
representing portions of the El and E2 open read-
ing frames and another, less homologous region,
representing a portion of the L2 open reading frame
of the HPV-1 genome. Partial homologies in these
particular regions have been seen consistently be-
tween many pairs of papilloma virus genomes an-
nealed under conditions of reduced stringency.
Therefore, alignment of the HPV-5 DNA homology
to HPV-1 DNA allowed us to approximate the po-
sitions of the corresponding genetic regions of
HPV-5 DNA (Fig. 2A,C).
In addition to wild-type genomes, several sub-
HPV-lo
Frame [1]
2 M
3
4300 by
II
r`l
59.0 90.3 S
2400 cud. 800 by
51.3 75.0 83.8 87.5
I
3700 by 1800 nucl 700 by \ 1000 by
300nucl.
66.5 86 S
i
4900 by 1500 nucl. IIOObp
p ( A )
E2
L I
1.2 1
p(A)
1,
Figure 2
Diagrams of the genomic organizations of HPV-5 DNA and deletion mutants. (A) Restriction endonu-
clease map of HPV-5 DNA. Map positions indicate the percentage of the genome from the unique Sad
site. (B) Map positions of deletions in the 3.5-, 3.7-, and 4.0-MD subgenomic species of HPV-5 DNA.
Map positions of the deletions as determined by electron microscopic heteroduplex formation are indi-
cated by the open boxes. (C) Alignment of HPV-1 DNA relative to HPV-5 DNA by electron microscopic
heteroduplex mapping. The positions of the HPV-1 open translation frames are based on the revised DNA
sequence.
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genomic species of episomal HPV-5 DNA have
been detected in carcinomas of EV patients by
Southern blot hybridization (Ostrow et al., Proc.
Natl. Acad. Sci. 79: 1634 [1982]), and some have
been molecularly cloned in bacteriophage X. Re-
striction endonuclease mapping indicated that the
sequences deleted in these mutants overlapped a
single region of the wild-type genome. As depicted
in Figure 2B, we mapped three of these subgenomic
DNAs relative to wild-type DNA by electron mi-
croscopy of heteroduplexes to show that these DNA
species lacked portions of the genomic region as-
sociated with virion morphogenesis.
All of the mutants appeared to retain the ability
to transform C127 cells in culture. Preliminary re-
sults of Southern blots of transformed cells indicate
that virus-specific DNA was present in the trans-
ADENOVIRUSES/SV40
Adenovirus Early Gene Regulation
M. Rossini, R. Guilfoyle, W. Osheroff,
L. T. Chow, T.R. Broker [Electron
Microscopy Section]
During the study the
genome of human adenovirus type 2 (Ad2) as a
model for gene regulation. We have concentrated
our effort on the regulatory interactions between
early regions IA (E1A) and 2A (E2A). E2A en-
codes the DNA-binding protein (DBP) necessary
for replication. An interesting and unusual prop-
erty of E2A is that its transcription occurs from
different promoters: At early times after infection,
RNA synthesis initiates from a promoter located at
map coordinate 75 (Berk and Sharp, Cell 12: 45
[1977]; Evans et al., Cell 12: 733 [1977]; Kitching-
man et al., Proc. Natl. Acad. Sci. 74: 4392 [1977])
and at late times from a promoter at map coordinate
72 (Chow et al., J. Mol. Biol. 134: 265 [1979]).
The expression of DBP is under the control of E1A
(Berk et al., Cell 17: 935 [1979]; Jones and Shenk,
Proc. Natl. Acad. Sci. 76: 3665 [1979]; Nevins,
Cell 26: 213 [1981]).
E2A plasmids containing the DBP gene associ-
ated with its early or late promoter were microin-
jected into hamster cell nuclei in the presence or
absence of plasmids expressing some or all of the
E1A functions, and DBP production was monitored
by indirect immunofluorescence. E1A stimulates
the production of DBP from the early promoter and
represses the synthesis of DBP from its late pro-
moter (Rossini, Virology 131: 49 [1983]).
From these findings, we have analyzed which of
the El A products is involved in the stimulatory or
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formed cells in an episomal state. We have also as-
sayed purified fragments of the HPV-5 genome for
their ability to transform C127 cells. A 3.3-MD-
fragment BamHI (03)- Hindlll (71) and a 2.9-MD-
fragment BglII (03)-Bgill (62) were able to induce
transformation.
Thus, studies with HPV-5 subgenomic species
and genomic fragments have delineated the gen-
omic region necessary for in vitro transformation
and episomal replication and are consistent with the
organization of the genome that we propose as a
result of heteroduplex mapping relative to HPV-1
DNA. Through analyses of transcripts and proteins
in cells transfected with vectors containing HPV-5
DNA, we intend to help elucidate the requirements
for HPV-5 expression and transformation.
inhibitory effects on E2A expression. This investi-
gation has taken advantage of two preexisting and
characterized adenovirus E1A mutants: hrl, in
which a single-base mutation introduces a protein
termination codon into the 13S mRNA while leav-
ing the 12S mRNA functional (Ricciardi et
al., Proc. Natl. Acad. Sci. 78: 6121 [1981]), and
pEKpm975 (obtained from A. Berk, University of
California, Los Angeles), in which a single-base
transversion at the donor splice site for the 12S
mRNA eliminates its production while the 13S
message and its protein product are still made
(Montell et al., Nature 295: 380 [1982]).
Last year, we reported as preliminary results that
the E1A plasmid (pEKpm975) generating only the
13S mRNA maintained, in the microinjection sys-
tem, the ability to stimulate the production of DBP
from the early promoter clone but lost the ability to
inhibit its expression from the late promoter plas-
mid. Conversely, the E1A plasmid with an intact
12S mRNA (hrl) lost the ability to stimulate the
DBP early promoter but maintained the inhibitory
effect on the late promoter clone (M. Rossini et al.,
in prep.). These results have been confirmed by
many replicate experiments, and the same results
have also been achieved using cDNA clones (con-
structed by B. Zerler and E. Moran, this section)
of the 12S and 13S mRNAs.
To test the assumption that the effect of E1A on
E2A synthesis occurs at the transcriptional level,
we have constructed deletions at the E2A early and
late promoter regions by BAL-31 exonucleolytic
digestion to define the DNA sequences respon-
sive to E1A regulation. Microinjection analyses of
these deletion mutants have indicated that the se-
quences between nucleotides 87 and 51 upstream of
the E2A late transcription RNA cap site contain the
E1A regulatory interaction site. Surprisingly, dele-
tions in the early promoter region up to +5 (within
the normal transcript) fail to abolish the ability of
E1A to stimulate DBP production, suggesting a
less-specific mechanism of activation of E2A early
promoter by E1A.
Recognizing certain limitations of our experi-
mental system based on the immunofluorescent
staining of the final product (DBP) of a multistep
process, we have initiated experiments leading to a
more precise characterization of the regulation.
These consist of (1) immunoprecipitation of DBP
from microinjected cells for a better quantitation of
the stimulation or the inhibition of its production,
(2) analysis of RNA from cells transfected with
wild types and deletion mutants in the presence or
absence of E1A DNA, and (3) analysis of chlor-
amphenicol acetyltransferase (CAT) activity in cells
transfected with plasmids containing the E2A early
or late promoter upstream of the bacterial cat gene,
in the presence or absence of wild-type or mutant
E1A plasmids.
Analysis of the sequences in the E2A early pro-
moter has revealed the presence of a few stretches
of alternating purines and pyrimidines 7 or 8 nu-
cleotides long, apparently sufficient for the DNA
conformation to switch to the Z-helix structure.
This observation has been the basis to attempt in
vivo studies using the microinjection technique to
investigate the effect of antibodies against the Z-
DNA structure (obtained from A. Rich, Massa-
chusetts Institute of Technology) on the expression
of DBP. Preliminary results have indicated that
coinjection of anti-Z-DNA antibodies with the DBP
plasmid containing both its early and late pro-
moters significantly increases the percentage of
cells fluorescent in response to DBP.
We have also examined human cells infected with
Ad 5d1312, a mutant virus in which the E1A region
has been completely deleted (Jones and Shenk, Cell
17: 683 [1979]) and, accordingly, from which E2A
is not expressed. As expected, the cells did not
show any fluorescence for DBP. When an E1A
plasmid was injected into Ad5dl312- infected cells,
complementation occurred and the cells showed flu-
orescence for DBP. Cells infected with Ad 5d1312
and then microinjected with anti-Z-DNA anti-
bodies also produced DBP.
Although these results are preliminary, several
possibilities can be envisioned to explain the mech-
anism of action of anti-Z-DNA antibodies: (1) A
tract of alternating purines and pyrimidines ob-
served in the early promoter for DBP is recognized
by the antibodies, which act as Z-DNA-binding
proteins. A change from B conformation to Z con-
formation or, conversely, stabilization of a transi-
tory Z-DNA structure might occur by this interac-
tion, with a subsequent activation of the gene. (2)
The binding of antibodies to the early promoter re-
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gion blocks entry of RNA polymerase II at this site
and transcription initiates from the late promoter.
(3) The action of anti-Z DNA antibodies could be
indirect, through binding to a cellular gene coding
for the factor with a repressor function on early
gene transcription, as proposed by Nevins (Cell
26: 213 [1981]). In any case, the finding that an an-
tibody directed to a specific structure of DNA has
an effect on gene expression and can simulate the
action of a known protein is of great interest, and
additional investigation of the subject should shed
more light on the complex problem of gene regu-
lation.
Identification of Adenovirus DNA
Replication Proteins
B. Stillman, T. Grodzicker, E. White
The replication of adenovirus DNA in cell-free ex-
tracts remains the only such system available in
higher cells to study the detailed enzymology of
DNA synthesis and its control. Studies from a
number of laboratories over the past 5 years have
identified and purified five proteins that, when
combined, will initiate and complete one round of
adenovirus DNA synthesis. Three of these pro-
teins, encoded by the viral genome, are the single-
stranded DNA-binding protein (DBP), the precur-
sor terminal protein (pTP), and the adenovirus
DNA polymerase (Adpol). The latter two are re-
quired for initiation of DNA synthesis at the repli-
cation origin (see below), and probably all three
are required for elongation of DNA synthesis. Two
proteins, encoded by the host cell, are also required
to replicate adenovirus DNA in vitro and have been
named factor I and factor II. Factor I is a site-spe-
cific DBP required for initiation of DNA synthesis
and binds to sequences within the adenovirus origin
of DNA replication (see below), whereas factor II
is required for elongation of DNA synthesis and
has been shown to be a type I topoisomerase.
Biochemical characterization in vitro of adeno-
virus mutants that fail to replicate their DNA in in-
fected cells has proved an invaluable method to de-
termine the role of virus-coded proteins in the
replication process. Using such an approach, we
had previously identified and characterized a novel
DNA polymerase that is encoded by the virus and
is defective in the mutant Ad5ts149. Another tem-
perature-sensitive mutant Ad2ts111, isolated by
Martin et al. (J. Gen. Virol. 41: 303 [1978]), has
an unusual and interesting phenotype in infected
He La cells; it is unable to replicate its DNA at the
nonpermissive temperature, but it also induces deg-
radation of the host cell's chromosomal DNA
(D'Halluin et al., J. Virol. 32: 61 [1979]).
Replication extracts prepared from the nuclei of
cells infected with Ad2ts111 were unable to repli-
cate adenovirus DNA at 37°C, but they could rep-
licate DNA at 30°C. Thus, the virus contained a
mutation in a gene that encoded a thermolabile pro-
tein. The replication defect was shown to be at the
stage of elongation of DNA synthesis, since these
extracts could form a functional initiation complex
at 37°C.
A protein was purified from Ad2 wild-type-in-
fected He La cells that could completely comple-
ment the Ad2ts111 replication defect in vitro and
was shown to be the adenovirus DBP. This was an
unexpected finding, since a previous report sug-
gested that the mutation in Ad2ts111 did not map in
the gene encoding DBP (D'Halluin et al., J. Virol.
41: 265 [1982]). However, this proved to be incor-
rect, and we have demonstrated that Ad2ts111 con-
tains two mutations, one in the gene encoding DBP
and the other in an E1B gene.
The mutation in the DBP gene produces a defec-
tive protein that can be distinguished by several cri-
teria from the defective DBP produced in another
temperature-sensitive mutant Ad5ts125. Unlike the
Ad2ts111 DBP, which is stable and normally phos-
phorylated at the nonpermissive temperature, the
Ad5ts125 DBP is rapidly dephosphorylated and de-
graded by proteases at the restrictive temperature.
Second, the Ad5ts125 DBP, produced at the per-
missive temperature, is very difficult to heat-inac-
tivate in vitro, whereas the Ad2ts111 DBP is readily
inactivated in vitro. It is most likely that the muta-
tion in the gene encoding the Ad2ts111 DBP occurs
at an active site in the protein, and we are currently
sequencing this gene to determine the change in
primary protein structure.
A second mutation found in Ad2ts111 is respon-
sible for the degradation of cellular DNA that oc-
curs after infection with this virus. This defect oc-
curs at all temperatures in vivo and has been
localized by DNA sequence analysis and marker
rescue techniques to the E1B 19K tumor antigen, a
protein that is required for adenovirus-induced
transformation of cells to tumor equivalents. Bio-
chemical characterization of this protein and the
mutant phenotype is described below.
Mutations in a Nuclear-envelope-
associated Adenovirus Tumor Antigen
Induce Degradation of Cellular DNA
E. White, T. Grodzicker, B. Stillman
As indicated above, we have shown that an adeno-
virus mutant, Ad2ts111, contains two apparently in-
dependent mutations that affect viral DNA synthe-
sis and cellular DNA integrity. Upon infection with
this mutant, cellular DNA is degraded into low-
molecular-weight fragments (-- 40,000 to 300 bp)
that can be visualized by electrophoresis of extra-
chromosomal DNA through agarose. Wild-type vi-
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rus does not induce this DNA degradation. The
amount of degraded DNA increases with time post-
infection and with the multiplicity of infection, and
it is not a temperature-sensitive phenotype, unlike
the DNA replication defect (see above). The amount
of degraded DNA is also increased by preventing
viral and cellular DNA synthesis in infected cells,
which suggests that cellular DNA synthesis is not
required for the degradative process and that an
early viral gene is responsible, at least in part, for
the defect. This is consistent with our finding that
this mutation is localized in the E1B 19K tumor an-
tigen. A recombinant virus that contains the E1B
mutation from Ad2ts111 and the wild-type DBP
gene from Ad5 was obtained. This recombinant,
named Ad2cyt106, retains the ability to induce cel-
lular DNA degradation and, like its parent
Ad2ts111, causes enhanced cytopathic effect in the
host cell. These phenotypes are similar to those
previously observed with some Ad12 mutants (Tak-
emori et al., Virology 36: 575 [1968]; Ezoe et al.,
J. Virol. 40: 20 [1981]).
A number of mutants in the adenovirus E1B 19K
tumor antigen have been reported, and we have
studied three additional mutants, Ad2/p3, Ad21p5
(Chinnandurai, Cell 33: 759 [1983]), and Ad5d1337
(T. Shenk, pers. comm.). All of these mutants cause
enhanced cytopathic effect in infected HeLa cells,
but only 1p5 and d1337 induce degradation of cel-
lular DNA. Thus, 1p3 is an example of a cyto-
pathic-effect mutant (cyt) that fails to induce deg-
radation of cellular DNA and therefore eliminates
the possibility that the DNA degradation is a result
of general cell destruction by the virus.
The intracellular localization of the E1B 19K tu-
mor antigen was investigated using antibodies that
recognize synthetic peptides contained within either
the carboxyterminal or aminoterminal region of the
protein (Green et al., J. Virol. 48: 604 [1983]).
Both antisera stain, by indirect immunofluores-
cence, the E1B 19K antigen in wild-type-infected
HeLa cells. The protein is localized in both a cyto-
plasmic membrane structure (endoplasmic reticu-
lum) and the nuclear envelope at early to interme-
diate times postinfection, but late in infection it
localizes solely within the nuclear envelope (see
Fig. 1). The nuclear-envelope staining was similar
to that observed in cells stained with a human au-
toantibody (McKeon et al., Proc. Natl. Acad. Sci.
80: 4374 [1983]) that recognizes lamins A and C,
two proteins that form part of the nuclear lamina at
the internal surface of the nuclear envelope (see Fig.
1). Upon biochemical fractionation of infected
cells, the E1B 19K protein copurifies with the lamin
proteins, with 50% of the protein very tightly bound
to the lamina and 50% eluting with high-salt treat-
ment.
By indirect immunofluorescence, the E1B 19K
protein produced in /p3-infected cells was indistin-
guishable from wild-type protein; however, in the
Figure 1
Indirect immunofluorescence (A and C) of He La cells infected
with wild-type adenovirus and fixed at 40 hr postinfection. Cells
were labeled with antisera against the E1B 19K protein (A) or
the host-cell lamin protein (C). The corresponding phase-con-
trast photographs are shown in B and D.
mutants that induce degradation of cellular DNA,
the E1B 19K protein had an altered intracellular lo-
cation (tslll, cyt106, 1p5; the protein is not de-
tected in d1337-infected cells). These studies show
that the degradation of cellular DNA induced by
these mutants correlates with the failure of the El B
19K tumor antigen to localize with the nuclear en-
velope. However, in mutants that fail to produce the
E1B 19K protein (Ad5d1337 and Ad5d1313), the
degradation is still observed. This suggests that it
is not the E1B 19K protein that degrades cellular
DNA, but that degradation is caused by either a
cellular protein or another early adenovirus protein
that is activated in the absence of the E1B 19K pro-
tein. We are currently searching for this activity in
mutant-infected cells.
Adenovirus Mutants That Delay the
Onset of DNA Synthesis In Vivo
B. Stillman
In addition to the three virus-coded proteins that
are directly required for replication of viral DNA,
a number of "early" viral proteins are indirectly re-
quired. These include the E1A proteins, which en-
hance transcription of the early region genes that
encode replication proteins, and an E1B gene prod-
uct. The replication of adenovirus DNA in HeLa
cells infected with E1B host-range mutants was ex-
amined as part of a study to define the function of
E1B gene products. These studies employed two
host-range mutants, Ad5hr6 and Ad5hr7, which
were originally isolated by Harrison et al. (Virol-
ogy 77: 319 [1977]) and are capable of growth in
293 cells (a human embryo kidney cell that con-
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tains and expresses E1A and E1B gene products)
but fail to grow in HeLa cells (which do not contain
adenovirus gene products). When HeLa cells were
infected at low multiplicities of infection with either
mutant, the amount of accumulated intracellular
viral DNA at late times in infection was low com-
pared with the amount for similar infections with
wild-type virus. At higher multiplicities of infec-
tion, the difference between the amount of mutant
and wild-type DNAs was not as apparent.
Upon closer examination of the time course of
DNA synthesis using one of the host-range mu-
tants, Ad5hr7, it was found that the onset of viral
DNA synthesis was delayed in infected HeLa cells
by approximately 10 hours, relative to the onset of
DNA synthesis observed in wild-type-infected
HeLa cells. The rate of accumulation of viral DNA
was also reduced in Ad5hr7-infected HeLa cells.
But Ad5hr7 synthesizes normal amounts of early
viral proteins with no apparent delay in their rate
of accumulation (Ross et al., Virology 103: 475
[1980]), except for the E1B 57K tumor antigen,
which cannot be detected in mutant-infected cells.
This might suggest that the E1B 57K protein en-
hances the efficiency of viral DNA synthesis in an
indirect manner. We have produced a number of hy-
bridoma cells that make monoclonal antibodies
against the E1B 57K tumor antigen, and these will
aid in future biochemical characterization of the
role that this protein plays in controlling DNA syn-
thesis.
One intriguing feature of the E1B 57K host-range
mutants is that they appear to grow normally in
nontransformed, primary human embryo kidney
cells (Harrison et al., Virology 77: 319 [1977]),
which raises the possibility that some human em-
bryonic cells may contain a protein with a function
similar to that of the E1B 57K tumor antigen. A
number of human cell lines that do not contain ad-
enovirus sequences are currently being examined
for their ability to complement the DNA replica-
tion defect in Ad5hr7.
Characterization of DNA Sequences
Required for Adenovirus Replication
Origin Function
B. Stillman, F. Tamanoi
We had previously cloned into bacterial plasmid
vectors adenovirus DNA sequences that are re-
quired for the initiation and elongation of DNA
synthesis, using partially purified enzymes pre-
pared from adenovirus-infected HeLa cells. These
studies demonstrated that specific sequences were
required for the initiation of DNA synthesis in vi-
tro, and recent work has concentrated on defining
the precise boundaries of these sequences and their
function, particularly their interaction with repli-
cation proteins. Recently, we have also collabo-
rated with R. Guggenheimer and J. Hurwitz (Al-
bert Einstein College of Medicine) and have
examined the ability of purified replication pro-
teins to interact with origin sequences and their
mutant derivatives, and this has led to the func-
tional origin being divided into two independent
domains.
We introduced mutations into the origin se-
quences by creating deletions that remove se-
quences from either end of the cloned inverted ter-
minal repeat of adenovirus DNA, a structure that is
located at both ends of the linear adenovirus chro-
mosome and contains within its boundaries the rep-
lication origin. In addition, site-specific mutations
in this sequence were created using synthetic oli-
gonucleotides. The individual mutant DNAs were
tested for their ability to act as a template for initi-
ation and elongation of DNA synthesis using both
partially purified and purified replication proteins.
Furthermore, the mutant DNAs were also exam-
ined for their ability to bind to purified factor I,
a He La cell protein that is a site-specific DNA-
binding protein required for efficient initiation of
DNA synthesis in vitro. All plasmid DNAs that
contained a deletion of sequences that overlap with
the factor-I-binding site were not capable of bind-
ing to that protein and also were unable to support
DNA synthesis. Thus, in the presence of He La fac-
tor I, the factor-I-binding site is required for effi-
cient DNA synthesis, and we have called this re-
gion domain II (see Fig. 2). However, under
conditions where factor I is present in suboptimal
concentrations, as well as high DNA template con-
centrations, the factor-I-binding site was no longer
necessary for DNA synthesis, but a sequence of
only 20 by (domain I, see Fig. 2) could support
initiation in vitro. Domain I contains a 10-bp core
sequence (sequence A in Fig. 2) that we had previ-
ously shown to be perfectly conserved in all human
adenoviruses. The B region in Figure 2 is thought
to be a spacer sequence between the core sequence
DOMAIN I
DOMAIN II
10 20 30 40 50
11
CATCATCAATAATATACCT ATTTTGGATTGAAGCCAATATGATAATGAGGG
1
R8 S201
1 pLAS107R17
Figure 2
DNA sequences required for the adenovirus origin of DNA
replication. The origin has been functionally divided into two
domains and a cell protein binds to domain II. (Reprinted, with
permission, from Guggenheimer et al., Proc. Natl. Acad. Sci.
[1984, in press].)
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and the 5'-terminal dC residue where initiation takes
place.
The two domains of the adenovirus origin are
both required for efficient initiation of DNA syn-
thesis. The function of the factor I protein and its
specific binding site in adenovirus DNA may shed
light on the role that this protein plays in uninfected
cells.
Transcriptional Activation by the SV40
Enhancer: Possible Role for Z-DNA
W. Herr, Y. Gluzman
Enhancer elements were originally discovered as
novel elements contained in the SV40 early pro-
moter. They have received considerable attention
because of their ability to increase the transcrip-
tional activity in cis of a variety of heterologous
promoters as well as the bona fide SV40 promoter.
Enhancers are unique controlling elements because
they are capable of stimulating transcription irre-
spective of their orientation or position in relation
to the affected promoter. The mechanism of tran-
scriptional activation is not yet known.
In a recent study, A. Nordheim and A. Rich
(Massachusetts Institute of Technology) identified
sequences within the SV40 genome that have the
potential to form the Z configuration of DNA (Z-
DNA). Z-DNA is a left-handed double helix that
occurs in nucleotide sequences of alternating pur-
ine and pyrimidine residues and is stabilized in
negatively supercoiled, circular DNA molecules,
because the B Z form transition relieves stress
created by such supercoils. Using antibodies that
bind specifically to Z-DNA, Nordheim and Rich
identified two 8-nucleotide-long sequences of al-
ternating purines and pyrimidines that can form
Z-DNA in negatively supercoiled SV40 genomic
DNA. Because these sequences lie within the en-
hancer region, Nordheim and Rich suggested that
the potential to form Z-DNA may be important for
enhancer activity. In support of their hypothesis,
they found short stretches of alternating purines and
pyrimidines in many other enhancer elements.
This model can be tested by mutating these short
sequences within the SV40 enhancer so that the
ability to form Z-DNA is either destroyed or main-
tained and then to determine whether the enhancer
activity correlates with the ability to form Z-DNA.
Transitions (i.e., pyrimidine to pyrimidine) should
not markedly affect the ability to form Z-DNA,
whereas transversions (i.e., pyrimidine to purine),
which eliminate the alternating pattern of purines
and pyrimidines, should both destroy the potential
to form Z-DNA and, if the model is correct, dimin-
ish enhancer activity. We have tested the model in
this fashion by point mutagenesis of the SV40 en-
hancer region.
We constructed two sets of mutated enhancers by
oligonucleotide-directed mutagenesis in which two
of the eight nucleotides of the alternating purine
and pyrimidine stretches were each altered by either
transition or transversion mutations. The potential
of the mutated enhancers to activate transcription
was measured by analyzing the relative levels of
human 0-globin transcription in a He La cell tran-
sient expression assay. We have found that, con-
sistent with the model that Z-DNA is important for
enhancer function, the mutants containing trans-
versions exhibit a sevenfold reduction in the ability
to activate the13-globin promoter, whereas the tran-
sition mutants show a less than twofold effect.
To examine the effects of these mutations on
SV40 replication, we reinserted the altered enhan-
cer elements into the SV40 genome and assayed the
efficiency of plaque formation after transfection of
the DNAs into CV-1 cells. As in the O-globin tran-
scription assay, the wild-type SV40 and transition
mutants replicated with similar efficiencies,
whereas the mutants containing transversions
formed plaques at least 100-fold less frequently.
By passage of the SV40 stock containing the
transversion mutations, we have obtained 18 rever-
tants that have an increased ability to grow in CV-1
cells, albeit less efficiently than wild-type SV40.
The revertants are the result of tandem duplication
of the mutated enhancer region that varies in size
from 45 to 135 nucleotides. Although the exact
boundaries of the duplicated sequences differ
greatly, there is a 15-nucleotide-long sequence in
common to all of the duplications, suggesting that
this region may also be important for enhancer
function. Curiously, this 15-nucleotide stretch con-
tains the sequence GTGGAAAG that G. Khoury and
P. Gruss (National Cancer Institute) have suggested
is functionally important because the sequence is
conserved in a variety of enhancers. We plan to mu-
tate this latter sequence to verify its functional sig-
nificance.
SV40 Mutants That Differentiate the
Lytic and Transforming Functions of
Large T Antigen
M. Manos, Y. Gluzman
The large T antigen of SV40 is a multifunctional
phosphoprotein. It is essential both in the lytic cycle
of the virus and in the process of oncogenic trans-
formation of cells by SV40. T antigen is expressed
early in the lytic pathway and functions in numer-
ous processes throughout the infectious cycle. It is
required for the initiation of viral DNA replication;
it autoregulates early viral RNA synthesis, stimu-
lates late viral transcription, and induces host-cell
DNA synthesis and rDNA transcription. T antigen
also possesses a "helper function" that enables ad-
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enovirus to grow in simian cells. Recent evidence
also suggests that the T antigen is involved in the
assembly of viral particles. In nonpermissive cells,
T antigen is implicated in both the initiation and
maintenance of the transformed phenotype. This
96-kD protein specifically binds to the SV40 origin
of replication, has an ATPase activity, and is tightly
bound to a 53-kD cellular protein in vivo.
Several of these functions can be mapped to spe-
cific regions of the SV40 A gene encoding large T
antigen. This suggests that the T-antigen protein
may contain distinct domains that are able to func-
tion somewhat independently. Mutants deficient in
only a subset of the biochemical and physiological
activities of T antigen have been invaluable in map-
ping activities to different regions of the protein.
To investigate the role of the numerous activities of
T antigen in cellular transformation and the SV40
lytic cycle, we have utilized early mutants that are
deficient in viral DNA replication, but retain trans-
forming activity.
Mutant SV40 DNA insertions have been rescued
from a variety of permissive cells transformed by
UV-irradiated SV40 (simian cell lines C2, C11, C8,
T22, and BSC-SV1). Viral DNA was rescued by fu-
sion of these lines with COS-1 cells, which provide
a functional T antigen in trans that allows mutant
insertions to excise and replicate in the heterokary-
ons. The rescued SV40 inserts were cloned into
the plasmid vector pK1, restoring a complete SV40
genome containing the early region (BglI- BamHI)
from the mutants and a wild-type late region. These
DNAs were analyzed by marker rescue and DNA
sequencing. The mutants contain lesions in differ-
ent parts of T antigen that render the protein defec-
tive for viral DNA replication but efficient in trans-
forming cells in vitro.
Three mutants were sequenced and found to have
mutations predicting amino acid changes at posi-
tion 516, Lys - Arg (pC2); position 522, Pro- Ser,
and position 549, Pro- Arg (pCll); and position
203, His - Gln (pT22). Two mutations of the dou-
ble mutant (pC11) were separated by subcloning
pC11 restriction fragments. Two new mutant DNAs
(pC11-A and pC11-B) that contain only one of the
two mutations present in pCll were constructed.
pC11-A (position 522) retains the replication-neg-
ative phenotype, whereas pC11-B (position 549)
replicates at levels lower than those of wild type
and forms pinpoint plaques. T antigen isolated from
mouse cells transformed by pCll -A is deficient in
ATPase activity (no activity was detected in our as-
says). C2 and C 11-B T antigens were positive in
ATPase assays.
The tumorigenicity of pC2 and pC11 was inves-
tigated by subcutaneous injection of the plasmids
into newborn hamsters. Both pC2 and the double-
mutant pC11 caused tumors. pC2 appears to have
an enhanced tumorigenicity compared with plas-
mid pKl containing the wild-type SV40 genome.
Characterization of the Biological
Properties of cDNA Encoding SV40
Large T Antigen
Y. Gluzman
Last year, we reported cloning a complete cDNA
copy of the SV40 large-T-antigen mRNA and plac-
ing it under the control of the bona fide SV40 reg-
ulatory region. This early region was reconstructed
with the SV40 late region into the complete SV40
genome with the exception that the early region has
the cDNA for large T antigen. This DNA could
replicate on CV-1 cells with greatly reduced effi-
ciency and produce very small plaques 15-20 days
postinfection. Marker-rescue experiments located
the deficiency in the cDNA construct to a region
that spans only the splicing region. Complementa-
tion analysis with temperature-sensitive mutants
demonstrated that cDNA SV40 DNA could be
complemented by tsB, but not tsA, mutants. These
data suggest that the cDNA construct has a defi-
ciency in the early region, but not in the coding
region per se. Preliminary data comparing the
amounts of mRNA produced from the cDNA con-
struct and the bona fide early region indicate that
there is 3-5 times less mRNA made from the cDNA
template.
The SV40 cDNA construct transforms primary
baby rat kidney cells and mouse embryo fibroblast
cells, although with lower efficiency than wild-type
SV40. This reduced efficiency may be linked to the
deficiency of producing normal quantities of
mRNA or to the lack of small T antigen.
Heterologous Promoter Expression of
SV40 T Antigen
R.D. Gerard, Y. Gluzman
COS cells produce a relatively limited amount of
SV40 T antigen. For experimental purposes, it
would be advantageous to derive a COS-like cell
line that produces a higher level of T antigen. It
would also be useful to be able to regulate the level
of T antigen in these cells. Expression of the mouse
metallothionein gene has been shown to be induci-
ble by heavy metals such as cadmium and zinc. We
have used the metallothionein promoter to express
SV40 T antigen inducibly and to a high level.
A BAL-31 deletion series in the 5'-untranslated
sequences of the SV40 early gene has been con-
structed. These deletions in the leader sequences
have been fused to the metallothionein promoter to
produce a series of chimeric genes lacking SV40
on sequences and T-antigen autoregulatory se-
quences.
In transient assays on cells transfected with these
constructs, immunofluorescent staining shows that
the basal level of expression of T antigen is barely
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detectable. Induction by heavy metals gives effi-
cient expression of T antigen from all of the hybrid
constructs.
These hybrid genes have been used to transform
both mouse embryo fibroblasts and monkey kidney
cells. Transformants were obtained in the absence
of any induction of T-antigen expression by heavy
metals. The basal level of expression in these cell
lines is variable, as judged from both immunoflu-
orescent staining and immunoprecipitation of T an-
tigen. Most lines increase the level of expression
two- to threefold upon heavy-metal induction. Rep-
lication of SV40 on sequences in at least some of
the transformed monkey cell lines is much greater
in the presence of heavy metals.
We have also used a bovine papilloma virus vec-
tor containing the metallothionein promoter/T an-
tigen chimeric gene to transform C127 mouse cells
and have characterized the subsequent expression
of T antigen by these cells. In this system, the me-
tallothionein promoter directs the synthesis of lev-
els of T antigen equal to or greater than that in COS
cells and two- to threefold higher upon heavy-metal
induction. The T antigen produced by these cells is
capable of rescuing SV40 on sequences upon fu-
sion with C6 monkey cells; however, no replication
of SV40 on sequences can be detected in the trans-
formed mouse cells when transfected with on -con-
taining plasmids or infected with adenovirus-SV40
hybrids.
Transformation and Viral Tumor
Induction
W. C. Topp, M. Dermody-Weisbrod,
K. Lionetti, E. Rubin
Over the past several years, our group has been
studying the phenomenon of rat breast fibroaden-
oma induction by certain members of group D of
the human adenoviruses. We reported last year that
susceptibility to tumor induction appeared to seg-
regate as a single recessive locus linked to the MHC
haplotype of the animal. The F, cross between a
susceptible and a resistant strain gave 100% resist-
ance. We have now completed the N, backcross to
the susceptible parent and have recovered suscep-
tibility in 17 of 100 animals inoculated at birth with
human Ad9. To date, we have determined the MHC
haplotype of six tumor-bearing and six nontumor-
bearing animals. All six tumor-bearing animals ex-
pressed the MHC haplotype of the susceptible par-
ent, whereas four of the six resistant animals were
of the haplotype of the F, parent. Although this
strongly suggests that susceptibility to viral tumor
induction is linked to the MHC, we have good evi-
dence that this is not the sole determining factor. A
second inbred strain (Albany) of the same MHC
haplotype as a known susceptible rat (Buffalo) has
proved resistant to tumor induction. We now plan
genetic crosses between the Buffalo and Albany
strains to determine the nature of this resistance.
Although they are all very similar to one another
physically, only 2 of the more than 20 group-D vi-
ruses are tumorigenic. To date, we have tested ten.
It is interesting that of these ten, only two are as-
sociated with a known disease state in man, kera-
toconjunctivitis, and the same two viruses are on-
cogenic. We reported earlier (in collaboration with
L. Chow and T. Broker, this section) that a specific
gene bank, early gene region 3 (E3), is substan-
tially overexpressed in human Ad9-infected cells as
compared with other adenovirus infections. We have
now found that in cells infected by two nononco-
genic group-D viruses (13 and 26), E3 is not abun-
dantly expressed. This is particularly interesting in
light of the fact that E3 encodes at least one cell-
surface glycoprotein known to interact with the
MHC. Furthermore, keratoconjunctivitis is thought
to result from the formation of an antibody/antigen
precipitate over the cornea of the eye, and it is in-
triguing that E3 may encode this precipitating an-
tigen. Preliminary results, however, show that
Ad10, also oncogenic, does not noticeably over-
produce E3, but we are continuing to evaluate this
hypothesis and are repeating a number of these ex-
periments.
Monoclonal Antibodies to SV40
Nucleoprotein Complexes
R. D. Gerard, E. Harlow
During the lytic cycle of SV40 infection, the viral
DNA can be recovered from the nucleus as a nu-
cleoprotein complex. These complexes are hetero-
geneous in nature and include DNA that is being
actively replicated and transcribed. Consequently,
these complexes should contain a variety of eukary-
otic proteins that are involved in replication and
transcription. We have begun an analysis of the im-
munogenic proteins in these complexes.
SV40 nucleoprotein complexes (NPCs) were iso-
lated from virus-infected CV-1 monkey cells and
were purified by sucrose gradient centrifuga-
tion. After the complexes were fixed by formalde-
hyde treatment, they were used to immunize a
BALB/c mouse. Hybridomas were constructed, and
tissue-culture supernatants were screened for anti-
bodies specific for NPCs by indirect immunoflu-
orescence on SV40-infected CV-1 monolayers. Of
the 384 cultures examined, 36 hybridomas pro-
duced antibodies recognizing antigens present in
SV40-infected cells. Four distinct staining patterns
were observed: cell surface, diffuse cytoplasmic,
cytoplasmic network, and nuclear. Two of these hy-
bridomas produce antibodies specific for the SV40-
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coded large T antigen, one produces antibodies
against the viral VP1 protein, and four others se-
crete antibodies that recognize intermediate fila-
ments. An eighth hybridoma from this series pro-
duces antibodies that precipitate NPCs that have
been pulse-labeled with [3H]thymidine. Initial ex-
periments have indicated that this protein is not vi-
rus-coded, and we are currently attempting to iden-
tify this antigen.
Analysis of the Cellular Tumor
Antigen p53
E. Harlow, N. Williamson, T. Adams
Animals bearing tumors induced by a wide variety
of agents often produce antibodies specific for a
normal cellular protein known as p53. This protein
has been implicated in an obligatory role in one of
the steps between mitogen stimulation and the ini-
tiation of cellular DNA synthesis. Several studies
have demonstrated that the regulation of p53 syn-
thesis, phosphorylation, and/or turnover is altered
in a number of transformed cells. In SV40- and ad-
enovirus-transformed mouse cells, p53 is found in
a stable complex with one of the virus-coded early
proteins. In collaboration with S. Benchimol and J.
Jenkins (Imperial Cancer Research Fund Labora-
tories, London), we have isolated a cDNA copy of
a portion of the mouse mRNA for p53. Using this
cDNA as a hybridization probe, we have deter-
mined the levels of p53 mRNA in various tissues
and during development. Analysis of mRNA iso-
lated from different stages of embryonic develop-
ment of the mouse has revealed that the expression
of p53 mRNA is drastically reduced during the fi-
nal stages of embryogenesis. Preliminary evidence
suggests that the expression of p53 is also differ-
entially controlled in tissues of the adult mouse. We
have used the mouse cDNA clone to identify a hu-
man cDNA clone that appears to be a full-length
copy of the human p53 mRNA. This cDNA is cur-
rently being cloned into several of the well-char-
acterized eukaryotic expression vectors. Introduc-
tion of these vectors into the appropriate mam-
malian cells should allow the production of suffi-
cient quantities of p53 to begin purification and
biochemical analyses. Because of the small quan-
tities of p53 found in normal cells and tissues, these
experiments have not been possible until now.
Monoclonal Antibodies to the
Adenovirus E1A Proteins
E. Harlow, C. Schley
Following infection of mammalian cells with ad-
enovirus, the first virus-coded proteins synthesized
are the products of the E1A region. RNA from this
region is differentially spliced to produce two early
mRNAs of 12S and 13S. Translation of these RNAs
yields two proteins with identical amino and car-
boxyl termini, but the 13S product has 46 addi-
tional amino acids in the central region of this poly-
peptide. These proteins are phosphorylated and are
found primarily in the nucleus. Although their
functions are poorly understood at present, these
proteins have been implicated in the activation of
transcription from other adenovirus early pro-
moters as well as in the production of established
cell lines. Very little is known about the biochemi-
cal or immunochemical properties of these pro-
teins. To help in the studies of the E1A proteins,
we have begun the construction of a library of mono-
clonal antibodies specific for these polypeptides.
A bacterial expression plasmid (kindly supplied by
K. Spindler and A. Berk, University of California,
Los Angeles) that will direct the synthesis of a fu-
sion protein between the bacterial tryptophan E
gene product and a cDNA copy of the 13S mRNA
was used as a source to purify an E1A-related pro-
tein. This polypeptide was purified by SDS-poly-
acrylamide electrophoresis, electroeluted, and used
to immunize BALB/c mice. Hybridomas were
prepared, and tissue-culture supernatants were
screened for the production of antibodies that would
bind to the fusion protein in a solid substrate ra-
dioimmunoassay. These antibodies were detected
by their ability to bind to '"I-labeled protein A.
Seventy-seven hybridomas secreting antibodies
specific for the fusion protein have been isolated
and single-cell-cloned. Several of these hybrid-
omas secrete antibodies that will bind to the au-
thentic E I A proteins synthesized in 293 cells, an
adenovirus-transformed human cell line. We are
currently using these antibodies to immunoaffinity-
purify the E1A proteins from infected cells.
Monoclonal Antibodies to the Rabbit
Translation Release Factor
E. Harlow
The final step of the synthesis of a polypeptide is
the release of the nascent polypeptide from the ri-
bosome. The mechanism of termination and release
of the nascent polypeptide is a poorly understood
phenomenon, especially in eukaryotic cells. This is
primarily because of the lack of drugs that specifi-
cally inhibit steps in the termination procedure. It
has been demonstrated that termination is con-
trolled by a protein known as the release factor
(RF), and this process requires ATP. Using a par-
tially purified preparation of RF obtained from T.
Caskey (Baylor College of Medicine), we have pro-
duced monoclonal antibodies specific for RE. These
antibodies will be used for the study of the termi-
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nation of translation and also may be useful in the
construction of an in vitro system for the produc-
tion of large polysome complexes. A number of
laboratories have demonstrated that rare mRNAs
may be simply and efficiently cloned using anti-
bodies to immunoselect mRNAs from a polysome-
mRNA-nascent polypeptide complex. We are cur-
rently investigating the properties of rabbit reticu-
locyte lysates depleted in RF with the hope that
these systems will allow the generation of large po-
lysomes in vitro. These lysates could then be used
as a convenient source of polysomes for mRNA
isolation.
Monoclonal. Antibodies to SV40 Virions
E. Harlow, M. Wylen
BALB/c mice were immunized with CsCl-purified
virions of SV40, and hybridomas were prepared by
standard procedures. Tissue-culture supernatants
were screened for the production of antibodies spe-
cific for the external surface of viral particles. Fifty
positive cultures were identified, and five of these
were selected for further characterization. These
five hybridomas were single-cell-cloned, and both
tissue-culture supernatant and ascitic fluid were
prepared. Analysis of these antibodies showed that
all five were capable of precipitating both the na-
tive virions and the precursors of viral 250S parti-
cles. Western blotting and immunoprecipitations
using proteins prepared from denatured virions
have shown that two of the five monoclonal anti-
bodies are specific for the VP1 protein. The speci-
ficities of the remaining antibodies have not been
determined, but these antibodies are also likely to
recognize VP1 but probably will bind to epitopes
that are destroyed by denaturation. We are cur-
rently testing whether these antibodies can be used
to purify SV40 virions on immunoaffinity col-
umns. This would circumvent the tedious process
of CsC1 centrifugation and may serve as a test sys-
tem for developing similar technologies for other
viruses.
In Vitro Splicing
G.A. Freyer, K. Tohill
Our strategy for examining the mechanism of
mRNA splicing in vitro has been to construct a re-
combinant plasmid that could be used to produce
large amounts of a suitable precursor mRNA and
then to use that RNA as a substrate in various cell
extracts. The construction that was made posi-
tioned the X leftward promoter (XpL) next to the
Ad2 major late transcript in such a way that tran-
scription initiated at the exact nucleotide used in
vivo. Characterization of the in-vitro-synthesized
transcript revealed that it does indeed initiate at the
correct position. A key feature of this method is
that a completely unmodified transcript is pro-
duced, and thus any requirements for posttran-
scriptional modification can be studied. To this end,
a second clone, containing a poly(A) stretch adja-
cent to a unique restriction site, was made to allow
a study of the effect of polyadenylation. In either
case, the initial transcript can be modified in vitro
by the addition of a 5' cap structure, allowing its
significance to be examined.
To date, we have been unsuccessful in demon-
strating splicing with the in vitro transcript, irre-
spective of whether it is unmodified or modified,
i.e., capped, polyadenylated, or both capped and
polyadenylated. The extracts used have included the
one described by Hernandez and Keller (Cell 35:
89 [1983]), which has been shown to splice suc-
cessfully the Ad2 major late transcript prepared in
vitro in He La cell extracts according to the proto-
col of Manley (Proc. Natl. Acad. Sci. 77: 3855
[1980]). These results suggest that our in vitro tran-
script is lacking some crucial modification. We are
attempting to identify this modification by exam-
ining the fate of our transcript during incubation in
whole-cell extracts. In addition, we are construct-
ing two new clones that will produce a much sim-
pler transcript ( -200 bases) containing a large
deletion in the intron.
Finally, experiments are under way to examine
the possibility that the introns are removed by a re-
ciprocal mechanism in which the intron sequences
themselves become joined to generate circular mol-
ecules.
Early Region IV of Adenovirus 2
G.A. Freyer, Y. Katoh
A project aimed at mapping the splice junctions of
the early region IV (E4) mRNAs of Ad2 is now
complete. This has been accomplished by sequenc-
ing cDNA clones corresponding to early mRNA
isolated from Ad2-infected HeLa cells. The cDNA
libraries were constructed both by conventional
cDNA cloning methods and by a novel method de-
veloped in this laboratory. The new procedure in-
volved synthesizing a 20-base-long oligomer, whose
sequence corresponded to a segment of the leader
sequence present on all E4 mRNAs. This oligomer
was ligated onto pBR322 to produce a single-strand
3' extension, which was then used as a primer for
second-strand synthesis of the cDNA. This strategy
proved to be extremely useful in producing large
numbers of E4-specific recombinants, essentially
all of which contained the 5' leader sequence. This
new method was devised because of the low num-
ber (<5 %) of cDNA clones found to contain the 5'
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leader sequence, in cDNA libraries made by the
conventional procedure.
From the sequence analysis of these cDNA
clones, the exact splice sites of all but one of the
previously characterized mRNAs was obtained. In
addition, five new mRNAs were found that had not
been detected by either electron microscopy or S1-
nuclease analysis. A large number of cDNAs, con-
taining the large common intron between coordi-
nates 92.4% and 94.4 %, were obtained and se-
quenced. All but one of these clones contained the
same donor and acceptor splice sites, with the ex-
ception differing in the location of the acceptor
splice site. From in vitro translation studies, it had
been predicted that a large open reading frame
present in this large intron was used to make a va-
riety of E4 proteins. Our data failed to reveal any
mRNAs from which this reading frame might be
accessed directly. We could, however, tentatively
assign predicted polypeptides to the various E4
mRNAs, which should help in future studies on the
function of this region.
Adenovirus-2 Genomic Sequence
R.J. Roberts, K. O'Neill
The Ad2 DNA sequence is finally complete as a
result of work in this laboratory and in others, most
notably the groups of F. Galibert (Hopital Saint-
Louis, Paris), U. Pettersson (University of Upps-
ala, Sweden), and J. Sussenbach (University of
Utrecht, Holland). A contiguous sequence of 35,937
nucleotides can be constructed, although because
of sequence heterogeneity both within individual
viral stocks and between stocks in different labo-
ratories, the actual length varies ± 9 nucleotides.
Within this sequence, the coding regions for 25
well-characterized Ad2 proteins and 2 small virus-
associated (VA) RNAs can be identified. An addi-
tional 30 open reading frames, which might encode
polypeptides with molecular weights of 10,000 or
greater, are present in the sequence, and it is likely
that many of these encode polypeptides that are
synthesized during the viral life cycle. One of the
most striking features of this sequence is its ex-
traordinarily high information content. There are
numerous examples of overlapping genes, both on
the same strand and on complementary strands. In
general, distances between adjacent coding regions
are extremely short, and signals for mRNA initia-
tion, termination, and splicing are frequently found
to overlap the coding regions. Thus far, 47 splice
sites have been defined within the sequence, re-
flecting the extreme complexity of RNA processing
that takes place during the expression of the viral
genome. Current work is focused on discovering
the fate of the intron sequences, which in many
cases contain open reading frames within them.
Autoantibodies and Ribonucleoprotein
Particles
M.B. Mathews, M.R. Sadaie, C. Herrmann
In autoimmune diseases, the organism's tolerance
to "self" breaks down and antibodies arise to nor-
mal body components. Among the targets of this
inappropriate immune response are molecules of
intense biological interest, such as DNA, ribonu-
cleoproteins (RNPs), and proteins. In collaboration
with R. Bernstein of the Royal Postgraduate Medi-
cal School, London, we have screened a large num-
ber of patients' sera and measured the disease fre-
quency of more than 20 antibody systems. At the
same time, we have examined the molecular nature
of the corresponding cellular antigens and have
characterized a number of these in considerable de-
tail.
The La antigen, described in previous annual re-
ports, is a 46,000-dalton phosphoprotein that binds
many RNA species transcribed by RNA polymer-
ase III, including the adenovirus VA RNAs. Anti-
bodies to this cellular protein are found in rheu-
matic diseases, such as systemic lupus erythe-
matosus and Sjogrens syndrome, and have proved
to be invaluable aids to studying the protein. We
have now shown that the protein recognizes the 3'
tail of VA RNA, comprising a run of up to four
uridylate residues. When there are three or four
residues at the 3' end, the RNA molecule is effi-
ciently bound by the antigen; molecules with two
residues are partially bound, but those with only
one terminal uridylate residue fail to bind. We have
demonstrated directly that the binding site is the 3'
terminus by cross-linking the RNA to the protein
by UV-irradiation and then digesting it with ribo-
nuclease T1. The only portion of the RNA mole-
cule that is not released from the protein is its 3'
end. Thus, the La antigen recognizes and binds to
the 3' uridylate-rich terminus of these molecules.
Current data suggest that the antigen is not involved
in RNA synthesis or the release of new transcripts
from the template, and there is also evidence
against involvement in the translational role of VA
RNA. We are therefore led by elimination to pos-
tulate that La antigen functions in the poorly under-
stood transport or processing of these RNA species.
More definitive assignations have been obtained
with autoantibodies found in polymyositis and der-
matomyositis. Over one quarter of the patients suf-
fering from these muscle-wasting diseases have
antibodies of the Jo -1 type. Again, the antigen is an
RNA-binding protein, but in this case, the RNA is
a transfer RNA. By assaying for inhibition of
amino-acid-charging activity, we have demon-
strated that the antigen is the enzyme histidyl-tRNA
synthetase, responsible for coupling histidine to its
cognate tRNA.
As in the case of the La antigen that can bind the
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adenovirus VA RNAs, an indirect argument links
the Jo-1 antigen with viral RNA. We believe that
the viral connection is more than coincidental and
may point to an origin for at least some autoim-
mune diseases in viral infection.
A third antigen recognized by autoantibodies is
the proliferating cell nuclear antigen (PCNA). This
antigen is characteristically seen in dividing cells,
especially tumor cells, but not in resting cells. It is
also known to alter its localization within the nu-
cleus during the cell cycle, shuttling between the
nucleolus and nucleoplasm. Although this antigen
does not appear to be associated directly with RNA,
it can be solubilized from the nucleus by DNase
digestion, suggesting a possible association with
chromatin. We have shown that the antigen is an
acidic protein with a molecular weight of 35,000.
In collaboration with J. Garrels and R. Franza of
this laboratory, we have characterized the protein
as a spot on a two-dimensional gel of human pro-
teins and demonstrated its identity with the protein
known as "cyclin." The regulation of cyclin has
been described in the literature, and its properties
mirror those of PCNA as expected. We are cur-
rently attempting to exploit the PCNA autoantibod-
ies to isolate the gene for this interesting and poten-
tially important nuclear protein.
Translational Role of VA RNA
P.A. Reichel, R. O'Malley, M.B. Mathews
In addition to some 40 mRNA species, adenovirus
encodes two small RNAs known as the VA RNAs.
These RNAs, about 160 nucleotides in length, dif-
fer from other viral transcripts in being synthesized
by RNA polymerase III and in their inability to code
for proteins. Previous work from this and other
laboratories led to a description of the structure of
the VA RNAs, their binding to other cellular com-
ponents, and the organization of their genes on the
chromosome, but their significance remained an
enigma until Thimmappaya and his co-workers
(Cell 31: 543 [19821) constructed a mutant virus
lacking the major species, VA RNA,. This mutant
fails to translate mRNA late in infection, suggest-
ing that VA RNA might interact with elements of
the protein synthetic apparatus of the cell. To ex-
plore this possibility, we have prepared cell-free
systems from infected and uninfected HeLa cells.
These cell-free systems duplicate the properties of
the infected cells in that extracts of mutant-infected
cells are unable to translate the viral mRNAs that
they contain. The deficiency extends to mRNAs
from other sources which, when added exoge-
nously, are also not translated by the cell-free sys-
tem from mutant-infected cells. This finding and
results obtained with specific inhibitors of transla-
tion support the idea that the block is at the level of
initiation of polypeptide chains.
We have tried to restore translational activity to
the extract by supplementing it with purified VA
RNA, but to no avail. Nor is the block overcome
by the addition of a competent cell-free extract from
uninfected cells or cells infected with wild-type vi-
rus. We conclude that the block is not due simply
to the lack of VA RNA, but must result from a more
complicated set of interactions involving VA RNA
in an indirect way. Reciprocal mixing experiments
indicated that the mutant-infected cell extract seems
to contain an inhibitor capable of interfering with
translation in either of the other systems. Likewise,
some inhibition is seen when the mutant-infected
cell extract is added to an unrelated translation sys-
tem, prepared from rabbit reticulocyte lysate; but
strikingly, the reticulocyte system makes use of the
adenovirus mRNAs, showing that they are not ir-
retrievably blocked. Fractionation of the reticulo-
cyte system shows that the component chiefly re-
sponsible for rescue of the protein synthetic ability
of the mutant system is not associated with ribo-
somes. We are currently engaged in purifying this
factor and in comparing its properties with those of
known initiation factors from reticulocytes.
Once the nature of this factor is understood, we
should be able to work back to the reactions in
which VA RNA takes direct part. As a complemen-
tary approach, we have also begun to study the in-
teraction of VA RNA with adenoviral mRNAs in
vivo. Plasmids containing a VA RNA gene and a
gene encoding a viral mRNA are introduced into
tissue-culture cells by transfection, and synthesis
of the corresponding protein is examined. By sys-
tematically altering regions of the two genes, we
hope to discover the sequences in each that are in-
volved in this novel kind of translational control.
Functional Analysis of the Adenovirus
E1A Gene
E. Moran, M.B. Mathews, R.J. Roberts,
B. Zerler
Adenovirus E1A is required for adenovirus-in-
duced cell transformation and is involved in the
regulation of expression of other adenovirus genes.
At least three different mRNAs are produced from
the E1A region, and our aim is to distinguish the
roles of the separate products of this gene. We have
therefore isolated cDNA clones corresponding to
the two largest known mRNA species, the 13S and
12S mRNAs. These cDNAs have been subcloned
into plasmids so that they are expressed either from
the adenovirus E1A promoter or from the inducible
mouse metallothionein gene promoter. They have
also been rebuilt into the entire viral genome in
place of the wild-type E1A region. Ribonuclease
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protection analyses using SP6 probes have shown
that only 13S ElA RNA is detectable from the 13S
virus or plasmids, and only 12S RNA is detectable
from the 12S constructs. In collaboration with E.
Ruley (this section), it has been shown that trans-
fection with either the 12S or 13S plasmids can es-
tablish primary baby rat kidney cells in culture in a
manner similar to that for wild-type E1A plasmids.
Both the 12S and 13S plasmids can also, like E1A,
cooperate with plasmids carrying the ras genes to
transform baby rat kidney cells. We have also stud-
ied these plasmids using a transient expression as-
say developed by Weeks and Jones (Mol. Cell. Biol.
3: 1222 [19831) in which expression of the bacte-
rial chloramphenicol acetyl transferase (cat) gene
is under the control of the adenovirus E3 promoter
and dependent on cotransfection with the ElA gene.
The 13S plasmids stimulate E3-cat expression when
substituted for the E1A gene, but the 12S plasmids
do not. These assays will be extended by construct-
ing plasmids in which the cat gene is placed under
the control of various other adenovirus promoters.
In collaboration with T. Grodzicker (this sec-
tion), we have studied the roles of the 12S and 13S
products in the lytic and transforming functions of
reconstructed adenovirus. Viruses containing the
13S cDNA region in place of E1A are competent
for lytic functions in HeLa, whereas the 12S vi-
ruses are defective. Immunofluorescence studies of
virus-infected HeLa cells indicate that the adeno-
virus DNA-binding protein, a product previously
shown to be dependent on E1A, is made during in-
fection of HeLa cells with the 13S virus but is not
detectable during infection with the 12S virus. Reg-
ulation of gene expression from various other re-
gions of adenovirus during infection by wild-type
and the 13S or 12S viruses is currently under inves-
tigation. Although defective for lytic functions in
human cells, the 12S virus transforms baby rat kid-
ney cells in culture at very high efficiency. Infec-
tion of these cells with the 13S virus, as with wild-
type E1A, results mainly in cell death.
We have recently constructed a 9S cDNA using
synthetic oligomers that span the splice junction.
The 9S cDNA has been placed under the control of
the mouse metallothionein promoter, and recombi-
nants with the ElA promoter in plasmids and in
whole virus are under construction. The role of the
9S product is being studied using the transforma-
tion and transient expression assays. In addition to
the "9S only" virus described above, a "9S minus"
virus is being constructed using oligonucleotide-di-
rected in vitro mutagenesis to alter the 9S splice
donor site in E1A. Current experiments are di-
rected toward the identification and purification of
the protein synthesized from the 9S mRNA.
To investigate the functions of the ElA products
in more detail, we are currently engaged in a mu-
tational analysis of their active sites. Using oligo-
nucleotide-directed and random mutagenesis in bac-
teriophage M13, we have obtained various point
mutations in the E1A gene or in the specific cDNA
clones. These mutations will be subcloned into
plasmids and viruses and assayed for their effect on
lytic, transforming, and gene-regulating functions.
Two-step Transformation of
Primary Cells
H.E. Ruley, J. Moomaw, K. Maruyama
During the past year, we have investigated the ge-
netic requirements for the oncogenic transforma-
tion of cultured primary cells. Work in other labo-
ratories has suggested that transformation of
primary cells by polyoma virus and by human ade-
noviruses requires the expression of at least two
viral functions. The first, an establishment func-
tion, is able to extend the life span of primary cells
in vitro, whereas the second, a transformation
function, is required for full expression of an on-
cogenic phenotype. Thus, establishment functions
expressed by adenovirus E1A or portions of the po-
lyoma virus large T antigen lead to the ability of
primary cells to grow indefinitely in culture. Ad-
ditional functions expressed by adenovirus E 1B or
the polyoma virus middle T antigen result in phen-
otypic changes characteristic of oncogenic trans-
formation, such as anchorage-independent growth
and the ability to form tumors when cells are trans-
planted into syngeneic animals. In contrast, trans-
formation of established cell lines can require fewer
viral functions. Thus, expression of the polyoma
virus middle T antigen alone is sufficient to trans-
form a variety of established cell lines. Apparently,
such cells constitutively express establishment
functions that can substitute for those of the virus.
The interaction between establishment and trans-
formation functions is poorly understood, as is the
mechanism by which they combine to elicit the
transformed phenotype.
Research in this area has addressed two ques-
tions. The first concerns the possibility of trans-
forming cultured primary cells by mixing and
matching viral establishment and transformation
functions. For example, would it be possible to
transform primary cells with a combination of the
adenovirus E1A and polyoma virus middle T anti-
gen genes? The second question concerns the abil-
ity of cellular oncogenes, isolated by virtue of their
ability to transform NIH-3T3 cells, to transform
cultured primary cells. Given the requirement for
at least two functions in the case of viral transfor-
mation, it seemed quite likely that cellular onco-
genes would also require two or more functions to
transform primary cells.
To address these questions, cloned viral and cel-
lular genes were introduced into primary cultures
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of baby rat kidney cells by coprecipitation with cal-
cium phosphate. Plasmid DNAs were introduced
both individually and in combinations to examine
potential interactions leading to oncogenic trans-
formation. The principal results from these studies
are summarized below:
1. The polyoma middle T antigen and the T24 Ha-
ras-1 genes are individually unable to transform
primary baby rat kidney cells. This result is par-
ticularly interesting given that these genes are
able to transform oncogenically a variety of es-
tablished cell lines.
2. The adenovirus E1A is able to provide functions
that enable these genes to transform primary
cells, indicating (a) that viral establishment and
transformation functions of polyoma virus and
adenovirus can be interchanged and (b) that cel-
lular ras oncogenes require additional functions
in order to transform primary cells.
3. A nonactivated c-Ha-ras-1 gene is unable to
transform even following cotransfer of E1A, in-
dicating that oncogene activation is necessary
but not sufficient for oncogenic transformation
of cultured primary cells.
Transforming Functions of Adenovirus
E1A Mutants
H.E. Ruley, K. Maruyama, J. Moomaw, T.
Grodzicker [in collaboration with E. Moran,
B. Zerler, M. Mathews, and R. Roberts]
During lytic infection, E1A transcripts are differ-
entially spliced, generating coding sequences for
three related proteins. Two of these are synthesized
in adenovirus-transformed cells: Proteins contain-
ing 289 and 243 amino acids are synthesized from
13S and 12S mRNAs, respectively. The metabolic
functions of the E1A proteins remain largely ob-
scure. The larger of these proteins expresses E1A
functions that are required for the transcriptional
activation of the other adenovirus early-region
genes, whereas no specific function has been at-
tributed to the smaller protein. Activities attributed
to the E1A region include (1) an establishment
function that leads to the ability of primary cells
to grow indefinitely in culture; (2) activities that
produce cell-cycle effects, such as the induction of
mitosis in quiescent cells and the induction of
chromosomal aberrations; and (3) effects on or
stimulation of the transcription of a variety of cel-
lular genes. Whether any of these activities of E1A
are related to one another is presently unknown.
To probe the function of E1A in transformation,
plasmids containing mutations in E1A were trans-
fected into primary baby rat kidney (BRK) cells
alone and together with the polyoma middle T an-
tigen and T24 Ha-ras-1 genes. Sequences con-
taining two E1A mutations, from Ad5hrl and
Ad5hr440 viruses, were cloned by D. Solnick (In-
stitute of Cell and Tumor Biology, Heidelberg). hrl
contains a deletion within the intron of the 12S
mRNA, resulting in the synthesis of a truncated
form of the 289-amino-acid protein while having
no effect on the 243-amino-acid peptide. hrl is de-
fective in E1A functions required to activate the
transcription of the other adenovirus early-region
genes. hr440 contains two base changes that abol-
ish processing of 12S mRNA; consequently, the
243-amino-acid protein is not made. This lesion
also introduces a termination codon in the reading
frame of the 13S mRNA, resulting in the synthesis
of a truncated form of the 289-amino-acid protein.
Both hrl and hr440 plasmids express E1A estab-
lishment functions. Transfection of either plasmid
alone into primary BRK cells gives rise to cells with
extended growth potential in vitro, from which es-
tablished cell lines can be isolated. hrl is able to
provide functions required by both the polyoma
middle T antigen and T24 Ha-ras-1 genes to trans-
form primary BRK cells; however, the T24 Ha -ras/
hrl cotransformants are not tumorigenic in synge-
neic rats. hr440 is able to provide the functions re-
quired by the T24 Ha-ras gene for transformation
but is unable to assist the polyoma middle T antigen
gene in transformation. Despite this limitation, T24
Ha- ras /hr440 cotransformants are tumorigenic in
syngeneic rats.
Plasmids separately expressing the 12S and 13S
mRNAs have been constructed. Both plasmids ex-
press E1A establishment functions and both enable
the polyoma middle T antigen and T24 Ha-ras genes
to transform primary BRK cells. These results sug-
gest the following: (1) The activity of E1A required
for transformation of primary cells by viral and
cellular transforming genes is linked to establish-
ment functions and is not linked to E1A functions
required for transcriptional activation of the other
adenovirus early-region genes. (2) The establish-
ment functions of E1A are located in the aminoter-
minal portion of the E1A proteins common to both
the 12S and 13S products. (3) Although it is possi-
ble to mix and match establishment and transfor-
mation functions to a broad extent, certain combi-
nations do not work. The reasons for this are not
understood.
Establishment Functions of the
v-myc Oncogene of MC29 Virus
H. E. Ruley, J. Moomaw, K. Maruyama
Since E1A is a viral gene, the question arises as to
whether there are cellular genes that express activ-
ities similar to those of E1A that are important in
malignant transformation. A candidate for such a
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gene is myc, which is activated in a variety of tu-
mors, and yet myc is unable to transform NIH-3T3
cells. Consequently, the v-myc gene of MC29 virus
was tested for establishment functions either by
leading to the ability of primary baby rat kidney
cells to grow indefinitely in culture or by providing
the transforming functions required by the T24 Ha-
ras-1 gene. The v-myc gene was found to express
both activities, providing further evidence that
where primary cells are concerned, the require-
ment for separate establishment and transformation
functions reflects a basic mechanism of oncogenic
transformation. The fact that proteins made early
during the lytic infection by oncogenic DNA vi-
ruses express activities similar to those expressed
by oncogenes activated in certain human tumor cells
supports the conviction that the study of the onco-
genic DNA viruses will provide basic knowledge
concerning the mechanisms of oncogenic transfor-
mation.
Regulation of Viral Gene Expression:
Anti-death
T. Grodzicker, H. E. Ruley
We have also investigated the ability of mutant ad-
enoviruses to transform primary BRK cells. Ad5hrl
is defective in E1A functions required for the tran-
scriptional activation of the other viral early-region
genes and, consequently, is much less cytotoxic
than wild-type virus on primary BRK cells. Ad5hrl
also expresses E1A establishment functions as evi-
denced by the high frequency with which Ad5hrl
induces colonies of cells with extended growth po-
tential in vitro. Ad5hr440 also contains a mutant
E1A region; however, the viral early regions are
expressed to a much greater extent than in Ad5hrl.
As a result, Ad5hr440 is cytotoxic to an extent that
obscures detecting the establishment functions of
he virus. We investigated the ability of Ad5hr 1 and
Ad5hrA to complement for transformation of pri-
mary BRK cells, reasoning that the establishment
activity of Ad5hrl might complement the activation
of E 1B by Ad5hr440. We were surprised to find
that the establishment activity of Ad5hrl was dom-
inant over the cytotoxicity of Ad5hr440 (we have
called this activity of Ad5hr 1 anti-death). d1312 (a
mutant lacking E1A) failed to suppress Ad5hr440,
indicating that the interference by Ad5hrl was not
due to viral interference. In coinfection experi-
ments in HeLa cells, Ad5hrl was able to suppress
the induction of the 72K DNA-binding protein by
both hr440 and wild-type viruses, as judged from
immunofluorescence. These results suggest that an
activity associated with Ad5hrl is able to repress
the expression of adenovirus early-region genes.
Mutant adenoviruses expressing only the 12S E1A
ye in a manner similar to that of Ad5hrl,
suggesting that the anti-death activity results from
expression of the 12S E1A RNA and not from the
VIRAL VECTORS
Work on the development and use of eukaryotic
viral vectors has continued this year. The major
systems used are adenovirus and retrovirus vectors.
A variety of genes have been inserted into these
vectors, and the resulting viruses have been used
for several purposes, including overproduction of
proteins in mammalian cells; investigation of the
biological role of inserted gene products and their
controlling elements; study of the controlling ele-
ments, signals for RNA processing, and translation
of the viral vectors themselves; and integration of
vectors into mammalian cells to establish cell lines
producing gene products of interest.
Expression of Foreign Eukaryotic Genes
from Adenovirus Promoters and
Controlling Elements
M. Yamada, M. Merle, T. Grodzicker
We reported last year studies of the SV40 A gene
inserted into adenovirus as a model system for
studying adenovirus late gene transcriptional and
translational regulation. We also wanted to con-
struct viruses that would produce large quantities
of SV40 T antigen that could be easily purified and
used in biochemical studies (Thummel et al., Cell
23: 825 [1981]; Thummel et al., J. Mol. Appl. Ge-
net. 1: 435 [1982]; Thummel et al., Cell 33: 455
[1983]). These studies showed that the SV40 A gene
lacking its own promoter is transcribed very effi-
ciently when the gene is positioned in adenovirus
so that it is controlled by the strong adenovirus ma-
jor late promoter. Furthermore, the T-antigen pro-
tein is expressed at a high level when the A gene is
located in the third segment of the late tripartite
leader; in this case, the T-antigen mRNA that was
efficiently translated in vivo carried almost the en-
tire tripartite leader and the wild-type SV40 initia-
tion codon.
The following features are essential for con-
structing a hybrid virus in our vector system: (1)
Expression of the SV40 T-antigen helper function
for growth of adenovirus in monkey cells. Adeno-
virus grows well in human cells but very poorly in
monkey cells. This block can be overcome if SV40
T antigen is expressed in adenovirus-infected mon-
key cells. Thus, we can select and amplify hybrid
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truncated protein product of the 13S El A RNA
synthesized by Ad5hrl. The nature of the interfer-
ence by the 12S E1A product is being investigated.
adenoviruses that express T antigen. Furthermore,
if the SV40 A gene has been previously linked to
another foreign gene, the hybrid virus containing
the foreign gene can be selected by the same mech-
anism. (2) Use of in vivo as well as in vitro recom-
bination for construction of hybrid viruses. There
are no convenient unique restriction sites that can
be used to insert an exogenous gene in the third
segment of the tripartite leader downstream from
the adenovirus major late promoter. The starting
material is a plasmid containing adenovirus DNA
linked to the foreign gene that is lacking its own
promoter. The joint between the adenovirus DNA
and the foreign gene is at a position on the adeno-
virus genome (the third leader) where we want the
foreign gene to be located in the hybrid virus to be
constructed. Downstream from the gene (if it is a
gene other than the SV40 A gene) are sequences
that code for SV40 T antigen (including the SV40
early promoter). The entire insert is ligated to Barn-
digested adenovirus DNA. The resulting molecule,
which has normal adenovirus ends, contains a du-
plication of adenovirus DNA (in the left arm of the
vector and the insertion). Such molecules, once in-
troduced by transfection into 293 cells along with
wild-type helper DNA, may recombine, leading to
excision of the intervening DNA and placement of
the foreign gene at the desired and predetermined
location.
Integration and expression of the herpes simplex
virus type I thymidine kinase gene and the human
a-chorionic gonadotropin gene in adenovirus vec-
tors. The thymidine kinase (tk) gene of herpes
simplex virus type I (HSV) and the human a-cho-
rionic gonadotropin (a-HCG) gene were chosen as
representative exogenous genes. The tk gene con-
tains no introns, whereas the coding sequences for
a-HCG contain the two introns (Fiddes and Good-
man, J. Mol. Appl Genet. 1: 3 [1981]). The coding
sequences of these genes were separated from their
promoters, ligated at their 5' ends with a segment
derived from adenovirus for proper insertion into
the virus, and also ligated at their 3' ends with the
SV40 A gene for production of helper function.
These manipulations were carried out in plasmids
in Escherichia coli. The fragment carrying a piece
of the adenovirus-exogenous gene-SV40 A gene
was ligated with adenovirus DNA, mixed with
helper DNA, and transfected into 293 cells. The
hybrid viruses were grown in monkey cells to se-
lect viruses that express T antigen. After trying
many arrangements of the gene order and junction
point, we have so far obtained four hybrid viruses
containing either the tk gene (one) or the a-HCG
gene (three) that produced Tk or a-HCG, respec-
tively. In all cases, the exogenous gene was posi-
tioned in the third leader sequence, and the SV40
T-antigen gene had its own promoter. There were
no other ATG codons in the 5' end of the presumed
mRNA before the authentic starting codon. The
length of the exogenous DNA was 2.4 kb for the tk
gene, 4.5 kb for full-length genomic a-HCG, 3.3 kb
for the a-HCG gene with a deletion of its poly(A)
site, and 1.5 kb for the a-HCG gene with both a
deletion of the poly(A) site and a deletion of part
of an intron. Each of the DNAs, along with a 3.1-
kb insert of SV40 T-antigen DNA, replaced 11.9 kb
of adenovirus DNA from 26.5 to 59.5 map units, as
expected. There may be little preference in the
length of exogenous DNA to be inserted. On the
other hand, the presence of a poly(A)-addition sig-
nal in the a-HCG gene affected the propagation of
hybrid virus. The proportion of the hybrid virus
with a poly(A) site was estimated as 1 -5% of the
population, as judged from plaque formation on
CV-1 monkey cells and HeLa cells. In contrast, the
hybrid virus that did not contain a poly(A) site in
the a-HCG gene comprised 10 -30% of the viral
population.
The following results concerning foreign gene
expression have been obtained. (1) Hybrid viruses
containing the tk gene (Ad-SVR-TK): Ad-SVR-TK
produced, in the late stage of infection, a 1.55-kb
mRNA that hybridized with a tk probe. This size
corresponds to an mRNA containing the first, sec-
ond, and part of the third tripartite leader se-
quences and the coding sequence of tk. It suggests
that the tk gene was controlled by the major late
promoter of adenovirus, and its mRNA was pro-
cessed in the same way as normal adenovirus late
mRNAs. The virus produced 2-5 times more tk ac-
tivity in CV-1 monkey cells at late times after infec-
tion than is found in cells infected by HSV. A poly-
peptide with an apparent molecular weight of
47,000, which is indistinguishable from that pro-
duced by HSV, could be precipitated with anti-tic
antiserum from infected cells. (2) Hybrid viruses
containing the a-HCG gene (Ad-SVR-HCG): Three
hybrid viruses isolated showed the same properties
with respect to the expression of the protein. At
late stages of infection of CV-1 cells, polypeptides
with apparent molecular weights of 21,000, 16,000,
15,000, and 12,000 could be detected in the cyto-
plasm by immunoprecipitation experiments using
anti-a-HCG antiserum. Only extremely low levels
of polypeptide could be detected in the culture su-
pernatant by immunoprecipitation. Uninfected CV-1
cells did not produce a-HCG. HeLa cells synthe-
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size a-HCG endogenously; the molecular weights of
the polypeptides are 20,000 and 16,000 in the cy-
toplasm, and a 22,000-molecular-weight form is
secreted into culture medium. The amount of these
products increased severalfold in late stages of in-
fection with the hybrid virus, but the ratio among
the three species was constant. This fact indicated
that the virus-coded a-HCG was expressed and gave
the same products as the endogenous ones. The dif-
ferent molecular-weight species probably represent
differently glycosylated forms of a-HCG. These
experiments indicated that there was a cell-line
specificity for secretion of a-HCG.
These results indicate that our adenovirus vector
system works well to express the exogenous genes
and produce their protein products. Furthermore,
we found several interesting phenomena in the
course of these experiments. For example, the level
of expression of the endogenous tk and a-HCG was
affected by adenovirus infection. Also, as men-
tioned above, there is cell-line specificity for gly-
cosylation and secretion of a-HCG. We are contin-
uing to analyze these phenomena in various ways.
Expression of polyoma T antigens in adenovirus.
In collaboration with R. Tjian and S. Mansour
(University of California, Berkeley), we are study-
ing the expression and production of polyoma T an-
tigens expressed from the adenovirus major late
promoter. These studies are being conducted in or-
der to produce large quantities of protein in in-
fected cells so that the T antigens can be analyzed
and purified.
Using the methods described above, a segment of
the polyoma early region that codes for large, mid-
dle, and small T antigens has been removed from
its promoter and joined to a segment of adenovirus
DNA so that they are joined at a position in the
middle of the third segment of the tripartite leader.
The SV40 A gene containing its promoter is located
at the 3' end of the polyoma DNA, and the entire
insert is cloned in a pBR-derived plasmid and
grown in E. coli. The insert is excised and inserted
into adenovirus as described above. Hybrid viruses
are grown in CV-1 cells.
Hybrid viruses have been isolated that contain
polyoma DNA in the desired position. CV-1 cells
infected with the virus synthesize polyoma large T
antigen, as determined by indirect immunoflu-
orescence using anti-polyoma T antisera. Immu-
noprecipitation of infected cell extracts with these
antisera shows that the hybrid virus synthesizes
middle and small T antigens as well as large T an-
tigen. The proportion of these antigens relative to
one another is different from that found in po-
lyoma-infected mouse cells. Regardless of whether
HeLa or CV-1 cells are infected with the hybrid vi-
rus, there is a large amount of middle and small T
antigens and small amounts of large T antigen pro-
duced. We wish to investigate whether this is due
to prererentiar splicing of polyoma-containing
RNAs in adenovirus-infected cells. We previously
found that in our adenovirus vectors containing the
SV40 A gene, much more large-T-antigen mRNA
was produced than small-T-antigen mRNA and that
the proportion of these mRNAs relative to one an-
other differed from that found in SV40-infected
cells.
We have also constructed viruses made with po-
lyoma DNAs that code for only large T antigens
(from R. Kamen, Genetics Institute). These viruses
produce large, but not middle or small, T antigen,
as determined by immunoprecipitation of infected
cell extracts. They clearly produce more large T
antigen than is found in polyoma-infected mouse
cells.
Retroviral Vectors
S. Hughes, E. Kosik, J. Sorge
When compared with other vector systems that can
be used either in vivo or in cultured cells from the
higher eukaryotes, retroviruses offer several ad-
vantages. Since retroviruses are the only naturally
occurring vectors in higher eukaryotes, it is reason-
able to expect that they can be readily adapted as
vectors capable of accepting a wide variety of in-
serts. Retroviral genomes are small, making it rel-
atively easy to manipulate a cloned DNA copy of
the genome. The viruses are efficient; in culture,
essentially all of the cells can be infected. Retrovi-
ruses are nonlytic; infection has little or no effect
on cultured cells. Certain strains of virus have little
or no effect on the intact animal. Since the viral
genome integrates into the host genome, the prog-
eny of a single infected cell are all infected, and the
provirus is in the same place in the genome of each
of the progeny cells. Infection is self-limiting; each
infected cell usually acquires 1-5 copies of the viral
genome. Intervening sequences can be removed
from genomic inserts cloned into a retroviral vec-
tor upon passage of the recombinant virus in cul-
tured cells. Retroviral vectors have considerable
potential for in vivo use, both for short-term infec-
tions and for insertion into the germ line.
Unfortunately, there are also some disadvan-
tages. Retroviruses, and the vectors derived from
them, are relatively unstable. When a helper virus
is present, there is extensive recombination, and
even in the absence of a helper, internal rearrange-
ments are frequently seen. The total size of the vec-
tor, including both the viral and nonviral se-
quences, is limited to about 10-11 kb.
For several reasons, we have chosen, at least in-
itially, to work with helper-independent retroviral
vectors. Helper-independent vectors offer certain
advantages. There is no requirement for a helper
(cell or virus), and, in general, this gives a signifi-
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cant increase in stability. There is no requirement
for the vector to carry a selectable marker. As long
as the helper-independent construction is itself sta-
ble, any sequence inserted into the vector will be
passively carried to all infected cells as a part of
the viral genome. There are also disadvantages. The
size of insert that can be introduced into the vector
is further reduced. Our vectors can accept cDNAs
about 2 kb in length. At least initially, helper-in-
dependent vectors are confined to the avian system.
The avian system, however, has two advantages:
Culturing a variety of different types of primary
cells is trivial, and birds, both chickens and related
species, are available that completely lack endoge-
nous viruses homologous to the avian sarcoma-leu-
kosis viruses.
Vector construction. With the above considera-
tions in mind, we began to construct a family of
helper-independent retroviruses a few years ago.
All of the constructions are derived from the
Schmidt-Ruppin A (SRA) strain of Rous sarcoma
virus (RSV), and all the helper-independent con-
structions are based on the replacement of the cel-
lular oncogene, src, carried by RSV, with other
genes or sequences. In experiments initiated by J.
Sorge (who was a postdoctoral fellow in our labo-
ratory and is now at Scripps), a cloned copy of the
unintegrated circular DNA from the SRA strain of
RSV was manipulated in vitro to remove src. CIaI
linkers were inserted at the end points of the dele-
tions. Such vectors can both carry and express DNA
sequences inserted in place of src; however, there
is a problem with these constructions. In all known
RSV strains, the src gene is flanked by direct re-
peats about 110 by in length. Homologous recom-
bination (presumably during reverse transcription)
results in the frequent loss of src in wild-type RSV.
It is hardly surprising that the vector constructions
lose their inserts by the same route. We chose to try
to eliminate one of two 110-bp direct repeats. This
ultimately led to a series of experiments that tested
the function in RSV of the regions lying between
env and src and between src and the long terminal
repeat (LTR) (Sorge and Hughes, J. Virol. 43: 482
[1982]; Hughes and Kosik, Virology [1984, in
press]; J. Sorge and S. Hughes, unpubl.). The con-
clusions of this work are summarized below.
One copy of the direct repeat sequences must be
retained for the virus to replicate; however, it is
possible to eliminate the region of homology flank-
ing src, either by eliminating the upstream copy of
the direct repeat or by removing a small portion of
the upstream copy and most of the downstream
copy. To express src, or another gene inserted in
place of src, there must be an appropriate splice
acceptor. A partially synthetic splice acceptor can
be substituted for the naturally occurring splice ac-
ceptor. Most of the segment of unknown origin
(which we call E.T.) that lies just upstream of src
in the SRA strain of RSV can be deleted without
interfering with viral replication or with src
expression.
RNA splicing. The available constructions can be
used for several purposes. Splicing has been stud-
ied with genomic inserts derived from both a ho-
mologous host (chick aD globin; Fischer et al.,
Proc. Natl. Acad. Sci. [1984, in press]) and a non-
homologous host (human a-HCG; Sorge and
Hughes, J. Mol. Appl. Genet. 1: 547 [1982]). In-
trons are removed from the genomic inserts rela-
tively slowly. The two introns present in the chick
aD globin are processed at different rates; viruses
can be found that have one of the two introns re-
moved (Fisher et al., Proc. Natl. Acad. Sci. [1984,
in press]). It may be possible to use these construc-
tions to examine splicing intermediates.
Since the virus replicates normally whether or not
the src gene is expressed, the src splice acceptor
can be modified and the effects on src expression
analyzed. We have successfully substituted a new
splice acceptor for the splice acceptor originally
present in RSV. Three closely related construc-
tions, which vary in the region ten bases upstream
of the new splice acceptor, fail to express src. Such
constructions not only are potentially useful vector
constructions, but also provide information about
splicing.
AUG choice in initiation. The vectors can also be
used to study how ATG codons are selected during
initiation. The four RSV messages gag, gag-pol,
env, and src are all derived from a full-length tran-
script. All four messages contain the same 5'-leader
segment. Three of the messages, gag, gag-pol, and
env, use the same ATG to initiate translation. The
src ATG initiation codon lies 3' to the gag ATG in
the spliced src mRNA. For the src ATG to be used
efficiently in initiation there must be, in the com-
pleted message, a termination codon in frame with
the gag ATG. A virus (1057 CGA) has been derived
by oligonucleotide-directed mutagenesis that has
this particular termination codon (TGA) altered to
CGA. The 1057 CGA virus initiates src translation
at the gag ATG. Cells infected by the mutant show
a spindle-shape morphology distinct from the
rounded morphology of cells infected with the wild-
type SRA strain RSV (S.H. Hughes et al., unpubl.).
The 1057 CGA mutant specifies a src protein of
63,000 daltons, which is currently being studied in
J. Brugge's laboratory (SUNY, Stony Brook).
Expression of foreign genes. The vectors nonse-
lectively express genes whose coding region is less
than 2 kb (v-src and Tn5 neo have been tested; pre-
sumably, any other would also work). The vector
derivatives are much more convenient for site-di-
rected mutagenesis of src than is wild-type RSV,
since in the vectors, src can be moved in and out of
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the virus via Clal sites. (These experiments are
being done in J. Brugge's laboratory.) In theory, the
vectors can be used to study mutants of any gene
whose coding region is less than 2 kb.
New vectors. In addition to the vector construc-
tions already tested, we are currently working on a
construction that will supply an initiation ATG to
inserts that lack an ATG appropriate for translation
initiation. Several different experiments would
benefit from such a construction. For example, with
such a vector, most or all of the retroviral portion
of viral oncogene fusions could be removed; in ad-
dition, we have large Escherichia coli expression
libraries that contain cDNAs inserted into the lac
expression plasmids pUC8 and pUC9 (see Stuc-
tural Studies in the Mammalian Cells Section). The
majority of the plasmids we have isolated and char-
acterized as expressing a portion of a particular
protein in E. coli contain cDNA inserts that lack
the 5' end of the coding region. In some cases, there
are reasons to express these incomplete genes in
chick cells as well as in E. coli. For these experi-
ments, the initiating ATG must be supplied by the
retroviral vector.
We could make constructions that would initiate
either at the gag ATG or at the src ATG. There are
several reasons to think that the src ATG construc-
tions will be better, and they will be tried first. The
advantages and uses of such constructions are dis-
cussed below.
There is a simple route by which the reading
frame of the retroviral vector constructions can be
made to match the reading frame of pUC8 and
pUC9. In such a system, a cDNA that is in frame
in the E. coli vector will, perforce, be in frame upon
insertion into the retroviral vector. Since the src
ATG is a part of an NcoI site (CCATGG), the vector
can be designed to add only 2-3 amino acids onto
the amino terminus of the protein.
Although there are obvious limitations, such a
system can be used to assay functional domains in
proteins made from the same DNA fragment both
in E. coli and in chick cells. Mutants can be made
with the insert in the pUC plasmid and a prelimi-
nary screen done with the protein that is synthe-
sized in E. coli. Potentially interesting mutants can
be transferred directly into the retroviral vector for
a more complete analysis in chick cells.
In vivo retroviral vectors. Although the vectors
that have already been described lack an oncogene,
these vectors are still oncogenic and can activate
the endogenous oncogenes c-myc and c-erbB. Al-
though such constructions are suitable for a variety
of experiments in cultured cells and possibly even
for some experiments in vivo, they may not be well
suited for long-term in vivo experiments or for in-
sertion into the germ line. The related endogenous
virus RAV-0 is not oncogenic. We have replaced the
avian leukosis virus (ALV) LTR of the vectors with
the RAV-0 LTR and, in collaboration with L. Crit-
tenden (USDA Poultry Laboratory, Michigan), have
shown that these recombinant viruses have little or
no tumorigenic potential in vivo. Because only the
LTR is replaced, essentially all of the ALV vector
derivatives can be readily converted to nononco-
genicity.
In addition to providing prototype in vivo vec-
tors, these constructions locate the sequences re-
sponsible for the difference in the oncogenicity of
the two viruses. Work from other laboratories (P.A.
Luciw, H.E. Varmus, J.M. Bishop, and M.R. Ca-
pecchi, unpubl.) suggests that the RAV-0 LTR lacks
an enhancer. We have subcloned the murine leuke-
mia virus (MLV) enhancer to test its effect on rep-
lication, expression, and oncogenicity of the ALV/
RAV-0 recombinants. If the RAV-0/ALV recombi-
nants lack a functional enhancer, they may also be
useful for cell-type-specific promoter assays (see
below).
Since the ALV/RAV-0 recombinants appear to
have a weaker "promoter" (lack of an enhancer?)
than the ALV vectors, the ALV/RAV-0 recombi-
nants should express inserts at lower levels. This is
being tested with v-src and Tn5 neo inserts. In many
cases, viruses that express a particular gene prod-
uct at various levels would aid in the analysis of the
gene product. For example, such a system could be
used to ask questions about threshold levels of on-
cogene products required for transformation.
Crittenden's laboratory is trying to define condi-
tions for efficient germ-line infection in chickens.
We have agreed to supply nononcogenic recombi-
nants for these experiments. If techniques can be
developed that permit the ready introduction of re-
troviruses into the germ line of chickens, the non-
oncogenic vectors will be most useful; however, the
retroviral vectors can be used to introduce genes
into the intact animal without germ-line integra-
tion.
Foreign promoters. In addition to analyzing the
proteins, it is possible that retroviral vectors can be
used as vehicles for testing whether particular DNA
segments are capable of initiating tissue-specific
RNA expression. There are numerous ways in
which such experiments can fail; however, some
modest test is warranted. We may be able to avoid
one potential problem simply by using construc-
tions that have the ALV LTR (which contains an
enhancer) replaced by the RAV-0 LTR (which ap-
pears to lack an enhancer). Initially, we plan to
compare two promoters, the chicken 0-actin pro-
moter, which we have isolated and characterized
(Kost et al., Nucleic Acids Res. 11: 8287 [1983]),
and the chicken a-actin promoter, isolated and pro-
vided on a collaborative basis by C. Ordahl (Uni-
versity of California, San Francisco). Such pro-
moters will be inserted into the retroviral vectors
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linked to a segment whose expression can be read-
ily monitored at the protein or the nucleic acid
level. The retroviral vectors can be introduced into
a variety of cell types in culture and the cells
checked for tissue-specific expression of the test
segment that was attached to the cell-type-specific
promoter. It may be useful to insert the promoter
and the test sequence in the orientation opposite to
the direction of transcription of the retrovirus, to
avoid confusion from transcripts arising from the
retrovirus.
Helper-free Adenovirus-5 Vectors
K. Van Doren, D. Hanahan, Y. Gluzman
Last year we reported the construction of helper-
independent adenovirus-5 (Ad5) vectors and the
cloning of several different genes in recombinant
helper-independent viruses. These genes included
(1) an SV40 T-antigen-coding region under control
of the Ad2 major late promoter, (2) a wild-type or
replication-defective SV40 early region with its
own promoter, or (3) a neomycin resistance gene
from Tn5 under control of the SV40 promoter.
Since then we have constructed recombinant vi-
ruses carrying (4) an SV40 T-antigen-coding re-
gion under control of the Ad2 major late promoter,
including most of the tripartite leader that normally
precedes all late adenovirus messages, (5) cDNA of
SV40 large T antigen under control of the Ad2 ma-
jor late promoter, and (6) cDNA of SV40 large T
antigen under contol of the SV40 early transcrip-
tion unit.
The biological properties of these genes were
evaluated in a variety of assays. During lytic infec-
tion of 293 cells with recombinant viruses carrying
the cDNA encoding SV40 large T antigen under
control of either the Ad2 major late or SV40 early
promoter, mRNAs were made and translated into
protein. Both mRNA and protein levels were three-
to fivefold lower than those of their wild-type
counterparts. Nevertheless, this result indicates that
this vector can be used to express certain cDNA
constructs.
Infection of 293 cells with the recombinant virus
carrying SV40 T-antigen-coding sequences under
control of the Ad2 major late promoter, including
most of the tripartite leader, results in production
of large quantities of SV40 T antigen. Comparison
with a similar construct of T antigen under control
of the Ad2 major late promoter, but containing only
half of the first leader (of the late tripartite leader),
reveals that the first construct is more efficient than
the latter one. These data are in agreement with the
work of others (Thummel et al., Cell 33: 455 [1983])
and indicate that the presence of the tripartite leader
in front of mRNA in adenovirus-infected cells im-
proves the translatability of the messages.
Helper-independent adenovirus vectors carrying
either a selectable marker for neomycin resistance
(under control of the SV40 early promoter) or the
early region of SV40 (origin positive or negative)
integrate viral DNA into host-cell chromosomes in
the absence of adenovirus early region 1. This in-
dicates that viral functions encoded in early region
1 are not essential for the integration of viral DNA.
We have analyzed DNAs from CV-1 and Rat 2
cells transformed to neomycin resistance and from
MEF (mouse embryo fibroblasts), HS74BM (hu-
man fibroblasts), and REF52 (rat fibroblasts)
transformed by SV40 recombinant adenoviruses.
Neomycin-resistant CV-1 cell lines contained usu-
ally 1 but sometimes 2 copies of the viral genome
integrated colinearly with the infecting viral DNA.
These cells contained between 60 % and 100 % of
the infecting viral DNA integrated into host-cell
chromosomes. Rat 2 cell lines transformed to neo-
mycin resistance also incorporated full-length viral
genomes, colinear with the infecting viral DNA.
One to several copies of the recombinant viral
DNA molecules were integrated. Three of the five
lines analyzed contained the left and right ends of
the viral DNA linked together and viral genomes
arranged in a tandem array. Tandem arrays were
not observed in transformed CV-1 cell lines, sug-
gesting the involvement of a cellular factor in either
promoting or preventing interaction between viral
DNA molecules. HS74BM cell lines established
from transformation using origin-defective SV40
recombinant viruses contained 1-2 copies of viral
DNA integrated in the host genome. The integrated
copies in these cell lines appear to be full length
and colinear with the infecting viral DNA, as was
observed with the neomycin-transformed cells.
SV40-transformed MEF cell lines contained 1-2
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full-length copies of viral DNA as described for
HS74BM transformants. The integration patterns in
these cell lines differed from those of the human
fibroblast lines in that some sequences had become
amplified in MEF cell lines and two of the eight
lines analyzed may contain the left and right ends
of the viral genome linked together, as observed
with the neomycin-resistant Rat 2 cell lines. Fur-
ther analysis of these cell lines is in progress.
We have recently begun to analyze cell lines es-
tablished from transformations of REF52 cells by
the SV40 recombinant viruses. Preliminary results
indicate that the integration patterns are different
in cell lines transformed by origin-positive SV40
recombinant viruses and those transformed by ori-
gin-defective viruses. Transformed cell lines of or-
igin-defective viruses, in general, contain fewer
copies of integrated DNA than cells transformed
with viruses carrying a functional SV40 origin of
replication. These data are the first we have ob-
tained to suggest that the SV40 origin of replication
may affect transformation in some nonpermissive
cell types. In addition, we have isolated cell lines
of baby rat kidney (BRK) cells transformed with
SV40 recombinant viruses alone or in conjunction
with neomycin recombinant viruses. It will be in-
teresting to analyze the integration patterns in the
cells to see what effect, if any, the origin of repli-
cation has had in these cells. It will also be of inter-
est to determine whether both the neomycin recom-
binant viruses and the SV40 recombinant viruses
are treated the same in cells transformed by both
viruses. We also wish to examine whether the pres-
ence of early region 1 will change the integration
pattern during nonlytic infections with these re-
combinant viruses.

MAMMALIAN GENETICS
Mouse t Haplotypes: A Model System
for Understanding the Organization,
Expression, and Evolution of the
Mammalian Genome
L.M. Silver, V. Bautch, L. Cisek, H. Fox,
C. Jackson, M. Krangel, D. Lukralle,
P. Mains, N. Sarvetnick
Mouse t haplotypes are naturally occurring, highly
variant forms of a region of mouse chromosome 17
that has multiple and interacting loci with profound
effects on embryogenesis and sperm differentia-
tion. The t haplotypes maintain themselves as dis-
crete genomic entities through recombination
suppression, and these chromosomal units are
propagated through wild populations by a male-
specific transmission ratio distortion in their favor.
Our understanding of t haplotypes has undergone
radical changes over the last 5 years, and it is now
possible to focus research efforts in attempts to an-
swer specific questions through the combined use
of molecular and genetic techniques.
t haplotypes represent a common polymorphism
(often present at a level of 20%) in house mouse
populations from all over the world and have been
found in three separate commensal species, Mus
domesticus, Mus musculus, and Mus molossinus,
that evolved apart between 1 and 2 million years
ago. A complete t haplotype is operationally de-
fined as one that suppresses recombination in +It
heterozygotes, along the entire 12-cM region of
chromosome 17 encompassing T and the H-2 com-
plex. In general, t haplotypes recovered from wild
mouse populations are complete. However, sup-
pression of recombination is not absolute -rare re-
combinants have been isolated in the laboratory and
are referred to as partial t haplotypes. These partial
t haplotypes are portions of a complete t haplotype
that continue to suppress recombination along their
length and express only a subset of the t-specific
properties.
Wild t haplotypes now appear to be genetically
and evolutionarily isolated from normal mouse
chromosomes, even as they coexist within the same
genome. These isolated genetic units are propagat-
ing themselves through mouse populations as self-
ish chromosomes without any obvious benefit to
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their hosts. The very existence of t haplotypes in
the mouse, and highly analogous genetic systems in
other species (e.g., SD in Drosophila, spore killer
in Neurospora, and pollen killer in tobacco), poses
important questions concerning genomic evolution
and the dynamics of chromosome polymorphism.
Knowledge of the structure and origin of t haplo-
types would certainly contribute to our understand-
ing of these broader biological questions. Further-
more, an understanding of the "natural" mech-
anisms by which t haplotypes have thwarted the
machinery of sperm differentiation to their advan-
tage would yield insight into the differentiation ma-
chinery itself. Finally, we hope that studies of em-
bryonic lethal genes will lead to a better under-
standing of normal embryogenesis.
Many of the molecular tools necessary for a con-
certed analysis of an isolated region of the mam-
malian genome are only now becoming available.
Although we have chosen to concentrate our efforts
on the t complex for the reasons just given, as an
added benefit, we expect many of our molecular
results to be indicative of general principles of
mammalian genome structure and function.
Isolation and Mapping of Random DNA
Clones of the t Complex
H. Fox, P. Mains
The pleiotropic effects of the t haplotypes indicate
that they have diverged from the corresponding
wild-type region of chromosome 17. As a result, it
is possible that the entire region, and not just the
relatively few genes in it so far identified, has di-
verged significantly from the wild type in arrange-
ment and DNA sequence. Indeed, M. Lyon (Medi-
cal Research Council, England) suggested that a
change in interstitial heterochromatin blocks re-
combination, and it has been proposed that t hap-
lotypes were introduced into the house mouse as an
introgression from another species.
To investigate these possibilities, as well as to
gain a molecular entrance into the t region, we are
collaborating with H. Lehrach's group (including
D. Rohme, B. Herrmann, A.-M. Frischauf, and
J.-E. Edstroem) at the European Molecular Biology
Laboratory in Heidelberg. They have obtained ran-
dom DNA clones of the region by microdissecting
the proximal half of chromosome 17 from meta-
phase chromosome spreads (chromosome 17 was
marked by a Robertsonian translocation). This
DNA was cloned into bacteriophage X in nanoliter
volumes and then subcloned into plasmids. These
are referred to as "microclones." To show that these
microclones were indeed from chromosome 17, we
have performed Southern blots using DNA from a
hamster-mouse hybrid cell line containing only
chromosome 17 of the mouse. Of 18 clones tested,
17 mapped to chromosome 17. Nine of these clones
were further mapped to the t region using 129.t
congenic mice. If a clone shows a restriction-frag-
ment-length polymorphism (RFLP) between 129
and 129.t mice, the clone must map to the only re-
gion that differs between the two lines -the proxi-
mal portion of chromosome 17. Similar analysis re-
vealed no RFLPs between any of the different t
haplotypes examined with 22 microclones, using an
average of three different restriction enzymes each.
However, there were no sequences present in wild
type that were absent in t, and the level of poly-
morphism between t and inbred strains is roughly
comparable to that between different inbred lines.
Thus, the t haplotypes appear to have a common
origin and have not radically diverged from other
mice at the nucleotide sequence level.
The microclones have been used to confirm that
the t complex is an extended region of the chro-
mosome rather than a single point. Rare recombi-
nants occur between t and wild-type chromosomes
at a 100-fold reduced frequency. Lyon used these
recombinants in an elegant genetic analysis of the t
complex. Different recombinant chromosomes,
termed partial t haplotypes, display different sub-
sets of the t phenotypes. By examining the cis and
trans interactions between different partial haplo-
types, she proposed that the T interaction factor and
the lethal factors mapped to single regions, sterility
resulted from the interaction of two separable re-
gions, and segregation distortion was controlled by
three regions. She derived a genetic map and de-
fined the crossover points for the partial haplo-
types. We have used RFLPs between t and wild type
to order the physical end points of the partial t hap-
lotypes. This physical map agrees with Lyon's ge-
netic map.
An a-Globin Pseudogene Maps
within the t Complex
H. Fox
The mouse a-globin gene family consists of three
"real" genes and two pseudogenes. With the use of
somatic-cell hybrids, it was found that one pseu-
dogene Hba-ps4 was located on chromosome 17. To
determine whether Hba-ps4 is located in the t coin-
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plex, we compared genomic DNA restriction pat-
terns from mice carrying a series of complete or
partial t haplotypes on the 129 background. We also
analyzed 11 inbred strains of mice and other wild-
derived ( + ) forms of chromosome 17. Restriction-
fragment-length polymorphisms were observed
when genomic DNA was digested with TaqI. All
wild-type forms of chromosome 17 carry one of two
alleles- either a single 3.4-kb fragment or a pair of
fragments of 3.8 kb and 1.4 kb. In contrast, all com-
plete t haplotypes carry an identical third allele of
Hba-ps4 represented by a single 5.2-kb TaqI re-
striction fragment. Analysis of partial t haplotypes
allowed the localization of Hba-ps4 to the distal
portion of the t complex.
Among the t haplotypes examined was t"°. This
t haplotype arose from t6 and was first identified by
the appearance of a tufted phenotype in a tf/th2°
mouse. For a number of reasons, Lyon suggested
that th2° carries a deletion within the t chromatin,
encompassing tufted as well as several other genes.
We have found that the th" chromosome carries no
a-globin pseudogene sequences; however, this
chromosome is not missing any other distally lo-
cated t-specific markers. Hence, it would appear
that th20 has deleted a small region of t chromatin
located near the distal edge of the t complex and
including the coat marker tf, the DNA marker Hba-
ps4, and an embryonic lethal gene called Kinky.
These three loci map close to one another in the
central t complex region of wild-type chromosome
17 (P. D'Eustachio [New York University], personal
communication for Hba-ps4 mapping).
Molecular Cloning of a t Complex
Structural Gene
N. Sarvetnick, L. Cisek, L.M. Silver
The t complex has been dissected biochemically
during the past several years in our laboratory. Two-
dimensional gel analysis has identified eight testic-
ular proteins (TCP-1 to TCP-8) that are specified
by this region of the mouse genome. Since t haplo-
types have profound effects on spermatogenesis, it
is likely that one or more of these proteins play a
crucial role. To investigate this possibility further
and obtain probes in the proximal region of the t
complex, we set out to clone TCP-1.
Using methods developed by J. Fiddes (Califor-
nia Biotechnology, San Jose), we constructed a
cDNA library starting with testis mRNA. The li-
brary was screened with several different radioac-
tively labeled probes. The probes were obtained by
sequential size fractionations of liver and testis
mRNAs. In vitro translations identified enriched
and nonenriched pools of TCP-1 message, and these
pools were reverse-transcribed and used as differ-
ential probes for the library. Utilizing what we
knew about TCP-1 message abundance and tissue
distribution, we made qualitative assessments from
the autoradiograms and selected 70 clones for fur-
ther analysis.
Northern blot analysis with a group of these con-
firmed the message length, and differential expres-
sion was inferred from the screen. DNA blotting
experiments with a hybrid hamster cell line con-
taining mouse chromosome 17 showed that two
clones of the first dozen checked indeed mapped on
chromosome 17. Hybrid-selection experiments with
one of these clones (testis RNA was hybridized to
immobilized clone DNA, eluted, and translated in
vitro) produced a band with a molecular weight be-
tween 61,000 and 64,000 on an SDS gel. The ac-
cumulated data strongly suggest that this clone
codes for the TCP-1 protein.
Further DNA blotting experiments were carried
out to identify restriction-fragment-length poly-
morphisms (RFLPs), which would then allow this
clone to be mapped within the t complex. Although
extensive, these experiments produced no RFLPs
between congenic lines. All strains examined pos-
sess several cross-hybridizing fragments, two map-
ping on another chromosome. A second set of blots
revealed a polymorphism between C3H, DBA, and
B6 inbred lines. We were therefore able to map cer-
tain alleles with recombinant inbred mouse DNAs
provided by the Jackson Laboratory. The B6/
DBA,C3H polymorphism is not surprising as B6 is
considered somewhat "speciated" from the other
inbred lines. However, we found the lack of RFLPs
between t/ + unexpected, as the suppression of re-
combination described by t geneticists over the
years led us to assume that there would be extensive
nonhomology between the chromosome-17 alleles.
We now realize that this view is narrow, as gross
rearrangements do not necessarily predict the de-
tection of polymorphisms on a local level. Further-
more, it would appear that the coding-sequence re-
gions identified by this clone are highly conserved.
Cross-hybridizing genomic clones have recently
been isolated from a library provided by H. Leh-
rach (European Molecular Biology Laboratory,
Heidelberg). Noncoding DNA could diverge more
readily, so hopefully a third series of blots might
allow RFLPs to be identified.
Studies are in progress to characterize this clone
further. Sequence analysis and expression in a pro-
karyotic vector system are the main focus. The lat-
ter efforts should produce an antibody that will tell
us more about TCP-1 intercellular localization and
its pattern of expression during spermatogenesis.
Recombinational Analysis of the
t Complex
P. Mains
The process of recombination, or crossing-over,
takes place during meiosis and results in the ex-
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change of genetic material between homologous
chromosomes. As a result, even though an individ-
ual inherited a certain combination of alleles on the
chromosomes from each parent, the combination
would be randomized in subsequent generations.
One property of t haplotypes is an inhibition of
crossing-over with wild-type chromosomes, which
causes the diverse set of phenotypes associated with
t to be locked together as a unit.
Recombination is dependent on homologous
chromosomes having the same order of genes; i.e.,
their genetic maps must be identical. The particular
order is for the most part unimportant; what mat-
ters is that they be the same. It has recently been
found that the coat marker tufted, tf, and the major
histocompatibility complex, H-2 (which itself is a
large gene family), are in opposite orders in t and
wild-type chromosomes. A chromosomal rearrange-
ment would explain why one t chromosome can
cross over with another, and one wild type can cross
over with another wild type, but t cannot cross over
with wild type. We are attempting to define pre-
cisely the chromosomal rearrangement between t
and wild type. These chromosomes may carry a
simple inversion or the rearrangement could be
complex, such as multiple overlapping inversions
or transpositions. A fine-structure genetic map of
both t and wild type will define the rearrangement.
Mice carrying chromosomes that show recombi-
nation between the markers T and tf (which map to
opposite ends of the t complex) are selected among
the progeny of females heterozygous for comple-
menting t haplotypes. These are then scored for
H-2 alleles by Southern blot analysis and for the
presence of lethal alleles by further breeding ex-
periments. We have currently isolated 29 recombi-
nant chromosomes. One of these crossovers oc-
curred within the H-2 complex and shows that genes
within the H-2 region are probably inverted with
respect to wild type.
We plan to extend the mapping analysis to in-
clude the chromosome-17 microclones. Because we
have not yet found any restriction-fragment-length
polymorphism between the parental t chromosomes
with the microclones, we plan to use a gel system
developed by L. Lerman (SUNY, Albany) that sep-
arates DNA fragments independently of size by the
use of a gradient of DNA denaturants. When a re-
striction fragment reaches a concentration of de-
naturants such that a portion "melts," it stops mi-
grating. Single-base-pair changes anywhere within
the melted region (usually 50-100 bp) can have a
profound effect on mobility. This should be a much
more efficient method of detecting polymorphisms
than by restriction fragment size. Thus, we hope to
increase the resolution of our map to detect com-
plex rearrangements by saturating the t region with
microclones as genetic markers. Currently, Leh-
rach is performing a similar recombinational anal-
ysis on wild-type chromosomes.
A long-term goal of this work will be the cloning
of the t lethal mutations. If enough microclones can
be mapped ( -100), a mutation could be localized
to a 200-kb region. It may then be feasible to clone
this area and attempt to rescue mutant embryos by
microinjection of oocytes. This approach may al-
low the cloning of a lethal allele without prior
knowledge of the gene product.
Genetic Analysis of Segregation
Distortion of the Mouse t Haplotypes
P. Mains
The t complex is one of the few exceptions to Men-
del's law of segregation. Normally, an organism
heterozygous for two alleles passes each to its off-
spring in equal frequencies. However, male mice
can transmit their t-bearing chromosomes to more
than 90% of their offspring. This phenomenon,
termed segregation distortion or transmission ratio
distortion, probably maintains the otherwise dele-
terious t chromosomes at high levels in wild popu-
lations.
M. Lyon proposed that segregation distortion is
controlled by three loci, one acting in cis and two
acting in cis or trans. Detailed analysis is ham-
pered by the fact that all complete t chromosomes
appear to carry identical (or at least very similar)
alleles at these loci; i.e., there are no polymorph-
isms to allow further genetic dissection. However,
wild-type chromosomes do show polymorphisms in
their interaction with segregation distortion. Both
linked and unlinked suppressors of segregation dis-
tortion are found in different inbred strains of mice
(this polymorphism has complicated the analyis of
segregation distortion, since most t chromosomes
are maintained as outbred stocks that are geneti-
cally heterogeneous). The fact that an allele can
suppress (or enhance) segregation distortion indi-
cates that it must interact with the t factors respon-
sible for the phenomenon. Therefore, analysis of
these loci in inbred mice may further elucidate the
mechanism of segregation distortion.
As a first step, we wish to map these suppressors.
Congenic 129.t' males (which show >90% trans-
mission of t) are being mated to females from a
variety of inbred mouse strains. The sons will then
be tested for the level of segregation distortion. The
F, males of the strains that show suppression will
then be backcrossed to 129, and those sons will be
tested. During a backcross, there is an equal prob-
ability that the suppressor or the permissive 129 al-
lele in the F, animal will be transmitted. Those sons
that happen to receive the suppressor(s) will show
no segregation distortion. The relative frequencies
of sons that show or do not show suppression in the
backcross generation will indicate the number of
unlinked suppressor loci present in the inbred
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strain. These suppressors can then be mapped
quickly by the use of the appropriate panel of re-
combinant inbred (RI) strains. These are inbred
mice that are derived from two different inbred
strains. The panel chosen will be such that one pa-
rental strain shows suppression while the other does
not.
Linked suppressors can be mapped by taking ad-
vantage of the fact that the H-2 complex maps
within the t complex. There exist a large number of
mouse strains derived from intra-H-2 recombina-
tion events between different inbred strains. By us-
ing the appropriate recombinants derived from pa-
rental strains in which one strain shows suppression
of segregation distortion while the other does not,
the suppressors can be mapped to subregions of
chromosome 17.
Genetic Analysis of Dosage Effects of
the Proximal Region of Chromosome 17
N. Sarvetnick, P. Mains
Two deficiencies within the proximal region of
chromosome 17 display peculiar breeding patterns.
One such chromosome, ThP shows a deletion of 3
cM. Offspring that acquire two copies of ThP die in
utero at the morula stage of embryogenesis. When
the deficient chromosome is acquired only through
the father, the resulting heterozygotes are normal
except for the short-tailed phenotype seen in all T
mutations. However, when the PP chromosome is
acquired through the mother, the heterozygous em-
bryos die 15 days after conception. Analysis of this
"maternal" effect is important because it may tell
us that the same chromosome acts differently when
it is derived from the egg or sperm. This nonequi-
valence of genetic material has been observed in a
few other instances and is reconciled most easily
by asserting that something is missing in the oocyte
that cannot be compensated for by the paternal gene
after fertilization.
A second chromosome showing the same mater-
nal effect as ThP has recently been identified by us
and H. Winking (Medical Institute at Lubeck, West
Germany). Biochemical studies indicate that the t'u'2
chromosome has lost the TCP-1 protein that maps
to this region, implying that it also has a deletion.
t'Ph2 arose as a recombinant between a complete t
haplotype and a "wild-type" chromosome 17. It ap-
pears that a deletion was introduced into this new
distal t haplotype chromosome as a result of une-
qual crossing over.
We have been interested in reversing the maternal
effect by manipulating the genetic backround of the
female harboring t'"" so that extra doses of a prox-
imal portion of chromosome 17 are provided. Dur-
ing the last several years, two-dimensional gel
analysis has enabled us to identify several other
partial t haplotypes that result from unequal cross-
ing-over and have duplications. Chromosomes that
duplicate TCP-1 should provide at least part of the
region missing from thth2. By utilizing these chro-
mosomes, we hope to determine when the region is
required and whether or not two doses in the egg
or sperm can rescue the embryo. A cross that at-
tempts to reverse the phenotype by providing two
doses of the proximal region in the sperm is as fol-
lows:
t'""/Ttf x th"tflth'tf (th45 has duplication)
(F) (M)
Rescued t'." offspring will have normal tails and be
nontufted. Similarly, another cross provides two
doses through the egg:
Th45tf/ t'ub2 x + tf/ + tf
(F) (M)
By looking for nontufted progeny, we can score for
the rescue of the maternally derived t' °b2 embryos.
During oogenesis, half the chromosomes are set
aside in polar bodies that can no longer contribute
genetic information to the egg. If this is the critical
period for the maternal effect, then the genes in the
polar body will not be available to rescue the egg.
However, a proximal duplication can accompany a
t'ub2 chromosome if crossing-over occurs. We could
monitor this by marking a chromosome with a Rob-
ertsonian translocation that could be visualized by
cytogenetic techniques. Such a genetic configura-
tion will allow us to score recombination anywhere
between the centromere and the tufted marker. If
the 0'2 offspring are observed and are all recom-
binants, this would imply that the region is required
after the first meiotic division.
Two-dimensional Protein Patterns of
Embryos with Lethal t Haplotypes
V.L. Bautch, M. S. Krangel
Mice that are homozygous for certain t haplotypes
die during embryogenesis as a consequence of le-
thal genetic factors within the t complex DNA.
Each complete t haplotype is associated with a spe-
cific lethal genetic factor, and each factor causes
morphological abnormalities and death at a differ-
ent stage in mouse development. The nature of
these lethal genetic factors is not known. In an ef-
fort to identify the products of these factors and to
understand their role in development, we are com-
paring the two-dimensional protein patterns of nor-
mal embryos with those containing one (heterozy-
gous) or two (homozygous) doses of the lethal
factors. This work utilizes the QUEST system di-
rected by J. Garrels (see Structural Studies in the
Mammalian Cells Section). Embryos with each of
these genotypes are all found in litters resulting
from mating a male and female that are both het-
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erozygous for the same t haplotype and associated
lethal factor. Embryos at different developmental
stages are dissected from the uterus, labeled in vi-
tro with ["S]methionine, and analyzed by high-res-
olution two-dimensional gel electrophoresis. The
genotype of each embryo is determined after elec-
trophoresis by the presence or absence of allelic
forms of a t-complex-specific protein (TCP-1 or
p63/6.9) in the two-dimensional gel pattern. The
embryos carrying t haplotypes are congenic on a
standard inbred background. This means that the
DNAs of normal and mutant embryos differ only in
the portion of chromosome 17 that contains the t
complex, and that a comparison of the two-dimen-
sional gel patterns of these staged embryos should
yield only those protein polymorphisms that result
from the lethal factors or other t-specific genes.
Different t haplotypes are remarkably similar in
terms of DNA structure and protein polymorph-
isms; therefore, the differences in two-dimensional
gel patterns of embryos carrying different t haplo-
types should reflect the action of the different le-
thal factors. The types of differences we are fol-
lowing in patterns of mice carrying t haplotypes
include (1) the presence of an aberrant protein spot,
(2) the absence of a normal protein spot, and (3)
the inappropriate temporal expression of a normal
protein spot during development. We have obtained
two-dimensional gel protein patterns of normal em-
bryos at several different developmental stages, and
we are compiling data on mutant embryos of three
different t haplotypes. Preliminary results indicate
that embryos homozygous for a particular t haplo-
type and its associated lethal genetic factor show
two-dimensional gel protein patterns very similar
to those of normal embryos. Those proteins whose
structure and/or temporal expression is altered in
the mutant embryos will be mapped genetically and
analyzed for tissue distribution. It is hoped that
these studies will result in the identification of
products of the lethal factors associated with t hap-
lotypes and help elucidate their role in mammalian
development.
Gene Transfer into Mice
D. Hanahan
During the past year, an embryology laboratory has
been established in the Harris Animal Facility. One
purpose of this laboratory is to manipulate mouse
embryos experimentally, in particular to transfer
cloned genes into the mouse germ line, as a means
of studying gene regulation in the context of the
organism. This is accomplished by injecting a so-
lution of DNA into fertilized one-cell mouse em-
bryos and then placing the inoculated embryos into
a foster mother, where a significant fraction de-
velop to term; about 10-30% of the mice contain
the injected DNA integrated into one of their chro-
mosomes. The past few years have seen demonstra-
tions that this approach can be used to study the
expression of cloned genes. The most notable are
the studies by Palmiter and Brinster (Palmiter et
al., Nature 300: 611 [1982]), which have shown
that the transfer of a rat growth-hormone gene into
mice will produce unusually large mice as a con-
sequence.
The ongoing studies at Cold Spring Harbor Lab-
oratory focus on examining the structure and ex-
pression of a series of hybrid genes following their
transfer into mice. The hybrid genes contain regu-
latory information derived from the rat insulin gene
or the chicken alpha-2 (I) collagen gene, each fused
to control expression of structural information
derived from three viral genes: SV40 T antigen,
MC29 gag-myc protein, and RSV-gag protein. The
purpose of using these genes is twofold: (1) to de-
fine cis-acting regulatory information associated
with insulin or collagen genes that elicits their cor-
rect expression in the organism and (2) to examine
the phenotypic consequences of the expression of
oncogenes in the tissues specified by the cellular
regulatory sequences.
Recent work from the laboratory of B. Mintz
(Wagner et al., Cell 35: 647 [1983]) has demon-
strated that integration of injected DNA can pro-
duce recessive lethal mutations at a remarkably high
frequency (33 %). This result motivates examina-
tion of the integrated structure of genes transferred
into mice. At Cold Spring Harbor Laboratory, this
question is being addressed by retrieving integrated
plasmids out of their resident status in mouse chro-
mosomes and establishing them as episomes in
Escherichia colt. It is possible to retrieve sequen-
ces flanking the integrated transgenes by this ap-
proach (plasmid rescue) and then to examine the
mouse DNA before and after the integration event.
This will facilitate assessment of the extent of dele-
tion, rearrangement, and/or translocation that oc-
curred upon integration, which in turn pertains to
alternative mechanisms of mutagenesis (which
could occur either by relatively clean insertion or
by consequent large deletion and rearrangement).
Molecular Analysis of Human
Histocompatibility Antigen Mutants
M.S. Krangel
Human histocompatibility antigens (HLA-A and
HLA-B) are highly polymorphic cell-surface mol-
ecules that play important roles in self-nonself dis-
crimination by the immune system. Polymorphism
at these loci represents the major barrier to trans-
plantation between different individuals of the spe-
cies. However, the primary physiological role of
these molecules is in mediating immune recogni-
tion of virally infected cells by cytotoxic T lympho-
cytes.
I have been interested in employing minor struc-
tural variants of these molecules to aid in drawing
detailed structure-function relationships. In collab-
oration with D. Pious (University of Washington,
Seattle), mutants in one particular HLA allele,
HLA-A2, have been obtained. Mutagenesis of a hu-
man B-cell line, followed by immunoselection with
a monoclonal antibody plus complement, has al-
lowed the selection of mutants that have lost cell-
surface antigenic determinants. Biochemical stud-
ies of the resulting HLA-A2 mutants have allowed
the identification of that region of the molecule that
is recognized by the selecting antibody. Other mu-
tants have been obtained in which the molecules do
not mature appropriately and fail to reach the cell
surface.
One mutant cell line displayed a particularly
complex phenotype and is the subject of ongoing
experiments. These cells synthesize two forms of
HLA-A2, a low-abundance cell-surface form and a
predominant form that is secreted. The latter form
is somewhat smaller than wild-type HLA-A2, and
this difference was localized to that region of the
molecule that interacts with the plasma membrane.
Further experiments suggested that the secreted
form was not derived from a membrane form by a
posttranslational mechanism. It was proposed that
the two forms of HLA-A2 in the mutant resulted
from alternative splicing of the same primary tran-
script, the secreted molecule deriving from tran-
scripts spliced so as to delete the exon encoding
that portion of the molecule that interacts with the
membrane.
To test this hypothesis, cDNA libraries were con-
structed from both the parent and mutant cell lines.
cDNA clones that encode HLA-A and HLA-B were
isolated from the mutant library using a general
HLA-specific probe, and restriction mapping was
used to identify a clone encoding the secreted HLA-
A2 molecule. A comparison of the DNA sequence
of this clone with that of an HLA-A2 encoding
cDNA derived from another cell line (D. Arnot,
pers. comm.) has demonstrated unequivocally that
the exon encoding the membrane-anchoring region
of the polypeptide has been precisely deleted. Other
minor differences between the sequences are most
probably cell-line-specific; however, this issue
awaits the isolation of the appropriate clone from
the wild-type cDNA library. An analysis of HLA-
A2 genomic clones from both parent and mutant
will likely be necessary to define precisely the mu-
tation leading to aberrant splicing in these cells.
Hormonal Control of Gene Expression
D. T. Kurtz, W.R. Addison, J. I. Maclnnes,
D. Danna, J. -Z. Li, E. Nozik
We have been studying the hormonal and develop-
mental regulation of gene expression in higher eu-
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karyotes. The model system we have been using is
a rat protein called a globulin. This protein is en-
coded by a multigene family (20-25 copies per
haploid genome), and its production is under com-
plex hormonal and developmental control in vivo.
The synthesis of a2 in rats is regulated by gluco-
corticoids, insulin, sex steroids, and growth hor-
mone.
DNA sequences involved in hormonal induction of
a2u. The generally accepted model for the molecu-
lar mechanism of action of steroid hormones pos-
tulates that the hormone binds to a cytoplasmic
protein, the receptor; this binding activates the re-
ceptor and renders it competent to induce (or re-
press) the synthesis of specific genes. The simplest
literal interpretation of this model predicts that
hormone-responsive genes have specific sequences
in or around them that are responsible for hor-
monal modulation and that a hormone-inducible
gene should respond in any cell in which a compe-
tent receptor exists. We have tested this model by
reintroducing cloned au, genes into mouse L cells,
which contain a functional glucocorticoid receptor.
The transfected 02u genes indeed do respond to glu-
cocorticoids, and the level of correctly initiated au
mRNA is induced 10-20-fold in individual clones.
We are identifying the sequences responsible for
the induction using the "linker-scanning" method
first devised by S. McKnight (Hutchinson Cancer
Research Center, Seattle). In this method, BAL-31
deletions are made in plasmids containing the au
promoter region. Independent deletions are made
coming from both the 5' and 3' directions, and an
Xho linker is added. Clones are selected in which
the deletion end points are in the 02 promoter re-
gion. BAL deletions from each direction with end
points near each other are then joined through the
Xho linker. This leads to a clustered point muta-
tion, in which the bases in the Xho linker substitute
for the wild-type sequence (if the BAL deletions
from opposite directions were exactly 8 bases
apart), or leads to small deletions or duplications
(if the BAL deletions were greater or less than 8
bases apart). We have saturated the region from the
au cap site back to -200 with such mutations.
These mutant genes have been reintroduced into L
cells, and the effects on hormonal modulation are
currently being assessed. Although this method is
more time consuming than simple 5' deletions, in
the long run, the information obtained from these
clustered point mutations will be more meaningful.
As many investigators are discovering, when BAL
deletions are made, and heterologous sequences are
brought in next to the end point of the deletion,
these sequences (even from pBR322) can have un-
predictable and artifactual effects on transcription.
Our method ensures that the mutation is localized
and that the neighboring sequences are identical to
wild type.
Another possible method to localize the DNA se-
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quences involved in hormonal modulation is to
compare the sequences of several au genes. We
have already found that at least two of eight genes
tested do not respond to hormones when trans-
fected into L cells. Interestingly, the rate of tran-
scription from these variant genes is constitutively
high. This is consistent with a model in which the
DNA region responsible for hormonal control is a
negative control element; i.e., these DNA sequen-
ces keep the au gene off in the absence of hor-
mones. The hormonal induction of au globulin,
then, is a derepression, rather than a positive in-
duction.
Tissue distribution of a2u synthesis in vivo. Until
recently, 02u was thought to be synthesized exclu-
sively in the liver of adult male rats. Indeed, the
liver is the major site of synthesis of this protein:
In adult male rats, 02, represents 1 -2% of hepatic
mRNA. In the liver, the level of 02u mRNA is influ-
enced by several hormones: Androgens, glucocor-
ticoids, thyroid hormone, insulin, and growth horn-
one all induce 02u mRNA, and estrogens repress
the level of au. However, we have found that au is
synthesized in several other rat tissues: the salivary
gland, the lachrymal gland, and the mammary
glands of pregnant females. The hormonal modu-
lation in each tissue is different, and different au
genes or gene sets are transcribed in the various
tissues.
1. Salivary gland: au protein and mRNA are found
in the submaxillary glands of both male and fe-
male rats of any age. The synthesis seems to be
constitutive, at a level - 1/20 of that in the liver.
No hormonal modulation is evident.
2. Lachrymal gland: a2, is also found in the ex-
traorbital lachrymal glands of rats and is present
in both males and females. The level seems to
rise somewhat at puberty, and in adults, it
reaches a level - 1/5 that found in the liver.
3. Mammary gland: a2u mRNA and protein are
found in day-17-19 pregnant rats. The level
seems to peak sharply but never reaches a level
greater than - 1/50 that found in the liver. The
mRNA declines precipitously following day
19, and by parturition ( day 22) it is essentially
absent. The hormonal modulation of au in the
mammary gland is currently under investiga-
tion. The time course of its appearance and sub-
sequent repression is consistent with a model in
which it is being induced by progesterone and
then shut off by prolactin.
The a2u mRNA found in each of the tissues ap-
pears to be a single species of approximately 1 kb.
5'-end mapping indicates that the cap site is identi-
cal in all tissues. Analysis of the au, protein being
made in the various tissues revealed that, on one-
dimensional gels, the protein made in the liver,
submaxillary gland, and the salivary gland is a ho-
mogeneous species with a molecular weight of
20,000, whereas the protein made in the mammary
gland is slightly smaller (- 19,000). Isofocusing
gels (one dimensional), however, reveal clear dif-
ferences in the a, proteins being made in the dif-
ferent tissues.
Liver a2 is represented by four or five isoelec-
tric species with pI values ranging from approxi-
mately 5.0 to 6.0. The ce, produced by the submax-
illary and lachrymal glands appears as three to four
species with pI values of approximately 4.0-4.8.
The mammary-gland pattern is more complex and
appears to comprise most of the liver proteins and
several more basic species. This finding is consis-
tent with different a, gene sets being transcribed in
different tissues. We are now in the process of iden-
tifying which 02 genes code for which tissue-spe-
cific proteins. Eighteen independent 02,, genomic
clones have now been isolated from a library of rat
DNA cloned in Charon 4A. These genes have been
transfected into L cells in tissue culture to assess
their response to various hormones. These same
cells can then be used essentially as a linked tran-
scription-translation system to determine which a,
isoelectric species each gene encodes. This is cur-
rently being performed using isofocusing followed
by Western blotting.
Once specific cloned a2 genes have been "as-
signed" to various tissues, it may be possible to de-
termine the molecular basis for the tissue specific-
ity of expression of the different genes by reintro-
ducing these genes into primary cultures of rat cells
or into immortalized or transformed analogs of
these primary cultures.
Cell-cycle-modulated Gene Expression
J. Lewis, D. Matkovich
Since the early 1960s, evidence has accumulated
demonstrating that the expression of various genes
in mammalian cells cultured in vitro is strictly
growth-phase-dependent. The enzymes thymidine
kinase, thymidylate synthetase, and dihydrofolate
reductase, for example, important to the biosyn-
thesis of DNA nucleotide precursors, can be read-
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ily assayed in cell cultures growing in mid-log
phase but are virtually undetectable in cultures
resting in stationary phase. This growth-phase-de-
pendent gene expression is presently understood to
reflect the exclusive expression of these genes dur-
ing the S phase of the mammalian cell-division
cycle. Our laboratory is working to define the ge-
netic determinants that govern this mode of differ-
ential gene expression, and as a first step toward
the development of an experimental system, we
have cloned the thymidine kinase (tk) gene from
Chinese hamster ovary DNA in recombinant bac-
teriophage X (Lewis et al., Mol. Cell. Biol. 3: 1815
[1983]). Our experimental plan is to search for such
genetic determinants by variously modifying the
hamster tk gene in vitro, transfecting such modi-
fied tk genes into mammalian Tk- cells, and then
studying the growth dependence of the modified tk-
gene expression in Tk*-transformed cells. In this
way, by defining the character and genetic location
of the determinants of growth-dependent gene
expression, we can begin to infer the physiological
processes they govern.
As we have previously reported, restriction en-
zyme sensitivity experiments and Southern and
Northern blot hybridizations indicate that the ham-
ster tk gene extends over 10-12 kb, from the HpaI
site in the 3.2-kb EcoRI fragment of XHaTK-5
through the HindIII site in the 5.5-kb EcoRI frag-
ment at the left-arm end of XHaTK-5 (Fig. 1). To
define the structure of this gene more precisely, we
have isolated a nearly full sequence (1250 nucleo-
tides) of double-stranded cDNA to hamster tk
mRNA from a cDNA library prepared from
poly(A)* RNA from the Chinese hamster A-29 cell
line. On the basis of preliminary S1 analysis, this
double-stranded cDNA lacks at its 5' end approxi-
mately 30 nucleotides of the hamster tk mRNA.
Various subclones of this cDNA have been pre-
pared in M13 and have been sequenced using the
Sanger-Coulson dideoxynucleotide method. The
cDNA sequence information, in conjunction with
sequencing data derived from M13 subclones of the
hamster tk gene, have permitted us to define the
structure of the hamster tk gene. In brief, the ma-
ture hamster tk mRNA sequences are organized into
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Figure 1
Restriction enzyme map of XHaTK-5. The Chinese hamster tk gene extends over 11 kb in the 17-kb recombinant insert in XHaTK-5,
from the HpaI site in the rightmost 3.4-kb EcoRI fragment through the leftmost HindIII site in the 5.2-kb EcoRI fragment.
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at least seven exon blocks (distributed over 11 kb of
genomic DNA) separated by intronic sequences that
range in size from 100 to 5400 nucleotides. We are
not yet certain whether the tk mRNA sequences that
are not represented in our cDNA are contained in
the genome as a continuous part of exon block (I).
Nonetheless, the information we now have avail-
able makes it possible for us to undertake construc-
tion of the first modified hamster tk gene.
The genetic determinants of growth-dependent tk-
gene expression might reside within 5' or 3' se-
quences flanking the gene, within its five introns,
or conceivably even within tk coding sequences.
Our experimental strategy, therefore, is to reduce
the size and complexity of the hamster tk gene by
first constructing a minimal hamster tk gene that
depends on the hamster tk-gene promoter to direct
transcription of the hamster tk cDNA and then test-
ing the extent to which the expression of this mini-
mal gene is growth-phase-dependent. We have con-
structed the prototype of a hamster minimal tk gene
designated pHaTK1 (Fig. 2) and have demon-
strated that it is active in transforming a variety of
Tk- mammalian cell lines to the Tic+ phenotype.
This gene, however, still embodies some 1000 nu-
cleotides to the 5' side of the hamster tk-gene pro-
moter, which we have tentatively mapped, on the
basis of restriction enzyme sensitivity data and
genomic nucleotide sequencing, to lie 200 nucleo-
tides to the 3' side of the Hpal site. We are presently
generating deletion derivatives of pHaTK1, using
the technique of Exo III/S, mutagenesis, to prepare
a hamster tk gene of approximately 1400 nucleo-
tides, of which 1250 nucleotides are derived from
the double-stranded cDNA and 150 are derived
from the promoter and its most proximal nucleo-
tides. Should the expression of this gene be growth-
phase-dependent, we will have quickly narrowed
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Figure 2
Structure of a minimal hamster tic gene. pHaTK1 was con-
structed by fusing the hamster tk-gene promoter lying between
the Smal and Xhol sites (open box) to a 1180-bp EcoRI-Smal
fragment of the hamster tk cDNA (solid line). pHaTK1 trans-
forms a variety of mammalian Tk- cells to the Tk* phenotype.
Cells transformed with this construction are currently being
studied for the growth dependence of their tk expression.
the search for the gene sequences that control
growth-phase-dependent expression. Should the
expression of this gene prove to be growth-phase-
independent, as is true for the herpesvirus tk gene
in Tk+-transformed mammalian cells, we intend to
modify our minimal tk gene further by adding to it
either 5' or 3' flanking segments from the genomic
tk clone or intron blocks that necessitate splicing of
the primary tk RNA transcript. From a full analysis
of this sort, we expect to provide insights into the
mode of growth-phase-dependent tk-gene expres-
sion.

YEASTS
The year 1983 marked a new stage in the develop-
ment of yeast genetics and molecular biology at
Cold Spring Harbor Laboratory. The addition of
David Beach and Mark Zoller and their research
groups to the laboratory staff has broadened the
scope of research to include regulation of the cell-
division cycle and the application of site-directed
mutagenesis to the study of DNA-protein interac-
tions in yeast. In addition, the startling observation
that proteins similar to mammalian cancer genes
occur naturally in yeast and may play functionally
similar roles in the control of the cell cycle (DeFeo-
Jones et al., Nature 306: 707 [1983]; Powers et al.,
Cell 36: 607 [1984]; Lorincz and Reed, Nature
307: 183 [1984]) has led the group headed by M.
Wig ler (Oncogene Section) to focus new efforts on
yeast as a model for cancer biology and has
spawned the study of "yeast oncogenes."
These developments, along with the long-stand-
ing research program on cell-type switching in
yeast and S. Bonitz' studies on mitochondrial RNA
processing, have established yeast genetics as a ma-
jor research area of the laboratory, with three re-
search groups in the Delbriick Laboratory building
and two groups in the Demerec building. This par-
allels the increased interest in yeast as an experi-
mental organism world wide.
Mechanism of Cassette Transposition
J.N. Strathern, A.J.S. Klar, J.B. Hicks,
M. Kelly, C. McGill, L. Miglio, R. Kostriken
Homothallic strains of the budding yeast Saccha-
romyces cerevisiae change from one mating type to
the other by a mechanism that involves specific
rearrangements of the genome. Copies of unex-
pressed regulatory genes are transposed from stor-
age sites to an expression site. This is called the
cassette mechanism of gene activation. The se-
quence present at the expression site, MAT, con-
trols the mating type of the cell. Elsewhere in this
report, experiments bearing on the mechanism by
which the unexpressed copies are kept repressed are
presented. Here, we describe recent experiments
designed to determine the mechanism by which this
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site-specific transposition/substitution process oc-
curs.
Several years ago, we cloned both alleles of the
expression locus, MATa and MAT«, and both of the
silent loci that serve as donors of the MAT cas-
settes, HML and HMR. These genes have been se-
quenced, and hence we have a complete end-prod-
uct description of the cassette switching event (Fig.
1). The MATa and MATa alleles differ by substitu-
tions Ya and Ya, respectively. There are regions of
homology (W, X, Z1, Z2) between the donor and
recipient loci on each side of the Y sequences that
one might expect have roles in the initiation and
resolution of the switching intermediate. Several
loci whose products might have catalytic roles in
the switching process have been identified (HO
RAD52 SWI). We are now in a position to examine
a specific gene conversion event that is efficient,
reproducible, and genetically regulated.
Over the past few years, we have shown that
homothallic switching is initiated by a site-specific,
double-strand cut in the recipient locus, MAT,
in the Z region near the cell-type-specific Y se-
quences. This observation is in contrast to gene
conversion models positing a nick in the donor lo-
cus. An enzyme that makes this cut (YZ endo) has
been identified in homothallic cells. Variants of the
MAT locus that have changes in this site are not
able to switch. The Z1 region of homology between
MAT and HMR is normally 230 bp. We made sev-
eral deletions of the right side of Z1 but found that
the rate of switching was not reduced when that ho-
mology was reduced to less than 100 bases. The
results did suggest that aberrant events leading to
fusion of MAT and the donor loci were elevated in
these strains.
Several different approaches have been employed
to determine whether sites essential to the switch-
ing reaction exist in the W and X regions of MAT.
In one set of experiments, a variety of deletions
throughout this region were tested for ability to
switch. This approach involved having the recipient
MAT locus on a plasmid. No essential sites were
identified using this assay. Any homology between
the donor loci and the recipient was sufficient to
allow completion of the switching process. A sec-
ond set of experiments involved making restriction-
enzyme-site polymorphisms between the X region
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Diagram of the mating-type cassettes on chromosome III. W, X, Y, Z1, and Z2
represent regions defined by homology between MAT and the HML or HMR loci.
The W region is 723 bases in length and is found at MAT and HML; the X region
is 704 bases in length and is found at MAT, HML, and HMR; MAT, HML, and HMR
can have either the a-specific sequence, Ya (642 bases), or the a-specific se-
quence, Ya (747 bases); Z1 is 239 bases in length and is found at MAT, HML, and
HMR; finally, Z2 is 88 bases in length and is found only at MAT and HML. The
HML and HMR copies of the mating-type genes are normally kept silent by the
MAR and SIR genes. Interconversion of MATa and MATa involves a unidirectional
transposition-substitution event from HML or HMR to MAT and is regulated and/
or catalyzed by the HO-gene product.
of the donor HMR and the X region of the MAT
locus. These sequence differences could then be
used to monitor the extent of the sequences trans-
posed into MAT. In other words, when the Y region
was switched, how much of the X region was also
changed? We observed that the switched MAT loci
sometimes had the X-region polymorphism of the
original MAT and at other times had the sequence
from the donor. These results suggested that the ex-
tent of the sequence transposed from HMR is vari-
able. We are currently testing several polymorph-
isms throughout the X region to see if there is a
gradient of switching that decreases with distance
from the Y region.
This year, we have concentrated on the resolution
step of recombination. MAT transposition is for-
mally equivalent to the genetic process of gene con-
version. Gene conversions studied at innumerable
other loci are known to be associated with recom-
bination of flanking markers in about 50 % of the
cases. This association is explained by the sugges-
tion that the four-strand-stage Holliday structure
freely isomerizes at the time of resolution. MAT
transposition conversions, however, are not associ-
ated with crossing over. Quite interestingly, our re-
cent results have shown that efficient recombina-
tion of flanking markers does occur, but during
MAT to MAT interchromosomal gene transposition;
i.e., crossing over is observed when transpositions
occur between allelic sites (MAT to MAT between
homologs) but not when transpositions occur from
HMR to MAT (in both inter- and intrachromosomal
transpositions). This constraint of lack of crossing
over in the latter case is not regulated by the MAR/
SIR control operative for keeping the HM loci
unexpressed and unswitched. Either some other
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property of the system restricts resolution without
the associated crossover or the extent of sequence
homology between interacting segments may be
limiting for isomerization.
Regulation of the HML and HMR Genes
J.B. Hicks, J.N. Strathern, A.J. S. Klar,
J. Abraham, J. Ivy, S. Weisbrod, G. Livi,
C. Stephens, J. Wood
The two major goals of this project group in 1983
were to characterize further the MAR and SIR genes
and gene products and to study the mechanism of
action of the cis-acting control sites at HML and
HMR, known as E and I.
The four MAR and SIR genes were identified by
mutations, unlinked to each other or any of the mat-
ing-type cassettes, which caused the silent cassettes
at HML and HMR to be expressed. Formally, then,
these genes are presumed to encode proteins that
act in concert as repressors of HML and HMR. The
site of MAR/SIR action is presumed to be the same
at both HML and HMR, since all known mar- or
sir- mutations cause coordinate expression of both
HML and HMR.
The mechanism by which the MAR/SIR genes
control the silent cassettes is especially intriguing
because of the structure of the cassettes them-
selves. When expressed at the MAT locus, both a
and a cassettes produce two transcripts divergently
from a central promoter region. The DNA se-
quence surrounding the promoter is identical at all
three locations, yet transcription is prevented at
HMR and HML. The sites of negative regulation
must therefore be located outside the silent cas-
settes, at the 3' termini of the transcripts, rather than
at the 5' end as in most regulated genes. During the
past 2 years, we have located the negative control
sites by in vitro mutagenesis and have developed
the working hypothesis that the MAR/SIR genes act
through these sites to "turn off" transcription be-
tween them (Fig. 2).
As a test of this hypothesis, we have placed a gene
for a biosynthetic enzyme not normally under
MAR/SIR control between the E and I control sites
and reintroduced the hybrid constructions into the
genome. Transcription assays have shown that the
yeast HIS3 gene, complete with its normal upstream
regulatory sequences, can be effectively turned off
by the MAR/SIR system, rendering cells lacking a
normal HIS3 allele auxotrophic for histidine in
Mar' cells but His" when the MAR/SIR genes are
missing. Thus, MAR/SIR control is not specific to
the a or a promoters but represents a general mech-
anism for negative regulation of a "domain" on the
chromosome as diagramed in Figure 2. Such a
mechanism might be employed in more complex
eukaryotic organisms to regulate "banks" of genes
during development.
The individual MAR and SIR genes have been
cloned by complementation in yeast, and the cloneil
segments have been used to test several possible
roles for these genes in the control of HMR and
HML. Because the E and I sites at the two storage
loci share a maximum of 10 by of sequence homol-
ogy -less than would be required to bind four sep-
arate repressor proteins -it was possible that the
b. Si, ' 0 2 /Promoter on
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Figure 2
Schematic diagram of the control sites flanking the HML and
HMR storage cassettes. The E site is essential for control. Dele-
tion of this site causes full constitutive expression of the cas-
sette. Deletion of the I (Important) site on the right side allows
only partial expression. E and I are presumed to be sites of
interaction with the SIR (Silent Information Regulator) proteins
(SIR], 2, 3, 4). Interaction of the SIR-gene products in an as
yet unspecified way is believed to cause a change in chromatin
structure in the domain between E and I, preventing access of
RNA polymerase to the promoter.
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four genes represented a sequentially regulated
cascade culminating in the production of a single
repressor. Transcription studies have shown, how-
ever, that each of the four genes is transcribed even
in the absence of function of the other three. Con-
versely, we have shown that overexpression of the
SIR3 gene can complement several different muta-
tions in the SIR4 locus, indicating that a more com-
plex protein-protein interaction may be involved.
In additional studies, we have used the cloned SIR]
and SIR4 genes to map the positions of these pre-
viously unmapped genes to chromosomes XI and
IX, respectively.
Schizosaccharomyces pombe Mating-type
Switching
A.J.S. Klar, D. Beach
The fission yeast, Schizosaccharomyces pombe,
also switches efficiently between le (Plus) and h-
(Minus) mating types. Last year, we reported that
mating-type switching in this yeast, as in Saccha-
romyces cerevisiae, also involves transposition of
"cassettes" from the silent MAT2-P (containing the
Plus element) and MAT3-M (Minus element) loci
into the expressed MAT1 locus to generate alternate
alleles of MAT1-P and MATT -M in the homothallic
119° strains. These strains spontaneously generate
quite stable Plus and Minus cultures. We have now
shown that such "heterothallic" cells result from
aberrant transposition events. h+N results from
transposition of MAT2 and MAT3 cassettes (along
with the intervening sequence) into MAT] . The
proximal cassette with the P element confers Plus
mating type. This cassette switches infrequently to
generate 11-0 phenotype. At low frequencies, h+"
and h-u can "revert" back to h" by removing both
cassettes from MAT1 and thus restoring the origi-
nal h9° configuration (Fig. 3).
As in S. cerevisiae, switching proceeds through
formation of a double-strand cleavage at the MAT1
locus (see Fig. 3). In collaboration with R. Egel
(University of Copenhagen), we have conducted
studies on mutants that are defective for switching.
By genetic studies, over 50 mutants have been as-
signed to one of ten loci. One class of mutants con-
sists of cis-acting mutations at MAT1 that reduce
the amount of the double-strand cut at MAT1. The
remaining nine groups are mutations in genes that
are not linked to MAT. Three genes are required
for formation of the double-strand cut. Mutations
of three other genes seem to be defective in proper
resolution of switching intermediates. The remain-
ing three have normal levels of cut, do not make
errors of resolution, and are possibly required
either for efficient utilization of the cut or for de-
termining the directionality of switching.
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Figure 3
Diagram of the structure of the mating-type locus in different strains. Each 1.3-kb cas-
sette is marked as a box, separated by the L and K regions, each approximately 15 kb in
length. The arrow marks the cut site of the double-stranded DNA.
The mating-type cassettes have recently been se-
quenced in the laboratory of M. Smith (University
of Vancouver). Future work in this system will con-
sist of identification of the role of each of the mat-
ing-type gene products and also further characteri-
zation of the mechanisms of switching.
Cell-cycle Control in Fission Yeast
D. Beach, S. Silbiger [in collaboration with
P. Nurse, University of Sussex]
The cell cycle of fission yeast is controlled at two
points: one in G, referred to as "start" and the other
in G2. Genes in which mutations cause no defect in
general cell metabolism but arrest cell-cycle pro-
gression are called cdc genes. cdc2 is one such
gene, and it has been found that its product is re-
quired both in G, at start and in G2. The percentage
of cells caught in the G, or G2 block depends en-
tirely on the age distribution of the cells at the time
of shift up to the restrictive temperature for cdc2.
The cdc2 gene was previously isolated, and by
cross-complementation experiments it was shown
that this gene of fission yeast and the cdc28 gene
of budding yeast are functionally equivalent. Se-
quencing of both genes reveals that they are evolu-
tionary homologs, which are also related to the ty-
rosine kinase family of mammalian oncogenes. The
cdc2 gene contains at least four introns. Our pres-
ent work consists of isolating a cDNA clone of the
cdc2 gene so that the gene product can be expressed
in Escherichia coli. The protein expressed in E. coli
will be used for raising antibodies against the pro-
tein and to establish whether it is a protein kinase.
During the isolation of cdc2, a second sequence
was found that is capable, when present on an au-
tonomously replicating plasmid, of rescuing cer-
tain alleles of cdc2. This sequence integrates at a
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locus unlinked to cdc2. The gene, suci, has been
subjected to "gene destruction" by insertion of a
yeast selectable marker, leu2, into a transcribed re-
gion. When this construction is integrated into the
chromosome in a manner that displaces the original
copy of the gene, the cell is inviable. Spores car-
rying this mutation germinate and undergo between
one and three cell divisions before dying. The dead
cells do not have an obvious cdc phenotype. The
relationship between cdc2 and suci will be the
subject of further investigation.
Regulation of Yeast Mitochondrial
Gene Expression
S. Bonitz, C. Moomaw
Gene expression in yeast mitochondria is regulated
by proteins made from yeast nuclear genes. To de-
termine which nuclear genes regulate mitochon-
drial gene expression, a set of nuclear mutants that
affect mitochondrial functions have been isolated
by A. Tzagoloff at Columbia University. Over 200
different nuclear genes regulate various mitochon-
drial functions, such as RNA splicing and mito-
chondrial protein synthesis. Many of these nuclear
genes regulate the gene expression of one of the
mitochondrial proteins, cytochrome oxidase.
Cytochrome oxidase is a protein required for the
synthesis of adenosine triphosphate. It contains
seven subunits, four made from nuclear DNA and
three made from mitochondrial DNA. The three
largest subunits, subunits 1, 2, and 3, are made from
mitochondrial DNA. The gene encoding the sub-
unit-1 protein is a complex gene coding for a pro-
tein with a molecular weight of 56,000. DNA se-
quence analysis has revealed that the subunit-1 gene
is a split gene containing 10,000 nucleotides. The
subunit-1 coding sequence consists of six to eight
exons separated by five large introns. The entire
gene is transcribed, and the introns are removed in
several steps to generate the subunit-1 mRNA. The
mRNA is then translated to give the subunit-1 pro-
tein. Therefore, the possibility exists that the
expression of the subunit-1 gene can be regulated
at either of three different levels: transcription,
splicing, or translation.
To determine how the expression of the subunit-
1 gene is regulated, we are studying the set of nu-
clear mutants that control the synthesis of subunit
1 of cytochrome oxidase. Of the 200 different nu-
clear genes affecting mitochondrial functions,
10-15 different nuclear genes specifically affect the
subunit-1 gene. These mutants lack only the sub-
unit-1 protein of cytochrome oxidase and contain
all other mitochondrial proteins. To characterize
these mutants at a more detailed level, we have been
studying the mitochondrial RNA from these mu-
tants. Mitochondria were isolated and lysed to re-
lease their RNA. This RNA was separated by size
on an agarose gel and then transferred to DBM pa-
per. Using a radioactively labeled exon fragment,
the RNA was probed to determine whether any sub-
unit-1 mRNA was present. RNA prepared from
wild-type mitochondria contained the subunit-1
mRNA. However, several nuclear mutants con-
tained no mRNA but instead had some of the
higher-molecular-weight, subunit-1 RNA precur-
sors. These mutants may be defective in RNA
splicing. Other mutants have the subunit-1 mRNA
but no subunit-1 protein. Therefore, it appears that
there may be several different nuclear genes that
control expression of the subunit-1 gene of cyto-
chrome oxidase. Studies with the nuclear mutants
indicate that regulation by these nuclear genes may
occur at the level of mitochondrial splicing or
translation. Further characterization at the mito-
chondrial RNA level is continuing to determine ex-
actly how the nuclear gene products are affecting
subunit-1 gene expression.
Point Mutations in MATa That Affect
the Function of the HO Endonuclease
M. Zoller, R. Kostriken, K. Johnson
This is a new laboratory that began operation in
November, 1983. We are studying the interaction
between the HO endonuclease and MAT DNA in
the yeast Saccharomyces cerevisiae. Our aim is to
understand the role this enzyme plays in the trans-
position of mating-type DNA. In addition, we are
interested in the general problem of the means by
which a protein recognizes a specific sequence of
DNA. The HO endonuclease is required for effi-
cient transposition of mating-type DNA from an
unexpressed locus to MAT, the expressed locus.
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The mechanism by which this occurs is not fully
understood. It is believed that the HO endonuclease
initiates the event by creating a double-strand break
in the chromosome at MAT. R. Kostriken, who re-
cently joined the laboratory as a postdoctoral fel-
low, has demonstrated endonuclease activity in
yeast extracts from HO strains and has determined
the specific nucleotides that are cleaved in MAT
DNA. This work was done with F. Heffron in col-
laboration with the Yeast group at Cold Spring Har-
bor. Kostriken is currently purifying the HO endo-
nuclease from a strain of Escherichia coli that has
been engineered to express the HO-gene product.
This construction demonstrated that the HO gene
encodes the endonuclease.
The current effort in the laboratory stemmed
from the characterization of nonswitching strains
of yeast (inconvertible mutations). DNA sequence
analysis indicated that these strains contained point
changes within the HO recognition sequence at
MAT. To understand the specific determinants by
which the HO endonuclease recognizes the cut site,
we are analyzing the effects of point changes at
other positions within this region.
Seventeen single-point changes have been con-
structed in a clone of MATa using oligonucleotide-
directed mutagenesis. Wild type and each mutant
substrate were analyzed by an in vitro cutting assay
using extracts containing the HO endonuclease. The
results indicate that the major determinant of the
HO recognition sequence is a 13-bp region that
spans the YZ junction (see Fig. 4). MAT DNAs with
alterations at positions Z1, Z2, Z3, or Z6 are com-
pletely resistant to cleavage by the HO endonu-
clease. Substrates with base-pair changes at other
positions within this region are cleaved at slower
rates compared with wild type. By using HO en-
donuclease purified by Kostriken, we hope to iden-
tify which mutations affect binding and which
affect catalysis. In addition, we plan to conduct
footprinting experiments in order to identify ma-
jor- and minor-groove interactions.
The second phase of these experiments will be to
analyze the effects of these mutations on in vivo
switching. Each mutant will be integrated into the
yeast genome and assessed for the ability to serve
TCAGC
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Figure 4
Sequence of the HO endonuclease cut site at the Y-Z junction
of the mating-type cassette (see Fig. 1). The enclosed base pairs
represent the extent of the recognition sequence as determined
by site-directed mutagenesis. Arrows denote the actual cleav-
age sites, generating a 4-bp 3' overhang.
as either a donor or a recipient of a switch. In
strains that carry the mutations at MAT, we predict
that the frequency of switching will be correlated
with the efficiency of cutting. Furthermore, we
predict that the mutations will have no effect on the
ability of the cassette to serve as a switch donor.
Mutants that are unable to switch will be used to
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obtain revertants. Some may be in the cut site and
others may be in the HO endonuclease gene, thus
encoding an enzyme that recognizes and cuts the
altered recognition sequence. The latter mutations
will shed light on the amino acids that function in
specific protein/DNA interactions. These experi-
ments are currently in progress.
PLANTS
Maize Transposable Elements
S.L. Dellaporta, P. S. Chomet, J.B. Hicks [in
collaboration with J. P. Mottinger, University
of Rhode Island]
Genetic studies in maize have shown that progeny
from plants that are systemically infected with vi-
rus exhibit genetic instabilities, such as chromo-
somal breakage and high rates of spontaneous mu-
tation, even in the absence of the inciting virus for
many generations postinfection. We have been in-
vestigating the molecular basis for this aberrant ge-
netic behavior in spontaneous mutations at the
Shrunken (Shl) locus originally isolated by J. Mot-
tinger from maize lines exposed to systemic viral
infection. In work reported last year, we deter-
mined that several of these mutations resulted from
genomic rearrangements, probably insertions of
transposable elements. Genomic blotting data es-
tablishing the positions of the rearrangements are
shown in Figure 1.
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Recently, our efforts have been focused on the
molecular characterization of the sh-5586 and sh-
5584 mutations for several reasons: The sh-5586
mutation mapped at a position near the 3' end of the
shrunken gene, and in F3 and subsequent popula-
tions, numerous phenotypic reversion events have
been isolated. The sh-5584 mutant has the most in-
teresting genetic behavior; it appears to exhibit a
dosage effect due to reduced levels of the shrunken-
gene product sucrose synthase Mottinger, pers.
comm.).
We have cloned the sh-5586 allele and its Sh8
progenitor using standard genomic library con-
struction in bacteriophage vectors. Restriction
mapping data demonstrated that the alleles are
identical, with the exception of a 3.6-kb insertion
in sh-5586. This insertion maps to the wild-type
0.7-kb HindIII fragment located in the 3' region of
the shrunken gene. This region was sequenced from
both ShR and sh-5586, indicating that the sh-5586
element, which we refer to as Tz86, is integrated
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Figure 1
Restriction mapping data obtained from genomic blot analysis of the dominant Sh isoal-
Ides (Sh" and She and the sh tester allele (sh') used to generate the sh mutants described
in this study. Positions of four of the seven sh mutants are indicated by arrows in the
appropriate progenitor allele. The Sh transcriptional unit begins close to the position of
the sh-5584 insertion ( >3.5 kb) and ends within the 700-bp HindlII fragment of the She
allele. The sh-5586 insertion (3.6 kb) is 5' to the end of Sh transcription (see Fig. 2). sh-
5582 represents a 2.1-kb insertion within the Sh" gene.
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within a Sh exon (Fig. 2). Like mobile elements of
other organisms including maize, the insertion in
the sh-5586 mutation has caused a duplication of
host DNA at the site of insertion. In this case, a 10-
bp duplication of the sequence GAGGCTGATG is
present as a direct repeat at the termini of Tz86 and
only once in the wild-type gene. However, unlike
most transposable elements, this transposon does
not contain simple inverted or direct repeats im-
mediately adjacent to the insertion site. Instead, a
complex series of perfect and imperfect inverted
and direct repeats comprise the terminal regions.
This structural feature has also been identified re-
cently in the maize controlling elements Ac, Ds (J.
Messing, pers. comm.), and the Antirrhinum trans-
poson Tam 1 (H. Saedler, unpubl.). Complex stem-
and-loop secondary structures developed from these
regions may be important in controlling element
function.
We have also observed that the transposition abil-
ity of the sh-5586 element remains active for the
three generations we have studied this mutant. In
genetic studies of advanced progeny of the sh-5586
mutant, we have isolated phenotypic revertants
(ShR) to the wild-type Sh phenotype. Genomic blot
analysis of the ShR DNAs indicated that in one re-
vertant the element has excised and in another
phenotypic revertant a secondary rearrangement
has occurred without loss of the element at shrun-
ken.
Gel-blot analysis of maize genomic DNA has
shown that the Tz86 element represents a repetitive
family of heterogeneously related sequences with
different regions of the insertion represented at dif-
ferent levels ranging from about 5 to 50 copies per
genome. It is important to note that the element is
not homologous to the genome of barley stripe
mosaic virus, the virus used to induce the original
Sh
02 H3
mutations. It is thus possible that increased trans-
position activity of endogenous maize elements is a
response to the stress of viral infection. Tests of
this hypothesis will be the subject of work in the
coming year.
Cell and Developmental Genetics of
Tobacco
R.L. Malmberg, A.C. Hiatt, J. Mclndoo
We are interested in studying the regulation of the
polyamine synthesis pathway in tobacco cells. The
polyamines - putrescine, spermidine, and sperm-
ine - are small molecules with a high positive
charge that play a variety of roles in the cell and in
the whole organism. They have been implicated in
processes as diverse as the cell cycle, hormone re-
sponse, stress response, nucleic acid structure, and
protein synthesis. Our hope is that, by collecting
mutations altered in their synthesis, we will learn
more about the role of polyamines in the cell and
plant, in addition to studying the molecular genetic
regulation of the pathway. A simplified diagram of
the pathway is given in Figure 3.
One feature of this pathway that makes it suitable
for biochemical and genetic analyses is the exist-
ence of specific inhibitors that block the action of
the enzymes in the pathway, as shown in Figure 3.
When applied to cell cultures of tobacco, these in-
hibitors cause the levels of the polyamines to fall;
the cells become starved for the polyamines, stop
dividing, and eventually die. This suggests a simple
strategy for selection of mutants with altered po-
lyamine synthesis: Start with wild-type tobacco
cells, mutagenize, and then select for resistance to
the inhibitor. These mutants would then be ana-
lyzed to determine the nature of the genetic change.
H3
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Figure 2
Insertion site of the sh-5586 element (Tz86). The sh-5586 insertion element was determined to be within
a 700-bp HindIII fragment near the 3' end of the ShB gene. Sequence analysis of the corresponding wild-
type and mutant insertion regions indicated that the position of Tz86 was within Sh exon DNA (hatched
rectangles). Integration of Tz86 caused a duplication of 10 by of Sh DNA (solid arrowheads), which is
found as a direct repeat at the termini of the element. A 200-bp region at each end of Tz86 is rich in small
direct and inverted repeats (arrows), which have the potential for cruciform structures.
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Figure 3
Polyamine synthesis pathway. (OrnDC) Ornithine decarbox-
ylase; (SamDC) S-adenosylmethionine decarboxylase;
(ArgDC) arginine decarboxylase; (DFMO) difluoromethyl-
ornithine; (DFMA) difluoromethylarginine; (MGBG)
methylglyoxal bis(guanylhydrazone). OrnDC, ArgDC, and
SamDC are enzymes in the pathway; DFMO, DFMA, and
MGBG are specific inhibitors that block the action of the
enzymes indicated.
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The power of working with tobacco cell cultures is
that the mutants can then be regenerated into whole
plants. This allows us to perform conventional ge-
netic crosses and also to examine the effects of a
lesion in polyamine synthesis on the whole plant
and its development.
We have isolated a variety of mutants that are
either deficient in polyamine synthesis or resistant
to the specific inhibitors. When these mutants are
regenerated back into whole plants, we found the
surprising result that many of the mutants had ab-
normal flowers. All were male sterile, some were
female sterile, and most had altered morphologies,
i.e., anthers apparently turned into petals, ovules
turned into stamens, sepals turned into petals, and/
or anthers turned into pistils in individual mu-
tants.This suggests that polyamines are important
in the normal development of the flower; however,
SamDC -MGBG
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a direct cause-and-effect relationship has not yet
been demonstrated. Genetic tests to determine
causality are currently in progress.
Our mutant collection has provided a molecular
entry into the pathway. One of our mutants makes
abnormally large amounts of the second enzyme in
the pathway, S-adenosylmethionine decarboxylase.
Also, we can induce wild-type cells to make an ex-
cess of the enzyme by treating them with methyl-
glyoxal bis(guanylhydrazone) (MGBG). Recently,
we have shown that in wild-type cells, MGBG
causes an increase in abundance of the enzyme by
protecting it from degradation, rather than by in-
creasing its rate of synthesis. Our goal for future
research is to use our mutant collection further to
explore the regulation of polyamine synthesis and
to clarify the effects of polyamines on flower de-
velopment.

PROKARYOTES
Cloned Genes for the MspI Restriction-
Modification System
P. -M. Lin, R.J. Roberts
The Mspl restriction-modification system recog-
nizes the sequence 5'-CCGG-3' and is found in an
organism originally characterized as a Moraxella
species, although there is now reason to believe that
this identification was incorrect. DNA from this
organism has been cloned in a random fashion into
the plasmid vector pUC9, and a clone has been iso-
lated that expresses both the methylase and restric-
tion endonuclease activities of the Mspl restriction
system. This clone contains a 15-kb insert. Both
plasmid DNA and host DNA from the clone have
been shown to be resistant to MspI cleavage in vi-
tro, and the endonuclease has been partially puri-
fied from cell-free extracts of the clone.
A series of subclones of the original 15-kb insert
have been prepared, and one of these, containing a
1.55-kb insert, still retains methylase activity. This
insert has been sequenced and contains a single
open reading frame that could code for a polypep-
tide of 418 amino acids (M, = 47,664). This is the
only large open reading frame present in the se-
quence and must therefore encode the Msp methyl-
ase. A series of specific deletions of this clone have
been prepared. Removal of the aminoterminal se-
quences of the open reading frame destroys the
ability of the clone to produce active methylase.
One deletion, which removes 14 amino acids from
the carboxyl terminus of the reading frame, still re-
tains methylase activity. Immediately upstream of
the first AUG in this reading frame is a sequence
that closely resembles the Pribnow box found in
Escherichia coli promoters. This is probably the
natural promoter, since clones containing the 1.55 -
kb insert express the methylase gene irrespective of
its orientation in pACYC184. Another subclone
carries an insert of 3 kb and, like the parent clone,
carries both the methylase and the restriction en-
zyme genes. The latter is currently being se-
quenced.
One interesting feature of plasmids carrying the
Mspl methylase gene is that they show considerable
variation in their ability to transform different E.
coli strains. The original clones were isolated using
the host E. coli RR1, in which plasmid propagation
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is normal. However, attempts to transfer the plas-
mid into the E. coli strains MM294, JM107, or DHI
lead to extremely low transformation efficiencies.
This suggests that the expression of this gene in an
inappropriate genetic background can severely dis-
rupt normal cell metabolism. A similar effect has
been observed with the BsuRI methylase gene (see
A. Kiss, this section)
EcoRII Restriction-Modification
Genes and dcm Gene
A. Bhagwat
N3, a 60-kb natural plasmid of Escherichia coli,
codes for the EcoRII restriction-modification en-
zymes. The enzymes recognize the sequence 5'-
CC(A/T)GG-3; the endonuclease breaks the DNA
before the first C residue unless the methylase has
methylated the second C residue. The genes that
code for these enzymes have been cloned from N3
into the plasmids pBR322 and pACYC184. A 5.8-
kb fragment of N3 contains all the information re-
quired to express these proteins.
Random insertions of the transposon Tn3 into the
pACYC clone and a series of deletions constructed
in these plasmids have helped narrow the coding
region to about 2.8 kb. Of this, no more than 350
by is likely to contain the noncoding space between
the two genes. A StuI site within this region may
lie within the methylase promoter. Tn3 insertions,
350 by upstream of this site, do not significantly
affect the methylase, but the insertion of an 8-bp
Part linker at the StuI site gives only partial meth-
ylase expression. This and other data suggest that
the two genes are transcribed from the central non-
coding region in divergent directions.
The product of the endonuclease gene does not
appear to be required for the methylase expression,
and vice versa. Tn3 insertions in the putative en-
donuclease gene have the phenotype R-M+. A set
of eight clones containing Tn3 insertions spanning
a 1.3-kb region can survive only when a functional
EcoRII methylase gene exists on another plasmid
in the same cell. This suggests that these insertions
lie within the methylase gene and that the continued
synthesis of the endonuclease in these cells threat-
ens their survival unless a functional methylase is
provided by a complementing plasmid. A further
conclusion from these data is that the functional
dcm gene within the chromosome of these cells is
unable to complement the Tn3 insertions in the
EcoRII methylase gene. The product of dcm has
been reported to have the same specificity as the
EcoRII methylase (Schlagman et al., J. Bacteriol.
126: 990 [1976]). This may mean that either (1) the
amount or the efficiency of the dcm product in the
cell is much less than that of the EcoRII methylase
or (2) the methylation specificities of the two en-
zymes are not identical.
The Bacillus subtilis R Restriction-
Modification System
A. Kiss
The enzymes of the restriction-modification sys-
tem of Bacillus subtilis R recognize the sequence
5'-GGCC-3'. The endonuclease cleaves between the
G and C residues to produce blunt-ended frag-
ments, whereas the modification enzyme meth-
ylates the internal C residue. I began studies of this
system while at the Biological Research Center of
the Hungarian Academy of Sciences, and these
studies resulted in the cloning of the BsuRI meth-
ylase gene. Escherichia coli clones carrying this
gene expressed the BsuRI methylase but did not ex-
press the BsuRI endonuclease (Kiss and Baldauf,
Gene 21: 111 [1983]). The methylase gene was lo-
cated close to one end of the cloned segment, and
one possibility was that the endonuclease gene was
wholly, or partially, on an adjacent fragment, since
genetic data from T. Trautner's laboratory (Max
Planck Institute) indicated that the two genes were
linked.
The cloned methylase gene was used as a hybrid-
ization probe, in Southern experiments, to identify
fragments of B. subtilis R DNA that would carry
the methylase gene and would extend into the
neighboring sequences. One such fragment was a
9.5-kb SalI-Sphl fragment. This fragment was
cloned into pBR322, using E. coli RR1 as the host,
by in vitro selection for the presence of the meth-
ylase gene. Both the recombinant plasmid and the
chromosomal DNA from the clone were resistant
to HaeIII digestion (HaeIII is an isoschizomer of
BsuRI), indicating the presence and expression of
the BsuRI methylase gene. Cell-free extracts from
the clone were prepared and partially purified by
Bio-Gel A0.5m chromatography. Fractions were
tested for the presence of the BsuRI endonuclease
and were found to be positive. Preliminary esti-
mates suggest that the amounts of endonuclease are
comparable with those found in the parent strain.
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In vivo restriction-modification by the clone was
demonstrated using bacteriophage X. The degree of
restriction was between 10-s and 10-4. The endo-
nuclease and the methylase genes were further lo-
calized to a 4.3-kb Hpal-SalI fragment, and a de-
tailed restriction map of the DNA region coding for
the BsuRI enzymes was established. The two genes
are less than 0.5 kb apart.
The attraction of the BsuRI enzymes as a model
system for the study of sequence-specific DNA-
protein interaction is that genes of three other mod-
ification methylases, recognizing the sequence
GGCC, have also been cloned. These are M.BspRI,
M.SPR, and M.HaeIII. Comparison of the primary
sequence of these enzymes is likely to give infor-
mation about the structural determinants of this type
of specific DNA recognition.
During these studies we found that the related E.
coli strains, RR1 and HB101, can be transformed
easily with the plasmid carrying the BsuRI genes.
In contrast, several other E. coli strains (DHI,
GM272, GM161) cannot be transformed, even with
plasmids carrying only the methylase gene. Plas-
mids coding for other cloned GGCC-specific meth-
ylases (M.BspRI, M.SPR, and M.HaeIII) showed a
similar pattern of transformation. We have shown
that this phenomenon is related to the methylase
function and its cause is being examined.
Transposase Recognition Sites
A.I. Bukhari
The temperate bacteriophage Mu is a very efficient
transposon and yet the sequences at its ends are not
the typical inverted repeats of most prokaryotic
transposons. To gain more insight into the function
of these terminal sequences, we have determined
the nucleotide sequences at the left end of bacte-
riophages D108 and Mu. The rationale for this ex-
periment is that D108 and Mu are essentially iden-
tical viruses, both in sequence and in mechanism of
transposition. However, as shown by Toussaint et
al. (Mol. Gen. Genet. 190: 70 [1983]), the A-gene
product (the transposase) of Mu specifically acts at
its own left end and does not recognize the D108
left end. Similarly, the D108 transposase is specific
to its own left end. This difference in specificity
must reflect a difference in the nucleotide se-
quences at the left ends of Mu and D108 and must
signify at least one site that is recognized by the
respective transposases. The left-end 1-kb HindIII
fragment of Mu and the left-end 1.5-kb EcoRI frag-
ment of D108 were purified and cloned into M13
vectors for dideoxy sequencing. The fragments
were positioned so that extension of the primer
yielded the sequence of the host segment attached
to the left end, followed by the specific phage se-
quence. Sequencing of several independent clones
has shown the following: (1) The first 53 by in Mu
and D108 are identical. At that point the 8-bp pair
sequence GATCTGAT in Mu is replaced by
TATTTGGC in D108. (2) The sequences between
nucleotides 61 and 200 are substantially the same
with only scattered base changes. (3) The host se-
quences show some common features. For exam-
ple, a sequence TTTGGCGG is found in several
host segments. This sequence is also present in
D108 and overlaps the 8-bp change between Mu and
D108. A part of this sequence is present in Mu. (4)
The first five nucleotides of the host sequence pre-
ceding the host-phage junction are generally, but
not always, GC-rich.
These results suggest that the transposase recog-
nizes a sequence at least 53 by from the end of Mu
and that it probably makes a large complex that
covers the Mu-host junction during transposition.
Studies on the Regulation of the
Bacteriophage Mu Transposition
Functions
T. Patterson, K. Martin, R. Weiss, J. Gould,
A. I. Bukhari
The regulation of the transposition functions of a
transposable element is crucial to its persistence,
since unchecked transposition would certainly re-
sult in the death of the host. Since transposition is
an integral part of the Mu lytic cycle, the mode of
regulation employed by Mu should share features
in common with nontransposing bacteriophage as
well as with nonviral transposable elements. In-
deed, what has been learned thus far about Mu reg-
ulation is consistent with this notion.
The current picture of Mu regulation has been
developed from a number of different experimental
systems, many of which have involved the use of
high-copy-number plasmids carrying cloned frag-
ments of the Mu genome. We feel that the use of
these plasmids may have precluded the formulation
of a unified model of Mu regulation, consistent with
most of the available evidence. For example, the
involvement of host functions in Mu regulation
could be swamped out by the increased gene-dos-
age effect when using high-copy-number plasmids.
We are taking a different, systematic approach to
the study of Mu regulation that involves the use of
fusions between the Mu genome and a lacZ gene
located on a F' prolac episome. Starting with an
insertion of a temperature-inducible Muamp pro-
phage in the lad region of an episome carrying
fused lacl and lacZ genes, we have isolated 100 in-
dependent Lac' revertants that carry defective Mu
prophage. We have been able to divide these re-
vertants into four categories: (I) those in which lacZ
expression is tightly regulated in cis by the
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temperature-sensitive Mu repressor, (II) those in
which lacZ expression is loosely regulated in cis by
the Mu repressor, (III) those in which lacZ expres-
sion is unaffected by temperature but is affected by
host-strain mutations, and (IV) those in which lacZ
expression is not influenced by the Mu repressor or
any host mutations tested so far.
Since the fusions were isolated on an F' episome,
we can easily transfer them into strains carrying
different alleles of host genes that may affect reg-
ulation, strains carrying different genetically
marked Mu prophage, or strains carrying various
plasmids. Thus far, we have transferred the Mu-
lacZ fusion episomes into strains with mutations in
the dam (deoxyadenine methylase) gene and the
himA gene (encoding the a subunit of the integra-
tion host factor protein), into a strain carrying a
wild-type Mu prophage, and into a strain carrying
a low-copy-number mini-Mu plasmid. The result-
ing strains were tested for lacZ activity at high and
low temperatures, and the following observations
were made: (1) lacZ activity from category I fu-
sions becomes noninducible by temperature in the
presence of a wild-type Mu prophage, indicating
that the fusions are subject to regulation in trans.
These fusions are apparently unaffected by himA or
dam mutations, but interestingly, some of them lose
temperature regulation in the presence of the mini-
Mu plasmid. (2) lacZ activity from category II fu-
sions becomes noninducible in the presence of a
wild-type Mu prophage and becomes tightly regu-
lated in the presence of the mini-Mu plasmid. This
suggests that the fusions retain the target sites nec-
essary for regulation but do not synthesize suffi-
cient or necessary regulatory molecules. These fu-
sions appear to become more tightly regulated at
low temperature in the presence of a himA mutation
and are unaffected by dam mutations. (3) lacZ ac-
tivity from category III fusions is unaffected by the
presence of a wild-type Mu prophage or by the
mini-Mu plasmid. However, these fusions become
subject to temperature regulation in the presence of
a dam mutation and exhibit increased but unregu-
lated lacZ expression in the presence of a himA mu-
tation. These studies are being extended by trans-
ferring the episomes to strains carrying the host
mutations, prophage, or mini-Mu plasmids in var-
ious combinations.
In conjunction with the work described above, we
have been approximating the extent of Mu DNA in
the fusions by hybridization of DNA from the epi-
some-bearing strains to plasmid DNA carrying de-
fined restriction fragments of Mu. We have also
been successful in moving some of the fusions onto
a multicopy plasmid by in vivo recombination. This
will allow us to define more precisely the fusion
junctions through restriction mapping and/or DNA
sequence analysis and to test the effects of gene
dosage. Correlation of the location of the fusion end
points with their phenotypic properties will pro-
vide valuable insight into the regulatory elements
of Mu.
As a corollary to the studies employing the fu-
sions isolated in vivo, we are creating fusions be-
tween Mu and lacZ in vitro on multicopy plasmids
and are developing a method for moving the fu-
sions into a chromosomal or episomal location. Us-
ing information gained from our experiments with
the F' Mu-lacZ fusions, we will be able to target
specific regulatory regions of Mu for detailed study
employing techniques of in vitro mutagenesis.
Synthetic Transposons
T. Patterson, A.I. Bukhari
The basic requirements for the movement of bac-
terial transposable elements are the ends of the
elements, element-encoded transposition proteins
that recognize the ends and catalyze transposition,
and various functions provided by the host. With
the goal of performing a detailed study of the role
of the terminal sequences in the transposition pro-
cess, we are constructing synthetic transposons in
collaboration with S. Narang's group at the Na-
tional Research Council, Canada. The synthetic
transposons consist of chemically synthesized right-
and left-end terminal sequences of a naturally oc-
curring transposable element cloned into a plas-
mid. The ends are synthesized with a restriction en-
zyme recognition site in between to allow the in
vitro insertion of a selectable marker, such as a drug
resistance determinant. The presence of a selecta-
ble marker will allow us to monitor transposition
of the synthetic transposon. Our initial efforts have
been with the ends of two elements, the insertion
element IS5 and bacteriophage Mu.
The 16-bp inverted terminal repeats of IS5 (with
1 by difference) have been synthesized with a BglII
restriction site in between. This oligonucleotide was
inserted into the EcoRI site of pBR328, and the re-
sulting plasmid was designated pSN162. We in-
serted a 1-kb kanamycin resistance determinant into
the BglII restriction site in pSN162 but have been
unable to detect transposition of kanamycin resis-
tance mediated by the synthetic IS5 ends. Since we
are relying on IS5-specific transposition proteins
synthesized from the 10-12 copies of IS5 present in
the E. coli chromosome to act efficiently in trans,
it may be necessary to insert IS5 (without its ends)
into the plasmid carrying the synthetic transposon
to provide the transposition proteins in cis. Alter-
natively, it may be necessary to increase the length
of the synthetic sequences to include regions lo-
cated outside the inverted repeats that may be re-
quired for transposition. Both of these approaches
are being tried.
Although we have been unable to detect transpo-
sition of the IS5 transposon, we have observed an-
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other activity of the synthetic IS5 ends. Plasmid
pBR328 carries an inverted duplication of a 482-bp
segment that lies at the end of the tetracycline re-
sistance gene. We have observed the low-frequency
recA-independent appearance of a dimeric pBR328
molecule that has a structure consistent with having
been formed by intermolecular recombination
within the region of the inverted repeats. The plas-
mid carrying the synthetic IS5 ends (pSN162) also
generates this dimeric form. However, the propor-
tion of pSN162 in the dimeric form after 30 gener-
ations of growth is almost tenfold higher than with
pBR328. Our preliminary results indicate that this
increase in the amount of dimeric pSN162 does not
occur in a recA- strain of the closely related spe-
cies, Salmonella typhimurium. Since S. typhimu-
rium does not carry IS5 in its chromosome, this
suggests that the increase in dimer formation in E.
coli is due to an IS5-encoded function acting on the
synthetic ends present in pSN162. Experiments to
test this hypothesis are in progress.
The construction of a plasmid analogous to pSN-
162, which will consist of the chemically synthe-
sized right- and left-end sequences of bacterio-
phage Mu cloned into pUC9, is almost complete. A
kanamycin resistance determinant will be inserted
between the ends, and the transposition of the re-
sulting mini-Mu will be tested. An advantage of the
Mu system is that the production of Mu-specific
transposition proteins can be triggered at will using
a temperature-inducible prophage and that these
functions will act efficiently in trans. Once trans-
position of the synthetic transposons is successful,
we will perform site-specific mutagenesis on the
ends to determine which nucleotides are important
in the transposition process.
Visualization of the Mu Lytic Cycle
A.I. Bukhari, K. Martin
The structure of the bacterial chromosome
throughout the lytic cycle of bacteriophage Mu is
being studied using a technique that allows the rapid
isolation of genetically active nucleic acid-protein
complexes for analysis in the electron microscope.
During the time required for one doubling of the
Escherichia coli chromosome, the phage is able to
increase from 1 copy to 100 copies. The replication
of Mu is accompanied by its transposition within
the chromosome. Analyses of structures associated
with the chromosome's replication forks are being
carried out in an attempt to observe directly the
process of Mu DNA transposition. Preliminary ex-
periments show that when cells are opened and pre-
pared for microscopy immediately prior to lysis,
viral particles are observed extruding from the cell.
At this time point, the bulk of the chromosomal
DNA appears to be degraded, but there are many
visible polysomes. The DNA that is observed ap-
pears to be significantly more supercoiled than the
DNA from cells harvested less than 15 minutes after
induction of the Mu lytic cycle. The significance,
if any, of this finding awaits further analysis. A
more surprising preliminary finding is the presence
of significant numbers of circular molecules in cells
harvested approximately 10 minutes prior to the
time at which mature viruses are observed. These
molecules are heterogeneous in size (range, 4-50
kb), and one putative circle displays a polysome
gradient, suggesting the presence of an active tran-
scription unit. One hypothesis is that these mole-
cules arise as a result of the removal of Mu DNA
from the bacterial genome during phage matura-
tion. The circles would then be the result of a re-
circularization of the bacterial DNA present be-
tween two copies of the Mu DNA within the
chromosome. This hypothesis is being tested by
spreading cultures at earlier time points after the
induction of Mu to determine whether larger cir-
cles that still contain Mu are observable prior to the
appearance of the small, circular DNA molecules.
Electron microscopic analysis of the structure of
the chromosomal DNA-protein complex during the
proliferation of Mu DNA should contribute to a
better understanding of the mechanism of transpo-
sition and the action of the bacteriophage Mu pro-
teins in the cell.
Shifty Ratchets: Molecular Mechanics
of Protein Synthesis Revisited
R. Weiss
The physical mechanism of ribosome translocation
has remained shrouded in mystery, inaccessible to
experimental tests. Fourteen years ago, a potential
solution to the problem of a plausible physical basis
for the mechanics of translocation was proposed by
C.R. Woese (University of Illinois). His model re-
placed the notion of phantom movements of the
peptidyl-tRNA across the ribosome's surface with
a simple, precise, and defined conformational flip
of the codon:anticodon helix. This conformational
flip, termed ratcheting, serves to move the mRNA
by precise triplet intervals and provides a mecha-
nism for the strict maintenance of reading frame.
One of the more important aspects of the ratchet
model is the implication for the evolution of ribo-
somes and genetic code, which has been pursued in
detail by F.H.C. Crick (Salk Institute), S. Brenner
(MRC, England), A. Klug (MRC, England), and G.
Piecznik (Origins Life 7: 389 [1976]). However,
Woese's model has not gained general acceptance,
and most investigators still labor under an insuffi-
cient paradigm: the A-site-P-site model.
Recently, I discovered a hidden prediction in
Woese's original proposal; the prediction involves
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how abnormal translocation (2- or 4-base mRNA
movement) should occur. The prediction is very
precise (Weiss, Proc. Natl. Acad. Sci. [1984, in
press]). When all observations concerning abnor-
mal translocation, from frameshifting by normal
tRNA to frameshift suppressor tRNAs, are exam-
ined under this prediction, a unified explanation of
the mechanics of normal and abnormal transloca-
tion emerges. This new view of the ratchet model
provides specific testable predictions concerning
the mechanism, and these are now under investi-
gation.
Homology-dependent Repair of Double-
strand Breaks and Chromosomal
Transformation in Exonuclease-deficient
Escherichia coli Strains
A.I. Bukhari, R. Weiss
Recent evidence from Saccharomyces cerevisiae
suggests that double-strand DNA breaks are re-
combinogenic. The free duplex end is thought to
invade a homologous segment, thus establishing a
Holliday junction. The repair of double-strand
breaks and gaps within regions of homology can be
easily demonstrated by the rescue of linearized
plasmid DNA during transformation. Such experi-
ments have not been attempted in Escherichia coli
because of high levels of exonuclease activity in
wild-type strains. Use of recB- recC- sbcB- strains
as recipients overcomes the exonuclease problem
by removing two major nucleases (ExoI and ExoV)
but leaving the cell "recombination *." The recB
recC sbcB strain is known to be competent for high-
level chromosomal transformation.
Initial experiments with plasmids linearized or
gapped by restriction endonucleases and trans-
formed into recB recC sbcB strains have revealed
frequencies of high-level, homology-dependent
rescue of linear plasmid DNA comparable to the
frequency of double-strand break repair in S. cere-
visiae; i.e., the double-strand break reduces the
transformation frequency by only 3-5-fold in a recB
recC sbcB strain versus 1000-fold in wild-type E.
coli. The majority of transformants, however, suf-
fer deletions encompassing the site of the break or
gap. This is in sharp contrast to the high fidelity of
double-strand break and gap repair in yeast. The
implication is that E. coli is unable to prime the
repair DNA synthesis needed to establish the pos-
tulated double-Holliday-junction intermediate nec-
essary to repair a gapped plasmid. Since resolution
of the postulated double Holliday junction should
yield an equal ratio of integrated repaired plasmid
versus extrachromosomal repaired plasmid, the
ability to detect integration events is important. The
recB recC sbcB strains are unable to maintain
ColE 1-derived replicons in a stable form, and this
may prove usetul for detecting integration of cut
circular molecules. The homology requirement for
mutagenic repair of cut plasmid can be dissected by
introduction of various rec- alleles (such as recA
and recF) into the recB recC sbcB strain. Involve-
ment of heteroduplex regions of DNA, indicative
of Holliday junction formation, can be probed by
scoring chromosomal markers flanking the area of
the double-strand break.
The recB recC sbcB strain also provides a unique
tool for disrupting E. coli chromosomal genes by
direct chromosomal transformation with cloned
segments altered in vitro. The coding sequences of
the cloned release factor genes (Weiss et al., J.
Bacteriol. [1984, in press]) are being disrupted with
antibiotic resistance genes, and these markers will
be used to select for disruption of the chromosomal
genes during transformation. A genetic analysis can
then be applied to the unique codon-recognition
properties of the release factors. This should illu-
minate the mysterious "tRNA-like" properties of
these protein molecules.
Nucleotide Sequences Encoding Mu
Transposition Proteins
A.I. Bukhari, P. Koka
The transposition of bacteriophage Mu into the host
genome occurs by replication. The product of the
A gene, transposase, is essential for transposition.
The function encoded by the B gene, which also
affects transposition by enhancing the transposition
frequency, is implicated in the replication. Thus,
both the A- and B-gene products play a role in Mu
transposition. However, the relative amounts of the
70,000-dalton protein of the A gene and the 33,000-
dalton protein of the B gene present in the cells vary
substantially, with the B-gene protein much in ex-
cess over the A-gene protein. This differential
expression of these genes could be due to the nature
and presence of the DNA sequences that control the
expression of the A and B genes. One line of inves-
tigation to establish the reasons for this varying
content of A- and B- gene proteins is to determine
the DNA sequence of the A and B genes and the
sequences preceding these genes. Knowledge of the
DNA sequence will also provide information on the
nature of the proteins. Both orientations of the left-
end BalI -HpaI fragment of Mu DNA consisting of
3.6 kb have been cloned into the SmaI site of
M13mp8. This fragment consists of the A gene car-
rying an amber mutation and the majority of the B
gene. The remaining portion (74 bp) of the B-gene
sequence and the sequence preceding the A gene
and of its first 260 by are available. Using in-vitro-
synthesized primers (M. Zoller, Yeast Section), the
3.6-kb fragment is being sequenced from both the
Ball and the HpaI sites. This will provide infor-
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mation on the DNA and protein sequences respon-
sible for Mu transposition. The amber mutant se-
quence will allow us to identify unambiguously the
coding sequence of the A gene.
Photosynthetic Reaction Center and
Light-harvesting Genes
D. Youvan, S. Ismail
Purple nonsulfur bacteria such as Rhodopseudo-
monas capsulata have a very diverse metabolism
that includes the ability to grow photosynthetically
under anoxygenic conditions. At least seven poly-
peptides (three reaction-center and four light-har-
vesting polypeptides) are induced, along with the
biosynthetic enzymes for carotenoid and bacte-
riochlorophyll biosynthesis during the differentia-
tion of the respiratory membrane into the invagin-
ated photosynthetic membrane. These polypeptides
are necessary for the proper binding of the carot-
enoid and bacteriochlorophyll pigments, quinones,
and other cofactors that absorb light, mediate pri-
mary charge separation, and generate reductant. An
adjacent oxidoreductase complex utilizes reduced
quinones to generate a transmembrane proton gra-
dient. Many of the bacterial photosynthetic pro-
cesses are analogous or identical to processes that
occur in the thylakoid membranes of higher plant
chloroplasts. Because it is easier to study and ma-
nipulate photosynthetic bacteria, we have chosen R.
capsulata as a model organism for the study of the
photosynthetic membrane.
Several genetic techniques have been employed
in the past 10 years in the characterization of pho-
tosynthetic mutants and in the localization of the
genes involved in the differentiation of the photo-
synthetic apparatus. Initially, the gene-transfer
agent (GTA) was isolated from R. capsulata and
was used to show that mutations in carotenoid and
bacteriochlorophyll biosynthesis were linked. Co-
transduction of these markers was used to generate
a genetic map, and mutations were correlated with
intermediates in bacteriochlorophyll and carot-
enoid biosynthesis. Later, these genes were mobi-
lized for conjugation using a broad host-range con-
jugative plasmid. R-prime plasmids were obtained
carrying the photosynthetic gene cluster. The 46-kb
photosynthetic gene insert on the R-prime plasmid
pRPS404 was shown to complement all known mu-
tations in carotenoid and bacteriochlorophyll bio-
synthesis.
The complete nucleotide sequence (8867 bp) and
the predicted polypeptide sequence have now been
determined for 11 proteins from the photosynthetic
gene cluster of R. capsulata (46 kb), including the
photosynthetic reaction center (RC) L, M, and H
subunits and the light-harvesting I (LHI) and a
polypeptides. Hydropathy plots indicate that the L
duces a cold labile enzyme that is less sensitive to 
its inhibitor, fructose-1,6־bisphosphate.
The wild-type gene and its mutant derivatives 
have been cloned and sequenced. The 5׳ control re- 
gion has been defined by construction of operon 
fusions between the 5-proximal part o f pfkB and 
the coding part o f the galactokinase genes, and by 
in vitro transcription. Comparison of the overpro- 
ducing mutant with the wild-type gene revealed that 
overproduction is mediated by increased transcrip- 
tion due to a C —T single-base-pair change in the 
—10 region of the pfkB promoter. The nature of the 
second mutation affecting the structure of the en- 
zyme has yet to be defined at the nucleotide se- 
quence level.
The 5-proximal region controlling the expres- 
sion of the pfkB gene is complex. In addition to the 
in vitro functional promoter, proximal to the cod- 
ing part o f the gene, there is another potential pro- 
moter, about 100 bp upstream of the first one. An 
operatorlike sequence and a p-dependent termina- 
torlike hairpin structure are both located within this 
second promoter region. Furthermore, adjacent to 
the —35 region of the first promoter, a CRP-bind- 
ing consensus sequence is present. The functions, 
if  any, of these features are not yet known. We have 
shown that a fragment carrying this CRP sequence 
is able to bind in vitro, although weakly, the CRP 
protein in the presence of cAMP. However, since 
the pjkB  gene is thought to be expressed constitu- 
tively, the meaning of this interaction is not clear.
To analyze the role o f these features, we took ad- 
vantage of the galactose-sensitive phenotype of pfkB 
up promoter-ga lK  fusions. galK  strains carrying 
such fusions on multicopy plasmids are inhibited 
by galactose, presumably due to the accumulation 
of galactose-l-phosphate. Several mutants resis- 
tant to galactose and still presenting a functional 
galactokinase were selected. By retransformation 
back into the galK  strain, it was found that most 
of the mutations were localized on the plasmids. 
Analysis of the total cell proteins by SDS-PAGE 
indicated the presence of two major classes of mu- 
tants. In the first class, the galactokinase protein is 
present at a much lower amount than the parent, 
and in the second class, it is barely detectable. 
Since, in the fusion strains, galactokinase produc- 
tion is under pfkB control, apparently these muta- 
tions affect the pfkB promoter. Their molecular na- 
ture is now being determined by DNA sequence 
analysis. It is hoped that some of these mutations 
will help us to understand the functions of the fea- 
tures found in the 5׳ control region of the pfkB gene.
Clostridium pasteurianum Galactokinase
F. Daldal, J. Applebaum
In the past, no gene from a bacterium like Clostri- 
dium pasteurianum, which has a very high A +  T
and M subunits are transmembrane proteins that 
may cross the membrane five times with highly hy- 
drophobic stretches of amino acids. The H subunit 
has only one hydrophobic section near the amino 
terminus that may be transmembrane. The L and M 
subunits are homologous over their entire length 
and have a high degree of homology with the 32- 
kD quinone-binding (Q/3) protein from photosys- 
tern II o f higher plants (Youvan et al., Cell [1984, 
in press]).
We have recently identified the light-harvesting 
II (LHII; infrared maxima: B800 -I- 850 com- 
plex) genes from R. capsulata by probing a X li- 
brary of chromosomal EcoRl fragments with oli- 
gonucleotide probes. Two oligonucleotide probes 
with a degeneracy of 32 were synthesized based on 
the amino acid sequence of the j8 and a  subunits of 
LHII. Both probes hybridize specifically to a 6-kb 
EcoRl restriction fragment in genomic Southern 
hybridizations (hybridization to total bacterial DNA 
digested with EcoRl). Several X phages that carry 
the 6־kb EcoRl fragment were identified by filter 
hybridization to a library of R. capsulata chromo- 
somal EcoRl fragments (courtesy of R Scolnick, 
Cold Spring Harbor Laboratory). The 6-kb EcoRl 
fragment has been recloned in pBR322, and both 
probes hybridize to an internal 1250-bp Smal frag- 
ment. This indicates that the structural genes for /3 
and a  are adjacent. Southern hybridization of the 0 
and ol probes to the 46-kb photosynthetic gene clus- 
ter carried by pRPS404 indicates that the LHII genes 
are outside of this cluster. The structural genes for 
!8, 0׳, and the upstream regulatory elements (light- 
intensity-modulated) will be sequenced.
When the sequencing of LHII is completed, R. 
capsulata will be the only organism in which all of 
the structural genes involved in the primary light 
reactions of photosynthesis have been mapped and 
sequenced. DNA mutagenized in Escherichia coli 
by transposons, or in the future by oligonucleo- 
tides, may be returned to R. capsulata using ge- 
netic techniques specifically developed for this or- 
ganism. Structure-function problems involving 
specific residues in the RC and LH polypeptides 
and their role in the light reactions of photosyn- 
thesis may be first addressed in R. capsulata.
5׳ Control Region of Escherichia coli 
pfkB  Gene
F. Daldal, J. Applebaum
The pfkB gene encodes the Escherichia coli minor 
phosphofructokinase Pfk-2. In the past, two inter- 
esting mutants affecting this gene have been iso- 
lated. One of them has a mutation that increases the 
expression of the wild-type gene about 20- to 40- 
fold. The other one, apparently a double mutant, 
not only has increased Pfk-2 activity, but also pro­
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pasteurianum galK  gene, even when expressed at a 
low level, are not yet understood.
Isolation of Mutants from Clostridium
pasteurianum
F. Daldal, J. Applebaum
The genetics of strict anaerobes belonging to the 
genus of Clostridiae is not well studied. We have 
chosen Clostridium pasteurianum as a prototype for 
such studies because it is a true prototroph, it has 
no reported pathogenicity, and it has been the an- 
aerobic microorganism of choice for several bio- 
chemical studies.
To explore possible genetic exchange between 
cells, we first isolated and characterized a collec- 
tion of spontaneous or mutagen-induced mutants of
C. pasteurianum ATCC 6013 either by direct selec- 
tion or by screening after enrichment. To date, 
about 25 independent mutants, including several 
auxotrophs, several antibiotic and UV resistants, 
and several others defective in sporulation, have 
been obtained. A procedure for the formation of 
osmotically sensitive cells, “protoplasts,” by lyso- 
zyme treatment and for the regeneration of such 
cells on protective media has also been developed. 
However, we have not yet been able to detect pro- 
totrophs by fusing the auxotrophic mutant proto- 
plasts with polyethylene glycol. It is hoped that 
emerging techniques, such as Zimmerman dielec- 
trie field fusion, will be useful in the future to over- 
come such difficulties.
Molybdenum Metabolism in Clostridium
pasteurianum
S. Hinton
For several years I have been studying molybdenum 
(Mo) metabolism in Clostridium pasteurianum, a 
nitrogen-fixing anaerobe. To date, it is not known 
how the nutrient, molybdate, is biologically pro- 
cessed or chemically transformed into a biological 
catalyst (molybdenum cofactors). My efforts have 
been directed toward identifying and characterizing 
molybdoproteins that may play a role in the synthe- 
sis of the Mo-containing cofactors.
An anaerobic native gel-electrophoresis proce- 
dure was developed to identify all (oxygen-sensi- 
tive) molybdoproteins in clostridial crude extracts. 
Six distinct molybdoproteins were identified by an- 
aerobic electrophoresis, and four of the molybdo- 
proteins have characteristics that suggest they might 
play a role in the synthesis of the Mo-containing 
cofactor(s). One of the molybdoproteins identified 
as a “suspected” intermediate in the synthesis of the
content (72%), has been isolated. To study the 
structure of such a gene, and also to use it as a 
marker in genetic studies, we cloned the galK  gene 
of C. pasteurianum by complementation of an 
Escherichia coli galactokinase-defective mutant.
Initial screening of a C. pasteurianum chromo- 
somal library in an E. coli galK mutant revealed no 
plasmid conferring complementation. However, 
after longer incubation, several galactose-utilizing 
papillae were defected. A recombinant plasmid iso- 
lated from one of them provided a galactokinase 
activity detectable by enzyme assay. The amount of 
the activity is lower than would be expected from a 
gene carried by a multicopy plasmid. Restriction 
analysis, subcloning, and Tn5 mutagenesis indi- 
cated that the galK  gene is located on a 2-kb EcoRl- 
BamHl fragment. Use of “maxicells” and in vitro 
transcription-translation-coupled E. coli extracts 
showed that this plasmid encodes a protein with a 
relative molecular weight of approximately 40,000. 
Strong hybridization detected by Southern analysis 
between this gene and C. pasteurianum, but not E. 
coli, chromosomal DNA indicated that the galK 
gene originated from C. pasteurianum. It seems 
that even though the subunit molecular weights of 
both gene products are similar, there is little ho- 
mology at the DNA level.
In the absence of selection, this Gal+ phenotype 
is unstable in E. coli. Even when the maintenance 
of plasmid is forced by the use of antibiotic selec- 
tion, about 0.1% of the cells are still Gal־ . Analy- 
sis of these derivatives showed that about 25% of 
them had insertions. In two distinct cases, we have 
detected the presence of IS 7 and IS5 within the 
gene. Therefore, it appears that in E. coli, the C. 
pasteurianum galK gene presents a hot spot for IS 
insertions. Using this gene as a probe, by colony 
hybridization, the original clone from the starting 
library has also been isolated and was found to be 
unable to grow on galactose. However, analysis of 
the total cell proteins by SDS-PAGE revealed that 
galactokinase was overproduced in this clone. Thus, 
as is also the case for the E. coli enzyme, overprod- 
uction of the C. pasteurianum galactokinase is del- 
eterious to E. coli in the presence of galactose. 
Papillae growing upon longer incubation are pre- 
sumably mutants expressing the kinase at a lower, 
but tolerable, amount.
Comparison of these plasmids, producing low or 
high levels of galactokinase, indicated that the low- 
level producer carries a deletion of approximately 
300 bp located in the 5׳ region of the gene. This 
region is now being characterized by DNA se- 
quencing. Assuming that in E. coli, the C. pasteu- 
rianum galactokinase is expressed from its authen- 
tic control region, comparison of these sequences 
will define the molecular structures governing the 
expression of a clostridial gene. However, the rea- 
sons for the instability in E. coli of the active C.
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Mo cofactor was purified and biochemically char-
acterized. The purified molybdoprotein, Mop, has
an unusually low molecular weight ( 6000), and
UV, visible, and fluorescence spectroscopy suggest
that a pterin derivative is associated with it. J. John-
son (University of North Carolina) has proposed a
model that all molybdoenzymes (except the MoFe
protein of nitrogenase) have a common Mo cofac-
tor (Mo-co) in which the Mo atom is bound to a
pterin derivative via sulfur ligands. X-ray absorb-
ance spectroscopy (XAS) has shown that all mo-
lybdoproteins studied to date have at least one mo-
lybdenum-sulfur ligand. In collaboration with S.
Cramer (Exxon Research Co.), the structure of the
Mo environment in Mop was determined by XAS.
The mononuclear Mo site in Mop is unusual in that
it has three terminal oxo groups and three oxygen
or nitrogen ligands (no sulfur ligands). Recently,
formate dehydrogenase found in C. pasteurianum
has been shown to have a Mo site identical to Mop.
Evidence suggests that Mop binds a precursor of
the Mo-co that eventually is inserted into formate
dehydrogenase, the end product of the Mo process-
ing pathway. From biochemical analysis, it is ap-
parent that Mop might be useful in studying the
structure of the Mo-co and how the Mo-co is bound
to the molybdoproteins.
There is a parallel effort using recombinant DNA
technology to complement the biochemical studies
of Mop. In collaboration with G. Freyer and M. So
(Tumor Virus Section), a genomic library of C.
pasteurianum was constructed in a pBR322 vector,
and an expression clone of the mop gene was iden-
tified using immunoscreening. The coding region
of the mop gene was identified by aligning the se-
quence of the first 26 amino acids of the amino ter-
minus with the DNA sequence. The DNA sequence
predicts that the protein is hydrophobic and is en-
riched with lysine and glutamic acid residues that
are potential ligands to the Mo atom. The DNA se-
quence upstream of the mop gene shows comple-
mentarity to Escherichia coli promoter sequences,
which may explain why Mop is expressed in E. coli.
Since Clostridium as yet has no gene-transfer sys-
tem, further characterization of the cloned gene will
have to be performed in E. coli. If mop is func-
tional (binds Mo-co) in E. coli, site-directed muta-
genesis will be used to attempt to determine the Mo-
co binding site.
Isolation of Nitrogenase Genes from
Clostridium pasteurianum
D.J. Lundell
Certain prokaryotic organisms can satisfy their ni-
trogen requirement by reduction of atmospheric
dinitrogen to ammonia. Dinitrogen is quite unreac-
tive under ambient conditions and therefore under-
standing the mechanism of its reduction is of some
interest. The reaction is carried out by two pro-
teins, collectively called nitrogenase - an oe2(32 mo-
lybdenum-iron-sulfur protein (MoFe protein; coded
for by the nifD and nifK genes in Klebsiella pneu-
moniae; nif, nitrogen fixation) of 250,000 daltons
that appears to contain the active site for dinitrogen
reduction and an a2 iron-sulfur protein (Fe protein;
niffl-gene product) that acts as the unique reductant
of the MoFe protein. My aim is to use in vitro mu-
tagenesis to understand the structure and mecha-
nism of nitrogenase. To this end I have started clon-
ing the Fe and MoFe protein genes from Clos-
tridium pasteurianum. This organism is being used
because an X-ray crystal structure is being deter-
mined for its MoFe protein.
Prior to my arrival, various genomic libraries of
C. pasteurianum DNA were constructed in the
expression vectors, pUC8 and pUC9, by F. Daldal
and S. Hinton (this section). Two MoFe protein
clones were identified by immunoscreening. The
smaller clone (MF4), containing an insert of 550
bp, was shown by Southern hybridization to be
completely represented within the larger clone
(MF21), which contained a 2700-bp Pstl-BamHI
fragment. Western blot analysis showed that MF21
directed synthesis of a - 60,000-dalton polypep-
tide corresponding in molecular weight to the nifK-
gene product and a - 35,000-dalton polypeptide,
probably a fragment of the nifD-gene product.
DNA sequence analysis of MF4 showed it to match
a portion of the nifD polypeptide sequence recently
published. Knowing the position of MF4 within the
larger clone, MF21 can be shown to contain the
carboxyterminal portion ( 330 amino acids out
of 529) of the nifD-gene product immediately fol-
lowed by the entire nifK gene. This gene order,
nifDK, is the same as is seen in K. pneumoniae.
The Pae Restriction-Modification
System
T.R. Gingeras, J.E. Brooks, D. O'Loane
Restriction and modification systems are present in
many bacteria as a means of preventing foreign
DNA from entering the host cell. Such systems
consist of a restriction endonuclease that recog-
nizes and cleaves a specific short nucleotide se-
quence and a DNA methylase that modifies the
same recognition sequence, thus protecting the host
from self-destruction.
Because the activity of the endonuclease pro-
duces a double-strand break in the chromosomal
DNA, expression of this gene without the protec-
tion of the companion methylase gene has been
considered to be lethal. Consequently, expression
of both of these genes is thought to be highly con-
trolled and coordinated. Such regulation would be
needed most in those instances where restriction-
modification systems are located on mobilizable
plasmids.
The PaeR7 restriction-modification system from
an R-type plasmid (pMG7) found in Pseudomonas
aeruginosa has been cloned and sequenced in col-
laboration with G. Theirault (Lavelle University,
Quebec) over the course of the last year. The orga-
nization of the two genes in this system is in the
form of an operon with the methylase gene preced-
ing the endonuclease gene on the same strand of
DNA. This operon covers approximately 2300 nu-
cleotides and is regulated by a control region whose
sequence has been determined. Deletions of vary-
ing segments of this control region by BAL-31 nu-
clease give rise to a collection of clones that dis-
plays a spectrum of restriction-modification
phenotypes. The DNA sequence of these clones in-
dicated deletions concentrated within an 80-bp re-
gion at the 5' end of the operon. Such deletions af-
fect the expression of both genes. Analysis of the
DNA sequence of this region showed a sequence
used as a Pribnow box by the araC gene of Esche-
richia coli. Deletions within and proximal to this
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putative Pribnow box region of the operon resulted
in a reduction in the levels of phage restriction.
The most striking feature first noted about this
Pae system was the ability to construct subclones
that express only the endonuclease gene. Such
clones were viable but incapable of restricting in-
fecting phage. How such a phenotype was possible
was somewhat puzzling. However, measurement of
the levels of expression by these unusual clones in-
dicated that they, like the deletion mutants involv-
ing the control region, made 100-fold less endonu-
clease than the clones carrying the intact system.
This was due to the deletion of most of the 5' end
of this system and, presumably, the activation of a
secondary promoter. A lower level of endonuclease
appears tolerable in vivo when no methylase is
present. Since dimers are the active form of the en-
donuclease, it may be that at such low levels of en-
donuclease expression, formation of dimers is re-
tarded.
Deletion mutants involving both the regulatory
and structural segments of this operon produced re-
striction phenotypes. Thus, it appears that the lev-
els of endonuclease within bacteria are important
in order for the restriction phenotype to be ob-
served.
NEUROBIOLOGY
Our strategy for probing the molecular basis of
neuronal connectivity is to isolate monoclonal anti-
bodies (mAbs) that stain single types of neurons or
sets of different neurons. Now, after 4 years, we
have reached a vantage point from which we can
begin to formulate categories for the various pat-
terns stained by our monoclonal antibodies. We
recognize three broad categories of staining pat-
terns that are informative with respect to the molec-
ular heterogeneity of the leech nervous system, one
of them already pointing promisingly to combina-
torial markers that may specify neuronal connec-
tivity.
The first category of antibodies that we are gen-
erating binds to 130K glycoproteins on Western
blots. In CNS tissue, some of these antibodies are
specific probes for select cell bodies and axons that
run in tight bundles; other antibodies bind to 130K
antigens that are shared by select axons and glial
cells. Possibly, these 130K surface antigens are
nCam-like molecules subserving specific adhesion
between axons or between axons and glial cells,
with implications for such phenomena as axonal
guidance.
The second type of monoclonal antibody that we
are generating gives staining patterns similar to
those created by polyclonal antisera against pep-
tides. These antibodies stain neuronal processes
with varicosities that resemble typical leech nerve
terminals. Usually, these antibodies only stain a few
neurons per ganglion, or sometimes even only a few
neurons found in specialized ganglia. None of these
monoclonal antibodies react with proteins on West-
ern blots, but they might very well be directed
against low-molecular-weight peptides.
The third category consists of those antibodies
that are currently the most promising in terms of
pointing to molecular markers important for iden-
Figure 1
Drosophila monoclonal antibody 2G4B specifically stains
the a cell (arrowheads) and is one of our four a-cell-specific
markers.
101
tifying synaptic connectivities in leech CNS. Inter-
estingly, antibodies in this category were generated
not only against leech CNS, but also against the
Drosophila CNS by S. Benzer's laboratory (Cali-
fornia Institute of Technology, Pasadena). Both
leech and Drosophila monoclonal antibodies stain
different intersecting sets of neurons and thereby
reveal an assortment of combinatorial markers. For
example, a class of primary mechanosensory neu-
rons, the pressure-sensitive P cells, are stained by
four different monoclonal antibodies as part of dif-
ferent-sized neuronal sets. Thus, the four mono-
clonal antibodies point to four different combina-
torial markers in these identified neurons. Another
example is the a cell for which one leech and three
Drosophila monoclonal antibodies have also dis-
covered four combinatorial markers (Fig. 1).
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The Macroglial Cells of the Leech Are
Molecularly Heterogeneous
M. S. Flaster, B. Zipser
Using monoclonal antibodies obtained from either
whole nerve cords or CNS extract run on polyacry-
lamide gels of the leech Haemopis marmorata, we
have cataloged the distribution of several mono-
clonal antibodies directed against the macroglia of
the nerve cord and have partially characterized
some of these glial antigens biochemically. The
identifiable macroglia of the leech, those in the lat-
eral connectives, the ganglionic neuropil, the gan-
glionic packets, and the ganglionic roots, are dis-
tinguishable anatomically by position. Here, we
report several monoclonal antibodies that promi-
nently stain some, but not all, macroglia, differen-
tiating these cells at the molecular level. One mono-
clonal antibody stains the processes of the macro-
glial cells of the lateral connectives, the ganglionic
neuropil, and the ganglionic roots but does not stain
the packet glia appreciably. Immunoblots of SDS
gels indicate that this monoclonal antibody binds a
single protein antigen with an apparent molecular
weight of 130,000. The antigen is a glycoprotein.
A second monoclonal antibody strongly stains
throughout the interior of the connective and root
macroglia but does not appear to stain the other
macroglial cells, whereas a third monoclonal anti-
body stains throughout the interior of only the con-
nective macroglial cells. This monoclonal antibody
binds a single protein antigen with an apparent mo-
lecular weight of 77,000, and this antigen is not a
glycoprotein, as judged from multiple lectin col-
umn chromatography. The underlying significance
of the differences in these identified glia to the de-
velopment or adult function of the leech nervous
system remains to be thoroughly explored, al-
though in developmental studies, the time of ap-
pearance of one of these monoclonal antibodies has
already been established.
Combinatorial Leech Antigens
B. Zipser, C. Schley, T. Flanagan, J. Perez
A panel of monoclonal antibodies generated against
either leech or Drosophila CNS divide the leech
ganglion into different sets of antigenetically ho-
mologous neurons. Some of the smaller sets are en-
tirely contained within larger sets; other sets over-
lap only partially. An electrophysiological analysis
of the set of Laz2-1-stained neurons has identified
sensory and motor neurons and interneurons, which
are already shown to be in synaptic contact. Laz2-
1, together with leech mAbs Lan3-5, and Droso-
phila mAbs, 3A4 and 8G1 (Fujita et al., Proc. Natl.
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Acad. Sci. 79: 7929 [19821), identify an assortment
of combinatorial markers. For sensory neurons (the
pressure cells), three different markers have been
identified using three leech monoclonal antibodies.
For a ventral medial pair of neurons, one leech and
two Drosophila monoclonal antibodies have also
identified three markers. Neurons are hypothesized
to use an assortment of combinatorial factors to
form precise synaptic connections. These hy-
potheses predict the type of overlapping chemically
labeled sets our monoclonal antibodies have dis-
covered.
Analysis of a Neuron-specific
Leech Antigen
B. Zipser, T. Flanagan, M. Flaster, C. Schley
[in collaboration with E. Macagno and
R. Stewart, Columbia University]
Is there a common denominator to leech neurons
carrying the Laz2-1 antigen? In the CNS, the mono-
clonal antibody labels about 40-odd neurons, or 20
bilateral pairs of different neurons. Five of these
neurons have been identified through intracellular
dye injections and all were observed to project their
primary axons into roots, enabling them to inner-
vate the periphery as sensory or motor neurons.
Among these neurons are both pairs of the exten-
sively studied primary mechanosensory neurons re-
sponding to pressure. The function of the other
three cells has not yet been determined. Of partic-
ular interest is the one pair next to the Retzius cells
that is the most likely candidate to be the first neu-
ron expressing the Laz2-1 antigen during CNS de-
velopment. The expression of the Laz2-1 antigen
has been extensively characterized both embryoni-
cally and postembryonically and is seen to appear
in a precise spatial and temporal pattern both within
the CNS and in the periphery.
In the periphery, Laz2-1 stains putative sensory
neurons in each annulus of the body wall. It also
stains neurons within the esophagus and cells that
appear to be part of the testicular primordia. A pos-
sible mechano- or chemosensory function of the
peripheral neurons remains to be explored. In our
attempt to find a common functional denominator
for Laz2 -l- labeled neurons, we are very interested
in identifying the functions of the other Laz2-1-
stained CNS neurons to determine whether they,
like the pressure cells, are associated with first- or
higher-order sensory function.
Our other interest in the Laz2-1 pattern relates to
the temporal pattern of antigen expression in the
CNS. Measured immunocytochemically, some of
the Laz2 -l- labeled neurons only express their anti-
gen postembryonically. This offers the opportunity
to analyze a given neuron before and after antigen
expression has begun. Since some of the neurons
within the staining patterns are known to be syn-
aptically connected, the possibility arises that neu-
rons accumulate the Laz2-1 antigen as they become
sequentially inserted in a functional network.
A Monoclonal Antibody Specific to the
Leech Pressure-sensitive
Mechanosensory Neurons
C. Schley, B. Zipser [in collaboration with C.
Loer and W. Kristan, University of
California, San Diego]
Two pairs of pressure-sensitive mechanosensory
neurons (P cells) are found in the standard midbody
ganglion of the glossophoniid leech, Haementeria.
We have produced a monoclonal antibody specific
to the somata and neurites of these cells and to a
small number of unidentified fibers. The anti-
bodies were prepared by immunizing BALB/c mice
with lightly fixed, homogenized Haementeria nerve
cords. Their spleen cells were fused with myeloma
cells to produce hybridomas. After a standard HAT
selection, the clones were screened on paraformal-
dehyde-fixed ganglia of adult Haementeria using an
HRP-conjugated secondary antibody and staining
with DAB and H202. Four large cell bodies stain in
the standard adult ganglion, along with their neu-
rites in the neuropil, peripheral nerves, and con-
nectives. A few as yet unidentified fibers are found
more medially in the neuropil and connectives;
these also sometimes appear to be sending branches
out the nerves to the periphery. Some specialized
ganglia stain differently. The two sex ganglia have
only one pair of cell bodies staining, and the last
two unfused ganglia have one pair of large cell bod-
ies and one pair of small cell bodies that stain. The
tail brain, composed of seven fused ganglia, has
cells staining that appear to be the segmental hom-
ologs of the P cells; the head brain, composed of
four fused ganglia and a supraesophogeal ganglion,
segmental homologs are again apparent, as well as
a few additional cell bodies.
We have found as well that the antibody cross-
reacts with another glossophoniid leech, He lob-
della triserialis, in which experimental manipula-
tions of P-cell progenitors are possible. We are now
using the antibody to examine the consequences of
ablations and other experimental manipulations of
P-cell progenitors. We are investigating the possi-
ble function of the antigen by a variety of means.
First, by light microscopy, the antigen appears to
be located both on the surface and inside the cell;
these observations will be confirmed by other
methods. Second, the molecular weight of the an-
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tigen will be ascertained. Finally, the antibody will
be applied to live ganglia while recording from the
P cells and their postsynaptic targets.
Varicosity Patterns and Rare Neuron
Types in the Leech Central
Nervous System
T. Flanagan, B. Zipser
Our studies indicate that the neuropile of leech gan-
glia is compartmentalized with reference to the
distributions of several types of immunoreactive
varicosities. The leech neuropile is also compart-
mentalized with reference to the characteristic dis-
tribution of neurites from identified cell types. We
suspect that such compartments may correspond to
regions restricted to specific types of cellular com-
munication. We report here the results of our im-
munocytological studies of 11 varicosity patterns
and an in depth morphological and electrophysio-
logical description of one set of these immunoreac-
tive cell types.
Monoclonal antibodies raised against leech nerve
cords react with specific neuronal antigens. Of the
1200 hybridoma lines screened, 57% were immu-
noreactive, 3 % stain restricted neuronal sets, and
1 % stain varicosities. These immunoreactive vari-
cosities resemble leech varicosities stained with
commercial anti-Leu-enkephalin antisera in terms
of varicosity size, approximate number, and gan-
glionic distribution pattern. Varicosities extend
throughout the leech nervous system and are partic-
ularly conspicuous within the cephalic neurohemal
sites. Antisera that stain varicosities also stain a re-
stricted number of immunoreactive soma that either
lie clustered within specialized ganglia or are reg-
ularly distributed in sparse cell sets in segmental
ganglia. The mAb Lan3-11, for example, stains so-
ma within the subesophageal and the second seg-
mental ganglia. These cells are well suited for elec-
trophysiological and morphological analyses and
allow us to demonstrate that immunoreactive vari-
cosities arise from immunoreactive soma. Using
double-labeling methods, we have established that
these cells are interganglionic interneurons pro-
jecting to ganglionic sites that contain immuno-
reactive varicosities and that their neurites display
swellings comparable to these varicosities. We rec-
ognize three Lan3-11 subtypes, and thus we are
presently studying the extent to which Lan3 -11 pro-
jection fields overlap and varicosity distribution
patterns correspond. Perhaps distinct neuropile tar-
get sites will suggest separate follower cell types
and shed light on their individual physiological
functions.
Identifying Cell Types in Adult and
Developing Mammalian CNS
S. Hockfield, E. Walvogel, C. Bautista
The mammalian CNS is composed of many differ-
ent neuronal types. Much of neurobiology over the
last 100 years has been concerned with the descrip-
tion of neuronal diversity on the basis of anatomi-
cal, physiological, and pharmacological criteria.
These studies have shown that the morphology and
physiology of identified neuronal types are consist-
ent among animals of the same species and often
among animals of different mammalian species.
Many hypotheses for the generation and expression
of neuronal diversity have postulated that molecu-
lar differences among neurons could direct cellular
differentiation and the establishment and mainte-
nance of specific connections. In our laboratory we
are using hybridoma and recombinant DNA tech-
nologies to explore the molecular basis of neuronal
diversity. During the past year, we have used these
techniques to examine further the cellular organi-
zation of the adult mammalian brain and to study
the development of the CNS by identifying early
cell types and the sequence of events that give rise
to the adult structure.
Monoclonal antibodies identify subsets of neurons
in the adult CNS. Monoclonal antibody Cat-301
recognizes subsets of neurons in many areas of the
In the dorsal lateral genicu-
late nucleus (LGN) of both cat and monkey, the
subset of Cat-301-positive neurons appears to cor-
relate with a physiological class of neurons. In the
visual cortex of monkeys, Cat-301 recognizes
patches of neurons in both normal and monocularly
enucleated animals. These groups of neurons lie in
register with ocular dominance columns and may
define a functionally distinct subset of cells. These
studies show that the neurons in the LGN and vis-
ual cortex are molecularly heterogeneous and that
the heterogeneity correlates with features of the or-
ganization of each of these areas. We have further
identified antibody-positive neurons by showing
that they project to specific sites within the CNS
using retrograde transport techniques. In addition,
in collaboration with M. Sur (Yale University), we
are electrophysiologically identifying individual
LGN neurons and marking them using intracellular
electrodes. These neurons are then stained with
Cat-301 to determine precisely which physiological
classes of neurons carry the Cat-301 antigen.
Defining cell types in the developing mammalian
CNS. In our initial efforts to study developmental
events, we used the markers we have developed that
recognize antigens in the adult CNS. All of these
markers are not expressed until relatively late in
development. For example, Cat-301, which recog-
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nizes a surface antigen, is not expressed on the sur-
face of most spinal cord neurons until after the
second postnatal week. At this time, synapse elim-
ination, one of the late events in neuronal matura-
tion, is at its peak. This suggests a role for Cat-301
in the establishment or maintenance of adult syn-
aptic patterns.
We have now raised monoclonal antibodies to rat
embryonic day-15 spinal cord. At this age the ner-
vous system contains both the rapidly proliferating
neuroepithelial cells and the recently differentiated
postmitotic neurons, some of which have begun to
extend their axons. We have obtained reagents that
identify (1) postmitotic neurons; (2) early develop-
A Rat - 202
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Figure 2
Markers that differentiate among prevalent cell types in devel-
oping CNS. Transverse sections of embryonic day-15 rats. (A)
Monoclonal antibody Rat-202 stains axons in the developing
spinal cord and periphery. (B) Monoclonal antibody Rat-401
stains radial glia in the CNS, nonneuronal cells in nerve routes,
and developing muscle cells. (C) Lectins from Bandeiria sim-
plicofolia stain developing blood vessels in embryos but not in
adults. Bar, 1 mm.
ing axons and their growth cones; (3) a class of
proliferating cells, the radial glia; and (4) the em-
bryonic vascular system (Fig. 2). We have used
these monoclonal antibodies to define major cell
types and to study the developmental events that
give rise to the diverse cell types in the adult ner-
vous system. One example of this approach is given
by our studies using antibody Rat-401.
The antigen recognized by antibody Rat-401 (a
200-kD species on immunoblots of SDS-polyacry-
lamide gels) first appears in the developing rat CNS
after neural tube closure, on embryonic day 11 (Ell).
As neural development proceeds, antibody-positive
cells come to resemble the radial glial cells de-
scribed by Ramon y Cajal. Electron microscopic
immunocytochemistry has shown that the antibody
recognizes mitotic cells.
Cerebellum: P2
A
P12
Rat-401 recognizes radial cells in all areas of the
developing rat brain but not in the adult. In each
area we have examined, antibody staining begins to
decrease at the end of the period of neuronal migra-
tion (Fig. 3). This has important implications as the
radial glial cells are thought to guide neuronal mi-
gration. We have shown that a radial cell carrying
the Rat-401 antigen is transiently present during the
period of neuronal migration-a cell that is spa-
tially and temporally suited to serve as a structural
guide for migrating neurons.
We have used other monoclonal antibodies to fol-
low the development of axons. One antibody, Rat-
202, recognizes axons at very early stages and rec-
ognizes the entire axon, including the growth cone
and its filopodia. As these early axons travel into
the periphery, they appear to be in close contact
P28
Spinol Cord. E19 P2 P6
Figure 3
Antigens recognized by Rat-401 are lost during development in cerebellum (A-C) and spinal cord (D-F). (A) Postnatal
day-2 (P2) cerebellum contains numerous Rat-401-positive profiles. (B) By P12 the intensity of Rat-401 staining begins to
decrease. (C) At P28 the cerebellum contains no Rat-401-positive profiles. The loss of Rat-401 staining is achieved by P21.
In the developing cerebellum, the majority of neuronal proliferation and migration is complete by P21. (D) In the spinal
cord, Rat-401 staining begins to decrease at embryonic day 19 (compare with E15 in Fig. 2). (E) At P2 very few antibody-
positive profiles remain in the spinal cord (arrows). (F) By P6 the spinal cord contains no positive profiles. This section of
P12 spinal cord illustrates the lack of Rat-401 staining at later stages. In the spinal cord, neuronal proliferation and migra-
tion are complete by E19. Bar, 1 mm.
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with a peripheral Rat-401-positive cell. This cell is
present at the location of axon routes before axons
have grown out. This suggests that these nonneu-
ronal cells may pioneer axon pathways and that the
first axons may use these cells as a guide from CNS
to PNS.
Other axonal antigens are expressed later in ax-
onal maturation than Rat-202. We have used anti-
bodies against these antigens to follow different
time courses in axon development. Together, these
studies on antigen expression in the developing and
adult mammalian CNS show that the amount of di-
versity among the cells in the CNS is large. They
also indicate that an elaborate, but tractable, pat-
tern of antigenic expression occurs during neuronal
development.
Molecular Studies of Neural
Organization
R. McKay, S. Hockfield, K. Frederiksen,
0. Sundin
Recently, the tools of molecular biology have be-
come sufficiently simple to allow the experimental
investigation of patterns of gene expression in com-
plex tissues. We have used hybridoma technology
to study both the molecular complexity and the cel-
lular organization of the nervous system. More re-
cently, we have applied recombinant DNA tech-
niques, particularly cDNA cloning, plus-minus
screening, and in situ hybridization to these same
problems.
Using hybridoma technology, we showed that the
nervous systems of the leech and of the cat were
composed of antigenically diverse cell types. With
both invertebrate and vertebrate systems, it became
clear that specific monoclonal antibodies allowed a
high-resolution analysis of in vivo cellular organi-
zation (Hockfield and McKay, J. Neurosci. 3: 369
[1983]; Hockfield and McKay, Proc. Natl. Acad.
Sci. 80: 5758 [1983]; Hockfield et al., Cold Spring
Harbor Symp. Quant. Biol. 48: 877 [1983]; Hendry
et al., Nature 307: 267 [1984]).
Axon Organization
R. McKay, K. Frederiksen, S. Hockfield
The large numbers of antibodies that stained differ-
ent subsets of neurons in the leech suggested that
we were very far from saturating the pool of subset-
specific antigens. To combat this complexity, we
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concentrated our efforts on the specific problems
raised by a set of antibodies that recognized a par-
ticular subset of central neurons, the nociceptive or
N cells. These cells give the leech information
about noxious stimulation of the skin. We mapped
these N cells in different ganglia physiologically
and showed that all the segmental N cells carry spe-
cific antigens (Johansen et al., J. Comp. Neural.
[1984, in press]). These specific antigens are found
on axons as well as cell bodies, and we showed that
these axons occupy specific locations in the CNS.
The specific location of leech central axons was
confirmed by electron microscopy of labeled axons
after electrophysiological identification of cells
(Johansen et al., J. Comp. Neurol. [1984, in press]).
The regulation of axonal morphology has been rec-
ognized as a central question of neural develop-
ment. Although there are many properties of neu-
rons that may contribute to axonal morphology, it
has often been postulated that different surface
molecules might play a role in axon pathfinding as
the growth cone establishes axonal morphology. We
then showed that the specific antigens which were
present on stereotypically organized axons were
present on the axon surface (McKay et al., Science
222: 788 [1983]) and that these protease-sensitive,
glycosylated antigens are found on axons and filo-
podia during the earliest stages of axon outgrowth
(McKay et al., Cold Spring Harbor Symp. Quant.
Biol. 48: 599 [1983]). This work established that
growing axons can carry distinct surface mole-
cules. Using a cell culture of identified invertebrate
neurons that send out neurites, we plan to explore
further the biochemistry of axon pathfinding.
Genetic Complexity of the Rat Brain
0. Sundin, R. McKay, S. Hockfield
We are now using recombinant DNA techniques to
obtain systematic data on the molecular complexity
of the vertebrate brain. cDNA libraries in various
plasmid vectors have been made with oligo(dt)-se-
lected sequences from the embryonic neural tube
and different regions of the adult brain of the rat.
We are now using plus-minus screening and in situ
hybridization to obtain probes that mark cell types
during particular stages of differentiation. Our first
results with these cDNA libraries show that there
is a high degree of genetic complexity in the ver-
tebrate brain. We now plan to use these techniques
to obtain a more complete description of the num-
ber and organization of different cell types in the
vertebrate brain.
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COLD SPRING HARBOR
MEETINGS

48TH COLD SPRING HARBOR
SYMPOSIUM ON QUANTITATIVE
BIOLOGY
MOLECULAR NEUROBIOLOGY
June 1 -June 8
223 participants
Ever since the genetic code was solved in 1966, the brain and the phenomena it oversees -perception, mem-
ory, and thinking -have stood out like Himalayan peaks to the world of molecular biologists. Until very
recently, however, most of us have believed that we have little unique to offer those long professionally
involved in neurobiological phenomena and that the brain in particular was far beyond our capabilities.
Those few molecular biologists who did move into neurobiology we have in the past regarded as frightfully
brave or recklessly silly.
Apparently particularly hopeless was the approach that should be the most natural to us, that of focusing
first on the structure and functioning of the molecules out of which the nerve cells are made. Although such
research of itself could become fun to do, for many years the chances seemed nil that it would be through
molecular biology that the intimate secrets of the brain would fall out. So an audacious few of us had moved
into the fields of psychophysics, hoping that bouts of hard thinking could do the job. But here again the odds
that fundamental revelations would quickly emerge seemed painfully low.
Today, however, we sense a new mood among those molecular biologists who gaze upwards toward the
brain. By using recombinant DNA, monoclonal antibodies, and the facts of receptor biochemistry to the
fullest, we should have a fighting chance to understand the uniqueness of nerve cells and the ways they come
together to form functional networks. To mark this new mood, we decided to hold the 48th Symposium on
Molecular Neurobiology.
In putting together this meeting, we received excellent advice from many colleagues, especially Eric
Kandel and Charles Stevens, both long associated with the Cold Spring Harbor summer courses in neuro-
biology. The final result was a Symposium that will be long remembered as a decisive turning point in the
development of neurobiology.
Funding for this meeting was provided by the National Institutes of Health, National Science Foundation,
and the Department of Energy.
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C. ELEGANS
May 4-May 8
Arranged by
Robert H. Waterston, Washington University,
St. Louis
David Hirsh, University of Colorado
Jonathan Hodgkin, MRC Laboratory of
Molecular Biology
Sam Ward, Carnegie Institution of Washington,
Baltimore
178 participants
The fourth international C. elegans meeting at Cold
Spring Harbor attracted more than 170 scientists
from 40 laboratories studying diverse aspects of this
small nematode. The results presented at the meet-
ing included a description of the complete neuro-
anatomy; genetic and molecular studies of the speci-
fication of neural development and neuron-specific
polypeptides; a genetic pathway of sex determina-
tion and the identification of genes specifying sex-
specific proteins; a description of mutants affecting
developmental lineages, including some with ho-
meotic effects; the localization of gene products
within cells, from the asymmetric distribution of
proteins during cell division both in the embryonic
cleavages and in spermatogenesis to the specific
positions occupied by myosin isoforms in the thick
filament; the molecular and genetic analysis of pro-
teins of the cuticle and muscle, especially of the
myosin heavy-chain gene; the search for transpos-
able elements by genetic and molecular ap-
proaches; the conclusive identification of a tRNA
amber nonsense suppressor; a detailed deletion map
of a region of the second chromosome; and the first
successful DNA transformation of C. elegans. The
gathering of workers from all fields to share results
produced a wealth of ideas and collaborations,
demonstrating the value of the meeting.
This meeting was supported in part by funds from
the National Institute on Aging, National Institutes
of Health.
MICROBIAL
DEVELOPMENT
May 11-May 15
Arranged by
Richard Losick, The Biological Laboratories,
Harvard University
Lucy Shapiro, Albert Einstein College of
Medicine
Amar Klar, Cold Spring Harbor Laboratory
143 participants
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Relatively simple microorganisms are exception-
ally attractive systems in which to study develop-
ment because of the facility with which they can be
manipulated by genetic and molecular techniques.
The meeting on Microbial Development was un-
usual in bringing together workers in a wide variety
of prokaryotic and eukaryotic microbial systems in
which general problems of cellular differentiation,
cell-cell interaction, and morphogenesis are being
addressed. A special feature of the meeting was the
comparison of similar biological problems posed by
very different experimental systems, such as cell
division and differential gene expression in E. coli,
Caulobacter, and yeast; spore formation in Bacil-
lus, Streptomyces, yeast, and Aspergillus; mating
interactions in Streptococcus, Streptomyces, E.
coli, Chlamydomonas, and yeast; and parallel pat-
terns of social behavior in Myxobacteria and Dic-
tyostelium. Despite the diversity of systems, a co-
herent set of recurring issues shaped the discussions:
the role of nutritional signals in triggering devel-
opment, the way in which sets of genes are acti-
vated in ordered sequences during differentiation,
polarity, and the role of positional information, cell
communication, and the transduction of sensory in-
formation. An important success of the meeting was
that workers in diverse systems found themselves
on common ground with respect to the questions
being addressed and the experimental approaches
being employed. The meeting conveyed a strong
sense of excitement, since it was clear that many
microbial developmental systems were yielding
rapidly to genetic and molecular approaches, with
many molecular details and, in some instances, im-
portant general principles already emerging.
This meeting was supported in part by Abbott
Laboratories; American Cyanamid Co.; Biogen
S.A.; Eli Lilly Co.; Miles Laboratories, Inc.; Mon-
santo; Monsanto Agricultural Products Co.; Up-
john Co.; the National Science Foundation; and
Searle Research and Development.
RNA PROCESSING
May 18 -May 22
Arranged by
John Abelson, University of California, San
Diego
James Dahlberg, University of Wisconsin
Michael Mathews, Cold Spring Harbor
Laboratory
224 participants
Modification of primary transcripts plays an essen-
tial role in the mobilization and expression of ge-
netic information. The alterations can be of several
kinds, from changes in single nucleotides to the ad-
dition or deletion of lengthy sequences, and they
can modulate the stability and function of RNAs of
all types. It is not surprising, then, that the topics
discussed at this year's meeting on RNA Processing
ranged widely, including nuclear structure and
function, ribonucleoprotein particles, and RNA
structure, as well as mRNA, tRNA, and rRNA
processing. In some areas, definitive answers have
begun to emerge -the detailed chemistry and bio-
chemistry of tRNA cleavage and ligation reactions
are a notable example. In others, such as mRNA
splicing and polyadenylation, it was clear that suf-
ficiently active cell-free systems are now in hand
and rapid advances are anticipated. Yet other areas
are moving through a more descriptive phase: The
structural analysis of ribonucleoprotein particles is
well advanced, for instance, while their functions
offer food for thought and subjects for debate.
This meeting followed a successful predecessor
in 1982, and plans for a further meeting in 1984 are
now in hand. We are fortunate that the granting
agencies, recognizing the significance of RNA
processing, approved funding for two consecutive
years -a rare act. Support comes from grants from
the National Science Foundation, the National In-
stitutes of Health, the National Institute of General
Medical Sciences, and the Fogarty International
Center.
RNA TUMOR VIRUSES
May 25-May 29
Arranged by
Edward Scolnick, Merk Sharp & Dohme
Research Laboratories
Nancy Hopkins, Massachusetts Institute of
Technology
441 participants
The annual RNA Tumor Virus meeting once again
achieved a record number of applicants and ab-
stracts, the abstract booklet being almost one inch
thick. The continuing intense interest in this field
is, of course, in large part due to viral oncogenes,
those cellular sequences captured by retroviruses
and thereby turned into cancer-inducing genes. At
least 50% of the abstracts dealt directly or indi-
rectly with viral oncogenes and their cellular ho-
mologs, and it was clear that the existence of mutant
v-onc genes will continue to provide an important
probe into c-onc function. Central issues con-
cerned the various mechanisms of oncogene acti-
vation and the structure of c-onc genes in species
as diverse as Drosophila, the frog X. laevis, man,
and most novel and striking, yeast, where one group
reported finding ras-gene homologs.
Retroviruses as vectors was a subject of increas-
ing interest. Also, there were numerous abstracts
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dealing with human retroviruses, both endogenous
sequences and the exogenous human T-cell leuke-
mia viruses. The mechanism of HTLV-induced leu-
kemogenesis remains obscure and clearly of great
interest. There is no reason to think that the RNA
Tumor Viruses meeting will be any smaller next
year.
This meeting was supported in part by funds from
the Cancer Center Grant to Cold Spring Harbor
Laboratory from the National Cancer Institute, Na-
tional Institutes of Health.
THE MOLECULAR
BIOLOGY OF YEAST
August 16-August 21
Arranged by
James B. Hicks, Amar Klar, and Jeffrey N.
Strathern, Cold Spring Harbor Laboratory
473 participants
Well over 600 scientists applied to attend the 1983
Yeast meeting. This reflects both the proliferation
of the laboratories and the rapid progress in appli-
cation of molecular approaches to a variety of bio-
logical problems in yeast. As a result of this over-
subscription, it was both more difficult to organize
the sessions and more rewarding to absorb their
content. One take-home lesson obvious from the
meeting is that the recombinant DNA and transfor-
mation technologies have progressed to the point
where the cloning of most genes is routine. Nearly
a quarter of the mapped genes have been cloned.
Several molecular approaches to simplify mapping
techniques have been developed that are expanding
our understanding of the organization of the ge-
nome. Finally, enriched messages, genes from het-
erologous systems, immunological screening, and
synthetic probes are allowing the cloning of genes
for which there are no mutations. All of these tech-
niques provided the raw material for several ele-
gant molecular studies on the regulation and ex-
pression of genes that were reported at this meet-
ing. Talks and posters addressed such topics as the
control and expression of cell-cycle-specific genes;
the coordinated expression of banks of genes such
as cell-type-specific, ribosomal, and sporulation;
and the induction of metabolic genes. This past year
has seen the development of techniques for return-
ing in-vitro-generated mutant sequences to their
proper place in the chromosome. Thus, the analysis
of the function and regulation of genes is progress-
ing to the point of making single base-pair changes.
Cloned sequences have allowed the physical char-
acterization of genetic rearrangements such as re-
combination between reiterated sequences, hops by
the transposon Ty 1, amplification of genes, and
mating-type switching. These same technologies
provide the raw material for the characterization of
yeast extracts exhibiting replication or recombina-
tion of yeast plasmids. Furthermore, this meeting
provided a forum for exchanging observations on
the use of yeast to express and properly localize or
secrete proteins for use in biochemical or commer-
cial enterprises. In summary, this meeting provided
an invaluable opportunity to bring major yeast lab-
oratories together to compare notes on their prog-
ress toward utilizing the various molecular ap-
proaches to understand the biology of yeast.
This meeting was supported by financial contri-
butions from Biogen Research Corp.; Hoffman-
LaRoche, Inc.; Pfizer, Inc.; Smith Kline & French
Laboratories; Biogen N.V.; Genentech, Inc. ;
Zymos Corp.; and LaBatt Brewing Company.
PHAGE AND BACTERIAL
REGULATORY
MECHANISMS
August 23-August 28
Arranged by
Ahmad Bukhari, Cold Spring Harbor
Laboratory
Sankar Adhya, National Cancer Institute
Harrison Echols, University of California,
Berkeley
228 participants
This meeting formally joined the phage and its host
for the first time at the level of their scientific ad-
mirers. Presentation of recent work on the ge-
netics, physiology, and biochemistry of prokaryotic
organisms attested to the value of this union be-
cause of the similarity of molecular mechanisms
and of techniques for elucidating them. One high-
light of the meeting was the opportunity to note the
enormous diversity of regulatory mechanisms, an
aspect of prokaryotic control once overshadowed
by the early understanding of the lac system of neg-
ative regulation. Transcription is regulated posi-
tively and negatively at the initiation and termi-
nation stage; posttranscriptional regulatory mech-
anisms abound, including initiation and completion
of protein synthesis and protein stability. Another
highlight was the chance to view the integration of
diverse individual mechanisms into a unified regu-
latory response, as in the lysis-lysogeny decision
by bacteriophage X and the SOS and heat-shock re-
sponses of bacteria.
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MODERN APPROACHES
TO VACCINES
August 31-September 4
Arranged by
Robert Chanock, National Institutes of Health
Richard Lerner, Research Institute of Scripps
Clinic
241 participants
This meeting concentrated on the latest contribu-
tions of a worldwide selection of leading laborato-
ries in the field of vaccines. Topics included viral
structure and function as they relate to the devel-
opment of vaccines; chemistry of virus neutraliza-
tion; new experimental approaches to the construc-
tion of viral proteins, including cloning and the
expression of viral genes in prokaryotic and eukary-
otic cell systems; attenuation of virulence; and en-
hancement of antigenicity and immunogenicity.
The broad scope of this meeting was of interest
to individuals doing research on infectious disease,
public health officials concerned with new strate-
gies in the study and control of infection, members
of the pharmaceutical industry involved in the de-
velopment of vaccines, regulatory authorities who
set safety and efficacy standards for vaccines, and
immunologists.
Funding was provided in part by Merieux Insti-
tute, Inc.; Merck and Co., Inc.; and Wellcome Bio-
technology, Ltd.
THE CANCER CELL
September 8-September 13
Arranged by
Arnold Levine, State University of New York,
Stony Brook
William Topp, Cold Spring Harbor Laboratory
George Vande Woude, NCI, National Institutes
of Health
James D. Watson, Cold Spring Harbor
Laboratory
262 participants
The Cancer Cell meeting begins a new series of
meetings on this topic that will replace the Cell
Proliferation and Cancer Conferences. The meet-
ing format sought to bring together scientists from
diverse disciplines and approaches to focus on the
molecular and cellular aspects of the cancer cell.
Both RNA and DNA tumor virologists discussed
the gene structure, gene products, and functions of
oncogenes and virogenes involved in transforma-
tion and tumorigenesis. Cell biologists contributed
sessions on growth factors, the keratins and cyto-
skeletal elements, chromosomal rearrangements,
tumor promoters, and cancer cell surface antigens.
The meeting succeeded in providing some unifying
principles for the mechanisms of action of cell-de-
rived oncogenes and DNA-virus-derived virogenes
in the transformation process. The bridge from vi-
rology to cell biology has begun with new relation-
ships between oncogene products and growth fac-
tors, chromosome rearrangements and oncogenes,
and altered cytoskeletal genes and gene products.
The first clues to these unifying principles of on-
cogenic mechanisms and their apparent relation-
ships to the problem of human cancer provided an
appropriate level of excitement for this meeting
dedicated to Mrs. Albert D. Lasker. Her contribu-
tions to the funding of this research over four de-
cades were celebrated by the high caliber of science
and the rapid rate of progress now evident in this
field.
This meeting was supported by grants from the
American Cancer Society, Becton-Dickinson and
Company, the Fogarty International Center, and the
National Cancer Institute.
HUMAN T-CELL
LEUKEMIA VIRUSES
September 14-September 15
Arranged by
Myron Essex, Harvard School of Public Health
Robert Gallo, National Cancer Institute
121
113 participants
This was the first international meeting on human
T-cell leukemia viruses (HTLV). HTLV is the first
retrovirus that has been characterized that is clearly
associated with human leukemia/lymphoma. The
initial isolation in 1979 by Gallo and co-workers
was followed by additional isolations in Japan and
elsewhere. To date, there are approximately 35 iso-
lates of HTLV worldwide. All of the HTLV isolates
except two belong to the HTLV-I subgroup. The
other two isolates belong to a related but distinctly
different group designated HTLV-II, originally iso-
lated from a patient with hairy-cell leukemia. The
clustering of adult T-cell leukemia/lymphoma
(ATLL) in the southern islands of Japan led to the
suspicion that ATLL might be caused by an infec-
tious agent. Further epidemiologic analysis world-
wide has exposed other areas of HTLV-associated
disease. HTLV is endemic in the southern islands
of Japan, regions of Africa, southeastern United
States, the Caribbean, and regions of Central and
South America. Another disease of current world-
wide interest is the acquired immune deficiency
syndrome (AIDS). HTLV has been isolated from
several AIDS patients. Although there is no clear
etiology, HTLV has been linked to AIDS by virus
isolation, molecular biology, and seroepidemiol-
ogy.
This meeting was supported in part by grants
from the National Cancer Institute and Fogarty In-
ternational Center, Cancer Research Institute, and
N.Y.S. Department of Health.

POSTGRADUATE
COURSES

The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects which are either so new or so specialized that they are not ade-
quately treated by universities. Our aim is to provide intensive study in the most recent developments and tech-
niques in these subjects and to prepare students to enter directly into research in a particular area. To ensure up-
to-date coverage of current research work, we bring together a workshop staff from many laboratories around
the world and supplement this staff with a series of seminar speakers.
THE CELLULAR AND
MOLECULAR BIOLOGY
OF BEHAVIOR
June 10-June 23
INSTRUCTORS
Kandel, Eric, M.D., Columbia University, New
York, New York
Koester, John, Ph.D., Columbia University, New
York, New York
Nottebohm, Fernando, Ph.D., Rockefeller
University, New York, New York
Pearson, Keir, Ph.D., University of Alberta,
Canada
This lecture course was designed to introduce stu-
dents to cellular and molecular biological approaches
to the study of behavior and learning. Rather than
being exhaustive, the lectures provided an intensive
coverage of four main areas: (1) general principles of
behavior and of cellular neurobiology, including reg-
ulation of gene expression; (2) simple forms of be-
havior, learning, and motivation, and the role of bio-
genic amines, hormones, and peptides in their
modulation; (3) initiation and maintenance of com-
plex locomotor sequences, including voluntary move-
ment and motor learning; and (4) communication. To
illustrate general principles, suitable systems for study
were selected from both invertebrate and vertebrate
behavior. Emphasis was placed on the application of
recombinant DNA technology in the analysis of be-
havior. To put the cellular work into perspective, se-
lected examples were also taken from human behav-
ior and its abnormalities. Guest lecturers included: R.
Axel, A. Fuchs, P. Getting, C. Ghez, I. Kupfermann,
G. Ojemann, R. Scheller, N. Suga, T. Thach, J. Tru-
man, J. Wine, R. Wurtz, and R. Zigmond. This
course was designed for advanced graduate students
and research workers. A prior course in neurobiology
was required.
MOLECULAR BIOLOGY OF
PLANTS
June 10-June 30
INSTRUCTORS
Bedbrook, John, Ph.D., Advanced Genetic
Sciences, Berkeley, California
Malmberg, Russell, Ph.D., Cold Spring Harbor
Laboratory, New York
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Sussex, Ian, Ph.D., Yale University, New Haven,
Connecticut
ASSISTANTS
Waldren, John, CSIRO, Canberra, Australia
Brown, Susan, Massachusetts General Hospital,
Boston
Dunn, Barbara, Harvard University, Cambridge,
Massachusetts
Mclndoo, Jean, Cold Spring Harbor Laboratory,
New York
LABORATORY INSTRUCTORS
Dunsmuir, Pamela, Ph.D., CSIRO, Canberra,
Australia
Jones, Jonathan, Ph.D., Advanced Genetic
Sciences, Berkeley, California
Dellaporta, Stephen, Ph.D., Cold Spring Harbor
Laboratory, New York
Miles, Don, Ph.D., University of Missouri,
Columbia
Steinbeck, Kit, Ph.D., Advanced Genetic Sciences,
Berkeley, California
Ho, David, Ph.D., University of Illinois, Chicago
This course provided an introduction to current tech-
niques for the manipulation of plant material as ap-
plied to experiments in molecular biology and ge-
netics. It was designed primarily for scientists working
in other areas who wish to pursue research in plants.
It was assumed that applicants had a general working
knowledge of molecular biology, but no previous ex-
perience with plants was required. Experiments were
designed to emphasize aspects unique to plant sys-
tems, including mutagenesis and analysis of mutants,
tissue culture techniques, protoplast isolation and cul-
ture, regeneration of plants from culture, DNA and
RNA isolation and cloning procedures, crown gall tu-
morigenesis, chloroplast genetics, and nitrogen fixa-
tion. Guest lecturers provided a background in plant
morphogenesis, physiology, pathology, genetics, and
cytology. Different plant species were used to illus-
trate particular experimental techniques, but the
course emphasized tobacco and maize as model
systems.
NERVOUS SYSTEM OF
THE LEECH
June 10-June 30
INSTRUCTORS
Nicholls, John, Ph.D., M.D., Stanford University
Medical School, California
Muller, Ken, Ph.D., Carnegie Institution of
Washington, Baltimore, Maryland
Thompson, Wesley, Ph.D., University of Texas,
Austin
In this laboratory course students used intracellular
and extracellular recording techniques to recognize
individual motor and sensory nerve cells, to map the
fields they innervate in the periphery, to measure their
membrane properties, and to trace their synaptic
conpections.
Other techniques used included: staining cells with
horseradish peroxidase and Lucifer yellow, making
chronic lesions in the CNS, and recording from cells
in swimming preparations. In addition, the technique
involved in staining leech cells with monoclonal anti-
bodies was demonstrated. Last year, seminars and
demonstrations were given by B. Zipser, W. Kristan,
G. Stent, D. Weisblat, 0. Friesen, R. McKay, and S.
Hockfield.
Our aim was to accept students who want to go on
and work with the leech or a similar preparation. On
the other hand, students that wished to use this course
as an advanced techniques course were accepted if
their interest was great enough. Some prior knowl-
edge of neurobiology and experience in electrical re-
cording were required for this course.
MOLECULAR CLONING OF
EUKARYOTIC GENES
June 10-June 30
INSTRUCTORS
Fritsch, Edward, Ph.D., Genetics Institute,
Boston, Massachusetts
Davis, Mark, Ph.D., Stanford University,
California
Mullins, James, Ph.D., Harvard School of Public
Health, Boston, Massachusetts
ASSISTANTS
Kim, Stu, B.S., California Institute of Technology,
Pasadena
Boyer, Paul, B.S., Michigan State University, East
Lansing
Federspiel, Mark, B.S., Michigan State University,
East Lansing
This laboratory and lecture course covered the prin-
ciples of recombinant DNA technology and the appli-
cation of these procedures to the study of eukaryotic
genes. The isolation and characterization of cellular
structural genes were emphasized. Among the topics
covered were the construction of cDNA libraries in
plasmid or bacteriophage X vectors, construction of
bacteriophage X and cosmid libraries of high-molec-
ular-weight eukaryotic DNA, screening DNA librar-
ies with gene-specific hybridization probes and by re-
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combination, purification and characterization of
recombinant clones using restriction endonuclease and
blot hybridization analyses, and reintroduction and
expression of cloned genes in heterologod systems.
Strategies for isolating genes that encode rare mRNA
sequences were discussed. Guest lecturers discussed
the application of molecular cloning procedures to the
study of specific eukaryotic gene systems.
GENETICS AND
MOLECULAR BIOLOGY OF
CHLAMYDOMONAS
June 26-June 30
CHAIRMAN
Gillham, Nicholas W, Ph.D., Duke University,
Durham, North Carolina
ORGANIZING COMMITTEE
Boynton, John E., Ph.D., Duke University,
Durham, North Carolina
Harris, E.H., Ph.D., Duke University, Durham,
North Carolina
Luck, David J.L., M.D., Ph.D., Rockefeller
University, New York, New York
Goodenough, Ursala, Ph.D., Washington
University, St. Louis, Missouri
The green alga Chlamydomonas is recognized as a
particularly favorable model system for the study of a
variety of basic biological problems. Students in this
4-day combined course and conference participated
in workshops with invited scientists working on the
molecular biology, physiology, and genetics of this
organism. Through review lectures, panel discus-
sions, and demonstrations, specialists working on
Chlamydomonas explored the use of this organism in
investigations of photosynthesis, flagellar structure
and function, the cell cycle, porphyrin biosynthesis,
chloroplast genetics, phototaxis, mating, and other
topics. In addition, techniques such as genetic analy-
sis, transformation, and gene cloning in Chlamydo-
monas were covered. This conference/course was de-
signed to bring together established workers in the
field with people interested in using Chlamydomonas
as a research tool and was conducted in an informal
setting where maximum interaction is possible be-
tween the participants.
MOLECULAR
EMBRYOLOGY OF THE
MOUSE
July 3-July 16
Single-channel recording and other applications of the 
patch-clamp technique were taught in this intensive 
lab/lecture course.
The laboratory work, in which two participants 
work with each instructor, began with all groups 
working on a common preparation. Participants 
learned to make electrodes; establish giga-seals; form 
inside-out, outside-out, and cell-attached patches; 
voltage clamp whole cells; and to recognize and spe- 
cifically activate different channel species. The third 
week was spent on individual projects with prepara- 
tions of particular interest to the participants. Lee- 
tures covered electrode fabrication; properties of 
glasses and formation of a seal; design of the patch- 
clamp circuit and sources of electronic noise; primary 
cell culture and cell lines; ion permeation and single- 
channel conductance; procedures for whole-cell 
clamp, separation of currents; rate theory and mac- 
roscopic kinetics; stochastic processes and single- 
channel statistics; single-channel behavior and noise 
spectra; stimulation and data acquisition with com- 
puters; and algorithms for single-channel analysis.
ADVANCED
NEUROANATOMICAL
METHODS
July 3 —July 23 
INSTRUCTORS
Jones, Edward G., Ph.D., Washington University, 
St. Louis, Missouri
Hand, Peter J., Ph.D., University of Pennsylvania, 
Philadelphia
Pickel, Virginia M., Ph.D., Cornell Medical 
School, New York, New York
Wise, Steven P., Ph.D., National Institute of 
Mental Health, Bethesda, Maryland
Hendry, Stewart, Ph.D., Washington University,
St. Louis, Missouri
ASSISTANTS
Donoghue, John, National Institute of Mental 
Health, Bethesda, Maryland
McClure, Bertha, Washington University, St.
Louis, Missouri
Hand, Carol, University of Pennsylvania, 
Philadelphia
This is an intensive laboratory course in basic and 
advanced neuroanatomical methodology given by six 
or more faculty, three assistants, and six visiting 
speakers. Students, individually or in pairs, carried 
out an anatomical analysis of one of several parts of 
the mammalian CNS. Methods used were anterograde 
and retrograde axonal tracing by autoradiography, en- 
zyme histochemistry, and fluorescent dyes; neuro- 
transmitter uptake and receptor binding techniques;
INSTRUCTORS
Hogan, Brigid, Ph.D., Imperial Cancer Research 
Fund, London, England
Costantini, Frank, Ph.D., Columbia University, 
New York, New York
Lacey, Liz, Ph.D., Memorial Sloan-Kettering 
Cancer Institute, New York, New York
ASSISTANTS
Barlow, Denise, Ph.D., Imperial Cancer Research 
Fund, London, England
Raphael, Katherine, Columbia University, New 
York, New York
This course was designed for biochemists, molecular 
biologists, and cell biologists interested in applying 
their expertise to the study of mouse development. In 
particular, the genetic manipulation of the mouse 
through the introduction of foreign genes and cells 
into early embryos was stressed. Through laboratory 
exercises and lectures, the participants were intro- 
duced to the following procedures and their possible 
applications: the isolation and in vitro culture of germ 
cells and preimplantation and early postimplantation 
embryos, the microinjection of DNA into fertilized 
eggs, nuclear transplantation, the formation of chi- 
meras, dissection of germ layers, the localization of 
antigens and mRNAs in embryonic tissue sections, 
and basic mouse handling and breeding techniques. 
Guest speakers discussed current research in related 
fields.
SINGLE-CHANNEL
RECORDING
July 3 —July 23 
INSTRUCTORS
Aldrich, Richard W., Ph.D., Yale University, New 
Haven, Connecticut
Cahalan, Michael D., Ph.D., University of 
California, Irvine
Corey, David P., Ph.D., Yale University; New 
Haven, Connecticut
Dionne, Vincent E., Ph.D., University of 
California, San Diego
Hume, Richard I., Washington University, St.
Louis, Missouri
Lewis, Richard, Ph.D., California Institute of 
Technology, Pasadena
Stevens, Charles F., M.D., Ph.D., Yale University, 
New Haven, Connecticut
LECTURERS
Breakfield, Xandra O., Ph.D., Yale University,
New Haven, Connecticut
Yellen, Gary, Ph.D., Yale University, New Haven, 
Connecticut
ASSISTANT
Stevens, Meg, Harvard University, Boston, 
Massachusetts
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immunocytochemistry using conventional and mono-
clonal antibodies; and metabolic mapping by 2-deoxy-
D-glucose uptake and certain oxidative enzymes.
Students received training in conventional light and
electron microscopy methods, fluorescence micros-
copy, animal surgery, microinjection methods under
electrophysiological control, photomicrography, au-
toradiography, and immunocytochemistry, as well as
practice in the use of most of the more common lab-
oratory instruments.
Lectures by the faculty and by a series of visiting
speakers covered the methodologies used, dealt with
selected research on the parts of the CNS being inves-
tigated, and provided insights into newly developed
techniques.
ADVANCED BACTERIAL
GENETICS
July 3 -July 23
INSTRUCTORS
Berman, Michael L., Ph.D., NCI, Frederick
Cancer Research Facility, Frederick, Maryland
Enquist, Lynn W., Ph.D., Molecular Genetics,
Inc., Minnetonka, Minnesota
Silhavy, Thomas J., Ph.D., NCI, Frederick Cancer
Research Facility, Frederick, Maryland
ASSISTANTS
Bear, Susan, Ph.D., NCI, National Institutes of
Health, Bethesda, Maryland
Garrett, Stephen, B.A., NCI, Frederick Cancer
Research Facility, Frederick, Maryland
Bremer, Erhard, Ph.D., NCI, Frederick Cancer
Research Facility, Frederick, Maryland
This course demonstrated the use of gene fusions,
transposable elements, and recombinant DNA for ge-
netic analysis in Escherichia coli. Students learned to
construct gene fusions both in vivo and in vitro. Sub-
sequent experiments stressed the use of these fusions
for monitoring gene expression and, in conjunction
with transposable elements, for obtaining defined mu-
tations (nonsense, deletion, and insertion) either in
the target gene or in regulatory genes. Recombinant
DNA was applied to clone and define physically the
target gene, the regulatory genes, and the sites of ac-
tion of the regulatory proteins at the target gene. In
addition, the cloned DNA and the defined mutations
were used to analyze the genes and the regulatory sys-
tem genetically. For the sake of clarity, the course fo-
cused on a particular regulon; however, the experi-
mental techniques presented were sufficiently general
to be applicable to any gene in E. coli for which
there exists a mutation conferring a recognizable
phenotype.
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MOLECULAR AND
CELLULAR
NEUROBIOLOGY
July 3 -July 23
INSTRUCTORS
Rahamimoff, Rami, M.D., Hebrew University,
Jerusalem, Israel
McMahan, U. Jack, Ph.D., Stanford University,
California
PART-TIME INSTRUCTORS
Herbert, Edward, Ph.D., University of Oregon,
Eugene
Stevens, Charles, M.D., Ph.D., Yale Medical
School, New Haven, Connecticut
Yoshikami, Doju, Ph.D., University of Utah, Salt
Lake City
The aim of this intensive course was twofold: (1) to
examine in detail the principles of nervous system
function, structure, and development at the cellular
and molecular level, and (2) to define specific prob-
lems in neurosciences that can be studied by recently
developed techniques in molecular and cellular biol-
ogy. One week was devoted to the application of mo-
lecular biological methods to nervous system prob-
lems. Specific topics included general principles of
molecular biology; the use of recombinant DNA
methodology to study the regulation of neuropeptides
and acetylcholine use of hybridoma tech-
nology for identification and characterization of spe-
cific molecules in the nervous system; and examina-
tion of the genetic basis of specific patterns of
behavior. The cellular approach focused on the syn-
apse. Topics covered included synaptic excitation and
inhibition; structure of presynaptic and postsynaptic
elements; release, storage, and inactivation of neuro-
transmitters; noise analysis and single-channel record-
ing; structure, distribution, and metabolism of recep-
tor molecules; synaptic immunology; electrical
synapses and gap junctions; slow synaptic potentials;
synaptic development; degeneration and regenera-
tion; role of peptides in neural function; and neuro-
biology of certain diseases.
NEUROBIOLOGY OF
HUMAN DISEASE
July 24-July 30
INSTRUCTORS
Black, Ira B., M.D., Cornell University Medical
College, New York, New York
Breakefield, X.O., Ph.D., Yale University School
of Medicine, New Haven, Connecticut
This intensive seminar course explored the cellular
and molecular basis of abnormal neural function, de-
lineating the pathogenesis of neuropsychiatric disor-
ders. Experimental models and human disease coun-
terparts were examined in detail. Topics included: (1)
molecular basis of neurotransmitter derangement; (2)
mechanisms of consciousness and the genesis of
coma; (3) neurophysiology of lateralization of brain
function; (4) cellular basis of regeneration of brain
systems; (5) mechanisms of dementia, including Alz-
heimer's disease; (6) experimental models of degen-
erative disorders, including Huntington's disease; (7)
genesis of movement disorders, including dystonia;
(8) mechanisms underlying epilepsy; (9) biochemis-
try of the lipidoses; (10) slow virus infections of the
nervous system; (11) molecular basis of pain syn-
dromes; (12) cellular biology of peripheral neuropa-
thy; (13) pathogenesis of myasthenia gravis; and (14)
diseases of DNA repair.
ADVANCED TECHNIQUES
IN MOLECULAR CLONING
OF EUKARYOTIC GENES
July 26-August 15
INSTRUCTORS
Smith, Michael, Ph.D., University of British
Columbia, Vancouver, Canada
Zoller, Mark, Ph.D., University of British
Columbia, Vancouver, Canada
Atkinson, Tom, B.S., University of British
Columbia, Vancouver, Canada
Fiddes, John, Ph.D., California Biotechnology,
Inc., Mountain View
Shortle, David, Ph.D., State University of New
York, Stony Brook
This was a laboratory and lecture course on advanced
aspects of molecular cloning designed for scientists
who are familiar with basic recombinant DNA tech-
niques. It included the chemical synthesis of oligo-
deoxyribonucleotides of defined sequence and their
characterization by the Maxam-Gilbert sequencing
method. These oligonucleotides were used in various
ways, including their use as probes for the isolation
of specific genes from libraries and as reagents for
directing site-specific in vitro mutagenesis. Specific
mutants were isolated, and the sequence of the altered
genes was determined. Other methods of in vitro mu-
tagenesis such as nucleotide misincorporation into
DNA, sodium bisulfate treatment of DNA, and linker
insertion were covered in both laboratory exercises
and lectures.
Guest lectures and demonstrations covered the ap-
plication of these techniques to analysis of various
cloned genes, as well as the use of alternate methods
of mutagenesis, expression, and analysis of cloned
genes by immunological screening.
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ELECTROPHYSIOLOGICAL
METHODS USED IN
ANALYZING THE MODE
OF ACTION OF
TRANSMITTERS
July 26-August 15
INSTRUCTORS
Schuetze, Stephen, Ph.D., Columbia University,
New York, New York
Siegelbaum, Steven, Ph.D., Columbia University,
New York, New York
Ascher, Philippe, D.Sc., Ecole Normale
Superieure, Paris, France
In this experimental course, students were introduced
to the various electrophysiological techniques that are
currently applied to the study of transmitter action on
ion channels in skeletal muscle and invertebrate neu-
rons. They used both basic voltage-clamp techniques
(including a single microelectrode voltage clamp) as
well as the patch-clamp technique for single-channel
recording. Aspects of the theory of the techniques as
well as some basic biochemical and biophysical prin-
ciples of transmitter actions were also covered.
YEAST GENETICS
July 26-August 15
INSTRUCTORS
Sherman, Fred, Ph.D., University of Rochester,
New York
Fink, Gerald, Ph.D., Massachusetts Institute of
Technology, Cambridge
Hicks, James, Ph.D., Cold Spring Harbor
Laboratory, New York
ASSISTANT
Kim, Jinimi, Massachusetts Institute of
Technology, Cambridge
The major laboratory techniques used in the genetic
analysis of yeast were studied, including the isolation
and characterization of chromosomal and mitochon-
dria) mutants, tetrad analysis, chromosomal mapping,
mitotic recombination, and test of allelism and com-
plementation. Micromanipulation used in tetrad anal-
ysis was carried out by all students. Recombinant
DNA techniques, including yeast transformation, fil-
ter hybridization, and gel electrophoresis, were ap-
plied to cloning and genetic analysis of yeast DNA.
Lectures on fundamental aspects of yeast genetics
were presented along with seminars given by outside
speakers on topics of current interest.
ers covered the following topics: structure and func- 
tion of immunoglobulins; thermodynamics of antigen- 
antibody interaction; molecular genetics of antibody 
diversity; cellular regulation of the immune response; 
hybridoma technology; c־DNA expression vectors; 
synthetic peptides; cell recognition and differentiation 
antigens; immunological characterization of the ace- 
tylcholine receptor, the neuromuscular junction, and 
synaptic components of the central nervous system; 
and immunological characterization of cellular diver- 
sity in the invertebrate and vertebrate nervous system.
The laboratory work focused around a practical in- 
troduction to generating monoclonal antibodies to 
simple and complex antigens. In addition, some of the 
growing number of associated immunological tech- 
niques were taught, e.g., antigen preparation, com- 
plement-mediated lysis, solid-phase immunoassays, 
immunoprecipitation, Western blotting, purification 
and conjugation of immunoglobulins, double diffu- 
sion, affinity purification, and immunocytochemical 
techniques.
IMMUNOGLOBULINS: 
MOLECULAR PROBES OF 
THE NERVOUS SYSTEM
July 26—August 15 
INSTRUCTORS
Brockes, Jeremy, Ph.D., Kings College, London, 
England
McKay, Ronald, Ph.D., Cold Spring Harbor 
Laboratory, New York
ASSISTANT
Kitner, Chris, Ph.D., Kings College, London, 
England
Through laboratory work and lectures, this course was 
designed to provide an advanced understanding of the 
power and limitations of immunoglobulins as a means 
of identifying and characterizing molecules of interest 
to neuroscientists. It was intended for research scien- 
tists at all levels. A series of lectures by invited speak­
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BANBURY CENTER
Recto: Interior view of Sammis Hall, Banbury Center's guest house, designed by Moore Grover Harper, PC., 1981.
REPORT OF THE DIRECTOR
Scientific meetings have been recognized as being important to the progress of science at least since the
1660s, when the newly established Royal Society assumed the regular holding of such meetings at Gresham
College in London as one of its main functions. The establishment, in 1977, of an intimate and informal
biological sciences conference center within the magnificent estate atop Banbury Lane was entered upon
very much within this tradition. The small, highly interactive conferences of the Banbury Center have
proven of particular value not just in the promotion of rapid and efficient communication of new data and
concepts, but also in their further refinement and development during the spontaneous discussions and anal-
yses that are an intrinsic part of the meeting dynamic itself. This is especially important in areas where
previously divergent approaches may be coming together for the first time as well as in facilitating progress
in existing fields either through identification of critical areas to be addressed or by placing possible imped-
iments to progress within broader disciplinary perspectives.
This, the sixth year of such activities at the Banbury Center of Cold Spring Harbor Laboratory, saw a
continuation and development of the Center's three broad areas of identified interest: human health risk
assessment; pivotal areas accruing from newer approaches such as recombinant DNA methodologies and
related molecular genetic manipulations; and the bringing of such perspectives to the attention of major
public health concerns, especially in the area of biological aspects of, and possible interventions in, aging.
The first 1983 meeting occurred early in February and addressed the increasingly pressing public health
problem presented by acquired immunodeficiency syndrome (AIDS). This meeting, by bringing together
immunologists, epidemiologists, pathologists, virologists, and public health officials in a small, informal
yet intensive environment, proved particularly useful for setting priorities and developing a greater coher-
ence of effort in approaches to this growing health concern. It was fairly clear, by the meeting's conclusion,
that a consensus was developing for a concerted search for a blood-borne viral agent, the properties of
which could at least begin to be loosely defined. Subsequent events are tending to bear out the soundness of
what was then still a tentative and perhaps somewhat controversial proposal.
If the AIDS conference was meant to help facilitate the coalescing of divergent approaches addressing the
same central problem, the next two Banbury meetings were perhaps more useful in delineating and better
defining critical areas to be addressed in already recognized important research areas. The first of these
meetings, Plant Viruses and Viroids, considered an area of great potential importance not only in molecular
biology, but also with regard to practical application. These often strange infectious agents, apparently
unique to plants, present possible new mechanisms by which genetic material may be replicated, perpetu-
ated, and transmitted from cell to cell or from plant to plant. The second meeting, held in the early spring,
considered an equally important topic from both research and practical application perspectives -the ways
in which the activities of genes may be regulated. This conference, Enhancers and Controlling Elements,
focused on eukaryotic DNA sequences that, when placed anywhere in the vicinity of a given gene, have
great effects upon the expression of that gene within the cell. Identification of such sequences will have
great significance for fundamental questions of biology, such as molecular mechanisms of development, as
well as for the manipulation of gene products in practical application. Plant Infectious Agents and Enhancers
and Eukaryotic Gene Expression have both been published in extended abstract form as part of the Cold
Spring Harbor Laboratory series Current Communications in Molecular Biology.
The Banbury Center publishing program also remained quite active in 1983 with the appearance of three
new titles, two in the ongoing Banbury Report series and one as the first Banbury publication directed to a
wider, nonscientific audience. Banbury Report 14, Recombinant DNA Applications to Human Disease, grew
out of a fall 1982 conference considering new approaches that combine DNA cloning and hybridization
techniques with more traditional genetic methodologies for identification and diagnosis of genetic defects at
the level of the defective gene itself. The second 1983 book emanating from the 1982 conference program
was Banbury Report 15, Biological Aspects of Alzheimer's Disease. Reflecting the impetus of the original
conference in bringing together clinicians and basic researchers for an exploration of the origins and path-
ological bases of this devastating major health concern, this volume has proved a useful compendium both
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derstanding of what these technologies are likely to 
achieve and of the relative advantages and disad- 
vantages of competing approaches. They must also 
have an overall feel for the benefits, risks, and costs 
that these technologies will potentially bring to the 
U.S. health care capability at large. The December 
workshop, which considered everything from the 
theoretical foundations of this technology to the 
practical installation of the apparatuses themselves, 
together with multiple examples of just what such 
approaches are currently achieving and are likely 
to achieve in the near future, helped to clarify con- 
siderably the complexities of this new area of med- 
ical technology.
Finally, two full Banbury Conferences, each with 
an ensuing Banbury Report, were held in the fall of 
1983. The first of these, held in early October, con- 
sidered the genetic predisposition of the individual 
in response to chemical exposure. Many of the bod- 
ily systems concerned with maintenance and integ- 
rity of function, or with metabolic activation or de- 
toxification of chemicals, have such a large degree 
of underlying genetic variability that each individ- 
ual almost certainly presents a unique profile of 
strengths and susceptibilities. Individualized ge- 
netic susceptibility profiles could clearly have a 
place in preventive medicine or even as personal- 
ized guides toward maximizing health and safety. 
There have already been controversial nascent at- 
tempts to apply such concepts to workers employed 
in hazardous workplace environments. The Octo- 
ber conference, considering in depth the scientific 
data base underlying such possible approaches, is 
to be published as Banbury Report 16, Genetic Var- 
lability in Responses to Chemical Exposure.
The second full Banbury Conference, held at the 
end of October and into early November, examined 
the health consequences of coffee consumption. 
Due to the great popularity and prevalence of this 
beverage, even possible minor deleterious effects 
have potentially far-reaching impact. The Coffee 
and Health conference assembled researchers from 
both private and public sectors representing both 
epidemiological and experimental approaches to 
this question. These proceedings, reviewing major 
ongoing studies together with assessment of where 
such research thrusts may be leading, is to be pub- 
lished as Banbury Report 17 in the spring of 1984.
Michael Shodell
of the current state of knowledge and of possible 
leads on how this might further be developed in the 
future. The final publication of 1983 also grew out 
of a 1982 Banbury conference, but it was the first 
Banbury publication outside of the Banbury Report 
series. Gene Therapy: Fact and Fiction, published 
as a “Banbury Public Information Report,” com- 
bined the edited transcribed proceedings of the 
original conference with additional interpretive and 
descriptive material in an attempt to make known 
to the public at large the import of this high-level 
scientific meeting on a topic that continues to be of 
significant public interest and concern.
Although Gene Therapy: Fact and Fiction was a 
departure in publishing for the Banbury Center, the 
function of the Center in broadly disseminating in- 
formation about developments in key areas of the 
biological sciences has been ongoing almost since 
Banbury’s inception. Under continuing support 
from the Sloan Foundation, Banbury Center has 
carried out a series of informational workshops 
specifically designed either for media representa- 
tives or for congressional aides and staff members. 
Two such Sloan Informational Workshops were held 
in 1983. The first of these, New Concepts in Mu- 
tation, was a summer workshop for journalists. For 
many years, mutational mechanisms could be stud- 
ied productively mainly in microorganisms. The 
advent of current DNA methodologies, however, 
has presented opportunities for the highly effective 
study of such processes in higher organisms as well. 
The cumulative body of microorganismal data, to- 
gether with the rapidly emerging new concepts de- 
rived from approaches in higher organisms, is lead- 
ing to new perspectives on the origins and roles of 
mutation and on the mutational dynamic underlying 
biological evolution. These topics were considered 
in depth at the Sloan Journalists’ Workshop, as well 
as at the subsequent full Banbury scientific confer- 
ence, Mechanisms of Mutagenesis.
The second Sloan workshop, Biological Imaging 
and Nuclear Magnetic Resonance, was held early in 
December for congressional staff members. This 
rapidly developing area of medical technology is 
achieving spectacular results in imaging both struc- 
ture and function in the living body while employ- 
ing minimally invasive procedures. However, the 
costs can also be spectacular, and during this rela- 
tively early stage of development, it is imperative 
for congressional decision makers to have an un­
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1983 SUPPORT
Together with the donation to Cold Spring Harbor
Laboratory of his estate on Banbury Lane, Charles
S. Robertson also generously supplied an endow-
ment for upkeep of the grounds and of Robertson
House proper. However, maintenance of Sammis
Hall and the conference center, as well as support
for Banbury Center conferences and publicatioris,
remains strictly dependent upon government and
foundation grants and corporate contributions. In
1983, Banbury Center activities were greatly facil-
itated by unrestricted core support accruing from
the generous donations of nine corporations: The
Bristol-Myers Fund, Inc., Conoco, Inc., The Dow
Chemical Company, E.I. du Pont de Nemours &
Company, Exxon Corporation, Getty Oil Company,
International Business Machines Corporation, Eli
Lilly & Company, and Texaco Philanthropic Foun-
dation, Inc. In addition, the Center was able to pro-
ceed with specific conference programs as a result
of the following grants and contributions: The Role
of Genetic Predisposition in Responses to Chemi-
cal Exposure was supported by the National Cancer
Institute, the National Institute of Environmental
Health Sciences, and the Fogarty International
Center, together with essential additional support
from the American Occupational Medical Associa-
tion, the Aluminum Company of America, E.I. du
Pont de Nemours & Company, Johnson & Johnson,
the Occupational Health Institute, Inc., and United
States Steel. Support for Coffee and Health was ob-
tained from Cold Spring Harbor Laboratory, with
major additional funding from the National Coffee
Association of the U.S.A., Inc., and the Interna-
Alfred Pfeiffer
1919 - 1984
When the Banbury estate was donated to Cold
Spring Harbor Laboratory, the Laboratory was es-
pecially fortunate in being able to retain the serv-
ices of the estate's head groundskeeper, Fred Pfeif-
fer. Fred not only continued to give his special type
of care to the estate's grounds, but also brought to
the Banbury community a special sense of culture
and thoughtfulness. Fred's sudden death in March,
1984, just months before he was due to retire, was
a great loss. He will continue to be missed by the
staff and visitors to the Banbury Center.
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tional Coffee Organization; contributions toward
publication of these proceedings were received
from the Folger Coffee Company, the Nestle Com-
pany, Inc., and Tetley, Inc. The conference on Plant
Viruses and Viroids received corporate contribu-
tions from Monsanto Company, ARCO Plant Cell
Research Institute, Pfizer Central Research, Agri-
genetics Corporation, and Calgene Corporation.
The Enhancers and Controlling Elements confer-
ence was made possible by donations provided by
Abbott Laboratories, Applied Molecular Genetics,
Inc., Biogen N.V., the Cetus Corporation, Collab-
orative Research, Inc., E.I. du Pont de Nemours &
Company, Genentech, Inc., Lilly Research Labo-
ratories, and the Monsanto Company. The confer-
ence on Acquired Immunodeficiency Syndrome was
supported by a grant from the Cancer Research In-
stitute and the National Cancer Institute (National
Institutes of Health). The meeting on Mechanisms
of Mutagenesis was supported in part by a grant
from the March of Dimes Birth Defects Founda-
tion. These generous grants and donations in sup-
port of the Banbury Center program are gratefully
acknowledged. Collectively, these grants and con-
tributions, the ongoing Sloan Foundation sponsor-
ship of informational workshops for journalists and
congressional staff, and contributions received
from the Kaiser Family Foundation financing the
publication of Gene Therapy: Fact and Fiction and
the original conference on this topic have formed
the financial base that has permitted continuation
of the Banbury Center program through its sixth
year of operation.
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FINANCIAL SUPPORT OF THE
LABORATORY
Cold Spring Harbor Laboratory is a non-profit research and educational institution chartered by the
University of the State of New York. Contributions are tax exempt under the provisions of Section
501(c)(3) of the Internal Revenue Code. In addition, the Laboratory has been designated a "public
charity" and, therefore, may receive funds resulting from the termination of "private" foundations.
Because its endowment is limited and the uses of research grants are formally restricted, the Labo-
ratory depends on generous contributions from private foundations, sponsors, and friends for central
institutional needs and capital improvements.
Over the years, the Laboratory has won a reputation for innovative research and high-level science
education. By training young scientists in the latest experimental techniques, it has helped spur the
development of many research fields, including tumor virology, cancer genes, gene regulation, move-
able genetic elements, yeast genetics, and molecular neurobiology. However, the continued develop-
ment of new research programs and training courses requires substantial support from private sources.
Methods of Contributing to Cold Spring Harbor Laboratory
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities
You can generally deduct the full amount of the gift on your income tax return, and, of course,
you need pay no capital gains tax on the stock's appreciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring Harbor Laboratory.
(2) Deliver the stock certificates to your broker with instructions to him to open an account for
Cold Spring Harbor Laboratory and hold the securities in that account pending instructions
from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold Spring
Harbor Laboratory, Cold Spring Harbor, New York 11724. In a separate envelope send an
executed stock power.
Bequests
Probably most wills need to be updated. Designating Cold Spring Harbor Laboratory as benefi-
ciary ensures that a bequest will be utilized as specified for continuing good.
Appreciated real estate or personal property
Sizable tax benefits can result from such donations; the Laboratory can use some in its program
and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the donor's specific desires
as to extent, timing, and tax needs.
Conversion of private foundation to "public" status on termination
This may be done by creating a separate fund within Cold Spring Harbor Laboratory whereby
the assets of the private foundation are accounted for as a separate fund and used for the purposes
specified by the donor. Alternatively, the private foundation can be established as a "supporting
organization of Cold Spring Harbor Laboratory."
For additional information, please contact the Director of Information Services, Cold Spring Harbor
Laboratory, Box 100, Cold Spring Harbor, N.Y. 11724, or call 516-367-8397.
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FINANCIAL STATEMENT
BALANCE SHEET
year ended December 31, 1983
with comparative figures for year ended December 31, 1982
ASSETS
1983 1982
CURRENT FUNDS
Unrestricted
Cash and Short-term investments $ 4,119,413 $ 2,658,863
Accounts Receivable 375,687 464,261
Prepaid expenses and other assets 289,940 258,587
Inventory of books 194,111 203,899
Due from restricted fund 286,290
Due from Banbury Center 115,810 284,630
Total unrestricted 5,094,961 4,156,530
Restricted
Grants and contracts receivable 3,779,375 4,615,780
Due from unrestricted fund 660,906
Total restricted 4,440,281 4,615,780
Total current funds $ 9,535,242 $ 8,772,310
ENDOWMENT FUNDS
Robertson Research Fund
Cash 3,536,782 508,041
Marketable securities
(quoted market 1983-$13,466,772;
1982-13,987,572) 11,446,963 11,585,922
Total Robertson Research Fund 14,983,745 12,093,963
Olney Memorial Fund
Cash 4,623 1,420
Marketable Securities
(quoted market 1983-$23,252;
1982-$23,284) 27,538 27,538
Total Olney Memorial Fund 32,161 28,958
Total endowment funds $15,015,906 $12,122,921
PLANT FUNDS
Investments 454,212 461,239
Due from unrestricted fund 983,773 961,628
Land and improvements 1,129,875 1,111,213
Buildings 9,621,165 7,307,583
Furniture, fixtures and equipment 2,485,774 1,647,248
Books and periodicals 365,630 365,630
Construction in progress 960,709 727,245
16,001,138 12,581,786
Less allowance for depreciation
and amortization 4,013,770 3,371,273
Total plant funds $11,987,368 $ 9,210,513
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LIABILITIES AND FUND BALANCES
1983 1982
CURRENT FUNDS
Unrestricted
Accounts payable $ 835,166 $ 171,326
Deferred income 140,000 -
Mortgage payable - 33,300
Due to plant fund 983,773 961,628
Due to restricted fund 660,906 -
Fund balance 2,475,116 2,990,276
Total unrestricted 5,094,961 4,156,530
Restricted
Due to unrestricted fund - 286,290
Fund balance 4,440,281 4,329,490
Total restricted 4,440,281 4,615,780
Total current funds $ 9,535,242 $ 8,772,310
ENDOWMENT FUNDS
Fund balance $15,015,906 $12,122,921
PLANT FUNDS
Fund balance $11,987,368 $ 9,210,513
141
ASSETS (continued)
BANBURY CENTER
Current funds
Unrestricted
1983 1982
Cash 700 700
Prepaid and deferred expenses 15,025 70,001
Inventory of books 36,857 25,777
Due from Banbury restricted fund 95,505 35,999
Total unrestricted 148,087 132,477
Restricted
Grants and contracts receivable 142,988 91,046
Total restricted 142,988 91,046
Total current funds 291,075 223,523
Endowment Funds
Robertson Maintenance Fund
Cash 494,054 89,768
Marketable securities
(quoted market 1983 -
$2,314,259; 1982-$2,385,039) 1,978,853 1,971,628
Total endowment funds 2,472,907 2,061,396
Plant funds
Land 772,500 772,500
Buildings 845,967 846,028
Furniture, fixtures and equipment 176,318 176,284
Construction in progress 1,386 1,386
1,796,171 1,796,198
Less allowance for depreciation 320,450 275,311
Total plant funds 1,475,721 1,520,887
Total Banbury Center $ 4,239,703 $ 3,805,806
Total-All funds $40,778,219 $33,911,550
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LIABILITIES AND FUND BALANCES (continued)
1983 1982
BANBURY CENTER
Current funds
Unrestricted
Accounts payable 32,277 11,376
Due to CSHL unrestricted fund 115,810 284,630
Fund balance (163,529)
Total unrestricted 148,087 132,477
Restricted
Due to Banbury unrestricted 95,505 35,999
Fund balance 47,483 55,047
Total restricted 142,988 91,046
Total current funds 291,075 223,523
Endowment funds
Fund balance 2,472,907 2,061,396
Plant funds
Fund balance 1,475,721 1,520,887
Total Banbury Center $ 4,239,703 $ 3,805,806
Total-All funds $40,778,219 $33,911,550
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CURRENT REVENUES, EXPENSES AND TRANSFERS
year ended December 31, 1983
with comparative figures for year ended December 31, 1982
COLD SPRING HARBOR LABORATORY
1983 1982
REVENUES
Grants and contracts $11,650,901 12,175,270Indirect cost allowances on grants
and contracts 3,626,022 3,155,513Contributions
Unrestricted 27,800 30,682Restricted and capital 868,528 225,000Long Island Biological Association 33,300 46,500Robertson Research Fund Distribution 453,000 453,000Summer programs 491,049 433,188Laboratory rental 20,732 20,732Marina rental 56,170 53,192Investment income 481,992 376,587Publications sales 1,655,691 1,650,263Dining Hall 490,678 469,196Rooms and apartments 216,179 269,061Other sources 26,371 12,347
Total revenues 20,098,413 19,370,531
EXPENSES
Research* 10,098,170 8,855,612Summer programs* 993,338 775,528Publications sales* 1,306,539 1,132,856Dining hall* 671,602 535,399Research support 256,676 203,631Library 223,117 191,344Operation and maintenance of plant 1,921,985 1,719,729General and Administrative 1,632,045 1,192,215Depreciation 643,097 505,252
Total expenses 17,746,569 15,111,566
TRANSFERS
Capital building projects 1,738,298 2,003,518Banbury Center to (from) (80,420) 212,235
Total transfers-net 1,657,878 2,215,753
Total expenses and transfers 19,404,447 17,327,319
Excess of revenues over
expenses and transfers $ 693,966 $ 2,043,212
*Reported exclusive of an allocation for research support, operation andmaintenance of
plant, general and administrative, library, and depreciation expenses.
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BANBURY CENTER
1983 1982
REVENUES
Endowment income $100,000 $ 99,000
Grants & contributions 261,436 288,226
Indirect cost allowances on
grants and contracts 13,576 19,880
Rooms and apartments 76,522 46,353
Publications 191,993 136,391
Conference fees 54,096 20,375
Dining Hall 4,708 6,484
Transfer from (to) Cold
Spring Harbor Laboratory (80,420) 212,235
Total revenues 621,911 828,944
EXPENSES
Conferences 206,659 151,631
Publications 126,618 168,011
Operation and maintenance
of plant 93,548 109,474
Program administration 202,651 163,312
Depreciation 45,107 53,954
Capital plant 53,271
Total expenses 674,583 699,653
Excess (deficit) of revenues
over expenses $ (52,672) $129,291
Note: Copies of our complete, audited financial statements, certified by our independent auditors, Peat, Marwick, Mitchell
& Co., are available upon request from the Comptroller, Cold Spring Harbor Laboratory.
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GRANTS
January 1, 1983-December 31, 1983
COLD SPRING HARBOR LABORATORY
Grantor
National Institutes of Health
Program Project Grants
Research Grants
Biomedical Research
Support Grants
Fellowship Training
Course Support
*New grants awarded in 1983.
Principal Investigator
and Program Total Award Duration of Grant
Dr. Bukhari-Genetics
Dr. Roberts-Cancer Research Center
Dr. Sambrook-Gene Organization
Dr. Blose
Dr. Feramisco
Dr. Gething
Drs. Gingeras & Roberts
Dr. Hicks
Dr. Hockfield
Dr. Klar
Dr. Klar
Dr. Kurtz
Dr. Lin
Dr. Mathews
Dr. Matsumura
Dr. McKay
Dr. Silver
Dr. Stillman
Dr. Topp
Dr. Topp
Dr. B. Zipser
Dr. B. Zipser
Dr. Watson
Dr. Watson
Dr. Grodzicker (Institutional)
Dr. Bautch
Dr. Flanagan
Dr. Flaster
Dr. Ivy
Dr. Krangel
Dr. LeMaster
Dr. Livi
Dr. Roth
Dr. Taparowsky
Dr. Welch
Dr. Hockfield-Neurobiology
Dr. Hockfield-Neurobiology
Dr. Grodzicker- Cancer Center
Dr. Hicks-Advanced Bacterial Genetics
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$ 2,375,371 06/01/80-11/30/83
18,604,426 01/01/77-12/31/86
5,626,997 04/01/81-03/31/86
449,929 12/01/78-11/30/84
686,968 07/01/80-07/31/86
976,587 *02/01/83-01/31/87
408,085 03/01/80-02/28/83
1,710,283 07/01/81-06/30/86
282,400 02/01/82-01/31/85
1,572,978 07/01/81-06/30/86
286,070 *12/01/83-11/30/85
606,389 04/01/80-03/31/86
290,636 09/24/82-08/31/85
729,283 04/01/80-03/31/86
385,649 *07/01/83-06/30/86
288,546 07/01/81-06/30/84
625,803 02/01/82-01/31/85
677,384 *07/01/83-06/30/86
279,134 03/01/82-02/28/84
303,452 07/01/80-06/30/83
299,219 12/01/81-11/30/84
358,081 *12/01/83-11/30/86
104,822 04/01/82-03/31/83
111,124 *04/01/83-03/31/84
852,578 07/01/78-11/30/83
57,244 *09/01/83-08/31/86
36,204 *09/16/83-09/15/85
34,776 09/15/82-09/14/84
38,776 01/27/82-01/26/84
54,584 10/01/82-09/30/85
34,681 06/01/81-02/15/83
57,244 *10/16/83-10/15/86
36,776 *09/01/83-08/31/85
54,584 10/16/82-10/15/85
56,584 *09/01/83-08/31/85
131,277 05/01/82-04/30/85
646,143 06/01/79-03/31/86
657,174 06/01/82-12/31/86
302,523 05/01/80-04/30/88
Grantor
National Institutes of Health (continued)
Meeting Support
Construction
National Science Foundation
Research Grants
Course Support
Meeting Support
Construction
Principal Investigator
and Program Total Award
Dr. Mathews-RNA Processing
Dr. Watson-Human T-Cell Leukemia
Viruses
Dr. Watson-Symposium: Molecular
Neurobiology
Dr. Watson-Genetics of
Chlamydomonas
Dr. Watson-C. elegans
Dr. Watson-Cell Proliferation
Conference: The Cancer Cell
Duration of Grant
18,000 04/15/82-04/30/84
27,436 *09/13/83-08/31/84
41,977 *04/01/8343/31/84
5,000 *06/26/8346/25/84
29,290 *04/01/8343/31/84
61,350 08/15/81-07/31/84
Mr. Udry -Cancer Research Facility 1,411,011 09/15/77-12/31/83
Dr. Bukhari
Dr. Garrels
Dr. Harshey
Dr. Heffron
Drs. Hicks, Klar, Strathern
& Malmberg
Dr. Lewis
Dr. Roberts
Dr. Roberts
Dr. Roberts
Dr. Roberts
Dr. Roberts
Dr. So
Dr. Tamanoi
Dr. D. Zipser
60,000 07/82-12/83
140,000 09/80-02/83
78,001 01/82-05/83
167,000 02/81-07/83
330,134 07/82-12/84
140,000 *11/83-12/85
210,000 12/79-05/83
270,000 08/80-07/83
28,442 *01/8348/86
200,000 *01/83-12/86
252,000 *07/83-12/86
32,194 07/82-12/83
88,000 07/82-12/84
100,000 01/81-06/83
Dr. Hicks-Plant Molecular Biology 99,600 05/81-10/84
Workshop
Dr. Bukhari-4th Bacteriophage Mu 32,000 *11/83-10/84
Workshop (Pakistan)
Dr. Klar - Microbial Development 8,940 *04/8343/84
Dr. Mathews-RNA Processing 5,000 *05/8344/84
Dr. Watson-Symposium: 6,000 *07/83-06/84
Molecular Neurobiology
Dr. Watson-Genetics of 8,000 *06/83-11/84
Chlamydomonas
Dr. Watson-Plant Genetics Laboratory 406,350 *12/83-05/85
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Principal Investigator
Grantor and Program Total Award Duration of Grant
Research Grants
A.B.C. Foundation
Rita Allen Foundation
American Cancer Society
Cancer Research Institute
Cell Biology Corporation
Central General Hospital
Exxon
McKnight Foundation
Muscular Dystrophy Assn.
New England Bio-Labs
Marie Robertson
Memorial Fund
Stauffer Chemical
Strasser Company
State University of New York,
Stony Brook
Yamasa Shoyo Co., Ltd.
Fellowships
Jane Coffin Childs
Helen Hay Whitney
Leukemia Society of America,
Inc.
Muscular Dystrophy Assn.
Robert P. Olney Memorial
Cancer Fund
Damon Runyon-
Walter Winchell
Cancer Fund
Training
Bayer Aspirin (Glen Brook
Labs)
Burroughs Wellcome Fund
J.M. Foundation
Grass Foundation
Volkswagen Foundation
Dr. Wigler
Dr. Stillman
Dr. Chow
Dr. Rossini
Dr. Stillman (Institutional)
Dr. Garrels
Dr. Sambrook
Research
Research
Dr. Malmberg
Dr. Garrels
Dr. Lin
Dr. Mathews
Dr. Matsumura
Dr. Roberts
Dr. Sambrook-Neurobiology Support
Dr. Hicks
Dr. Hicks
Dr. Topp (Subcontract)
Dr. Katoh
Dr. Sundin
Dr. Herr
Dr. Kost
Dr. Powers
Dr. Helfman
Dr. Dudley, Jr.
Dr. Abraham
Dr. Bhagwat
Dr. Gerard
Dr. Mains
Dr. Roth
Dr. White
Undergraduate Research Program
Undergraduate Research Program
Undergraduate Research Program
Neurobiology Scholarships
Neurobiology Scholarships
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600,000 05/01/82-04/30/87
150,000 *01/01/83-12/31/87
150,000 01/01/82-12/31/84
110,000 01/01/82-12/31/84
50,000 07/01/82-06/30/84
36,000 *07/01/83-06/30/84
627,746 01/01/82-12/31/83
2,000 *01/01/83-12/31/83
7,500,000 01/01/82-12/31/86
105,000 *03/01/83-02/28/86
80,000 01/01/80-12/31/83
95,350 01/01/81-12/31/83
25,000 *07/01/83-06/30/84
15,228 *01/01/83-12/31/83
14,000
75,000 *01/01/83-12/31/83
15,000
20,000
7,267 08/01/82-07/31/83
94,480 10/01/81-09/30/83
32,000 07/01/82-06/30/84
39,250 *01/01/83-06/14/85
22,375 07/01/82-09/15/83
34,000 *12/31/83-12/30/85
17,000 *07/01/83-06/30/84
2,800 *1983
35,000 08/01/81-07/31/83
35,000 07/01/82-06/30/84
35,000 *05/01/83-03/31/85
35,000 *04/01/83-03/31/85
17,000 09/01/82-08/31/83
35,000 *11/01/83-10/31/84
3,500 *1983
7,000 *1983
25,300 *1983
45,190 1980-1983
64,049 1980-1983
Principal Investigator
Grantor and Program Total Award Duration of Grant
Construction
Pew Memorial Trust
Equipment
Fannie E. Rippel Foundation
Course Support
National Foundation for Jewish
Genetic Diseases, Inc.
Hereditary Diseases Foundation
The Esther A. & Joseph
Klingenstein Fund
Meeting Support
Abbott Laboratories
American Cancer Society
American Cyanamid Company
Becton-Dickinson
Biogen
Cancer Research Institute
Department of Energy
Genentech, Inc.
Hoffmann-La Roche, Inc.
Eli Lilly Research Labs
LaBatt Brewing Company
Long Island Biological
Association-Dorcas
Cummings Memorial
Fund
Martin Marietta Laboratories
Merck & Co., Inc.
Merieux Institute
Miles Laboratories
Monsanto
N.Y.S. Department of Health
Pfizer, Inc.
Searle Research & Development
Standard Oil Co. of Ohio
Smith Kline & French
Upjohn Company
Wellcome Biotechnology, Ltd.
Zoecon Corporation
Zymos Corporation
Matching Grant Support
Matching Grant Support
Neurobiology of Human Diseases Course
Neurobiology of Human Diseases Course
Neurobiology Support
Microbial Development
The Cancer Cell
Microbial Development
The Cancer Cell
Microbial Development
The Molecular Biology of Yeast
Human T-Cell Leukemia Viruses
Genetics of Chlamydomonas
Symposium: Molecular Neurobiology
The Molecular Biology of Yeast
The Molecular Biology of Yeast
Microbial Development
The Molecular Biology of Yeast
Community Conference on the Gypsy Moth
Genetics of Chlamydomonas
Modern Approaches to Vaccines
Modern Approaches to Vaccines
Microbial Development
Genetics of Chlamydomonas
Microbial Development
Human T-Cell Leukemia Viruses
The Molecular Biology of Yeast
Microbial Development
Genetics of Chlamydomonas
The Molecular Biology of Yeast
Microbial Development
Modern Approaches to Vaccines
Genetics of Chlamydomonas
The Molecular Biology of Yeast
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400,000 1981-1983
100,000 *1983-1984
2,000 *1983
2,000 *1983
150,000 1982-1983
500
34,000
500
5,000
1,000
1,500
4,060
5,000
9,000
1,000
2,000
750
250
4,000
3,192
5,000
15,000
750
3,000
6,000
4,060
1,000
500
2,000
1,000
2,000
6,000
1,500
1,000
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*05/15/83-05/14/84
*07/15/83-07/14/84
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
*1983
Grantor
Meeting Support
National Institutes of Health
Abbott Laboratories
Agrigenetics Research
Associates, Ltd.
Alcoa Foundation
American Occupational
Medical Association
Applied Molecular Genetics
Arco Solar, Inc.
Biogen
Calgene, Inc.
Cancer Research Institute
Cetus Corporation
Collaborative Research
E.I. du Pont de Nemours &
Co., Inc.
Genentech, Inc.
International Coffee
Organization
Johnson & Johnson
Eli Lilly Research Laboratories
March of Dimes
Massachusetts Institute of
Technology
Monsanto
Pfizer, Inc.
National Coffee Association
of USA, Inc.
Occupational Health Institute,
Inc.
Sloan Foundation
United States Steel
BANBURY CENTER
Principal Investigator
and Program
Dr. Topp-AIDS and Kaposi's Sarcoma
Dr. Watson-The Role of Genetic
Predisposition in Responses to Chemical
Exposure
Enhancers and Controlling Elements
Plant Viruses and Viroids
The Role of Genetic Predisposition in
Responses to Chemical Exposure
The Role of Genetic Predisposition in
Responses to Chemical Exposure
Enhancers and Controlling Elements
Plant Viruses and Viroids
Enhancers and Controlling Elements
Plant Viruses and Viroids
AIDS and Kaposi's Sarcoma
Enhancers and Controlling Elements
Enhancers and Controlling Elements
Enhancers and Controlling Elements
The Role of Genetic Predisposition in
Responses to Chemical Exposure
Enhancers and Controlling Elements
Coffee and Health
The Role of Genetic Predisposition in
Responses to Chemical Exposure
Enhancers and Controlling Elements
Mechanisms of Mutagenesis
Marr Memorial Conference: Mechanisms
of Perception
Enhancers and Controlling Elements
Plant Viruses and Viroids
Plant Viruses and Viroids
Coffee and Health
The Role of Genetic Predisposition in
Responses to Chemical Exposure
Journalists' Workshop: New Concepts
in Mutation
Congressional Workshop: Biological
Imaging and NMR
The Role of Genetic Predisposition in
Responses to Chemical Exposure
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Total Award Duration of Grant
20,367 *01/07/83-12/31/83
31,575 *08/01/83-07/31/84
1,000 *1983
500 *1983
5,000 *1983
5,000 *1983
2,000 *1983
2,000 *1983
3,000 *1983
250 *1983
4,050 *1983
3,000 *1983
3,000 *1983
3,000 *1983
5,000 *1983
1,000 *1983
15,000 *1983
3,000 *1983
1,000 *1983
4,000 *1983
23,369 *1983
3,000 *1983
2,000 *1983
1,000 *1983
10,000 *1983
5,000 *1983
10,000 *1983
10,000 *1983
5,000 *1983

CONTRIBUTORS
Action
Dr. Bruce Alberts
Albert Einstein College of Medicine
Anonymous
Dr. & Mrs. Alfred Azzoni
Myra Blum
Boehringer Mannheim Biochemicals
Cailor Resnick Studio
Mr. & Mrs. S.R. Callaway
Ms. Patricia Casentini
Chubb & Son, Inc.
Mr. John P. Cleary
Collaborative Research
Mr. & Mrs. R. Cunningham
Dr. & Mrs. James A. de Tomasi
Mr. & Mrs. C. Deregibus
Dr. & Mrs. Lester Dubnick
Duke University
Mr. & Mrs. D.C. Engle
Mr. Walter N. Frank, Jr.
Dr. & Mrs. H. Bentley Glass
Mrs. Arlene A. Golden
Mr. Oliver R. Grace
Mrs. Charles A. Guarneri
Dr. & Mrs. Alfred Hershey
Dr. Ira Herskowitz
Dr. Bernhard Hirt
Dr. Joy Hockstadt
Dr. Alexander Hollaender
Dr. Nancy H. Hopkins
Mrs. David Ingraham
Dr. George Khoury
Dr. & Mrs. Arthur Landy
Mr. & Mrs. George Leckerling
Mr. & Mrs. Richard Leckerling
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Dr. & Mrs. Monroe L. Levin
Dr. & Mrs. R.V. Lewis
Mr. & Mrs. Robert V. Lindsay
Mrs. V.S. Littauer
Mr. Daniel Maguire
Dr. & Mrs. Julius Marmur
Mrs. John B. Marsh
Massachusetts Institute of Technology
Leila L. McKnight
Dr. & Mrs. Norman E. Melechen
Memorial Sloan-Kettering
Mr. Arthur C. Merrill
Morgan Guaranty Trust
Ms. Edith Muma
Mr. Rem V. Myers
New York University
Ms. Linda Peyton
Mrs. William R. Potts
Mrs. Marjorie Robertson Rose
Mrs. Franz Schneider
Mr. Thomas J.M. Schopf
Dr. A. Schuz
Dr. Philip A. Sharp
Dr. & Mrs. W. Shropshire, Jr.
Mr. & Mrs. Robert Smirnow
Dr. & Mrs. A.R. Srinivasan
Dr. Gunther S. Stent
James E. Swiggett
Dr. Charles A. Thomas, Jr.
Mr. & Mrs. George Toumanoff
University of Wisconsin
Dr. Robert A. Weisberg
Mr. & Mrs. Johnny Wilson
WOR Radio
Yale University

THE LONG ISLAND
BIOLOGICAL ASSOCIATION
OFFICERS
Mr. Edward Pulling, Chairperson
Mr. George J. Hossfeld, Jr., Vice-Chairperson
Mr. James A. Eisenman, Treasurer
Mrs. James J. Pirtle, Jr., Secretary
Mr. William R. Udry, Assistant Secretary-Treasurer
DIRECTORS
Mrs. Donald Arthur
Dr. Alfred A. Azzoni
Mrs. Gilbert A. Ball
Mr. Edmund Bartlett
Mr. Samuel R. Callaway
Mrs. John P. Campbell
Mrs. Miner D. Crary, Jr.
Mr. Arthur M. Crocker
Mr. George W. Cutting
Mr. Lawrence L. Davis
EXECUTIVE COMMITTEE
The Officers, also
Mr. Samuel R. Callaway
Mrs. Henry U. Harris, Jr.
Mrs. Richardson Pratt
Mr. Joseph C. Dey, Jr.
Mr. Charles Dolan
Mr. James A. Eisenman
Mr. Charles S. Gay
Mrs. Henry U. Harris, Jr.
Mr. George J. Hossfeld, Jr.
Mr. Edward M. Lamont
Mr. Arthur C. Merrill
Mr. Grinnell Morris
Mr. William Parsons, Jr.
Mrs. James J. Pirtle, Jr.
Mrs. Richardson Pratt
Mr. Edward Pulling
Mr. John R. Reese
Mr. Harvey E. Sampson
Mr. Stanley S. Trotman, Jr.
Dr. James D. Watson
Mrs. Alex M. White
Ambassador John P Humes with Mr and Mrs. Norris Darrell, Jr., at a dinner party held at Airslie House to honor a combined
40 years of service to the Laboratory by Walter Page and Edward Pulling.
THE LONG ISLAND BIOLOGICAL ASSOCIATION (LIBA)
and Its Relation to the Cold Spring Harbor Laboratory
Biological research at Cold Spring Harbor began in 1890 when the Brooklyn Institute of Arts and Sci-
ences was looking for a place to set up a summer laboratory as the headquarters of its Department of
Zoology. Representatives of the Institute were invited by Eugene S. Blackford, at that time one of the first
Fish Commissioners of the State of New York, to inspect a site on Bungtown Road across Northern Boule-
vard (25A) from the Fish Hatchery. The site was found to be ideal, and so the original Laboratory was
organized with Mr. Blackford as president of the Board of Trustees. The land was leased from Mr. John
D. Jones, whose family since 1819 had operated various industries including shipbuilding, coopering, and
textile manufacture (later whaling, also) at the head of Cold Spring Harbor. Bungtown Road, which runs
through the Lab property, got its name from the factory that specialized in making bungs-or stoppers -
for barrels.
In 1892 the Laboratory's land was leased for a dollar a year from the Wawepex Society, which Mr.
Jones had organized as a corporation for holding real estate and for investing funds for the propagation
of fishes and for scientific research. In 1904 the Wawepex Society leased additional land to the Carnegie
Institution of Washington, which wanted to locate a Department of Experimental Evolution in the Cold
Spring Harbor area. Charles B. Davenport, who had been directing the Laboratory since 1896, assumed
the additional duties of director of the Carnegie Institution's experimental station. It is interesting to note
that Mr. Davenport lived in what came to be known later as the Carnegie Dormitory, the Victorian house
on 25A built by John D. Jones before the turn of the century, and recently repainted in its original colors.
The Long Island Biological Association was established in 1924 when the Brooklyn Institute decided to
discontinue its research at Cold Spring Harbor and offered its laboratory to two universities. Fortunately,
a local group of interested neighbors decided to assume responsibility for the Lab, and thus LIBA came
into being. For 38 years LIBA actually operated the Laboratory in conjunction with the Carnegie Institu-
tion, but in 1962 it seemed advisable for the Laboratory to be reorganized as an independent unit. There-
fore, the property on which it now stands was conveyed to it by LIBA, which, however, still retains rever-
sionary rights. Today LIBA is one of twelve institutions participating in the support of the Laboratory,
each institution being represented on the Laboratory's Board of Trustees.
What has happened, in effect, is that LIBA has become an expanding group of local "Friends of the
Laboratory" who help support it through annual contributions. Also, from time to time, the Association
undertakes campaigns to finance special important projects for which the Lab cannot obtain funds from
the Federal Government or from other sources. For instance, in 1974, LIBA made possible the building of
the James Laboratory Annex and the renovation of Blackford Hall; and in 1976 the rebuilding of Williams
House.
The affairs of LIBA are handled by a board of 28 directors who are elected to office by the membership
at an annual meeting. At least twice a year LIBA members are invited to bring their friends to a lecture or
an open house at the Lab.
Membership in LIBA requires a minimum annual contribution (tax deductible) of $25 for a husband
and wife, $15 for a single adult, $5 for a junior member (under 21). Further information can be
obtained from the Long Island Biological Association, Box 100, Cold Spring Harbor, N.Y. 11724, or
by telephoning the Laboratory's administrative director, Mr. William R Udry, at (516) 367-8300.
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REPORT OF THE CHAIRMAN FOR 1983
The major effort of LIBA in 1983 was a continuation of our campaign launched in 1982 to raise at least $500,000
over a two-year period to help the Lab finance the construction of the urgently needed new auditorium.
The Cold Spring Harbor Laboratory has become the world center for the exchange and distribution of infor-
mation about the latest discoveries in molecular biology. As the number of molecular biologists from all over the
world who apply for participation in the June Symposium and other seminar meetings continues to increase, the
need for an auditorium large enough to accommodate them has become increasingly urgent.
Of special interest to LIBA members and to all North Shore residents is the fact that the new auditorium has
been planned to make it suitable for concerts, lectures, and other appropriate community functions during the off-
season for Laboratory meetings.
I am pleased to report that as of February 1984 we have reached our original goal of $500,000 and are now
striving substantially to increase our support of the auditorium project, which has turned out to be more expensive
than was anticipated at the time we began our campaign.
As usual, LIBA members and their guests were invited to two lectures during the year. At the first, the annual
Dorcas Cummings Memorial Lecture, our speakers were Amory and Hunter Lovins of the Rocky Mountain
Institute at Snowmass, Colorado. They have become world famous for their study of the sources and proper use
and conservation of energy, and gave us a fascinating account of their findings, followed by provocative sugges-
tions for the solution of energy problems.
At the Annual Meeting in December, the lecturer was Dr. Arnold Levine, Chairman of the Department of
Microbiology at Stony Brook. He gave his audience a remarkably clear and exciting over-view of recent signifi-
cant research in molecular biology, with a detailed explanation of the way mutation can change a healthy gene
into an oncogene.
The custom of giving dinner parties for visiting scientists during the June Symposium was successfully contin-
ued in 1983. It is a custom enjoyed equally by the scientists and by their hosts and hostesses. This year's parties
were given by
Mrs. Gilbert A. Ball
Mr. & Mrs. F. Sedgwick Browne
Mr. & Mrs. John P. Campbell
Mr. & Mrs. David C. Clark
Mr. & Mrs. Miner D. Crary
Mr. & Mrs. Henry U. Harris, Jr.
Mr. & Mrs. George J. Hossfeld, Jr.
Mr. & Mrs. Grinnell Morris
Mr. & Mrs. James J. Pirtle, Jr.
Mrs. H. Irving Pratt
Mr. & Mrs. Franz Schneider
Mr. & Mrs. Martin B. Travis
Mr. & Mrs. Bronson Trevor, Jr.
Mr. & Mrs. Robert P. Walton
Mr. & Mrs. R. Ray Weeks
Mr. & Mrs. William A. Woodcock
At the Annual Meeting regret was expressed that the terms of office as directors for Messrs. David Clark,
Roderick Cushman, Norris Darrell, Walter Frank, and Clarence Galston had terminated after eight years of
faithful service, and that Mrs. Shirley Ames and Mrs. Stephen Ulman had found it necessary to resign from the
Board. To fill the vacant places, the following directors were elected to office: Mrs. Donald Arthur, Mr. Arthur
M. Crocker, Mr. George W Cutting, Mr. Lawrence L. Davis, Mr. Arthur C. Merrill, and Mr. Harvey E. Sampson.
At the subsequent meeting of the Board of Directors the previous officers and members of the Executive
Committee were re-elected to office with the exception of Mrs. Ames, who had resigned. Mr. Callaway was
elected to take her place in the Executive Committee.
Edward Pulling, Chairman
Long Island Biological Association
February 21, 1984
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MEMBERS
Of the Long Island Biological Association
Mr. & Mrs. Thomas Ackerman
Mr. & Mrs. Amyas Ames
Mrs. Charles E. Ames
Mrs. Shirley F. Ames
Mr. & Mrs. Hoyt Ammidon
Drs. Harold & Shirley Andersen
Mr. Robert W. Anthony
Mr. & Mrs. J.S. Armentrout
Mrs. Donald Arthur
Dr. & Mrs. Joseph T. August
Mrs. Robert W. Ayer
Dr. & Mrs. Alfred Azzoni
Mr. & Mrs. Henry D. Babcock, Jr.
Mr. & Mrs. Benjamin H. Balkind
Mrs. Gilbert Ball
Mr. & Mrs. William M. Bannard
Mrs. George C. Barclay
Dr. & Mrs. Henry H. Bard
Mrs. Lila Barnes
Mr. & Mrs. Dudley R. Barr
Mr. & Mrs. Edmund Bartlett
Mrs. Robert E. Belknap, Jr.
Dr. & Mrs. Stefan Belman
Miss Linda Bennetta
Mr. & Mrs. Loren C. Berry
Mr. & Mrs. Robert P. Beuerlein
Mr. & Mrs. Nicholas Biddle, Jr.
Mrs. William Binnian
Mr. F. Roberts Blair
Mrs. Mary Lenore Blair
Mr. & Mrs. Bache Bleecker
Mrs. Margery Blumenthal
Mr. & Mrs. Elito Bongarzone
Mr. & Mrs. A.L. Boorstein
Mr. & Mrs. Murray Borson
Dr. & Mrs. George Bowen
Mr. & Mrs. William Braden
Dr. & Mrs. Arik Brissenden
Mrs. Horace Brock
Mr. & Mrs. F. Sedgwick Browne
Mr. & Mrs. G. Morgan Browne Jr.
Mr. & Mrs. Frank Bruder
Mr. & Mrs. James Bryan, Jr.
Mr. & Mrs. Julian Buckley
Mrs. R.P. Burr
Mr. & Mrs. John Busby
Mr. & Mrs. Albert Bush-Brown
Mr. & Mrs. Sidney G. Butler
Miss Grace T. Caidin
Mr. & Mrs. T.J. Calabrese, Jr.
Mr. & Mrs. Samuel Callaway
Mr. & Mrs. John P. Campbell
Mr. & Mrs. Ward C. Campbell
Miss Martha Worth Carder
Mr. & Mrs. John Carr
Mr. & Mrs. T.C. Cattrall, Jr.
Mr. & Mrs. Lionel Chaikin
Dr. Carton Chen
Mrs. Helen Chenery
Mr. & Mrs. Beverly C. Chew
Mr. & Mrs. Charles M. Clark
Mr. & Mrs. David C. Clark
Dr. & Mrs. Bayard Clarkson
Mr. & Mrs. John P. Cleary
Mr. & Mrs. Thomas N. Cochran
Dr. & Mrs. Peter Cohn
Mrs. C. Payson Coleman
Mr. & Mrs. Francis X. Coleman, Jr.
Mr. & Mrs. John H. Coleman
Mrs. John K. Colgate
Mr. & Mrs. Emilio G. Collado
Mr. & Mrs. Bradley Collins
Mr. & Mrs. Patrick Collins
Mr. & Mrs. Kingsley Colton
Mrs. Ralph C. Colyer
Dr. & Mrs. Crispin Cooke
Mr. & Mrs. Howard Corning, Jr.
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MEETINGS PROGRAMS
48TH COLD SPRING HARBOR SYMPOSIUM
ON QUANTITATIVE BIOLOGY
Molecular Neurobiology
June 1-June 8
Opening Remarks: W.M. Cowan, Salk Institute, San Diego, California
SESSION 1 Electrically Excitable Channels
Chairperson: A. Karlin, Columbia University College of Physicians and Surgeons, New York, New York
Aldrich, R.A., Stevens, C.F., Dept. of and functional reconstitution of the
Physiology, Yale University School sodium channel from rat brain.
of Medicine, New Haven, Connect- Fritz, L.C.,' Moore, H.-P.H.,2 Raf-
icut: Rates of sodium channel Mac- tery, M.A.,' Brockes, 'Divi-
tivation depend on the channel's sion of Chemistry, California In-
state. stitute of Technology, Pasadena;
Catterall, WA., Talvenheimo, J.A., 'Dept. of Biochemistry, University
Hartshorne, P., Tamkun, M.M., of California, San Francisco;
Messner, D.J., Sharkey, R.M., 'MRC, Biophysics Unit, London,
Dept. of Pharmacology, University England: Monoclonal antibodies as
of Washington, Seattle: Structure probes for the eel electroplax so-
dium channel.
Agnew, WS.,' Miller, J.A.,' Ellis-
man, M.H.,' 'Dept. of Physiology,
Yale University School of Medi-
cine, New Haven, Connecticut;
'Dept. of Neurosciences, Univer-
sity of California, San Diego: The
voltage-regulated sodium channel
from electroplax of Electrophorus
electricus.
SESSION 2 The Biochemistry and Molecular Genetics of the Acetylcholine Receptor
Chairperson: C.F. Stevens, Yale University, New Haven, Connecticut
Karlin, A.,' Cox, R.,' Dwork, A.,' organ of Torpedo californica. Barnard, E . A.,' Richards, B.M.,'
Kaldany, R.-R.,' Kao, P.,' Lobel, P.,' Stengelin, S., Ueno, S., Ballivet, M., 'Dept. of Biochemistry, Imperial
Yodh, N.,' Holtzman, E.,' 'Dept. of Heinemann, S., Patrick, J., Molec- College of Science and Technology,
Biochemistry and Neurology, ular Neurobiology Laboratory, Salk London, England; 'Searle Research
'Dept. of Biological Sciences, Co- Institute, La Jolla, California: Mo- and Development Laboratories,
lumbia University, New York, New lecular cloning of acetylcholine G.D. Searle Co., High Wycombe,
York: The arrangement and func- receptor. England: Structural requirements in
tions of the chains of the acetylcho- nicotinic acetylcholine receptors, as
line receptor of Torpedo electric Noonan, D., Hershey, N.D., Mixter,
K revealed by translation of mRNA.S., Claudio, T., Davidson, N.,tissue. and cloning of cDNA.Dept. of Chemistry, California In-
Raftery, M.A., Conti-Tronconi, B., stitute of Technology, Pasadena: Numa, S., Noda, M., Takahashi, H.,
Dunn, S.M.J., Division of Chemis- Structure and function of Torpedo Tanabe, T., Toyosato, M., Furutani,
try and Chemical Engineering, Cal- acetylcholine receptor genes. Y., Kikyotani, S., Dept. of Medical
ifornia Institute of Technology, Chemistry, Kyoto University Fac-
Pasadena: J.P.,' Sebbane, R.,' Gardner,: Signaling to and through ulty of Medicine, Japan: Molecular5.,2 Olson, E.N.,' 'Dept. of Phar-
nicotinic acetylcholine receptors. structure of Torpedo californicamacology, Washington University,
Forrest, J.W., Ingraham, H.A., Bal- St. Louis, Missouri; 'Dept. of Bio- acetylcholine receptor.
livet, M., Patrick, J., Heinemann, logical Sciences, University of Ballivet, M., Nef, P., Spierer, P., Uni-
S., Molecular Neurobiology Labo- Pittsburgh, Pennsylvania; 'Dept. of versity of Geneva, Switzerland:
ratory, Salk Institute, La Jolla, Cal- Biochemistry, Washington Univer- Genomic sequences encoding the
ifornia: Isolation and analysis of a sity, St. Louis, Missouri: Studies of alpha subunit of the nicotinic ace-
cDNA clone synthesized from the regulation of acetylcholine re- tylcholine receptor are highly con-
mRNA isolated from the electric ceptor synthesis. served in evolution.
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SESSION 3 Genetic Analysis of the Nervous System
Chairperson: N. Davidson, California Institute of Technology, Pasadena, California
Hahn, W., Chaudhari, N., Beck, L.,
Morrison, K., Dept. of Anatomy,
University of Colorado Health Sci-
ences, Denver: Genetic expression
in postnatally developing brain.
Sutcliffe, LG.,' Milner, R.J.,' Bloom,
F.E.,2 'Scripps Clinic and Research
Foundation; 'Salk Institute, La
Jolla, California: Cellular localiza-
tion of the proteins encoded by
brain-specific mRNAs.
Axel, R., Buck, L., Stein, R., Palaz-
zolo, M., Claudio, T., Gallay, B.,
Anderson, D., Jackson, J., Ma-
daule, P., Schwartz, J., Institute of
Cancer Research and Center for
Neurobiology and Behavior, Co-
lumbia University, New York, New
York: Isolating genes expressed in
single neurons.
Kuenzle, C.C., Heizmann, C.W.,
Hiibscher, U., Hobi, R., Winkler,
G.C., Jaeger, A.W., Morgenegg, G.,
Dept. of Pharmacology and Bio-
chemistry, School of Veterinary
Medicine, University of Zurich,
Switzerland: Chromatin changes
accompanying neuronal differen-
tiation.
Sulston, J.E., Laboratory of Molecu-
lar Biology, MRC, Cambridge,
England: Neuronal cell lineages in
the nematode C. elegans.
Horvitz, R., Ellis, H.M., Fixsen, W,
Greenwald, I., Sternberg, P., Dept.
of Biology, Massachusetts Institute
of Technology, Cambridge: Muta-
tions that affect neuronal develop-
ment in the nematode C. elegans.
SESSION 4 Studies on Neuronal Proteins with Recombinant DNA Techniques
Chairperson: E. Barnard, Imperial College, London, England
Mallet, J., Biguet, N.F., Grima, B.,
Julian, J.F., Lamouroux, A., Insti-
tut de Microbiologie, University
Paris, France: A molecular genetics
approach to the study of catechol-
amine biosynthesis.
Chikaraishi, D.M., Brilliant, M.H.,
Lewis, E.J., Tomasiewicz, H.G.,
Molecular and Cellular Biology,
National Jewish Hospital/National
Asthma Center, Denver, Colorado:
Cloning and characterization of
brain-specific transcripts - Rare,
and tyro-
sine hydroxylase.
O'Malley, K., Mauron, A., Kedes, L.,
Barchas, J., Stanford University
School of Medicine, California:
Structure, regulation, and brain lo-
calization of mRNA for rat dopa-
mine-/3- hydroxylase.
Joh, T.H., Baetge, E.E., Ross, M.E.,
Moon, H.M., Albert, V.R., Reis,
D.J., Laboratory of Neurobiology,
Cornell University Medical Col-
lege, New York, New York: Evi-
dence for the existence of a gene
family coding for catecholamine
biosynthetic enzymes.
DeGennaro, L.J.,' Wallace, W.C.,2
Kanazir, 5.,2 Lewis, R.M.,2 Green-
gard, P.,2 'Max-Planck Institute for
Psychiatry, Martinsried, Federal
Republic of Germany; 'Dept. of
Pharmacology, Yale University
School of Medicine, New Haven,
Connecticut: Neuron-specific phos-
phoproteins as models for neuronal
gene expression.
Lewis, R.M., Wallace, W.C., Kana -
zir, S., Greengard, P., Dept. of
Pharmacology, Yale University
School of Medicine, New Haven,
Connecticut: Expression of cell-
type-specific neuronal phospho-
proteins.
Fambrough, D.M., Dept. of Em-
bryology, Carnegie Institution of
Washington, Baltimore, Maryland:
Regulation of the sodium pump.
SESSION 5 Neuronal Surface Molecules
Chairperson: Z. Hall, University of California, San Francisco, California
Rutishauser, U., Dept. of Anatomy,
Case Western Reserve University
School of Medicine, Cleveland,
Ohio: Chemistry and biology of a
neural cell adhesion molecule.
Goridis, C., Centre d'Immunologie
INSERM-CNRS de Marseille-Lu-
miny, France: Neural surface anti-
gens during nervous system
development.
Schubert, D., LaCordbiere, M., Salk
Institute, La Jolla, California: A role
for adherons in the adhesion of
nerve and muscle cells.
Edelman, G.M., Hoffman, S., Cun-
ningham, B.A., Rockefeller Uni-
versity, New York, New York:
Structure and modulation of neural
cell adhesion molecules.
Zipser, B., Flanagan, T., Flaster, M.,
Macagno, E., Stewart, E., Cold
Spring Harbor Laboratory, New
York: Analysis of neuron-specific
leech antigen.
Schachner, M., Faissner, A., Meier,
D., Kruse, J., Lindner, J., Rathjen,
F., Wernecke, H., Dept. of Neuro-
biology, University of Heidelberg,
Federal Republic of Germany:
Characterization of cell-surface
components involved in cell
adhesion.
Raff, M.C.,' Miller, R.H.,' Noble,
M.,2 'MRC Neuroimmunology
Project, Dept. of Zoology, Univer-
sity College London, England;
'Institute of Neurology, London,
England: Glial cell lineages in the
rat optic nerve.
SESSION 6 Biochemical Analysis of Electrically Active Proteins
Chairperson: G. Edelman, Rockefeller University, New York, New York
Lindstrom, J.,' Tzartos, S.,' Gullick,
W.,' Hockschwender, S.,' Swanson,
L.,' Montal, M.,2 'Salk Institute for
Biological Studies; 'University of
California, San Diego: Use of mono-
clonal antibodies to study acetyl-
choline receptors from electric or-
gans, muscle, and brain and the
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autoimmune response to receptor in
myasthenia gravis.
Anderson, DI,' Blobel, G.,2 'Insti-
tute for Cancer Research, Colum-
bia University College of Physi-
cians and Surgeons, New York,
New York; 'Laboratory of Cell Bi-
ology, Rockefeller University, New
York, New York: Biosynthesis of
the acetylcholine receptor in vitro.
Changeux, J.P., Institut Pasteur, Paris,
France: Allosteric properties of the
acetylcholine receptor.
Kristofferson, D., Fairclough, R.,
Love, R., Moore, J., Young, E.,
Stroud, R., Dept. of Biochemistry
and Biophysics, University of Cali-
fornia, San Francisco: The struc-
ture of an acetylcholine receptor
and what it tells us about function.
Papazian, D.,' Chan, S.,' Hess, E.J.,'
Rahamimoff, H.,3 Goldin, S.,2
'Dept. of Biochemistry; 'Dept. of
Pharmacology, Harvard Medical
School, Boston, Massachusetts;
'Dept. of Biochemistry, Hadassah
Medical School, Jerusalem, Israel:
Purification and characterization of
synaptosomal Ca pumps.
Triggle, D.J.,' Bolger, G.T.,' Gengo,
P.J.,' Luchowski, E.M.,' Rampe,
D.,' Janis, R.A.,2 'Dept. of Bio-
chemical Pharmacology, State Uni-
versity of New York, Buffalo;
'Miles Institute for Preclinical
Pharmacology, New Haven, Con-
necticut: Ca-channel antagonists-
SESSION 7 Behavior
Chairperson: M.C. Ralf, University College London, London, England
Adler, J., Dept. of Biochemistry and
Genetics, University of Wisconsin,
Madison: How E. coli does neuro-
biology .
Boyd, A.,' Kirkos, A.,2 Mutoh, N.,2
Simon, N.,2 'Leicester Biocentre,
University of Rhode, England;
'Division of Biology, California In-
stitute of Technology, Pasadena:
The structure of proteins that act as
receptors and sensory transducers
in bacteria.
Koshland, D.E., Jr., Russo, A.F.,
Gutterson, N.I., Dept. of Biochem-
istry, University of California,
Berkeley: Information processing in
a sensory system.
Schwartz, J.H., Bernier, L., Castel-
lucci, V.F., Eppler, C.M., Saitoh,
T., Kandel, E.R., Center for Neu-
robiology and Behavior, Columbia
University College of Physicians
and Surgeons and New York State
Psychiatric Institute, New York,
New York: What enzymatic steps
determine the time course of short-
term memory in Aplysia?
Kandel, E.R., Abrams, T.W., Carew,
T.J., Hawkins, R.D., Columbia
University College of Physicians
Radioligand binding in neuronal
and nonneuronal tissue.
Birdsall, N.J.M.,' Hulme, E.C.H.,'
Stockton, J.,' Wong, E.H.F.,2
'Division of Molecular Pharmacol-
ogy, National Institute for Medical
Research, London, England; 'Dept.
of Biochemistry, University of Cal-
ifornia, Riverside: Muscarinic re-
ceptor subclasses - Allosteric in-
teractions.
and Surgeons, New York, New
York: Classical conditioning in
Aplysia- Conditioning and sensiti-
zation seem to share aspects of the
same molecular cascade.
Aceves-Pina, E.O., Brooker, R.,
Duerr, J.S., Livingston, M.S.,
Quinn, W.G., Smith, R.T., Sziber,
RP., Tempel, B.L., Tully, T., Dept.
of Biology, Princeton University,
New Jersey: Genetic studies of
learning and memory in Dro-
sophila.
SESSION 8 The Regulation of Axon Organization
Chairperson: U.J. McMahan, Stanford University, Stanford, California
Bentley, D., Caudy, M., Dept. of Zo-
ology and Biophysics Group, Uni-
versity of California, Berkeley:
Pathways and pathfinding by pe-
ripheral pioneer neurons in
grasshoppers.
Goodman, C.S., Bastiani, M.J., Ko-
tria, K.J., Dept. of Biological Sci-
ences, Stanford University, Califor-
nia: Guidance of neuronal growth
cones-Cell recognition and filo-
podial interactions during embry-
onic development.
McKay, R.D.G., Hockfield, S., Jo-
hansen, J., Cold Spring Harbor
Laboratory, New York: The orga-
nization of molecularly distinct ax-
ons in the leech connective.
Reichardt, L.F., Calof, A.L., Green-
span, R.J., Greig, K.F., Lander,
A.D., Matthew, W D., Tomaselli,
K.J., Winter, J., Depts. of Physiol-
ogy and Biochemistry, University of
California, San Francisco: Studies
on factors that promote neurite out-
growth in vitro.
SESSION 9 Molecular Aspects of Neuropeptides I
Chairperson: H. Reuter, University of Berne, Berne, Switzerland
Jan, Y.N., Bowers, C., Evans, L., Jan,
L.Y., Dept. of Physiology, Univer-
sity of California, San Francisco:
Roles of peptides in neuronal func-
tion-Studies using frog autonomic
ganglia.
Gould, R.J., Murphy, K.M.M., Sny-
der, S.H., Dept. of Neuroscience,
Johns Hopkins University School of
Medicine, Baltimore, Maryland:
Studies of voltage-operated Ca
channels using radioligands.
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White, J.G., Southgate, E., Thomson,
J.N., Brenner, S., Laboratory of
Molecular Biology, MRC, Cam-
bridge, England: Patterns of con-
nectivity in the nervous system of
C. elegans.
Wyman, R.J., Thomas, J.B., Dept. of
Biology, Yale University, New Ha-
ven, Connecticut: Genetic ap-
proach to the molecular basis of
neural connectivity.
Evans, R.M.,' Swanson, L.,' Saw-
chenho, P.,' Vale, W,' River, J.,'
Amara, S.,2 Rosenfeld, M.G.,' 'Salk
Institute for Biological Studies;
'University of California School of
Medicine, San Diego: Generation of
diversity in the nervous system -
Exon invasion, splicing control, and
complex genes.
Scheller, R.H., Dept. of Biological
Sciences, Stanford University, Cali-
fornia: The molecular basis of a
simple behavior.
Shine, J., Mason, A., Evans, B.,
Richards, R., Centre for Recombi-
nant DNA Research, Australian
University, Canberra: Proteolytic
processing and regulation of neu-
ropeptide biosynthesis.
SESSION 10 The Cellular Organization of Neurons
Chairperson: H. Thoenen, Max-Planck Institut, Martinsried, Federal Republic of Germany
Weber, K., Shaw, G., Osborn, M.,
Debus, E., Geis ler, N., Max-Planck
Institute for Biophysical Chemistry,
Gottingen, Federal Republic of
Germany: Neurofilaments -Struc-
tural aspects and expression during
development.
Lasek, R.J., Drake, P.F., Oblinger,
M.M., Neurobiology Center, Dept.
of Developmental Genetics and
Anatomy, Case Western Reserve
University, Cleveland, Ohio: Re-
gional differences in the periphery
of neuronal cytoskeletons may be
specified in the cell body.
Steward, 0., Dept. of Neurological
Surgery, University of Virginia,
Charlottesville: Polyribosomes at
the base of dendritic spines of CNS
neurons -Their possible role in
synapse construction and modifi-
cation.
Stallcup, W, Beasley, L., Levine, J.,
Molecular Neurobiology Labora-
tory, Salk Institute, La Jolla, Cali-
fornia: Cell-surface molecules that
characterize different stages in the
development of cerebellar inter-
neurons.
Matus, A., Friedrich Miescher Insti-
tute, Basel, Switzerland: Neuronal
microdifferentiation.
Ginzburg, I., Scherson, T., Rybak, S.,
Kimhi, Y., Neuman, D., Schwartz,
M., Littauer, U.Z., Dept. of Neu-
robiology, Weizmann Institute of
Science, Rehovot, Israel: Expres-
sion of mRNA for microtubule pro-
teins in the developing nervous
system.
Baitinger, C.,' Cheney, R.,' Clem-
ents, D.,' Glicksman, M.,' Hiro-
kawa, N.,' Levine, J.,2 Meiri, K.,'
Simon, C.,' Skene, J.H.P.,, Wil-
lard, M.,' 'Dept. of Anatomy and
Neurobiology, Washington Univer-
sity, St. Louis, Missouri; 'Dept. of
Neurobiology, Salk Institute, La
Jolla, California; 'Dept. of Neuro-
biology, Stanford University, Cali-
fornia: Intriguing axonally trans-
ported proteins.
SESSION 11 Synaptic Organization and Function
Chairperson: D. Bentley, University of California, Berkeley, California
McMahan, U.J., Dept. of Neurobiol- Psychiatry, Martinsried, Federal
ogy, Stanford University School of Republic of Germany: Quantitation
Medicine, California: Molecular and purification of neurotropic fac-
components of synaptic basal lam- tors from physiologically relevant
Ma that cause aggregation of ace- sources.
tylcholine receptors on regenerat- Dodd, J., Hamilton, P., Heath, M.,
ing myofibers. Jahr, C., Jessell, T., Dept. of Neu-
Sanes, J.R., Dept. of Physiology, robiology, Harvard Medical School,
Washington University School of Boston, Massachusetts: Neuro-
Medicine, St. Louis, Missouri: transmission and neuronal markers
Basal lamina in neuromuscular re- at sensory synapses in the spinal
generation and development. cord.
Thoenen, H., Korsching, S., Barde,
Y.-A., Edgar, D., Dept. of Neuro-
chemistry, Max-Planck Institute for
Kelly, R.B., Carlson, S., Burgess, T.,
Moore, H. -P., Buckley, K., Sch-
weitzer, E., Hooper, J., Pfeffer, S.,
SESSION 12 Aspects of Vision
Chairperson: T. Wiesel, Rockefeller University, New York, New York
Stryer, L., Dept. of Structural Biol- Benzer, S., Zipursky, S.L., Venka-
ogy, Stanford University School of tesh, T.R., Fujita, S.C., Biology
Medicine, California: Signal-am- Division, California Institute of
plifying proteins in the cyclic nu- Technology, Pasadena: A mono-
cleotide cascade of vision. clonal antibody study of the devel-
opment of the Drosophila retina.Dunn, R.J., Hackett, N.R., Huang,
K.-S., Jones, S.S., Khorana, H.G.,
Liao, M.-J., Lo, K.-M., Satterthwait,
A., Seehra, J.S., Yatsunami, K.,
Depts. of Biology and Chemistry,
Massachusetts Institute of Technol-
ogy, Cambridge: Studies on the
Barnstable, C.J., Akagawa, K., Hof-
stein, R., Dept. of Neurobiology,
Harvard Medical School, Boston,
Massachusetts: Monoclonal anti-
bodies that label discrete cell types
in the mammalian nervous system.
light-transducing pigments, bacter- Nirenberg, M., Krueger, K., Fukui,
iorhodopsin and rhodospin. H., Rotter, A., Wilson, S., Higash-
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Gumbiner, B., Miljanich, G., Uni-
versity of California, San Fran-
cisco: Sorting in neurons and pep-
tide-secreting cells.
Patterson, P.H., Dept. of Neurobiol-
ogy, Harvard Medical School, Bos-
ton, Massachusetts: Surface mem-
brane and secreted glycoproteins of
developing neurons.
ida, H., NHLBI, National Institutes
of Health, Bethesda, Maryland:
Synapse formation by neuroblas-
toma hybrid cells.
Hockfield , S. , ' McKay, R. D. G. , '
Hendry, S.H.,2 Jones, E.G.,' 'Cold
Spring Harbor Laboratory, New
York; 2Dept. of Neurology and
Neurosurgery, Washington Univer-
sity School of Medicine, St. Louis,
Missouri: Structural and organiza-
tional features of mammalian CNS
demonstrated with monoclonal
antibodies.
SESSION 13 Electrophysical Analysis of Membrane Properties
Chairperson: J. Schwartz, Columbia University College of Physicians and Surgeons, New York, New
York
Reuter, H.,' Cachelin, A.B.,' de
Peyer, J. E.,' Kokubun, S.,' Levitan,
I.,2 'Dept. of Pharmacology, Uni-
versity of Berne, Switzerland;
'Dept. of Biochemistry, Brandeis
University, Waltham, Massachu-
setts: Modulation by phosphoryla-
tion of Cat* channels and Ca2+-ac-
tivated channels.
Nowycky, M.C.,' Bean, B.P.,2 Hess,
P.,' Tsien, R.W.,2 'Dept. of Neu-
roanatomy; 'Dept. of Physiology,
Yale University School of Medi-
cine, New Haven, Connecticut:
Properties of Ca channels in neu-
rons and heart cells.
Salkoff, L., Dept. of Physiology,
University of California School of
Medicine, San Francisco: Genetic
and voltage-clamp analysis of a K.
channel in Drosophila.
Jan, L.Y., Barbel, S., Timpe, L., Laf-
fer, C., Salkoff, L., O'Farrell, P.,
Jan, Y.N., Depts. of Physiology and
Biochemistry, University of Cali-
fornia, San Francisco: Mutating a
gene for a potassium channel by hy-
brid dysgenesis- An approach to
the cloning of the shaker locus in
Drosophila.
Cull-Candy, S.G., Dept. of Pharma-
cology, University College Lon-
don, England: Glutamate and
GABA-receptor channels at the lo-
cust nerve muscle junction-Noise
analysis and single-channel re-
cording.
SESSION 14 Molecular Aspects of Neuropeptides II
Chairperson: S. Numa, Kyoto University, Kyoto, Japan
Herbert, E., Dept. of Chemistry, Uni-
versity of Oregon, Eugene: Regu-
lation of expression of opioid pep-
tide genes in man, rat, and mouse.
Roberts, J.L., Dept. of Biochemistry
and Center for Reproductive Sci-
ences, Columbia University Col-
lege of Physicians and Surgeons,
New York, New York: Pro-opiome-
lanocortin -A model for differen-
tial regulation of neuropeptide hor-
mone gene expression.
Darling, T.,' Petrides, P.,' Beguin, P.,'
Frey, P.,' Shooter, E.M.,' Selby,
C. ELEGANS
May 4-May 8
M.,2 Rutter, W.J.,2 'Dept. of Neu-
robiology, Stanford University
School of Medicine, California;
'Dept. of Biochemistry and Bio-
physics, University of California,
San Francisco: The biosynthesis
and processing of proteins in the
mouse 7S nerve growth factor
complex.
Ullrich, A., Gray, A., Berman, C.,
Dull, T.J., Dept. of Molecular Bi-
ology, Genentech, Inc., South San
Francisco, California: Characteri-
zation of the gene encoding the
subunit of nerve growth factor.
Barker, J.L., Owen, D.G., Segal, M.,
NINCDS, National Institutes of
Health, Bethesda, Maryland: Reg-
ulation of excitable membrane
properties in cultured CNS neurons.
Sakmann, B., Hamill, O.R, Max-
Planck Institut fiir Biophysikalische
Chemie, Gottingen, Federal Repub-
lic of Germany: The mode of action
of excitatory and inhibitory
transmitters.
Schramm, M., Dept. of Biological
Chemistry, Hebrew University, Je-
rusalem, Israel: Mechanism of re-
ceptor action in the adenylate cy-
clase system.
Rossier, J., Liston, D., Patey, G.,
Chaminade, M., Foutz, A., Vander-
haeghen, J.J., Laboratoire de Phy-
siologic Nerveuse, CNRS, Gif-sur-
Yvette, France: The enkephali-
nergic neuron-Implications of a
polyenkephalin precursor.
Summary: E. Kandel, Columbia
University College of Physicians
and Surgeons, New York, New
York.
SESSION 1 Neurobiology
Chairperson: P. Anderson, University of Wisconsin, Madison, Wisconsin
Rand, J., Dept.of Biological Sci-
ences, University of Pittsburgh,
Pennsylvania: cha-1, unc-1Z and
choline acetyltransferase in C.
elegans.
Perkins, L.,' Hedgecock, E.,2 Cu-
lotti, J.,' Thomson, N.,2 'North-
western University, Evanston, Illi-
nois; 2MRC Laboratory of Molecu-
lar Biology, Cambridge, England:
Behaviors of mutants defective in
fluorescein-concentrating sensory
neurons.
Chalfie, M., Dept. of Biological Sci-
ences, Columbia University, New
York, New York: Still more on
touch sensitivity in C. elegans.
Johnson, C.D., Stretton, A.O.W.,
Dept. of Zoology, University of
Wisconsin, Madison: Monoclonal
antibodies to Ascaris neurons.
Angstadt, J.D.,' Stretton, A.O.W.,2
'Neurosciences Training Program;
'Dept. of Zoology, University of
Wisccnsin, Madison: Intracellular
recordings and Lucifer yellow-fills
of interneurons in the nematode
Ascaris.
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Kenyon, C.J., Hedgecock, E.M.,
MRC Laboratory of Molecular Bi-
ology, Cambridge, England: A cell
lineage mutation that blocks neu-
roblast formation in the lateral
hypodermis.
Trent, C., Desai, C., Tsung, N.,
Horvitz, R., Dept. of Biology,
Massachusetts Institute of Technol-
ogy, Cambridge: Egg-laying defec-
tive mutants of C. elegans.
SESSION 2 Sex Determination and Gametogenesis
Chairperson: D.L. Riddle, University of Missouri, St. Louis, Missouri
Meneely, P.M., Wood, W.B., Dept. of
Molecular, Cellular, and Develop-
mental Biology, University of Col-
orado, Boulder: Autosomal genes
affecting dosage compensation and
sex determination.
Doniach, T., Hodgkin, J., MRC Lab-
oratory of Molecular Biology,
Cambridge, England: New alleles
of intersex-1 (isx-1).
Edgar, L.,' Kimble, J.,' Hirsh, D.,'
'NIADDK, National Institutes of
Health, Bethesda, Maryland;
'Laboratory of Molecular Biology,
University of Wisconsin, Madison;
'Dept. of Molecular, Cellular, and
Developmental Biology, University
of Colorado, Boulder: The role of
isx-2 in male sexual differentiation.
Fixsen, W, Horovitz, R., Dept. of Bi-
ology, Massachusetts Institute of
Technology, Cambridge: A lin-22
mutation causes apparent spatial
and sexual transformations in cell
fates.
Goldstein, P., Dept. of Biology, Uni-
versity of North Carolina, Char-
lotte: Associated autosomal struc-
tures (nondisjunction regulator
regions) may specifically influence
X-chromosome nondisjunction.
Burke, D.J., Ward, S., Dept. of Em-
bryology, Carnegie Institution of
Washington, Baltimore, Maryland:
Identification of a large multigene
family encoding the major sperm
protein of C. elegans.
Klass, M.,' Kinsley, S.,' Lopez,
L.C.," 'Biology Dept., University of
Houston, Texas; 'Biochemistry
Dept., M.D. Anderson Hospital and
Tumor Institute, Houston, Texas:
SESSION 3 Poster Session: Neurobiology, Sex, and Gametes
White, J.G., Southgate, E., Thomson,
J.N., Brenner, S., MRC Laboratory
of Molecular Biology, Cambridge,
England: The nervous system of C.
elegans.
Rand, J., Bashor, 0., Cavalier, L.,
Russell, R., Dept. of Biological
Sciences, University of Pittsburgh,
Pennsylvania: Anatomy and func-
tion of the juvenile motor nervous
system in C. elegans.
Albert, RS., Riddle, D.L., Division of
Biological Sciences, University of
Missouri, Columbia: Reversible
developmental alterations in dauer
larva sensory neuroanatomy.
Perkins, L.,' Hedgecock, E.,2 Thom-
son, N.,' Culotti, J.,' 'Northwestern
University, Evanston, Illinois;
'MRC Laboratory of Molecular Bi-
ology, Cambridge, England: Ultra-
structural analysis of mutants of the
fluorescein concentrating sensory
neurons.
Chen, V.,' Hieb, W,' 'Dept. of Bio-
physics, 'Dept. of Biological Sci-
ences, State University of New
York, Buffalo: Coordinated mass
movement in C. elegans and Tuba-
trix aceti.
Hieb, W.F.,' Chen, V.K. -H.,' 'Dept.
of Biological Sciences, 'Dept. of
Biophysical Sciences, State Univer-
sity of New York, Buffalo: Culture
morphology of C. elegans behav-
ioral mutants.
Lewis, J.A., McLafferty, S., Dept. of
Biological Sciences, University of
Missouri, Columbia: The deter-
gent-solubilized levamisole recep-
tor.
Kolson, D.L., Dept. of Biological
Sciences, University of Pittsburgh,
Pennsylvania: New alleles of ace-2.
Zuckerman, B.,' Damon, R.,' Ka-
hane, 'Dept. of Plant Pathol-
ogy; 'Dept. of Veterinary and
Animal Science, University of Mas-
sachusetts, Amherst; 'Dept. of
Biomembranes, Hebrew Univer-
sity-Hadassah Medical School, Je-
rusalem, Israel: Regulation of
chemotaxis of C. elegans by Con-
A-binding sites.
Siddiqui, S., Culotti, J., Dept. of Bio-
chemistry, Molecular Biology, and
Cell Biology, Northwestern, Uni-
versity, Evanston, Illinois: Charac-
terization of a 34 kD antigen pres-
ent on the surface of neurons and
their support cells in C. elegans us-
ing antibodies against horseradish
peroxidase (HRP).
Culotti, J.,' Siddiqui, S.,' Gremke,
L.,' Stretton, A.O.W.,2 Johnson,
C.D.,' 'Northwestern University,
Evanston, Illinois; 'University of
Wisconsin, Madison: Monoclonal
antibodies to nerve-enriched tissue
from Ascaris bind to C. elegans.
Okamoto, H., MRC Laboratory of
Molecular Biology, Cambridge,
England: Monoclonal antibodies to
C. elegans nervous tissue.
Davis, R.E.,' Stretton, A.O.W.,2
'Neurosciences Program, 'Dept. of
Zoology, University of Wisconsin,
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Isolation and characterization of a
developmentally regulated sperm-
specific gene family in the nema-
tode C. elegans.
Blumenthal, T., Donegan, M., Kirt-
land, S., Sharrock, W, Spieth, J.,
Dept. of Biology, Indiana Univer-
sity, Bloomington: The yolk protein
gene family of C. elegans.
Stock Center Report
Edgley, M.L., Swanson, M.M., Rid-
dle, D.L., Division of Biological
Sciences, University of Missouri,
Columbia: Caenorhabditis genetics
center.
Madison: Motorneuron membrane
constants and signaling properties
in the nematode Ascaris.
Donmoyer, J.E., Desnoyers,
Stretton, A.O.W., Dept. of Zool-
ogy, University of Wisconsin, Mad-
ison: Synaptic interactions of ven-
tral cord interneurons in Ascaris.
Hedgecock, E., MRC Laboratory of
Molecular Biology, Cambridge,
England: Q neuroblast migration
mutants.
Finney, M., Horovitz, R., Dept. of
Biology, Massachusetts Institute of
Technology, Cambridge: The ge-
netic analysis of unc-86.
Trent, C., Ellis, H.M., Horovitz,R.,
Dept. of Biology, Massachusetts
Institute of Technology, Cam-
bridge: Weakly sexually trans-
formed XX animals are herma-
phrodites that lack HSN neurons.
Hodgkin, J., MRC Laboratory of Mo-
lecular Biology, Cambridge, Eng-
land: Chauvinist dumpy genes.
Pavalko, F.M., Roberts, T.M., Dept.
of Biological Science, Florida State
University, Tallahassee: Mono-
clonal antibodies as probes for
membrane movement on C. elegans
sperm.
SESSION 4 Cell Biology
Chairperson: H.R. Horvitz, Massachusetts Institute of Technology, Cambridge, Massachusetts
Miller, D.M., III, Ortiz, I., Berliner,
G., Epstein, H.F., Dept. of Neurol-
ogy, Baylor College of Medicine,
Houston, Texas: The location of two
myosins within nematode thick
filaments.
Francis, R., Waterston, R.H., Dept.
of Genetics, Washington University
School of Medicine, St. Louis,
Missouri: Minor muscle proteins in
C. elegans.
Brown, S.J., Riddle,D.L., Division of
Biological Sciences, University of
Missouri, Columbia: Mutations in-
terfering with indirect suppression
of muscle defects in C. elegans.
Edgar, L.G., McGhee, J.D.,
NIADDK, National Institutes of
Health, Bethesda, Maryland: De-
velopment of digestive enzymes in
the intestine of C. elegans.
Clokey, G., Jacobson, L.A., Dept. of
Biological Sciences, University of
Pittsburgh, Pennsylvania: Endocy-
tosis by intestinal cells of C.
elegans.
SESSION 5 Postembryonic Development and Aging
Chairperson: D. Hirsh, University of Colorado, Boulder, Colorado
Sternberg, P., Ferguson, E., Tsung,
N., Greenwald, I., Horvitz, R.,
Dept. of Biology, Massachusetts
Institute of Technology, Cam-
bridge: Genetic control of C. ele-
gans vulval cell lineages.
setts Institute of Technology, Cam-
bridge: The lin-12 locus determines
cell fates in C. elegans.
Ambros, V., Horvitz, R., Dept. of Bi-
ology, Massachusetts Institute of
Technology, Cambridge: Genes af-
Ferguson, E., Horvitz, R., Dept. of fecting temporal patterns of
Biology, Massachusetts Institute of development.
Technology, Cambridge: Synthetic
multivulva mutations.
Hedgecock, E., MRC Laboratory of
Molecular Biology, Cambridge,
England: Two genes affecting cell
proliferation in many lineages.
Greenwald, I., Sternberg, P., Horvitz,
R., Dept. of Biology, Massachu-
O'Riordan, V., Burnell, A.M., Dept.
of Biology, St. Patrick's College,
Maynooth, Ireland: Intermediary
metabolism in dauer larvae of C.
elegans.
Mendis, A.H.W., Keene, N.M., Rees,
H.H., Goodwin, T.W., Dept. of
Biochemistry, University of Liver-
SESSION 6 Poster Session: Genetics and Development
Rosenbluth, R., Cuddeford, C., Scott,
G., Baillie, D.L., Dept. of Biolog-
ical Science, Simon Fraser Uni-
versity, Burnaby, Canada: EMS and
gamma-ray mutagenesis in C. ele-
gans.
Pulak, R., Samoiloff, M.R. Madrid,
A. Ager, D. Bogaert, T., Dept. of
Zoology, University of Manitoba,
Winnipeg, Canada: The 1983 ge-
netic map of Panagrellus redivivus.
Denich, K., Samoiloff, M., Dept. of
Zoology, University of Manitoba,
Canada: Mutation rates induced by
large doses of gamma, proton, and
neutron irradiation of the X-chro-
mosome of the nematode Panagrel-
lus redivivus.
Hartman, P., Dept. of Biology, Texas
Christian University, Fort Worth:
Wild-type and rad mutant radiation
sensitivities-Effects of parental
genotype and developmental stage.
Emmons, S.W., Roberts, S., Katzen-
berg, D. Sanicola, M. Rubinfeld, Rose, A.M.,' Baillie, D.L.,' Curran,
B., Dept. of Molecular Biology, Al- J.,' 'Dept. of Medical Genetics.
bert Einstein College of Medicine,
Bronx, New York: Mutations in
Bergerac induced by heat shock.
Park, J., Horvitz, R., Dept. of Biol-
ogy, Massachusetts Institute of
Technology, Cambridge: Dominant
mutations of C. elegans.
Hosono, R., Kuno, S., Dept. of Bio-
chemistry, Kanazawa University
School of Medicine, Ishikawa, Ja-
pan: Isolation and partial charac-
terization of temperature-sensitive
paralytic mutants of C. elegans.
Ferguson, E., Sternberg, P., Green-
wald, I., Horvitz, R., Dept. of Bi-
ology, Massachusetts Institute of
Technology, Cambridge: Mutations
in the locus sup-17 reduce the level
of lin-12 gene activity.
Greenwald, I., Horvitz, R., Dept. of
Biology, Massachusetts Institute of
Technology, Cambridge: sup-
10(n983) confers a phenotype that
is similar to the of unc-93(e1500).
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Ward, S., Dept. of Embryology, Car-
negie Institution of Washington,
Baltimore, Maryland: Asymmetric
distribution of specific proteins
during spermatogenesis.
Roberts, T.M., Dept. of Biological
Science, Florida State University,
Tallahassee: Crawing C. elegans
spermatozoa contain 2-nm fila-
ments.
pool, England: Identification, ti-
ters, and functions of molting hor-
mones in C. elegans.
Johnson, T.E.,' Roberts, L.,2 Cuc-
caro, P.M.,' 'Dept. of Molecular
Biology and Biochemistry, Univer-
sity of California, Irvine; 'Institute
for Behavioral Genetics, Boulder,
Colorado: Genetics of long-lived
variants of C. elegans.
University of British Columbia,
Vancouver, Canada; 'Dept. of Bio-
logical Sciences, Simon Fraser
University, Burnaby, Canada:
Overlapping duplications cover en-
tire chromosome I.
Sigurdson, D.C., Spanier, G., Her-
man, R.K., Dept. of Genetics and
Cell Biology, University of Minne-
sota, St. Paul: A deficiency map for
a region of chromosome II.
Rogalski, T.M., Baillie, D.L., Dept.
of Biological Sciences, Simon
Fraser University, Burnaby, Can-
ada: Genetic analysis of the unc-22
IV region of C. elegans.
Golden, J.W., Riddle, D.L., Division
of Biological Sciences, University
of Missouri, Columbia: Influence
of environmental cues on develop-
ment of the C. elegans dauer larva.
Klass, M., Biology Dept., University
of Houston, Texas: Age-correlated
changes in DNA in C. elegans.
Ishii, N., Suzuki, K., Dept. of Molec-
ular Biology, Tokai University
School of Medicine, Japan: Effect
of radiation on the life span of the
nematode Rhabditidae tolcai.
Yarbrough, P.O., Hecht, R.M., Dept.
of Biochemical and Biophysical
Sciences, University of Houston
Central Campus, Texas: Develop-
mental regulation of two glyceral-
dehyde-3-phosphate dehydrogen-
ases in C. elegans.
Abdulkader, N., Otsuka, A., Dept. of
Genetics, University of California,
Berkeley: Mutations affecting the
morphology of the tail of C.
elegans.
Kemphues, K., Wolf, N., Hirsh, D.,
Dept. of Molecular, Cellular, and
Developmental Biology, University
of Colorado, Boulder: Studies at the
zyg-11 locus.
Cowan, A., McIntosh, J.R., Dept. of
Molecular, Cellular, and Develop-
mental Biology, University of Col-
orado, Boulder: Effect of reposi-
tioning the first cleavage plane on
the development of C. elegans
embryos.
Denich, K.,' Cassada, R.,2 Isnenghi,
E.,2 Schierenberg, E.,3 'Dept. of
Zoology, University of Manitoba,
Winnipeg, Canada; 'Dept. of Mo-
lecular Biology, Max-Planck Insti-
tute for Experimental Medicine,
Gottingen, Federal Republic of
Germany; 'Dept. of Molecular,
Cellular, and Developmental Biol-
ogy, University of Colorado, Boul-
der: Cell lineage and develop-
mental defects of temperature-
sensitive embryogenesis mutants in
C. elegans.
Cassada, R., Denich, K., Isnenghi,
E., Schierenberg, E., Smith, K.,
Dept. of Molecular Biology, Max-
Planck Institute for Experimental
Medicine, Gottingen, Federal Re-
public of Germany: Temperature-
sensitive embryonic mutants-The
Gottingen set revisited.
SESSION 7 Transposons, Suppressors, and Transformation
Chairperson: J. Hodgkin, MRC Laboratory of Molecular Biology, Cambridge, England
Eide, D., Anderson, P., Dept. of Ge-
netics, University of Wisconsin,
Madison: Spontaneous unc-54
mutations.
Moerman, D.G., Waterson, R.H.,
Dept. of Genetics, Washington Uni-
versity School of Medicine, St.
Louis, Missouri: Spontaneous un-
stable unc-22 IV mutations in C.
elegans var. Bergerac.
Emmons, S.W., Yesner, L., Ruan, K.,
Katzenberg, D., Rubinfeld, B.,
Dept. of Molecular Biology, Albert
Einstein College of Medicine,
Bronx, New York: Evidence for a
transposon in C. elegans.
Liao, L.W, Rosenzweig, B., Hirsh,
D., Dept. of Molecular, Cellular,
and Developmental Biology, Uni-
versity of Colorado, Boulder: Tcl,
a transposable element in C.
elegans.
Rose, A.M., Mawji, N., Harris, L.,
Donati, L., Dept. of Medical Ge-
netics, University of British Co-
lumbia, Vancouver, Canada: Mo-
lecular and genetic analysis of the
dpy-14 unc-13 region of chromo-
some I.
Waterston, R.H., Bolten, S., Dept. of
Genetics, Washington University,
St. Louis, Missouri: Evidence that
sup-7 of C. elegans is a tRNAT'P
gene.
Stinchcomb, D., Shaw, J., Wood, W,
Hirsh, D., Dept. of Molecular, Cel-
lular, and Developmental Biology,
University of Colorado, Boulder:
DNA transformation of C. elegans.
SESSION 8 Genes and Molecular Biology
Chairperson: R.K. Herman, University of Minnesota, Minneapolis, Minnesota
Sanford, T.R., Golomb, M., Riddle,
D.L., Division of Biological Sci-
ences, University of Missouri, Co-
lumbia: RNA polymerase II from
wild-type and amanitin-resistant
strains of C. elegans.
Hedgecock, E., Salvato, M., Thom-
son, J.N., MRC Laboratory of Mo-
lecular Biology, Cambridge, Eng-
land: Nucleolar mutants.
Snutch, T.P., Bail lie, D.L., Dept. of
Biological Sciences, Simon Fraser
University, Burnaby, Canada: Cox, J., Kramer, J., Hirsh, D., Dept.
Structure and molecular organiza- of Molecular, Cellular, and Devel-
tion of genes coding for the major opmental Biology, University of
heat-shock peptide in C. elegans. Colorado, Boulder: Expression of
Russnak, R.H., Jones, D., Candido,
E.P.M., Dept. of Biochemistry,
University of British Columbia,
Vancouver, Canada: The 16kD heat-
shock protein gene family of C.
elegans.
Kramer, J., Cox, J., Hirsh, D., Dept.
of Molecular, Cellular, and Devel-
opmental Biology, University of
Colorado, Boulder: Organization
and sequence analysis of the colla-
gen multigene family of C. elegans.
SESSION 9 Poster Session: Proteins, DNA, and Polymorphisms
Burke, D.J., Ward, S., Kirschner, B.,
Dept. of Embryology, Carnegie In-
stitution of Washington, Baltimore,
Maryland: Identification of sperm-
specific proteins and isolation of
their genes.
Otsuka, A., Wang, D., Dept. of Ge-
netics, University of California,
Berkeley: A general method for the
identification of proteins affected
by null mutations.
Kolston, D.L., Russell, R.L., Dept.
of Biological Sciences, University
of Pittsburgh, Pennsylvania: Class
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collagen genes during C. elegans
development.
Politz, Kusch, M., Politz, S.M.,
Edgar, R.S., University of Califor-
nia, Santa Cruz: The search for cu-
ticle collagen primary gene
products.
Wild, M., Landel, C., Krause, M.,
Begley, M., Hirsh, D., Dept. of
Molecular, Cellular, and Develop-
mental Biology, University of Col-
orado, Boulder: C. elegans actin
genes.
Karn, J., MRC Laboratory of Molec-
ular Biology, Cambridge, England:
More myosins (not more of my
sins.)
C -A new class of acetylcholines-
terase in C. elegans.
Carton, M.,Culotti, J., Northwestern
University, Evanston, Illinois:
Electrophoretic separation of ace-
tylcholinesterase forms from C.
elegans.
Jen-Jacobson, L., Jacobson, L.A.,
Shah, M.V., Dept. of Biological
Sciences, University of Pittsburgh,
Pennsylvania: Biochemical charac-
terization of Cathepsin D.
Jacobson, L.A., Jen-Jacobson, L. Bo-
lanowski, M., Shah, M.V., Dept. of
Biological Sciences, University of
Pittsburgh, Pennsylvania: Mutants
deficient in lysosomal Cathepsin D
activity.
Jameel, S., McFadden, B.A. Bio-
chemistry/Biophysics Program,
Washington State University, Pull-
man: Isocitrate lyase from C.
elegans.
Starck, J., Dept. de Biologie Gener-
ale et Appliquee, Universite Claude
Bernard Lyon, France: Synthesis of
the four specific proteins in C. ele-
gans mutant strains, affected in
their gametogenesis or in their
embryogenesis.
Albertson, D.G., MRC Laboratory of
Molecular Biology, Cambridge,
England: Localization of genes on
C. elegans chromosomes.
Benian, G.M., Waterston, R.H.,
Dept. of Genetics, Washington Uni-
versity School of Medicine, St.
Louis, Missouri: Cloning of myosin
heavy chain genes and adjacent
regions.
Eide, D., Anderson, P., Dept. of Ge-
netics, University of Wisconsin,
Madison: A novel insertion muta-
tion in unc-54.
Prasad, S., Bail lie, D.L., Dept. of Bi-
ological Sciences, Simon Fraser
University, Burnaby, Canada: Clon-
ing and characterization of the gene
coding for the muscle protein tro-
pomyosin in C. elegans.
Nelson, D.W., Honda, B.M., Dept.of
Biological Sciences, Simon Fraser
University, Burnaby, Canada: 5S
RNA genesin C. elegans.
Stinchcomb, D., Mello, C., Roberts,
J., Hirsh, D., Dept. of Molecular,
Cellular, and Developmental Biol-
ogy, University of Colorado, Boul-
der: C. elegans DNA that directs
segregation in S. cerevisiae.
Bail lie, D.L., Beckenbach, K.A.,
Dept. of Biological Sciences, Si-
mon Fraser University, Burnaby,
Canada: Molecular analysis of the
unc-22 region of chromosome IV.
Felsenstein, K.M., Emmons, S.W.,
Dept. of Molecular Biology, Albert
Einstein College of Medicine,
Bronx, New York: Short, inter-
spersed repetitive sequences in C.
elegans.
Emmons, S.W., Felsenstein, K.,
Katzenberg, D., Rubinfeld, B., Yes-
ner, L., Dept. of Molecular Biol-
ogy, Albert Einstein College of
Medicine, Bronx, New York: Iden-
tification of distinct C. elegans
strains on the basis of restriction
fragment polymorphisms.
Carr, S., Cox, J., Hirsh, D., Dept. of
Molecular, Cellular, and Develop-
mental Biology, University of Col-
orado, Boulder: Polymorphism
mapping.
Jefferson, R., Hirsh, D., Dept. of
Molecular, Cellular, and Develop-
mental Biology, University of Col-
orado, Boulder: Plasmid expres-
sion vectors for the in vivo analysis
of regulatory sequences.
Himmelhoch, S.,' Zuckerman, B.,'
'Dept. of Biomembranes, Weiz-
mann Institute, Rehovot, Israel;
'Dept. of Plant Pathology, Univer-
sity of Massachusetts, Amherst:
Characterization from ultrathin
cryosections of negatively charged
groups on the cuticle and intestine
of C. elegans.
Emmons, S.W., Yesner, L., Dept. of
Molecular Biology, Albert Einstein
College of Medicine, Bronx, New
York: Optimal bacterial strains for
cultivation of C. elegans.
SESSION 10 Embryogenesis
Chairperson: S. Ward, Carnegie Institution of Washington, Baltimore, Maryland
Priess, J., Hirsch, D., Dept. of Mo-
lecular, Cellular, and Develop-
mental Biology, University of Col-
orado, Boulder: Embryonic cuticle
development.
Ellis, H.M., Tsung, N., Horvitz, R.,
Dept. of Biology, Massachusetts
Institute of Technology, Cam-
bridge: Activity of the gene ced-3 is
necessary for the initiation of pro-
grammed cell death.
Herman, R.K., Dept. of Genetics and
Cell Biology, University of Minne-
sota, St. Paul: Genetic mosaics of
C. elegans.
Schierenberg, E., Wood, W.B., Dept.
of Molecular, Cellular, and Devel-
opmental Biology, University of
Colorado, Boulder: Experimental
embryology.
Sulston, LE., Thomson, IN., MRC
Laboratory of Molecular Biology,
Cambridge, England: Ontogeny of
the anterior sensilla.
Strome, S., Wood, WD., Dept. of
Molecular, Cellular, and Develop-
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SESSION 1
Chairperson: J. Adler, University of Wisconsin, Madison, Wisconsin
Chemotaxis
Krikos, A., Mutah, N., Boyd, A., Si-
mon, M., Dept. of Biology, Cali-
fornia Institute of Technology, Pas-
mental Biology, University of Col-
orado, Boulder: Segregation of
germline-specific antigens during
embryogenesis in C. elegans.
Gossett, L.A., Hecht, R.M., Dept. of
Biochemical and Biophysical Sci-
ences, University of Houston Cen-
tral Campus, Texas: zyg-4 and its
allele emb-7 exhibit muscleless
phenotypes during embryogenesis
in C. elegans.
adena: Sensory transducers of E. Callahan, A.M., Sherris, D., Slocum,
coli are composed of discrete struc- M.K., Parkinson, J.S., Dept. of Bi-
tural and functional domains. ology, University of Utah, Salt Lake
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City: Genetics of a chemotactic
transducer protein in E. coli.
Stock J., Dept. of Biochemical Sci-
ences, Princeton University, New
Jersey: The role of receptor methy-
lation in chemotaxis as revealed by
the behavior of S. typhimurium mu-
tants lacking the methyltransferase
(cheR) or methylesterase (cheB)
enzymes.
Flagellar Structure
Huang, B., Dept. of Cell Biology,
Baylor College of Medicine, Hous-
ton, Texas: Genetic dissection of
eukaryotic flagella.
Dutcher, S.K., Ramanis, Z., Luck,
D.J.L., Rockefeller University, New
York, New York: Genetic behavior
of a new linkage group in
Chlamydomonas.
SESSION 2
Chairperson: N. Agabian, University of Washington Medical School, Seattle, Washington
Cell Division in E. coli
Donachie, W, Dept. of Molecular Bi-
ology, University of Edinburgh,
Scotland: Regulation of expression
in a cluster of cell-division genes in
E. coli.
Hirota,Y., Maruyama, I.N., Naka-
mura, M., Yamamoto, A., Nishi-
mura, Y., National Institutes of Ge-
netics, Mishima, Japan: Entire
nucleotide sequence of E. coli
structure gene coding for penicil-
lin-binding protein 3 (pbp-3).
Regulation of Polarity and Morpho-
genesis during Cell Division in
Caulobacter
Ely, B.,' Schoenlein, P.V.,' Winkler,
M.E.,' 'Dept. of Biology, Univer-
SESSION 3 Poster Session
Bellofatto, V., Amemiya, K. Shapiro,
L., Dept. of Molecular Biology, Al-
bert Einstein College of Medicine,
Bronx, New York: An RNA proc-
essing enzyme from Caulobacter
crescentus.
Curiel-Quesada, E., Fliss, E.R., Set-
low, P., Dept. of Biochemistry, Uni-
versity of Connecticut Health Cen-
ter, Farmington: Cloning and
analysis of the gene for the C pro-
tein- A spore-specific protein de-
graded during Bacillus megaterium
spore germination.
DeWitt, J.P., Abbott Laboratories,
North Chicago, Illinois: Genetic
instability involving regulation of
secondary metabolism in Strepto-
myces erythreus.
Donnelly, C.E., Sonenshein, A.L.,
Dept. of Molecular Biology and
Microbiology, Tufts University,
Boston, Massachusetts: Mutations
sity of South Carolina, Columbia;
'Dept. of Molecular Biology,
Northwestern University Medical
School, Chicago, Illinois: Gene or-
ganization of Caulobacter cres-
centus.
Shapiro, L., Dept. of Molecular Bi-
ology, Albert Einstein College of
Medicine, Bronx, New York: Mem-
brane biogenesis and the regulation
of differentiation in Caulobacter.
Agabian, N., Gill, P.R., Milhausen,
M., Dept. of Biochemistry, Univer-
sity of Washington, Seattle: The
flagellin gene family of Caulobac-
ter crescentus.
Ohta, N., Chen, L.-S., Newton, A.,
Dept. of Biology, Princeton Uni-
versity, New Jersey: Regulation of
in the promoter region of a Bacillus
subtilis gene.
Liu, C.-J.,' Pogell, B.M.,' Meade,
H.,' 'Dept. of Medicinal Chemis-
try/Pharmacognosy, School of
Pharmacy, University of Maryland,
Baltimore; 'Biogen, Inc., Cam-
bridge, Massachusetts: Complete
deletion of the argG gene occurs in
aerial mycelium-negative isolates of
streptomycetes.
Manis, J.J., Olsen, M.K., Fermenta-
tion Research and Development,
Upjohn Company, Kalamazoo,
Michigan: Construction of an E.
coli-Streptomcyes promoter-probe
shuttle vector.
Nelson, D.R.,' Zusman, D.R.,' 'Dept.
of Microbiology, University of
Rhode Island, Kingston; 'Dept. of
Microbiology and Immunology,
University of California, Berkeley:
Transport and localization of pro-
flagellum biosynthesis and assem-
bly in the Caulobacter crescentus
cell cycle.
Cell Division in Physarum
Burland, T.G.,' Dove, W ,' Gull,
Schedl, T.,' 'McArdle Laboratory,
University of Wisconsin, Madison;
'Biological Laboratories, Univer-
sity of Kent, Canterbury, England:
Expression of the tubulin gene fam-
ilies in the cycles of Physarum
polycephalum.
tein S, a spore coat protein, during
fruiting body formation in Myxo-
coccus xanthus
Piret, J.M., Cheer, K.F., John Innes
Institute, Norwich, England: Clon-
ing of genes involved in differentia-
tion of Streptomyces coelicolor
A3(2).
Ruby, E.G., Dept. of Biological Sci-
ences, University of Southern Cali-
fornia, Los Angeles: Differentia-
tion of intraperiplasmically growing
Bdellovibrio bacteriovorous- The
control of initiation of DNA
replication.
Yee, T., Correia, F., Inouye, M.,
Dept. of Biochemistry, State Uni-
versity of New York, Stony Brook:
Two-dimensional Si nuclease het-
eroduplex mapping-Detection of
rearrangements in bacterial
genomes.
SESSION 4 Spore Formation in Bacillus
Chairperson: R. Losick, Harvard University, Cambridge, Massachusetts
Ferrari, E, Hoch, J., Research Insti-
tute of Scripps Clinic, La Jolla,
California: Control of sporulation
by spoO genes.
Smith, I., Dubnau, E., Ramakrishna,
N., Weir, J., Dept. of Microbiology,
Public Health Research Institute of
the City of New York, Inc., New
York: The Bacillus spoOH gene.
Zuber, P., Johnson, W.C., Losick, R.,
Dept. of Cellular and Develop-
mental Biology, Harvard Univer-
170
sity, Cambridge, Massachusetts:
Developmental regulation of a
sporulation promoter in Bacillus
subtilis.
Sonenshein, A.L., Rosenkrantz,
M.S., Donnelly, C.E., Fisher, S.,
Emond, R., Dept. of Molecular Bi-
ology and Microbiology, Tufts Uni-
versity, Boston, Massachusetts:
Regulation in vivo of Bacillus sub-
tilis genes active during growth or
sporulation.
SESSION 5
Chairperson: D. Hopwood, John
RNA Polymerase Heterogeneity in
Bacillus
Pero, J., Costanzo, M., Hannett, N.,
Dept. of Cellular and Develop-
mental Biology, Harvard Univer-
sity, Cambridge, Massachusetts:
Sigma factors, promoters, and the
temporal control of gene
expression.
Gilman, M.Z., Glenn J., Chamberlin,
M.J., Dept. of Biochemistry, Uni-
versity of California, Berkeley: In
vivo expression of Bacillus subtilis
transcripts controlled by a2' RNA
polymerase.
Truitt, C.L., Ray, G.L., Trempy, J.E.,
Haldenwang, W.G., Dept. of Mi-
crobiology, University of Texas
Health Science Center, San Anto-
Set low, P., Dept. of Biochemistry,
University of Connecticut Health
Center, Farmington: Protein degra-
dation during bacterial spore
germination.
Youngman, P.J., Perkins, J.B., Dept.
Innes Institute, Norwich, England
nio: Isolation of Bacillus subtilis
mutants with altered expression of
a gene transcribed in vitro by a "-
containing RNA polymerase.
Price, C.W., Gitt, M.A., Wong, S.-L.,
Doi, R.H., Dept. of Biochemistry
and Biophysics, University of Cali-
fornia, Davis: Cloning and genetic
mapping of the RNA polymerase a"
gene of Bacillus subtilis.
Differentiation in Streptomyces
Chater, K.F., Bruton, C.J., Ikeda, H.,
King, A.A., Piret, J.M., Rodicio,
M.R., John Innes Institute, Nor-
wich, England: Genetics in Strep-
tomyces differentiation.
Baltz, R.H., Seno, E.T., Stonesifer,
J., Matsushima, P., Lilly Research
of Cellular and Developmental Bi-
ology, Harvard University, Cam-
bridge, Massachusetts: Develop-
mental genetics in Bacillus using the
Streptococcus transposon Tn9/7.
Laboratories, Indianapolis, Indi-
ana: Genetic control of tylosin bio-
synthesis in Streptomyces fradiae -
A model to study regulation of an-
tibiotic gene expression and DNA
amplification.
Westpheling, J., Dept. of Cellular and
Developmental Biology, Harvard
University, Cambridge, Massachu-
setts: RNA polymerase heteroge-
neity in Streptomyces coelicolor.
Solenberg, P.J., Mooney, P.Q.,
Schaus, N.A., Lilly Research Lab-
oratories, Indianapolis, Indiana:
Development of a model system for
the study of the regulation of gene
expression in Streptomyces.
SESSION 6 Sporulation and Bud Formation in Yeast and Other Fungi
Chairperson: A. Klar, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Pringle, J.R., Coleman, K., Adams,
A., Lillie, S., Oeller, P., Robinson,
J., Kelley, M., Division of Biologi-
cal Sciences, University of Michi-
gan, Ann Arbor: Cellular morpho-
genesis in the Saccharomyces cell
cycle.
Henry, S., Letts, V.A., Klig, L.S.,
Loewy, B.S., Dept. of Genetics,
Albert Einstein College of Medi-
cine, Bronx, New York: The role of
phospholipid synthesis and regula-
tion in membrane biogenesis in
yeast.
Nurse, P., Dept. of Biological Sci-
ences, University of Sussex Falmar,
Brighton, England: Cell cycle con-
trols in fission yeast.
Magee, RT.,' Clancy, M.J.,2 Primer-
ano, D.,' 'Dept. of Microbiology,
Michigan State University, East
Lansing; 'Dept. of Microbiology,
Notre Dame University, South
Bend, Indiana: Transcriptional con-
trol and mutant phenotype of genes
involved in sporulation in Saccha-
romyces cerevisiae.
Ninfa, E.G., Kaback, D.B., Dept. of
Microbiology, UMDNJ, New Jersey
Medical School, Newark: Isola-
tion of DNA sequences complemen-
tary to sporulation-specific tran-
scripts.
Timberlake, W.E., Gwynne, D.I.,
Miller, B.L., Miller, K., Zimmer-
mann, C.R., Dept. of Plant Pathol-
ogy, University of California,
Davis: Organization and develop-
mental regulation of the spoC1 gene
cluster of Aspergillus nidulans.
Champe, S.P., Yager, L.N., Butnick,
N.J., Kurtz, M.B., Waksman Insti-
tute of Microbiology, Rutgers Uni-
versity, New Brunswick, New Jer-
sey: Sporulation-defective mutants
of Aspergillus nidulans.
SESSION 7 Cell Communication and Morphogenesis in Dictyostelium
Chairperson: L. Shapiro, Albert Einstein College of Medicine, Bronx, New York
Lodish, H.F., Barklis, E., Chisholm,
R., Pontius, B., Dept. of Biology,
Massachusetts Institute of Technol-
ogy, Cambridge: Regulation of
Dictyostelium discoideum mRNAs
specific for prespore or prestalk
cells.
Mehdy, M.C., Mann, S.K.O., Firtel,
R.A., Dept. of Biology, University
of California, San Diego, La Jolla:
Induction and modulation of cell
type-specific gene expression in
Dictyostelium.
Gerisch, G., Max-Planck-Institut fiir
Biochemie Martinsried, Federal
Republic of Germany: Control of
early cell differentiation in Dictyo-
stelium discoideum.
171
MacWilliams, H., Dept. of Zoology,
University of Munich, Federal Re-
public of Germany: Morphogenesis
in cellular slime mold slugs.
David, C.N.,' Sternfeld, J.,'
'Zoologisches Institut, Munich,
Federal Republic of Germany;
'Dept. of Biology, University of
Southwestern Louisiana, Lafayette:
Formation of the prestalk prespore
pattern in Dictyostelium occurs by
cell sorting.
Kay, R., Brookman, J., Kopachik, W,
Pogge, R., Dhokia, B., Jermyn, K.,
Peacey, M., Gross, J., Imperial Can-
cer Research Fund, London, Eng-
land: The morphogens and intra-
cellular responses controlling the
choice between stalk- and spore-cell
differentiation in Dictyostelium.
Williams, J.G., Garreau, H., Imperial
Cancer Research Fund, Mill Hill
Laboratories, London, England:
Nuclear DNA-binding proteins of
Dictyostelium discoideum.
SESSION 8
Chairperson: D. Kaiser, Stanford University, Stanford, California
Cell Communication and Morphogen- ohs: Cell-surface interactions dur-
esis in Myxobacteria ing development in Myxococcus
Shimkets, L.,' Gill, R.,' Kaiser, D.,3 xanthus.
'Dept. of Microbiology, University Inouye, S., Teintze, M., Inouye, M.,
of Georgia, Athens; 'Dept. of Mi- Dept.of Biochemistry, State Uni-
crobiology, University of Colorado versity of New York, Stony Brook:
Health Center, Denver; 3Dept. of Development-specific calmodulin-
Biochemistry, Stanford University, like protein of Myxococcus xanthus.
California: Cell interactions in
Myxococcus development. Bacteroid Formatin by Rhizobium and
Nelson, D.R.,' Downard, J.S.,3 Zus- Heterocyst Formation by Anabaena
man, D.R.,' 'Dept. of Microbiol- Ausubel, F., Buikema, W, Sundare-
ogy, University of Rhode Island, san, V., Szeto, W, Zimmerman, L.,
Kingston; 'Dept. of Microbiology Dept. of Molecular Biology, Mas-
and Immunology, University of Cal- sachusetts General Hospital, Bos-
ifornia, Berkeley: Long-lived mes- ton: Identification and characteri-
senger RNA during fruiting body zation of Rhizobium meliloti
formation in Myxococcus xanthus. symbiotic genes.
Dworkin, M., Dept. of Microbiology, Piihler, A., Klipp, W., Priefer, U., Si-
University of Minnesota, Minneap- mon, R., Weber, G., Lehrstuhl fiir
Fontana, D.R., Devreotes, RN., Dept.
of Physiological Chemistry, Johns
Hopkins University School of Med-
icine, Baltimore, Maryland: Inhi-
bition of the cAMP signal relay re-
sponse in Dictyostelium discoideum
amoebae by agents which cross-link
surface components.
Genetik, Fakultat fur Biologie,
Universitat Bielefeld, Federal Re-
public of Germany: Analysis of
symbiotic genes of Rhizobium
meliloti.
Haselkorn, R., Curtis, S.E., Ri-
chaud, C., Robinson, Si., Turner,
N., Dept. of Biophysics, University
of Chicago, Illinois: Organization
and transcription of Anabaena
genes regulated during heterocyst
differentiation.
Pattern Formation in Pseudomonas
Shapiro, J.A., Dept. of Microbiology,
University of Chicago, Illinois:
Pattern formation in Pseudomonas
putida colonies revealed by inser-
tions of a Mud lac phage.
SESSION 9 Mating Interactions
Chairperson: I. Herskowitz, University of California, San Francisco, California
Hopwood, D.A., Bibb, M.J., Kieser,
T., Lydiate, D.J., Wright, H.M.,
John Innes Institute, Norwich, Eng-
land: Plasmid-mediated conjuga-
tion in Streptomyces.
Clewell, D., Ike, Y., White, B., Craig,
R., Yagi, Y., Dept. of Oral Biology,
University of Michigan, Ann Arbor:
Sex pheromones in Streptococcus
faecalis.
Silverman, P., Sambucetti, L., Al-
bins, R., Cuozzo, M., Dept. of Mo-
lecular Biology, Albert Einstein
College of Medicine, Bronx, New
York: Cellular contributions to
RNA PROCESSING
May 18-May 22
plasmid-dependent conjugal donor
activity of E. coli K-12.
VanWinkle-Swift, K., Aubert, B.,
Burrascano, C., Dept. of Biology,
San Diego State University, Cali-
fornia: Genetic anlaysis of sexual
reproduction in the homothallic alga
Chlamydomonas monoica.
Julius, D. ',3 Brake, Emr, 5.,3
Flessel, M.,' Thorner, J.,1 'Dept. of
Microbiology and Immunology;
'Dept. of Biochemistry, University
of California, Berkeley; 3Chiron
Corporation, Emeryville, Califor-
nia: Yeast peptide pheromones -
SESSION 1 Nuclear Structure and Function
Chairperson: G. Blobel, Rockefeller University, New York, New York
Berrios, M.,' Filson, A.,' Blobel, G.,'
Fisher, R,3 'Laboratory of Cell Bi-
ology, Rockefeller University, New
York; 'Dept. of Pharmacological
Biosynthesis and cell-type-specific
gene expression.
Herskowitz, I., Wilson, K., Jenson,
R., Fields, S., Dept. of Biochemis-
try and Biophysics, University of
California, San Francisco: Deter-
mination of yeast cell type by the
mating-type locus.
Beach, D., Klar, A., Cold Spring
Harbor Laboratory, New York: De-
velopmental switches of the mat-
ing-type locus in Schizosaccharo-
myces pombe.
Sciences, State University of New cifically identified by direct UV
York, Stony Brook: An ATPase/ photoaffinity labeling.
dATPase of the nuclear matrix- Risau, W, Symmons, F, Saumweber,
pore, complex-lamina fraction spe- H., Frasch, M., Bonhoeffer, F, Ab-
172
teilung fur Physikalische Biologie,
Max-Planck-Institut ftir Virusfor-
schung, Tubingen, Federal Repub-
lic of Germany: Nonpackaging and
packaging proteins of Drosophila
hnRNP.
Trendelenberg, M.F.,' Oudet, P.,'
Franke, WW,' Gallwitz, D.,'
'Institute of Cell and Tumor Biol-
ogy and Experimental Pathology,
German Cancer Research Center,
Heidelberg, Federal Republic of
Germany; 'CNRS, Strasbourg,
France; 'University of Marburg,
Federal Republic of Germany:
Structural organization of defined
pre -mRNP transcripts and patterns
of posttranscriptional RNP modi-
fications.
Leser, G.E. Monsma, S.A., Martin,
T.E., Dept. of Biology, University
of Chicago, Illinois: Immunologi-
cal studies of nuclear hnRNP and
snRNP complexes.
Scheer, U.,' Rose, K.M.,' 'Institute of
Cell and Tumor Biology, German
Cancer Research Center, Heidel-
berg, Federal Republic of Ger-
many; 'Milton S. Hershey Medical
Center, Pennsylvania State Univer-
sity, Hershey: Localization of tran-
scribed rRNA genes in interphase
cells and detection of RNA poly-
merase I bound to mitotic chromo-
somes by light and electron micro-
scope immunocytochemistry.
Bringmann, P., Rinke, J., Reuter, R.
Appel, B., Liihrmann, R., Max-
Planck-Institut fiir Molekulare Ge-
netik, Berlin, Federal Republic of
Germany: Structure-function rela-
tionships of U-snRNPs as studied
SESSION 2 RNPs and Processing
Chairperson: T. Martin, University of Chicago, Chicago, Illinois
LeStourgeon, W.M., Arenstorf, H.P.,
Lothstein, L., Dept. of Molecular
Biology, Vanderbilt University,
Nashville, Tennessee: Observations
on the arrangement of protein and
RNA in 40S hnRNP particles.
Wilk, H.-E., Schafer, K.P. Lehrstuhl
Biochemie, Ruhr-Universitat Bo-
chum, of Ger-
many: The in vitro reconstitution of
hnRNP-like complexes.
Thomas, J.0., Glowacka, S.K., Szer,
W, Dept. of Biochemistry, New
York University School of Medi-
cine, New York: Structure of an
hnRNP protein-poly nucleotide
complex.
Kloetzel, P.M., Bautz, E.K.F., Dept.
of Molecular Genetics, University
of Heidelberg, Federal Republic of
Germany: Organization of hnRNP
SESSION 3 Poster Session
Aloni, Y., Abulafia, R., Hay, N., Ben-
Ze'ev, A., Dept. of Genetics, Weiz-
mann Institute of Science, Rehovot,
Israel: The control of late SV40
transcription by the attenuation
mechanism, and transcriptionally
active ternary complexes are asso-
ciated with the nuclear matrix.
Aloni, Y., Hay, N., Skolnik-David,
H., Ben-Asher, E., Pruzan, R.,
Dept. of Genetics, Weizmann Insti-
tute of Science, Rehovot, Israel:
Attentuation in the control of viral
gene expression.
Alonso, A.,' Jorcano, J.L., Beck,E.,'
Spiess, E.,' Kubli, E.,' 'German
complex in heat-shocked Drosoph-
ila cells.
Economidis, I.V, Pederson, T., Cell
Biology Group, Worcester Founda-
tion for Experimental Biology,
Shrewsbury, Massachusetts: As-
sembly of a pre-mRNP in vitro.
Wieben, E., Madore, S., Pederson, T.,
Cell Biology Group, Worcester
Foundation for Experimental Biol-
ogy, Shrewsbury, Massachusetts:
Maturation of Ul and U2 RNAs.
Dahlberg, IE.,' Lund, E.,' Mitchen,
J.L.,' Skuzeski, J.M.,' Burgess,
R.R.,' Murphy, LT.,' Steinberg, T.,'
'Dept. of Physiological Chemistry,
'Dept. of Oncology, University of
Wisconsin, Madison: Synthesis and
process of wild-type and mutant
human Ul RNA transcripts.
Cancer Research Center, Heidel-
berg, Federal Republic of Ger-
many; 'Institute of Microbiology,
University of Heidelberg, Federal
Republic of Germany; 'Institute of
Zoology, University of Zurich,
Switzerland: Cloning and character-
ization of U2 and Ul snRNA genes
from D. melanogaster.
Beccari, E.,' Amaldi, F.,' Annesi, E,'
Bozzoni, I.,' Fragapane, P.,' Mileo,
A.M.,' Pierandrei-Amaldi, P.,2
'Centro Acidi Nucleici; 'Institute di
Biologia Cellulare, CNR, Rome, It-
aly: X. laevis ribosomal protein
genes-Processing of transcripts
173
with snRNA cap-specific anti-
bodies.
Mattaj, I.W, Btirglin, T., De Rober-
tis, E.M., Biocenter, University of
Basel, Switzerland: 7S and 42S
RNP particles are excluded from
the nucleoplasm of X. laevis
oocytes.
Forbes, D., Kirschner, M., Dept. of
Biochemistry and Biophysics, Uni-
versity of California, San Fran-
cisco: New nuclear structures con-
taining snRNP antigens in the
developing Xenopus embryo.
Atkinson, N.S., Nolan, S.L., Dunst,
R.W., Hopper, A.K., Dept. of Bio-
logical Chemistry, Milton S. Her-
shey Medical Center, Pennsylvania
State University, Hershey: Charac-
terization of a yeast gene affecting
RNA processing.
Branlant, C.,' Krol, A.,' Ebel, J.P.,'
Haendler,B.,' Lazar, E.,2 Jacob,
M.,' 'University of Strasbourg;
'CNRS, Strasbourg, France: A study
of snRNAs within hnRNPs using
DMS as a probe.
Sri-widada, J., Brunel, C., Liautard,
J.P. Jeanteur, P., Laboratoire de
Bochimie, Laboratoire de Biologie
Molecular, Universite des Sciences
et Techniques du Languedoc, Mont-
pellier, France: Interaction of sn-
RNAs with rapidly sedimenting
subnuciear structures (hnRNP).
Calvet, J.P., Myers, J.A., Dept. of
Biochemistry, University of Kansas
Medical Center, Kansas City: In
vivo secondary structure and inter-
molecular base-pairing interactions
involving the snRNAs analyzed by
psoralen cross-linking.
from genomic clones injected in X.
laevis oocytes.
Benyajati, C.,Dray, J.F., Frederick
Cancer Research Facility, Freder-
ick, Maryland: Expression of the
cloned adh gene in transfected Dro-
sophila tissue culture cells.
Billings, RB., Hoch, S.O., Division of
Cellular Biology, Research Institute
of Scripps Clinic, La Jolla, Califor-
nia: Isolation of Ul and U2, U4, and
U5 plus U6 snRNP populations.
Brandt, C.R., Morrison, S.L., Mil-
carek, C., Dept. of Microbiology,
Columbia University, New York,
New York: Altered RNA splicing in
immunoglobulin in heavy-chain
mutants.
Dreyfuss, G., Choi, Y.D., Adam,
S.A., Dept. of Biochemistry, Mo-
lecular and Cell Biology, North-
western University, Evanston, Illi-
nois: Characterization of proteins in
direct contact with mRNA and
hnRNA in vivo.
Frayne, E., Yeung, C., Hook, A., Al-
Ubaidi, M., Bobonis, C., Ingolia,
D., Kellems, R., Dept. of Biochem-
istry, Baylor College of Medicine,
Houston, Texas: ADA gene-ampli-
fication mutants-A model system
for studying ADA mRNA metab-
olism.
Fritz, A., Zeller, R., Carrasco, A.,
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D.J.,' 'Biomed Division, Brown
University, Providence, Rhode Is-
land; 'Dept. of Biology, McGill
University, Quebec, Canada; 'Dept.
of Microbiology, University of
Massachusetts Medical School,
Worcester: Toxin precursor gene
sequence in M, DS RNA.
Bussey, H.,' Tipper, D.J.,' Bostian,
K.A.,' 'Dept. of Biology, McGill
University, Montreal, Canada;
'Dept. of Molecular Genetics and
Microbiology, University of Mas-
sachusetts Medical School,
Worcester; 'Division of Biology and
Medicine, Brown University, Prov-
idence, Rhode Island: Secretion of
yeast killer toxin-Processing of the
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Sclafani, R.A., Fangman, W.L., Dept.
of Genetics,University of Washing-
ton, Seattle: Production of con-
served duplexes during killer DS
RNA replication in S. cerevisiae.
Bruenn, J., Field, L., Holmes, G.,
Reilly, J.D., Chang, T.H., Division
of Cell and Molecular Biol-
ogy, State University of New York,
Buffalo: Heterogeneity of yeast
viral DS RNAs and mapping of
viral genes.
Thiele, DJ., Hannig, E.M., Leibow-
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San Francisco: Chromosome walk-
ing toward RME.
Li, A.W., Johnston, G.C., Singer,
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Einstein College of Medicine,
Bronx, New York: Transcription of
an individual rDNA repeat unit.
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Mendenhall, M.D., Fen, H., Culbert-
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201
causes lethality of omnipotent sup-
pressors.
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ther a mitochondrial nor a typical
nuclear heredity.
Secretion
Ramirez, R.M., Atkinson, K.D.,
Dept. of Biology, University of
California, Riverside: Secretion
proceeds uncoupled from plasma
membrane growth in sucrose-grown
inositol-starved yeast.
Cuoto, J.R., Huffaker, T.C., Robbins,
RW., Dept. of Biology and Center
for Cancer Research, Massachu-
setts Institute of Technology, Cam-
bridge: Cloning and expression of a
mannosyl transferase in the N-
linked protein glycosylation path-
way.
Runge, K.W., Robbins, P.W., Dept. of
Biology and Center for Cancer Re-
search, Massachusetts Institute of
Technology, Cambridge: Two yeast
mutants in asparagine-linked
glycosylation.
Call, R, Schekman, R., Dept. of Bio-
chemistry, University of Califor-
nia, Berkeley: Golgi isolation from
a yeast secretory mutant-Presence
of secreted and vacuolar enzymes.
Julius, D.J.,1,2 Blair, L.C.,' Brake,
A.J.,3 Thorner, J.,' Depts. of
'Microbiology and Immunology,
'Biochemistry, University of Cali-
fornia, Berkeley; 'Chiron Corpora-
tion, Emeryville, California: Yeast
pheromone biosynthesis - Overgly-
cosylation of prepro-a-factor in
kex2 mutants.
Brown, RA., Perlman, D., Halvor-
son, H.O., Rosenstiel Center, Bran-
deis University, Waltham, Massa-
chusetts: Investigation of the role of
the signal sequence in the secretion
of yeast invertase.
Bitter, G.A., Chen, K.K., Banks,
A.R., Lai, P.-H., Amgen, Thou-
sand Oaks, California: Secretion of
foreign peptides from S. cerevisiae
directed by a-factor gene fusions.
Singh, A.,' Lugovoy, J.M.,' Chen,
E.Y.,' Perry, J.,2 Kohr, W.J.,2 Hitze-
man, R.A.,' Depts. of 'Molecular
Biology; 'Protein Biochemistry,
Genentech, Inc., South San Fran-
cisco, California: a-Factor genes
and the synthesis and secretion of
mammalian proteins in yeast.
Burn, V.,' Buckholz, R.,2 Adams, B.,'
Bostian, K.,' 'Brown University,
Providence, Rhode Island; 'Uni-
versity of Pittsburgh, Pennsylvania;
'University of Hawaii, Honolulu:
Analysis of a putative processing
mutant of yeast a-galactosidase.
Wise, J.A., Guthrie, C., University of
California, San Francisco: Genetic
analysis of the role of 7S RNA in
protein secretion.
Heyer, W-D.,' Amstutz, H.,' Szan-
kasi, P.,' Koh li, J.,' Aebi, R.,' Gys-
ler, C.,' Munz, P.,' Gamulin, V.,'
Soli, D.,' Leupold, U.,' 'Institute of
General Microbiology, University
of Bern, Switzerland; 'Dept. of
Molecular Biophysics and Bio-
chemistry, Yale University, New
Haven, Connecticut: Intergenic
conversion in a family of serine
tRNA genes in S. pombe.
Killer Workshop
SESSION 10 Mating Type
Chairperson: A. Klar, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Siliciano, P., Tatchell, K., Dept. of
Biology, University of Pennsylva-
nia, Philadelphia: Deletion map-
ping in the MATaTMATcr2 inter-
genic region.
Brake, A.J.,' Najarian, R.C.,' Lay-
bourn, P.J.,' Thorner, J. W.,
2Merryweather, J.P.,' 'Chiron Re-
search Laboratories, Chiron Cor-
poration, Emeryville, California;
'Dept. of Microbiology and Immu-
nology, University of California,
Berkeley: Identification and char-
acterization of a structural gene for
the yeast peptide mating phero-
mone a-factor.
Ammerer, G.,' Tatchell, K.,2 Spra-
gue, G.,3 'Zymos Corp., Seattle,
Washington; 2Dept. of Biology,
University of Pennsylvania, Pitts-
burgh; 'Institute of Molecular Bi-
ology, University of Oregon, Eu-
gene: Regulation of a-specific
genes.
Hagen, D., McCaffrey, G., Sprague,
G., Institute of Molecular Biology,
University of Oregon, Eugene:
Regulation of a-specific STE3 gene
and a possible role for the STE3
product in mating.
Stet ler, G.L., Thorner, J., Dept. of
Microbiology and Immunology,
University of California, Berkeley:
Yeast pheromone action-Isolation
and characterization of genes under
transcriptional control by a-factor.
Beach, D., Klar, A., Cold Spring
Harbor Laboratory, New York:
Mating-type switching in fission
yeast.
Stern, M., Jensen, R., Herskowitz, I.,
Dept. of Biochemistry and Bio-
physics, University of California,
San Francisco: Five SWI genes are
required for HO expression.
Haber, J., Stewart, S., Weiffenbach,
B., Brandeis University, Waltham,
Massachusetts: Effect of various
mutations on homothallic switching
of yeast mating-type genes.
Schnell, R., Kimmerly, W, Rine, J.,
Dept. of Biochemistry, University
of California, Berkeley: Genetic in-
teraction between the genes con-
trolling expression of the silent
mating-type genes in S. cerevisiae.
Hicks, J., Strathern, J., Klar, A.,
Abraham, J., Ivy, J., Kelly, M., Ste-
phens, C., Cold Spring Harbor
Laboratory, New York: Mating-type
switching and control of gene
expression.
Wilson, K.L., Herskowitz, I., Dept.
of Biochemistry and Biophysics,
University of California, San Fran-
cisco: Analysis of the STE6 gene
and its expression.
SESSION 11 RNA Processing and tRNA Suppressors
Chairperson: J. Abelson, University of California, San Diego, La Jolla, California
Gallwitz, D., Langford, C.J., Klinz,
F.-J., Donath, C., Physiologisch-
Chemisches Institut I, Universitat
Marburg, Lahnberge, Federal Re-
public of Germany: Splicing of
RNA polymerase II transcripts in S.
cerevisiae requires an intron-con-
tained conserved sequence element.
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Kaufer, N.F., Warner, J.R., Albert
Einstein College of Medicine,
Bronx, New York: Effect of intron
deletions on the cyh2 gene.
Teem, J.,' Pikielny, C.,2 Rosbash, M.,'
Depts. of 'Biology, 'Biochemistry,
Brandeis University, Waltham,
Massachusetts: A conserved se-
quence within mRNA introns is re-
quired for splicing and may be a
counterpart of U1 snRNA of
metazoans.
Parker, R., Guthrie, C., Dept. of Bio-
chemistry and Biophysics, Univer-
sity of California, San Francisco:
Genetic analysis of mRNA splicing
in S. cerevisiae.
Hopper, A.K.,' Hurt, D.J.,' Morales,
M.,2 Martin, N.C.,' 'Dept. of Bio-
logical Chemistry, M.S. Hershey
Medical Center, Pennsylvania;
'Dept. of Biochemistry, University
of Texas Health Science Center,
Dallas: Modification of both cyto-
plasmic and mitochondrial tRNAs
is affected by single nuclear
mutations.
Thompson, J.R.,' Last, R.,2 Larkin,
J. Z.,2 Levy, A.,2 Woolford, J.L.,2
Fournier, M.J.,' 'Dept. of Biochem-
istry, University of Massachusetts,
Amherst; "Dept. of Biological Sci-
ences, Carnegie-Mellon University,
Pittsburgh, Pennsylvania: A yeast
snRNA is tightly linked to a ribo-
somal protein gene.
Tollervey, D., Wise, J.A., Dunn, E.J.,
Maloney, D., Guthrie, C., Dept. of
Biochemistry and Biophysics, Uni-
versity of California, San Fran-
cisco: Yeast snRNAs - Characteri-
zation and genetic analyses of U2
and U4 analogs.
Cummins, C.M., Culbertson, M.R.,
Laboratories of Genetics and Mo-
lecular Biology, University of Wis-
consin, Madison: Frameshift sup-
pressor mutations outside the
anticodon in proline tRNAs con-
taining an intervening sequence.
Wakem, P.,' Consaul, S.,' Wilhelm,
J.,' Sherman, F.,' Depts. of
'Radiation Biology and Biophysics,
'Microbiology, University of Roch-
ester School of Medicine, New
York: Isolation and characteriza-
tion of omnipotent suppressors.
Willis, I., Chisholm, V., Pearson, D.,
Schaack, J., Frendewey, D., Soli,
D., Dept. of Molecular Biophysics
and Biochemistry, Yale University,
New Haven, Connecticut: Second-
site mutations in the sup3-e and
sup9-e loci of S. pombe-New in-
sights on transcription and process-
ing of eukaryotic tRNAs.
SESSION 12 Mitochondria
Chairperson: F. Sherman, University of Rochester Medical Center, Rochester, New York
Haldi, M.L., Anziano, P.Q., Perl-
man, P.S., Genetics Dept. and MCD
Program, Ohio State University,
Columbus: New insights into cis-
acting domains in yeast mitochon-
drial introns.
Novitski, C.E., John, U.R, Ooi, B.-
G., McMullen, G.L., Macreadie,
I.G., Maxwell, R.J., Choo, W.M.,
Watkins, L.C., Marzuki, S., Lu-
kins, H.B., Linnane, A.W., Nag ley,
P., Dept. of Biochemistry, Monash
University, Clayton, Victoria, Aus-
tralia: Mitochondrial aapl gene
coding for mitochondrial ATPase
subunit 8 -Nature of mutants and
mitochondrial revertants.
Szekely, E., Montgomery, D., Dept.
of Biochemistry, University of
Texas Health Science Center, San
Antonio: Glucose represses tran-
scription of nuclear genes coding
for mitochondria! components.
Prezant, T., Guarente, L., Dept. of
Biology, Massachusetts Institute of
Technology, Cambridge: Regula-
tion of mitochondrial genes in S.
cerevisiae.
Bonitz, S.,' Tzagoloff, A.,2 'Cold
Spring Harbor Laboratory, New
York; 'Dept. of Biological Sci-
ences, Columbia University, New
York, New York: Yeast nuclear gene
required for the correct expression
of a mitochondrial cytochrome
oxidase gene.
Underbrink-Lyon, K., Miller, D.,
Ross, N., Martin, N., Dept. of Bio-
chemistry, Division of Molecular
Biology, University of Texas Health
Science Center, Dallas: Deletion
and restriction mapping of a mito-
chondrial gene required for yeast
mitochondrial tRNA biosynthesis.
Mueller, P., Reif, M.K., Fox, T.D.,
Section of Genetics and De-
velopment, Cornell University, Ith-
aca, New York: The pet494-1 mu-
tation blocks a posttranscriptional
step leading to accumulation of cy-
tochrome oxidase subunit III, but it
can be suppressed by a mitochon-
drial gene rearrangement.
McEwen, J.E., Ko., C., Cumsky,
M.G., Forrester, H., Kloeckener-
Gruissem, B., Poyton, R.O., Dept.
of Molecular, Cellular and Devel-
opmental Biology, University of
Colorado, Boulder: Genetics of mi-
tochondrial membrane biogenesis in
S. cerevisiae-Identification of mu-
tants altered in nuclear structural
genes for cytochrome oxidase sub-
units.
Grivell, L.A., Van Loon, A.P.G.M.,
De Haan, M., Maarse, A.C., Sec-
tion for Molecular Biology of the
Laboratory of Biochemistry, Uni-
versity of Amsterdam, The Nether-
lands: Protein import by mitochon-
dria. Characterization and ex-
pression of genes coding for im-
ported subunits of the ubiquinol-
cytochrome c reductase.
McCammon, M.,' Geller, B.,' Emr,
S.,2 Douglas, M.,' 'Dept. of Bio-
chemistry, University of Texas
Health Science Center, San Anto-
nio; 'Dept. of Biology, California
Institute of Technology, Pasadena:
Targeting and mitochondrial im-
port of ATP2-lacZ fusion protein.
Sor, F.,' Bolotin-Fukuhara, M.,2 Fu-
kuhara, H.,' 'Institut Curie, Section
de Biologie; 2Laboratoire de Biolo-
gie Generale, Faculte des Sciences,
Orsay, France: Mutations of the mi-
tochondrial gene coding for the
large rRNA -Identification and lo-
calization on the secondary struc-
ture model of the RNA.
SESSION 13 Secretion and Protein Localization
Chairperson: E.W. Jones, Carnegie-Mellon University, Pittsburgh, Pennsylvania
Emr, S.,' Schekman, R.,' Flessel,
M.C.,2 Thorner, J.,' Depts. of
'Biochemistry, 'Microbiology and
Immunology, University of Califor-
nia, Berkeley: Yeast pheromone
biosynthesis- Use of an a-factor-
invertase (MFal-SUC2) gene fu-
sion to study protein localization
and cell-type-specific gene expres-
sion.
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Jones, E.W,' Hospodar, M.,' Stevens,
T.,2 'Dept. of Biological Sciences,
Carnegie-Mellon University, Pitts-
burgh, Pennsylvania; 2Dept. of
Biochemistry, University of Califor-
nia, Berkeley: Mutations of yeast
that affect processing of vacuolar
enzyme precursors.
Stevens, T.H.,' Emr, S.D.,2 'Institute
of Molecular Biology, University of
Oregon, Eugene; 2Division of Bi-
ology, California Institute of Tech-
nology, Pasadena: Intracellular lo-
calization of carboxypeptidase Y-
LacZ fusion proteins in yeast.
Schauer, I., Emr, S., Schekman, R.,
Dept. of Biochemistry, University
of California, Berkeley: SUC2 mu-
tants defective for secretion of ac-
tive invertase.
Chang, C.N., Matteucci, M., Perry,
J., Chen, C.Y., Hitzeman, R.A.,
Genentech, Inc., South San Fran-
cisco, California: Recognition and-
cleavage of hybrid invertase signals
and mature forms of human inter-
feron (IFN-a2) in yeast.
Moreland, R.B.,' Rozdzial, M.,2
Hereford, L.,' 'Dana-Farber Can-
cer Institute and Dept. of Microbi-
ology and Genetics, Harvard Medi-
cal School, Boston, Massachusetts;
'Dept. of Biology, University of
California, Riverside: Nuclear lo-
calization of yeast histones.
Hall, M.N.,' Hereford, L.,' Herskow-
itz, I.,' 'Dept. of Biochemistry and
Biophysics, University of Califor-
nia, San Francisco; 'Sidney Farber
Cancer Institute, Boston, Massa-
chusetts: Targeting of proteins to
the nucleus.
Barnes, G., Hansen, W, Holcomb, C.,
Rine, J., Dept. of Biochemistry,
University of California, Berkeley:
Identification of genes and muta-
tions affecting an enzyme of the en-
doplasmic reticulum.
Huffaker, T., Robbins, P.W., Dept. of
Biology and Center for Cancer Re-
search, Massachusetts Institute of
Technology, Cambridge: Mutants
deficient in protein glycosylation.
Ogrydziak, D.M., Fukayam, J.W., In-
stitute of Marine Resources, Uni-
versity of California, Davis: Pre-
cursors and processing of the
alkaline extracellular protease of S.
lipolytica.
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SESSION 1 Regulatory Mechanisms I
Danchin, A.,' Guiso, N.,2 Roy, A.,'
Ullmann, A.,' 'Institut de Biologie
Physico-Chimique, Paris; ' Institut
Pasteur, Paris, France: Structure
and regulation of adenylate cyclase
in E. coli.
Aiba, H., Radioisotope Laboratory,
Faculty of Medicine, Kyoto Univer-
sity, Japan: CRP-cAMP regulates
negatively the cya gene transcrip-
tion in vitro.
Nieuwkoop, A.J., Boylan, S.A.,
Bender, R.A., Division of Biologi-
cal Sciences, University of Michi-
gan, Ann Arbor: Regulation of
hutUH operon expression by the
CAP-cAMP complex in K. aero-
genes -"Double-negative" control.
Menzel, R., Gellert, M., NIADDK,
National Institutes of Health, Be-
thesda, Maryland: Analysis of the
control of gyrB gene expression.
Braun, R., O'Day, K., Wright, A.,
Dept. of Molecular Biology and
SESSION 2
Microbiology, Tufts University
School of Medicine, Boston, Mas-
sachusetts: Regulation and autoreg-
ulation of the dnaA gene in E. coli
K12.
Maloy, S., Menzel, R., Roth, J., Dept.
of Biology, University of Utah, Salt
Lake City: Genetic regulation by a
membrane-bound protein-Cloning
and characterization of the regula-
tory sites of the put operon.
Hu, J.C., Gross, C.A., Dept. of Bac-
teriology, University of Wisconsin,
Madison: Mutations of the a sub-
unit of E. coli RNA polymerase that
affect expression of the ara operon.
Mizusawa, S., Court, D., Gottesman,
S., NCI, National Institutes of
Health, Bethesda, Maryland: Cell
division regulation- Transcription
of the sulA gene and repression by
LexA.
Nguyen, T., Postle, K., Isackson, D.,
Bertrand, K., Dept. of Microbiol-
Regulatory Mechanisms II
Magasanik, B., Hunt, T., Ueno-Ni-
shio, S., Reitzer, L., Bueno, R.,
Dept. of Biology, Massachusetts
Institute of Technology, Cam-
bridge: Transcriptional and trans-
lational regulation of the complex
glnALG operon.
Garges, S., Adhya, S., NCI, National
Institutes of Health, Bethesda,
Maryland: Regulation of expres-
sion of the rho gene of E. coli.
Batik, S., Bhattacharya, P., Das, A.,
University of Connecticut School of
Medicine, Farmington: Regulation
of rho - Alterations of the protein
and depression of the gene activity.
Shigesada, K., Matsumoto, Y., Tsu-
rushita, N., Hirano, M., Imai, M.,
Institute for Virus Research, Kyoto
University, Japan: Attenuation con-
trol of the gene for transcription
termination factor rho in E. coli.
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ogy, University of California, Ir-
vine: Structure and regulation of the
Tn10 and pSC101 tetracycline-re-
sistance determinants.
Wolf, R.E., Jr., Baker, H.V. II, Dept.
of Biological Sciences, University
of Maryland, Baltimore County,
Catonsville: A site within the 6-
phosphogluconate dehydrogenase-
coding sequence for maximal
growth-rate-dependent expression
of gnd-lac gene fusions.
Garrett, S., Taylor, R.K., Sodergren,
E.J., Silhavy, T.J., NCI, Frederick
Cancer Research Facility, Freder-
ick, Maryland: Regulation of porin
expression in E. coli K12.
French, S.,' Martin, K.,' Patterson,
T.,2 Bauerle, R.,' Miller, 0.L., Jr.,'
'Dept. of Biology, University of
Virginia, Charlottesville; 'Cold
Spring Harbor Laboratory, New
York: Electron microscopic visual-
ization of trp operon expression in
S. typhimurium.
Lupski, J., Ruiz, A.A., Godson, G.N.,
Biochemistry Dept., New York
University Medical Center, New
York: Regulation of the rpsU-dnaG-
rpoD macromolecular synthesis op-
eron of E. coli K12.
Grossman, A.D., Gross, C.A., Dept.
of Bacteriology, University of Wis-
consin, Madison: Regulation of the
a operon of E. coli.
Burton, Z.,' Watanabe, K.,' Gross,
C.,' Burgess, R.,' 'McArdle Labo-
ratory for Cancer Research; 'Dept.
of Bacteriology, University of Wis-
consin, Madison: Structure of the
operon that encodes the sigma sub-
unit of RNA polymerase from S. ty-
phimurium.
Guidi-Rontani, C.,' Danchin, A.,2
Ullmann, A.,' 'Institut Pasteur;
'Institut de Biologie Physico-Chi-
mique, Paris, France: Transcrip-
tional control of polarity in lactose
and galactose operons in E. coli by
cAMP.
Zengel, J.M., Archer, R.H., Lindahl,
L., Dept. of Biology, University of
Rochester, New York: Attenuation
control of the S10 ribosomal pro-
tein operon.
Mackie, G.A., Parsons, G.D., Dept.
of Biochemistry, University of
SESSION 3 Regulatory Mechanisms III
Sambucetti, L., Silverman, P., Albert
Einstein College of Medicine,
Bronx, New York: Regulation of
conjugative plasmid transfer gene
expression in E. coli.
Krylov, V.N., Yanenko, A.S., Gorbu-
nova, S.A., Institute for Genetics of
Microorganisms, Moscow, USSR:
RP4-promoted expression of a si-
lent genetic material and SOS ef-
fects in E. coli and P. aeruginosa.
Brooks, J.E.,' Theriault, G.,' Gin-
geras, T.R.,' 'Cold Spring Harbor
Laboratory, New York; 'Dept. of
Biochemistry, Universite Laval,
Quebec, Canada: Control of
expression of a type-II restriction-
modification system fr9rn P. aeru-
ginosa.
Bhagwat, A., Brooks, J., Starr, P.,
Gingeras, T., Cold Spring Harbor
Laboratory, New York: Cloning and
analysis of EcoRII restriction-mod-
ification genes.
Torres-Cabassa, A., Gottesman, S.,
NCI, National Institutes of Health,
Bethesda, Maryland: Ion regulation
SESSION 4 Nusness
Franklin, N.C., Biology Dept., Uni-
versity of Utah, Salt Lake City: N
antitermination proteins of X, 021,
and P22 -Initial probings by com-
parison and by mutation.
Schauer, A.T., Friedman, D.I., Dept.
of Microbiology and Immunology,
University of Michigan Medical
School, Ann Arbor: X and P22 an-
titerminator interactions with phage
sites and host factors.
Olson, E.R.,' Tomich, C.-S.C.,'
Friedman, D.I.,' 'Dept. of Micro-
biology and Immunology, Univer-
sity of Michigan, Ann Arbor;
'Molecular Biology Research, Up-
john Co., Kalamazoo, Michigan:
Evidence that a unique nucleotide
sequence, "boxA," is involved in the
action of the nusA-gene product.
of capsular polysaccharide synthe-
sis in E. coli K12.
Strauch, K., Miller, C., Dept. of Mo-
lecular Biology and Microbiology,
Case Western Reserve University,
Cleveland, Ohio: S. typhimurium
genes regulated by growth phase.
Young, F.S.,' Furano, A.V.,' Cashel,
C.M., 'Dept. of Molecular Biology,
Genentech, Inc., South San Fran-
cisco, California; 2NIADDK,
'NICHHD, National Institutes of
Health, Bethesda, Maryland: The
tufB gene is essential for the regu-
lation of growth by E. coli.
Sarmientos, P., Cashel, M., NICHHD,
National Institutes of Health, Be-
thesda, Maryland: The rrnA down-
stream P2 promoter behaves as a
maintenance promoter during
growth rate control and carbon
starvation.
Shinagawa, H., Makino, K., Ame-
mura, M., Nakata, A., Research In-
stitute for Microbial Diseases,
Osaka University, Japan: Regula-
Haber, R.,' Levin, J.,' Carver, D.,'
Friedman, D.,' Adhya, S.,' 'NCI,
National Institutes of Health, Be-
thesda, Maryland; 'University of
Michigan, Ann Arbor: Characteri-
zation of the nusA gene of E. coli.
Shoemaker, K., Wolska, K., Das, A.,
University of Connecticut School of
Medicine, Farmington: Modulation
of transcription termination by nus-
gene products.
Warren, F., Shoemaker, K., Das, A.,
University of Connecticut School of
Medicine, Farmington: Formation
of termination-resistant transcrip-
tion complex at nut locus-Evi-
dence bearing on a tentative model.
Greenblatt, J., Li, J., Dulhanty, A.,
Banting and Best Dept. of Medical
Research, University of Toronto,
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Western Ontario, London, Canada:
Structure and expression of the gene
for ribosomal protein S20.
Cerretti, D.P., Nomura, M., Institute
for Enzyme Research, University of
Wisconsin, Madison: The spc ope-
ron of E. coli -Localization of the
S8 repressor target site in the S8
translational control unit.
tion of the phosphate regulon in E.
coli.
Lau, E.T.,' Landick, R.,2 Van-
Bogelen, R.A.,' Neidhardt, F.C.,'
'Dept. of Microbiology and Immu-
nology; 'Dept. of Biological Chem-
istry, University of Michigan, Ann
Arbor: Regulatory gene for the heat-
shock response in E. coli.
Woolford, C.,' Hendrix, R.,' Tilly,
K.,2 Georgopoulos, C.,' 'Dept. of
Biological Sciences, University of
Pittsburgh, Pennsylvania; 'Dept. of
Biochemistry and Molecular Biol-
ogy, Harvard University, Cam-
bridge, Massachusetts; 'Dept. of
Cellular, Viral, and Molecular Bi-
ology, University of Utah Medical
Center, Salt Lake City: Studies on
the E. coli heat-shock genes, groEL
and groES.
Freundlich, M., Friden, P., Tsui, P.,
Dept. of Biochemistry, State Uni-
versity of New York, Stony Brook:
IHF -A global regulator in E. coli?
Canada: Interactions among the
nusA and RNA polymerase of E.
coli and the N-gene protein of bac-
teriophage X.
Lau, L.F., Roberts, J.W., Wu, R.,
Dept. of Biochemistry, Cell and
Molecular Biology, Cornell Univer-
sity, Ithaca, New York: Transcrip-
tion termination at XtR 1.
Zuber, M., Court, D., NCI, National
Institutes of Health, Bethesda,
Maryland: Deletion analysis of
nutR and tR1 sites of phage X.
Leason, K.R., Baumann, M., Fried-
man, D.I., Dept. of Microbiology
and Immunology, University of
Michigan, Ann Arbor: Analysis of
the nin region.
Kroger, M., Decker, T., Hobom, G.,
Universitat Frieburg, Institut fur
motogie, Federal Republic of Ger-
many: Control mechanism for the
expression of bacteriophage X late
control gene Q.
Grayhack, E.J., Lau, L., Hart, C.,
Goliger, J., Verner, K., Yang, X.,
Roberts, J.W., Section of Biochem-
istry, Molecular and Cell Biology,
Cornell University, Ithaca, New
York: Antitermination by purified
X Q-gene protein in vitro.
SESSION 5 Poster Session
Ad ley, C.C., Bukhari, A.I., Cold
Spring Harbor Laboratory, New
York: Methylation-dependent ex-
pression of the mom gene of bacte-
riophage Mu -The promoter is lo-
cated about 200 by downstream
from the methylation sites.
Bear, S.E.,' Court, D.L.,2 Friedman,
D.,' 'NCI, National Institutes of
Health, Bethesda, Maryland; 'Dept.
of Microbiology, University of
Michigan Medical School, Ann Ar-
bor: Characterization of a X mutant
that grows with reduced efficiency
on integration host factor (IHF)
mutants of E. coli.
Brown, A.,' Drahos, D.,' Szybalski,
W,' 'McArdle Laboratory for Can-
cer Research, University of Wis-
consin, Madison; 'Corporate Re-
search Laboratory, Monsanto Co.,
St. Louis, Missouri: Synthesis and
effect of transcription antitermina-
tion of the postulated NusA-pro-
tein-binding sequence of E. coli
phage X.
Bussman, K., Pelzer-Reith, B.,
Rasched, I., Fakultat fiir Biologie,
Universitat Konstanz, Federal Re-
public of Germany: Bacteriophage
fd- Amplifying the expression of
gene III (adsorption protein).
Chattoraj, D.K.,' Das, A.,' Cordes,
K.,' 'NCI, Frederick Cancer Re-
search Facility, Frederick, Mary-
land; 'University of Connecticut
Health Center, Farmington: Muta-
genesis and mutation transfer in-
duced by UV in plasmid-cloned
DNA.
Craig, N.L., Nash, H.A., NIMH, Na-
tional Institutes of Health, Be-
thesda, Maryland: art sites juxta-
position during phage X site-
specific recombination -Collison
versus sliding.
Craigie, R.A., Mizuuchi, K.,
NIADDK, National Institutes of
Health, Bethesda, Maryland: Clon-
ing of bacteriophage Mu A and B
proteins.
Daniels, D., Nguyen, T., Moyed, H.,
Bertrand, K., Dept. of Microbiol-
ogy, University of California, Ir-
Chinali, G., Sarmientos, R, Glaser,
G., Mozer, B.A., Cashel, M,
NICHHD, National Institutes of
Health, Bethesda, Maryland: Ribo-
somal RNA operon transcription
termination and antitermination.
Gottesman, M.E.,' Chinali, G.,2 Sar-
mientos, P.,' Mozer, B.,2 Cashel,
M.,2 'NCI; ' NICHHD, National In-
stitutes of Health, Bethesda, Mary-
vine: Mutations in the divergent
overlapping promoters that control
Tn10 tetA and tetR.
Eliason, J.L., Ptashne, M., Dept. of
Biochemistry and Molecular Biol-
ogy, Harvard University, Cam-
bridge, Massachusetts: The bases in
the phage X operators recognized by
repressor and Cro- A mutational
study.
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proteins-Possible association with
the nuclear matrix.
Hayward, WS., Goodenow, M., Si-
mon, M.C., Shih, C.-K., Wiman,
K., Memorial Sloan-Kettering Can-
cer Center, New York, New York:
SESSION 6 Chromosomal Rearrangements
Chairperson: J. Rowley, University of Chicago, Chicago, Illinois
Marcu, K.B.,' Stanton, L.W ,' Harris,
L.J.,' Yang, J.Q.,' Remmers, E.F.,'
Fahrlander, P.,' Watt, R.,2 Eck-
hardt, L.A.,' Birshtein, B.K.,'
'Biochemistry Dept., State Univer-
sity of New York, Stony Brook;
2Wistar Institute, Philadelphia,
Pennsylvania; 'Cell Biology Dept.,
Albert Einstein College of Medi-
cine, Bronx, New York: Activation
of c-myc oncogene by chromosomal
translocation in murine plasmacy-
tomas.
Leder, P.,' Battey, J.,' Lenoir, G.,2
Murphy, W,' Stewart, T.,' Taub,
R.,' 'Dept. of Genetics, Harvard
Medical School, Boston, Massa-
chusetts; 'International Agency for
Research on Cancer, Lyon, France:
Translocations involving the c-myc
oncogene in Burkitt lymphoma.
Hayday, A.,' Saito, H.,' Wood, C.,'
Tonegawa, S.,' Wiman, K.,2 Hay-
ward, W.,' 'Center for Cancer Re- Hawley, R.G.,12 Shulman, M.1,',
search and Dept. of Biology, Mas- Hozumi, N.,12 'Ontario Cancer In-
sachusetts Institute of Technology,
Cambridge; 'Memorial Sloan-
Kettering Cancer Center, New
York, New York: Structure and
expression of the human c-myc gene
from germ line and from rear-
ranged loci.
Wirschubsky, Z., Dept. of Tumor Bi-
ology, University of Stockholm,
Sweden: Specific chromosomal
translocations and the genesis of B-
cell-derived tumors in mice, rat,
and man.
Groffen, J.,' Heisterkamp, N.,' Gros-
veld, G.,2 Stephenson, J.,' 'NCI,
Frederick Cancer Research Facil-
ity, Frederick, Maryland; "Dept. of
Cell Biology and Genetics, Eras-
mus University, Rotterdam, The
Netherlands: Chromosomal trans-
locations involving human cellular
oncogenes.
Activation of host c-onc genes.
Cole, M.D., Keath, E.J., Piccoli, S.P.,
Caimi, P., Kelekar, A., Dept. of
Biochemistry, St. Louis. University
School of Medicine, Missouri: Ac-
tivation of the c-myc oncogene by
chromosomal translocation.
Croce, C., Wistar Institute, Philadel-
phia, Pennsylvania: Differential
expression of the normal and of the
translocated human c-myc onco-
genes in B cells.
Diamond, A., Devine, J., Cooper,
G.M., Ritz, J., Lane, M.-A., Dana-
Farber Cancer Institute, Boston,
Massachusetts: Transforming genes
in human B-cell lymphomas.
stitute; 'Dept. of Medical Biophys-
ics, University of Toronto;
'Wellesley Hospital, Toronto, Can-
ada: Intracisternal A-particle genes
are mammalian transposable ele-
ments.
Dickson, C., Peters, G., Smith, R.,
Brookes, S., Laboratory of Viral
Carcinogenesis, Imperial Cancer
Research Fund Laboratories, Lon-
don, England: Tumorigenesis by
MMTV may involve provirus inte-
gration in a specific region and ac-
tivation of a cellular gene.
Varmus, H.,' Westaway, D.,' Fung,
Y.K.,' van Ooyen, A.A.,' Nusse,
R.,' 'Dept. of Microbiology and
Immunology, University of Califor-
nia, San Francisco; "Dept. of Virol-
ogy, Antoni van Leeuwenhoekhuis,
Amsterdam, The Netherlands: Re-
troviral insertion mutations during
oncogenesis by retroviruses with-
out viral oncogenes.
SESSION 7 mos, fos, erb, fes, rel, abl
Chairperson: H. Hanafusa, Rockefeller University, New York, New York
Blair, D.G., Wood, T.G., Propst, F.,
Seth, A., McGeady, M.L., Oskars-
son, M.K., Woodworth, A.M.,
Vande Woude, G.F., NCI, Freder-
ick Cancer Research Facility, Fred- Danos, 0., Yaniv, M., Molecular Bi-
erick, Maryland: Properties of the ology Dept., Pasteur Institut, Paris,
mouse and human mos oncogene France: An homologous domain
loCus. between the human c-mos gene
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for Biomedical Research, Massa- 
chusetts Institute of Technology, 
Cambridge: Transformation by Ab- 
MLV.
Anderson, S.J., Sherr, C.J., Division 
of Human Tumor Cell Biology, St. 
Jude Children’s Research Hospital, 
Memphis, Tennessee: Transform- 
ing glycoproteins encoded by the 
oncogene v-fms.
Hayman, M.J.,1 Beug, H.,2 1Imperial 
Cancer Research Fund, London, 
England; 2European Molecular Bi- 
ology Laboratory, Heidelberg, Fed- 
eral Republic of Germany: Analysis 
of the avian erythroblastosis virus 
erbB gene product.
Verma, I.M ., Curran, T., Miller, 
A.D., Muller, R., Van Beveren, C., 
Molecular Biology and Virology 
Laboratory, Salk Institute, San 
Diego, California: Viral and eellu- 
lar/as gene—Structure and expres- 
sioii.
Witte, O.N., Whitlock, C., Ziegler,
S., Swanson, S., Robertson, D., 
Stafford, J., Dept, of Microbiology 
and Molecular Biology Institute, 
University of California, Los An- 
geles: Transformation and differ- 
entiation of defined stages of mu- 
rine B .lymphocytes by the abl 
oncogene.
Baltimore, D., Prywes, R., Wang, J., 
Foulkes, J.G., Whitehead Institute
product and a papillomavirus poly- 
peptide with putative role in eellu- 
lar transformation.
Cohen, J.B., Dreazen, O., Horowitz, 
M., Klar, A., Unger, T., Rechavi, 
G., Givol, D., Canaani, E., Dept, 
of Chemical Immunology, Weiz- 
mann Institute of Science, Rehovot, 
Israel: Insertion of endogenous in- 
tracisternal A-particle genomes 
into the c-mos oncogene in mouse 
plasmacytoma.
Wilhelmsen, K.C., Tarpley, W.G., 
Temin, H.M., McArdle Labora- 
tory, University o f  Wisconsin, 
Madison: Identification of some of 
the parameters governing transfor- 
mation by oncogenes in retrovi- 
ruses.
SESSIO N  8 Gene Expression
Chairperson: A. Levine, State University o f  New York, Stony Brook, New York
Garrels, J.I., Franza, R , Cold Spring 
Harbor Laboratory, New York: 
Transformation-sensitive proteins 
detected by computer-analyzed two- 
dimensional gel electrophoresis.
Bravo, R., European Molecular Biol- 
ogy Laboratory, Heidelberg, Fed- 
eral Republic of Germany: Epider- 
mal growth-factor-induced changes 
in the polypeptide synthesis of A431 
cells.
Linzer, D.I.H., Nathans, D., Dept, of 
Molecular Biology and Genetics, 
Johns Hopkins University School of 
Medicine, Baltimore, Maryland: 
Growth-related changes in specific 
mRNAs of cultured mouse cells.
Celis, J.E., Fey, S.J , Larsen, P.M., 
Celis, A., Dept, of Chemistry, Aar- 
hus University, Denmark: Expres- 
sion of cellular proteins in normal 
and tumor cells of human origin.
Rigby, P.W.J.,1 Brickell, PM .,1 Latch- 
man, D .S.,1 Murphy, D .,1 Westphal, 
K .-H .,1 Willison, K.,2 Scott, 
M. R. D.,1 1 Dept I of Biochemistry, 
Imperial College of Science and 
Technology; 2Chester Beatty Re- 
search Laboratories, Institute of 
Cancer Research, London, Eng- 
land: Cellular genes activated in 
transformed cells and their rela- 
tionship to normal development.
SESSIO N 9 Keratins
Chairperson: H. Green, Harvard Medical School, Boston, Massachusetts
proteins to type human tumor ma- 
terial.
Geiger, B.,1 Gigi, O.,1 Kreis, T.E.,1 
Schmid, >E.,2 Jorcano, J.L.,2 Mitt- 
nacht, S.,3 Franke, W.W.,21Dept, o f  
Chemical Immunology, Weizmann 
Institute of Science, Rehovot, Is- 
rael; 2Institute of Cell and TUmor 
Biology, German Cancer Research 
Center; 3Center of Molecular Biol- 
ogy, University o f  Heidelberg, Fed- 
eral Republic of Germany: Dy- 
namic rearrangements of cyto- 
keratin polypeptides in cells.
Rheinwald, J.G., Dana-Farber Cancer 
Institute, Harvard Medical School, 
Boston, Massachusetts: Expression 
of subsets of the keratin family and 
vimentin in differentiated epithelial 
cell types as a function of growth 
and malignant transformation.
Franke, W.W.,1 Schiller, D .L.,1 Hatz- 
feld, M,,1 Magin, T.,1 Jorcano, J.,2 
Mittnacht, S .,2 Achtstaetter, T.,2 
Cohlberg, J.,1 Quinlan, R .,1 
Schmid, E .,1 Moll, R. ,1 Franz, 
J.K.,1 Kartenbeck, J.,1 Venetianer, 
A .,3 1Institute of Cell and Tumor 
Biology, German Cancer Research 
Center; 2Center of Molecular Biol- 
ogy, University of Heidelberg, Fed- 
eral Republic of Germany; 3Institute 
of Genetics, Hungarian Academy of 
Sciences, Szeged, Hungary: Cyto- 
keratins-Biosynthesis, complex 
formation, and interactions with 
desmosomes.
Osborn, M .,1 Debus, E .,1 Altmanns- 
berger, M.,2 Weber, K .,1 1Max- 
Planck Institute for Biophysical 
Chemistry; 2Dept, of Pathology, 
University of Goettingen, Federal 
Republic of Germany: Use of con- 
ventional and monoclonal anti- 
bodies to intermediate filament
Weber, K., Geisler, N., Max-Planck 
Institute for Biophysical Chemistry, 
Goettingen, Federal Republic of 
Germany: Structure of nonepithe- 
| | |  and epithelial intermediate fil- 
ament proteins—A molecular basil 
of their diversity.
Fuchs, E., Dept, of Biochemistry, 
University of Chicago, Illinois: Two 
distinct classes of keratins from the 
intermediate filaments of verte- 
brate epithelial cells.
Sun, T.-T.,1■2 Eichner, R.,2 Weiss, 
R.A.,2 Nelson, W.G.,2 Cooper, D .,1 
1Dept, of Dermatology and Phar- 
macology, New York University 
Medical School, New York; 2Depts. 
of Dermatology, Opthamology, and 
Cell Biology and Anatomy, Johns 
Hopkins University Medical 
School, Baltimore, Maryland: Im- 
munological characterization and 
functional significance of mammal- 
ian epithelial keratins.
SESSIO N  10 T, t, P53 EBNA
Chairperson: D. Nathans, Johns Hopkins University, Baltimore, Maryland
Kriegler, M., Botchan, M., Dept, of California, Berkeley: Enhanced DNA tumor viruses mediated by re-
Molecular Biology, University of morphological transformation by troviral expression systems.
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Cancer Research Fund Laborato- 
ries, London; 3Marie Curie Memor- 
ial Foundation, Oxted, England: 
Molecular analysis of the gene for 
the p53 cellular tumor antigen.
.Oren, M., Zakut, R., Bienz, B., Gi- 
vol, D., Dept, of Chemical Immu- 
nology, Weizmann Institute of Sci- 
ence, Rehovot, Israel: Structure and 
expression of the genes coding for 
murine p53.
Hearing, J., Levine, A.J., Dept, of 
Microbiology, State University of 
New York, Stony Brook: Expres- 
sion and genetic mapping of an EBV 
nuclear antigen.
Schlossman, R., Dana-Farber Can- 
cer Institute and Harvard Medical 
School, Boston, Massachusetts: 
Immunofluorescent localization and 
antigenic modulation of SV40 small 
T antigen in cells producing T but 
not large T antigen.
Mercer, W.E., Avignolo, C., Baserga, 
R., Dept, of Pathology, Temple 
University Medical School, Phila- 
delphia, Pennsylvania: p53 protein 
in cell proliferation.
Harlow, E .,1 Benchimol, S.,2 Craw- 
ford, L.,2 Lamb, P.,2 Leppard, K.,2 
Jenkins, J.,3 1Cold Spring Harbor 
Laboratory, New York; 2Imperial
Pipas, J.M., Chiang, L.-C., Barnes,
D.W., Dept, of Biological Sciences, 
University of Pittsburgh, Pennsyl- 
vania: Effect of cell type, hormonal 
conditions, and viral genetic back- 
ground on transforming infections 
of SV40.
Tijan, R., Dynan, W., Rio, D., Jones, 
K., Dept, of Biochemistry, Univer- 
sity of California, Berkeley: Posi- 
tive and negative regulation of tran- 
scription by binding of Spl and T 
antigen to the SV40 early promoter 
region.
Livingston, D.M., Murphy, C.I., Ell- 
man, M.S., Bikel, I., Figge, J.,
SESSION 11 Promoters
Chairperson: B. W einstein, Columbia University, New York, New York
and characterization of specific re- 
ceptor for biologically active phor- 
bol and ingenol esters—Homoge- 
neous receptor is a calcium- 
independent protein kinase.
N.A., Yeh, E., NCI, National Insti- 
tutes of Health, Bethesda, Mary- 
land: Membrane and cytosolic re- 
ceptors for the phorbol ester tumor 
promoters.
Shoyab, M., Boaze, B., Jr., NCI, 
Frederick Cancer Research Facil- 
ity, Frederick, Maryland: Isolation
Nishizuka, Y., Dept, of Biochemistry, 
Kobe University School of Medi- 
cine; Dept, of Cell Biology, Insti- 
tute for Basic Biology, Okazaki, Ja- 
pan: Protein kinase C and mechan- 
ism of action of tumor promoters.
Blumberg, P.M., Jaken, S., Jeng, A.Y., 
Konig, B., Leach, K.L., Sharkey,
SESSION 12 ras
Chairperson: P. Duesberg, University o f  California, Berkeley, California
and mechanisms of activation of the 
human c-rasKl oncogene in lung tu- 
mors.
Guerrero, I., Mayer, A., Pellicer, A., 
Dept, of Pathology and Kaplan 
Cancer Center, New York Univer- 
sity Medical Center, New York: 
Carcinogen- and radiation-induced 
mouse lymphomas contain an acti- 
vated c-ras oncogene.
Bassin, R.H .,1 Noda, M .,1 Scolnick, 
E.M.,2 Selinger, Z.,3 1NCI, Na- 
tional Institutes of Health, Be- 
thesda, Maryland; 2Merck Sharp 
and Dohme Laboratories, West 
Point, Pennsylvania; 3Hebrew Uni- 
versity, Jerusalem, Israel: Study of 
possible relationships among one 
genes using flat revertants isolated 
from Ki-MSV-transformed cells.
Laboratories, West Point, Pennsyl- 
vania: ra5-related gene sequence 
identified and isolated from S. 
cerevisiae.
Yuasa, Y., Eva, A., Needleman, S., 
Kraus, M., Pierce, J., Rhim, J., Sri- 
vastava, S., Gazit, A., Srinivasan, 
A., Gol, T., Tronick, S., Reddy, P., 
Aaronson, S., NCI, National Insti- 
tutes of Health, Bethesda, Mary- 
land: ras-related oncogenes of hu- 
man tumors.
Marshall, C.J., Hall, D., Newbold, 
R., Malcolm, S., Weiss, R., Insti- 
tute for Cancer Research, Chester 
Beatty Laboratories, London, Eng- 
land: ras genes and cell transfor- 
mation.
Nakano, H., Yamamoto, H., Neville, 
C., Evans, D., Perucho, M., Dept, 
of Biochemistry, State University of 
New York, Stony Brook: Structure
Wigler, M., Shimizu, K., Tapa- 
rowsky, E., Fasano, O., Birnbaum,
D. , Ruley, M.A., Goldfarb, M., 
Cold Spring Harbor Laboratory, 
New York: Structures of three ras 
genes activated in human tumor cell 
lines.
McGrath, J., Capon, D., Seeburg, P, 
Goeddel, D., Levinson, A., Dept, 
of Molecular Biology, Genentech 
Inc., South San Francisco, Califor- 
nia: Structure, organization, and 
activation of the human Kirsten-ras 
gene family.
Barbacid, M., Santos, E., Sukumar,
S., Notario, V., Pulciani, S., Reddy,
E. P., NCI, National Institutes of 
Health, Bethesda, Maryland: ras- 
transforming genes in human and 
experimentally induced tumors.
DeFeo-Jones, D., Scolnick, E.M., 
Merck Sharp and Dohme Research
SESSION 13 E1A, E1B
Chairperson: J. Darnell, Rockefeller University, New York, New York
van der Eb, A.J.,1 Bernards, R .,1 
Schrier, P.I.,1 Bos, J.L.,1 Vaessen, 
R.T.M.J.,1 Jochemsen, A.G.,1 Me- 
lief, C.,2 1Dept, of Medical Bio- 
chemistry, State University, Lei- 
den; 2Dept, of Tumor Immunology, 
Amsterdam, The Netherlands: Al-
version of primary rat embryo fi- 
broblasts.
Ruley, E., Cold Spring Harbor Labo- 
ratory, New York: Separate estab- 
lishment and transforming func- 
tions are required for transform- 
ation of primary cells by viral and 
cellular genes.
Land, H., Parada, L.F., Cunningham, 
J., Murray, M., Weinberg, R.A., 
Center for Cancer Research, Mas- 
sachusetts Institute of Technology; 
Whitehead Institute for Biomedical 
Research, Cambridge, Massachu- 
setts: Two cooperating oncogenes 
are required for tumorigenic con­
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bridge; Regulation of gene expres- 
sion by the El A region of Ad5.
Treisman, R., Green, M., Maniatis,
T., Dept, of Biochemistry and Mo- 
lecular Biology, Harvard Univer- 
sity, Cambridge, Massachusetts: 
Activation of globin gene transcrip- 
tion by viral immediate early gene 
products.
Nevins, J.R., Imperiale, M.J., Feld- 
man, L.T., Kao, H.-T., Rockefeller 
University, New York, New York: 
Function of the adenoviral El A 
gene product.
sylvania: Examination of the trans- 
forming and tumor-inducing capac- 
ity of a number of Ad 12 El host- 
range mutants and cells transform- 
ed by subgenomic fragments of 
Ad 12 El region.
Logan, J., Winberg, G., Pilder, S., 
Hearing, P., Shenk, T., Dept, of 
Microbiology, State University of 
New York, Stony Brook: Func- 
tional analysis of the Ad5 E1A and 
E1B transcription units.
Jat, P.S., Kingston, R.E., Sharp, P.A., 
Dept, of Biology, Massachusetts 
Institute of Technology, Cam­
tered expression of cellular genes in 
adenovirus-transformed cells.
Chinnadurai, G., Institute for Molec- 
ular Virology, St. Louis University 
Medical Center, Missouri: Ad2 
EIB-coded 19-kD tumor antigen 
plays an essential role in cell trans- 
formation.
Gallimore, P.H.,1 Byrd, P.J.,1 Grand, 
R.,1 Whittaker, J.,1 Breiding, D.,2 
Williams, J.F.,2 1Cancer Research 
Campaign Laboratories, University 
of Birmingham, England; 2Dept, of 
Biological Sciences, Carnegie-Mel- 
Ion University, Pittsburgh, Penn­
SESSION 14 Surface Antigens
Chairperson: S. Weissman, Yale University, New Haven, Connecticut
associated antigens defined by 
monoclonal antibodies.
Koprowski, H., Dept, of Anatomy 
and Biology, Wistar Institute, Phil- 
adelphia, Pennsylvania: Human tu- 
mor antigens.
nia State University College of 
Medicine, Hershey: Localization of 
antigenic sites reactive with cyto- 
toxic lymphocytes on the proximal 
half of SV40 T antigen.
Schlom, J., Colcher, D., Hand, P.H., 
Greiner, J., Wunderlich, D., NCI, 
National Institutes of Health, Be- 
thesda, Maryland: Human breast 
carcinoma and colon-carcinoma-
Gooding, L.,1 Geib, R.,1 O’Connell, 
K.,1 Harlow, E.,2 |Dept. of Micro- 
biology and Immunology, Emory 
University School of Medicine, At- 
lanta, Georgia; 2Cold Spring Har- 
bor Laboratory, New York: Anti- 
body and cellular detection of SV40 
T antigenic determinants on the 
surfaces of transformed cells.
Tevethia, S., Lewis, A., Tevethia, M., 
Dept, of Microbiology, Pennsylva­
H UM AN T-CELL LEUK EM IA VIRUSES
September 14-September 15
Welcoming Address: M. Essex, Harvard School o f Public Health 
Introduction: R. Gallo, National Cancer Institute
SESSION 1 Animal Models and Related Viruses
Chairpersons: Y. Ito, Kyoto University, Japan, and P. Vogt, School o f Medicine, University o f Califor- 
nia, Los Angeles
Short Talks
Ito, Y., Dept, of Microbiology, Fac- 
ulty of Medicine, Kyoto University, 
Japan: Tumor-promoting diterpene 
esters as possible environmental 
cofactor(s) for ATL.
Goodenow, M.M., Shih, C.-K., Hay- 
ward, W.S., Memorial Sloan-Ket- 
tering Cancer Center, New York, 
New York: ALV and c-myc activa- 
tion.
Rowley, J., University of Chicago 
Medical School, Illinois: Chromo- 
some abnormalities in human 
lymphoid disease.
Cancer Center, New York, New 
York: T-cell lymphoid malignan- 
cies and feline acquired immune 
deficiency syndrome (FAIDS) of 
pet cats induced by FLV.
de The, G., Faculty of Medicine, 
CNRS, Lyon, France: Pathobiology 
and epidemiology of Epstein-Barr 
virus.
Shafritz, D.A., Rogler, C.E., Liver 
Research Center, Albert Einstein 
College of Medicine, Bronx, New 
York: Review of properties of hep- 
atitis B virus related to DNA and 
RNA tumor viruses.
Vogt, P.K., Dept, of Microbiology, 
University of Southern California 
School of Medicine, Los Angeles: 
Mechanisms of viral leukemogene- 
sis.
Brack, C.,1 Ghysdael, J.,1 Portetelle, 
D. l^2׳ Burny, A .,1 1  2־University of 
Brussels; 2Faculty of Agronomy, 
Gembloux, Belgium: Antigenicity 
of the envelope glycoprotein (gp51) 
ofBLV.
Hardy, W.D., Jr., Zuckerman, E.E., 
Laboratory of Veterinary Oncol- 
ogy, Memorial Sloan-Kettering
SESSION 2 HTLV: Proteins and Nucleic Acids
Chairpersons: F. Wong-Staal, National Cancer Institute, Bethesda, Maryland, and M.M. Yoshida, Can- 
cer Institute, Tokyo, Japan
Sarngadharan, M.G., Dept, of Cell Kensington, Maryland: Introduc- Oroszlan, S.,1 Copeland, T.D.,1 Kaly- 
Biology, Litton Bionetics, Inc., tion. anaraman, V.S.,2 Sarngadharan,
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M.G.,' Schultz, A.M.,' Gallo,
R.C.,' 'NCI, Frederick Cancer Re-
search Facility, Frederick; 'Dept. of
Cell Biology, Litton Bionetics, Inc.,
Kensington; 'NCI, National Insti-
tutes of Health, Bethesda, Mary-
land: Chemical analysis of HTLV
structural proteins.
Lee, T.H., Howe, C.W.S., McLane,
M.F., Tachibana, N., Essex, M.,
Dept. of Cancer Biology, Harvard
School of Public Health, Boston,
Massachusetts: HTLV-associated
antigens recognized by human
serum antibodies.
Weiss, R., Nagy, K., Clapham, P.,
Cheingsong-Popov, R., Institute of
Cancer Research, Chester Beatty
Laboratories, London, England:
Biological properties of HTLV en-
velope antigens.
Wong-Staal, F., Franchini, G., Hahn,
B., Gelmann, E.P., Manzari, V.,
Gallo, R.C., NCI, National Insti-
tutes of Health, Bethesda, Mary-
land: Integration and expression of
HTLV genomes in fresh and cul-
tured T cells of adult T-cell leuke-
mia patients.
Yoshida, M., Seiki, M., Hattori, S.,
Watanabe, T., Dept. of Viral Oncol-
ogy, Cancer Institute, Tokyo, Ja-
pan: Genome structure of ATLV
(HTLV) and its involvement in leu-
kemogenesis of ATL.
Haseltine, WA., Sodroski, J.G., Pa-
tarca, R., Trus, M., Perkins, D.,
Crowther, R., Dana-Farber Cancer
Institute, Harvard Medical School,
Boston, Massachusetts: Structure
and function of HTLV.
Mullins, IL,' Brody, D.,' Kim, H.J.,'
McLane, M.E,' Essex, M.,' Rub-
samen, H.,' Gold, J.W.,' Feorino,
P.,' Cabradilla, C.,' Schooley, R.,'
Hirsch, M.,' Wong-Staal, F.,6 Fran-
chini, B.,6 Gallo, R.C.,6 'Harvard
School of Public Health, Boston,
Massachusetts; 'Paul Ehrlich Insti-
tut, Frankfurt, Federal Republic of
Germany; 'Memorial Sloan-Ketter-
ing Cancer Center, New York, New
York; 'Centers for Disease Control,
Atlanta, Georgia; 'Massachusetts
General Hospital, Boston; 6NCI,
National Institutes of Health, Be-
thesda, Maryland: HTLV se-
quences in leukemias and in AIDS.
Seigel, L.J.,' Nash, W.G.," Manzari,
V.,' Wong-Staal, E,' Gallo, R.C.,'
O'Brien, S.J.,' 'Laboratory of Tu-
mor Cell Biology, 'Laboratory of
Viral Carcinogenesis, NCI, Na-
tional Institutes of Health, Be-
thesda, Maryland: On the dynamic
nature of proviral integration in
HTLV-infected malignancies- A
genetic analysis.
Reitz, M.S., Jr., Clarke, M.F., Trai-
nor, C.D., Mann, D.L., Gallo,
R.C., NCI, National Institutes of
Health, Bethesda, Maryland: HTLV
and HLA antigen expression.
Short Talks
Gelmann, E., Popovic, M., Fran-
chini, G., Wong-Staal, F., Gallo,
R.C., NCI, National Institutes of
Health, Bethesda, Maryland: A new
human retrovirus associated with a
T-cell hairy cell leukemia.
SESSION 3 T-cell Biology and the Effects of HTLV
Chairpersons: K. Lennert, Christian-Albrechts University, Kiel, Federal Republic of Germany, and H.
Kaplan, Stanford University, Stanford, California
Greaves, M.F., Imperial Cancer Re-
search Fund Laboratories, London,
England: T-cell differentiation and
malignancy.
Haynes, B.F.,' Palker, T.J.,1 Scearce,
R.M.,' Robert-Guroff, M.,' Kaly-
anaraman, V.S.,2 Bolognesi, D.P.,'
Gallo, R.C.," 'Depts. of Medicine
and Surgery, Duke University, Dur-
ham, North Carolina; 'NCI, Na-
tional Institutes of Health, Be-
thesda, Maryland: Monoclonal
antibodies against human T-cell
leukemia virus (HTLV) p24 inter-
nal core protein and HTLV-associ-
ated p19 protein identify antigens in
normal human tissue.
Weissman, I., McGrath, M., Tid-
marsh, G., Marian, J., Dept. of Pa-
thology, Stanford University School
of Medicine, California: Retrovirus
receptors on T- and B-cell lympho-
cytes.
Popovic, M.,' Markham, P.,' Sarin,
P.,' Salahuddin, Z.,' Robert-Gur-
off, M.,' Mann, D.,' Allavena, P.,'
Minowada, J.,' Gallo, R.C.,' 'NCI,
National Institutes of Health, Be-
thesda; 'NCI, Frederick Cancer Re-
search Facility, Frederick, Mary-
land; 'Veterans Administration
Hospital, Hines, Illinois: Infection
and transformation of human T cells
by HTLV.
Michalski, M., Popovic, M., NCI,
National Institutes of Health, Be-
thesda, Maryland: Induction of
syncytia of HTLV isolates.
Miyoshi, I.,' Taguchi, H.,' Fujishita,
M.,' Yoshimoto, S.,' Ohtsuki, Y.,'
'Dept. of Medicine, 'Dept. of Pa-
thology, Kochi Medical School, Ja-
pan: Natural infection in monkeys
with adult T-cell leukemia virus or
a closely related agent.
Mituya, H., Gallo, R., Broder, S.,
NCI, National Institutes of Health,
Bethesda, Maryland: Cytotoxic T
cells specific for HTLV.
Short Talks
Mann, D.L.,' Clark, J.,' Clarke,
M.F.,' Strong, D.M.,' Franchini,
G.,' Trainor, C.D.,' Gallo, R.C.,'
Reitz, M.,' 'NCI, National Insti-
tutes of Health; 'Uniformed Serv-
ices University of the Health Sci-
ences, Bethesda, Maryland: HTLV-
infected B-cell lines established
from patients with adult T-cell leu-
kemias.
Poiesz, B., ',2,' Moore, J.,.3 Merl,
Tomar, R.,' Zamkoff,
Davey, E,' Planas, Gottlieb,
A.,' Runge, L.,' Cowan, B.,123
Reeves, W.,'2 Ruscetti, F.,' Han,
T.,° Cabradilla, C.,' Ehrlach, G.,'
R. Comis,',3 'Upstate Medical Cen-
ter, 'Veterans Administration Med-
ical Center, Syracuse; 'Barbara
Kopp Research Center, Auburn;
'Syracuse University, New York;
'NCI, Frederick Cancer Research
Facility, Frederick, Maryland;
6Roswell Park Medical Institute,
Buffalo, New York; 'Centers for
Disease Control, Atlanta, Georgia:
Biology and epidemiology of HTLV.
SESSION 4 Epidemiology and Natural History of HTLV-relatedDiseases
Chairpersons: D.P. Bolognesi, Duke University, Durham, North Carolina, and K. Takatsuki, Kumamoto
University, Japan
Takatsuki, K., Yamaguchi, K., Ka-
wano, F., Nishimura, H., Tsuda,
H., Sanada, I., Second Dept. of In-
ternal Medicine, Kumamoto Uni-
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versity Medical School, Japan:
Adult T-cell leukemia/lymphoma
(ATL)- Clinical feature, epide-
miology, and cytogenetic, pheno-
typic, and functional studies of leu-
kemia cells.
Blattner, W., Saxinger, C., Blayney,
D., Clark, J., Robert-Guroff, M.,
Gallo, R., NCI, National Institutes
of Health, Bethesda, Maryland:
HTLV- Epidemiology and rela-
tionship to human malignancy.
Catovsky, D., Matutes, E., Brito-Ba-
bapulle, V., MRC Leukaemia Unit,
Royal Postgraduate Medical School,
London, England: Laboratory stud-
ies in Caribbean patients with ATL.
Robert-Guroff, M.,' Saxinger, W C.,'
Schupbach, J.,' Blayney, D.W.,' Po-
povic, M.,' Kalyanaraman, V.S.,2
Sarngadharan, M.G.,' Gallo, R.C.,'
'NCI, National Institutes of Health,
Bethesda; 'Litton Bionetics, Inc.,
Kensington, Maryland: Seroepide-
miologic studies on HTLV.
Essex, M.,' McLane, M.,' Lee, T.H.,'
Tachibana, N.,' Homma, T.,' Mul-
lins, J.,' Falk, L.,' de The, G.,'
Gold, J.,' Schooley, R.,3 Hirsch,
M.,3 Evatt, B.,4 Cabradilla, C.,4
Francis, D.,4 'Dept. of Cancer Bi-
ology, Harvard School of Public
Health, Boston, Massachusetts;
'Memorial Sloan-Kettering Cancer
Center, New York, New York;
'Massachusetts General Hospital,
Boston; 4Centers for Disease Con-
trol, Atlanta, Georgia: Distribution
of antibodies to HTLV-MA in pa-
tients with AIDS and related con-
trol groups.
Greaves, M.E,' Verbi, W,' Blattner,
W.,' Robert-Guroff, M.,2 Hong-
Guong, G.,2 Reitz, M.,2 Gallo,
R.C.,2 'Imperial Cancer Research
Fund, London, England; 'NCI, Na-
tional Institutes of Health, Be-
thesda, Maryland: HTLV in immi-
grants to the United Kingdom.
Aoki, T., Hamada, C., Ohno, S., Mi-
yakoshi, H., Robert-Guroff, M.,
Ting, R.C., Gallo, R.C., Research
Division, Shinrakuen ' Hospital;
Dept. of Virology, Niigata, Univer-
sity School of Medicine, Niigata,
Japan; Dept. of Cell Biology, Bio-
tech Research Laboratory, Rock-
ville; NCI, National Institutes of
Health, Bethesda, Maryland: Lo-
cation of HTLV p19 antigen on
HTLV-producing cells and a role of
natural antibody to HTLV-related
antigens in antibody-dependent cell-
mediated cytotoxicity against
HTLV-producing cells.
Miyoshi, I.,' Taguchi, H.,' Fujishita,
M.,' Yoshimoto, S.,' Ohtsuki, Y.,'
'Dept. of Medicine, 'Dept. of Pa-
thology, Kochi Medical School, Ja-
pan: Natural infection in monkeys
with ATLV or a closely related
agent.
Saxinger, C.,' Blattner, W,' Lange-
Wantzin, G.,2 Lapin, B.,' Yakoleva,
L.,3 Guo, C.,' Robert-Guroff, M.,'
Gallo, R.,' 'NCI, National Insti-
tutes of Health, Bethesda, Mary-
land; 2Dept. of Dermatology, Fin-
sen Institute, Denmark; 'USSR
Academy of Medical Science, Suk-
hami: HTL-Seroepidemiological
studies in diverse populations.
SESSION 5 Possible Role of HTLV in AIDS
Chairpersons: J. Gutterman, University of Texas, Houston, and D. Francis, Centers for Disease Control,
Phoenix, Arizona
Fauci, A.S., NIAID, National Insti-
tutes of Health, Bethesda, Mary-
land: The immunobiology of AIDS.
Safai, B., Pollack, M., Dupont, B.,
Memorial Sloan-Kettering Cancer
Center, New York, New York: HLA
in cutaneous T-cell lymphoma and
Kaposi's sarcoma -A possible ge-
netic susceptibility to HTLV.
Letvin, Hunt, R.D.,' 'Dana-
Farber Cancer Institute, Boston;
'New England Regional Primate
Research Center, Southborough,
Massachusetts: Transmissible im-
munodeficiency syndrome and
lymphomas in Macaque monkeys.
Essex, M.,' McLane, M.,' Lee, T.H.,'
Tachibana, N.,' Homma, T.,' Mul-
lins, J.,' Falk, L.,' de The, G.,'
Gold, J.,' Schooley, R.,3 Hirsch,
M.,' Evatt, B.,4 Cabradilla, C.,4
Francis, D.,4 'Dept. of Cancer Bi-
ology, Harvard School of Public
Health, Boston, Massachusetts;
'Memorial Sloan-Kettering Cancer
Center, New York, New York;
'Massachusetts General Hospital,
Boston; 4Centers for Disease Con-
trol, Atlanta, Georgia: Distribution
of antibodies to HTLV-MA in pa-
tients with AIDS and related con-
trol groups.
Yoshida, M.,' Seiki, M.,' Watanabe,
T.,' Sugano, H.,' Kinoshita, T.,2
Kazawa, M.,2 Abe, T.,2 'Dept. of
Viral Oncology, Cancer Institute;
'Dept. of Internal Medicine, School
of Medicine, Teikyo University, To-
kyo, Japan: Proviral DNA of ATLV
(HTLV) in a hemophilia patient
with AIDS-like symptoms in Japan.
Gallo, R.C., Sarin, P., Popovic, M.,
NCI, National Institutes of Health,
Bethesda, Maryland: The family of
human retroviruses called human T-
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cell leukemia/lymphoma virus
(HTLV) -Their role in lymphoid
disorders (AIDS).
Montagnier, L.,' Barre-Sinoussi, F.,'
Dauguet, C.,' Rozenbaum, W.,'
Brun-Vezinet, F.,3 Rouzioux, C.,3
Klatzmann, D.,' Gluckman, J.C.,2
Chermann, J.C.,2 'Dept. of Virol-
ogy, Institut Pasteur; 2Hopital la
Pitie Salpetriere; 3H6pital Claude
Bernard, Paris, France: A human T-
lymphotropic retrovirus - Charac-
terization and possible role in
AIDS.
Scott, G., Parks, W, Kanner, S.,
Fischl, M., Dickenson, G., de Med-
ina, M., Schiff, E., Depts. of Pedi-
atrics, Microbiology, and Immu-
nology and Medicine, University of
Miami School of Medicine, Flor-
ida: AIDS and HTLV.
BANBURY MEETINGS
PROGRAMS
ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
AND KAPOSI'S SARCOMA
February 6-February 8
OVERVIEW
B. Safai, Memorial Sloan-Kettering
Cancer Center, New York, New York:
Clinical aspects.
J.W. Curran, centers for Disease Con-
trol, Atlanta, Georgia: Epidemiol-
ogy.
J. Shuster, McGill University, Mon-
treal, Canada: AIDS and the hemo-
philiac population.
SESSION 1 Immunological Aspects I
Chairperson: R.A. Good, Oklahoma Medical Research Foundation, Oklahoma City
B. Dupont, Memorial Sloan-Kettering H.C. Lane, National Institute of Al- of Medicine, Bronx, New York.
Cancer Center, New York, New York. lergy and Infectious Disease, Be- Al Ammann, University of Califor-
P. Rubinstein, The New York Blood thesda, Maryland. nia, San Francisco.
Center, New York, New York. A. Rubinstein, Albert Einstein College
Discussants: J. Reuben, M.D. Anderson Hospital and Tumor Institute, Houston, Texas; J.L. Fahey, University
of California, Los Angeles; F.P. Siegal, Mt. Sinai School of Medicine, New York, New York.
SESSION 2 Immunological Aspects II
Chairperson: K.W. Sell, National Institute of Allergy and Infectious Disease, Bethesda, Maryland
S. Cunningham-Rundles, Memorial
Sloan-Kettering Cancer Center, New
York, New York.
J. Laurence, Rockefeller University,
New York, New York.
G. Quinnan, National Institutes of
Health, Bethesda, Maryland.
S. Zolla-Pazner, New York University
School of Medicine, New York, New
York.
SESSION 3 Pathology and Cell Biology
Chairperson: R.C. Gallo, National Cancer Institute, Bethesda, Maryland
D. Gospodarowicz, University of Cali- L.C.M. Reid, Albert Einstein College
fornia, San Francisco. of Medicine, Bronx, New York.
SESSION 4 Virology I
D. Armstrong, Memorial Sloan-Ketter-
ing Cancer Center, New York, New
York.
M.S. Hirsch, Massachusetts General
Hospital, Boston.
SESSION 5 Virology H
K.K. Takemoto, National Institute of
Allergy and Infectious Disease, Be-
thesda, Maryland.
R.C. Gallo, National Cancer Institute,
Bethesda, Maryland.
G.M. Shearer, National Institutes of
Health, Bethesda, Maryland.
E.M. Shevach, National Institute of Al-
lergy and Infectious Disease, Be-
thesda, Maryland.
G. Noble, Centers for Disease Control, D. Francis, Centers for Disease Con-
Atlanta, Georgia. trol, Phoenix, Arizona.
W.L. Drew, University of California,
San Francisco.
M.S. Horwitz, Albert Einstein College D.H. Spector, University of California,
of Medicine, Bronx, New York. San Diego, La Jolla, California.
G.S. Hayward, Johns Hopkins Univer- I.M. Arias, Albert Einstein College of
sity, Baltimore, Maryland. Medicine, Bronx, New York.
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PLANT VIRUSES AND VIROIDS
February 27-March 2
SESSION 1
S.H. Howell, University of California,
San Diego, La Jolla: Introduction to
DNA viruses.
K.E. Richards, Institut de Biologie Mo-
loculaire et Cellulaire, Strasbourg,
France: Structure and expression of
CaMV DNA.
R. Hull, John Innes Institute, Norwich,
SESSION 2
R.M. Goodman, Calgene, Inc., Davis,
California: Genome structure and re-
lationships among whitefly-borne
geminiviruses.
K.W. Buck, Imperial College of Sci-
ence, London, England: Intracellular
forms of TGMV DNA.
R.H. Symons, University of Adelaide,
Australia: Characterizations of the
DNA genomes of the Australian
geminiviruses.
SESSION 3
W.O. Dawson, University of California,
Riverside: Examination of the mRNA
component of TMV RNA synthesis.
D.L.D. Caspar, Brandeis Univers; Ly,
Waltham, Massachusetts: Electro-
static interactions in the structure and
assembly of TMV.
A.O. Jackson, Purdue University, West
SESSION 4
T.C. Hall, University of Wisconsin,
Madison: Template and product spec-
ificity of plant virus replicases.
A. van Kammen, Agricultural Univer-
sity, Wageningen, The Netherlands:
Isolation and characterization of the
CPMV RNA replication complex.
J. Mottinger, University of Rhode Is-
land, Kingston: Genetic and molecu-
lar examination of virally associated
mutations in maize.
S. Dellaporta, Cold Spring Harbor
SESSION 5
D. Riesner, Universitat Dusseldorf,
Federal Republic of Germany: Struc-
ture and cellular organization of vi-
roids.
R.A. Owens, Plant Protection Institute,
USDA, Beltsville, Maryland: Biolog-
ical activity of cloned PSTV cDNAs.
G. Bruening, University of California,
England: Unencapsidated nucleic
acids of CaMV and their significance
in virus replication.
T. Hohn, Friedrich Miescher-Institut,
Basel, Switzerland: Reverse tran-
scription involved in CaMV replica-
tion.
T.J. Guilfoyle, University of Minnesota,
M. Zaitlin, Cornell University, Ithaca,
New York: Introduction to RNA vi-
ruses.
P. Goelet, MRC Laboratory of Molec-
ular Biology, Cambridge, England:
Nucleotide sequence of TMV RNA.
M. Zaitlin, Cornell University, Ithaca,
New York: Characterization of sin-
gle- and double-stranded subgenomic
RNAs from TMV-infected plants.
Lafayette, Indiana: Characterization
of the RNAs of four strains of BSMV.
G. Bruening, University of California,
Davis: RNA and nucleocapsid accum-
ulation in protoplasts resistant to
CPMV.
R.W. Goldbach, Agricultural Univer-
sity, Wageningen, The Netherlands:
Laboratory, New York: Molecular
and genetic examination of virally as-
sociated mutations in maize.
H.D. Robertson, Rockefeller Univer-
sity, New York, New York: Introduc-
tion to viroids, virusoids, and satel-
lites.
H. Sanger, Max-Planck-Institut fiir
Biochemie, Munich, Federal Repub-
lic of Germany: Studies on viroid
replication.
P. Palukaitis, Cornell University, Ith-
Davis: Properties and biological ef-
fects of satellite RNA of TobRV.
C.W. Collmer, Plant Protection Insti-
tute, USDA, Beltsville, Maryland:
Structural analyses of the cucumovi-
rus satellite RNAs differing in bio-
logical function.
P. Palukaitis, Cornell University, Ith-
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St. Paul: CaMV minichromosome.
S.H. Howell, University of California,
San Diego, La Jolla, California: Re-
combination of CaMV genomes.
L. Hirth, Institut de Biologie Molec-
ulaire et Cellulaire, Strasbourg,
France: CaMV DNA in the elabora-
tion of gene vectors.
A. Siegel, Wayne State University, De-
troit, Michigan: Characterization of
the subgenomic and host RNA spe-
cies encapsidated in vivo by TMV
capsid protein.
T.J. Morris, University of California,
Berkeley: Virus-specific dsRNA -
Functional role in RNA virus infec-
tion.
Structure and genetic organization of
CPMV RNAs.
D.L. Nuss, New York State Department
of Health, Albany: Molecular biol-
ogy of WTV -Characterization of
subgenomic RNAs associated with
extravectorial isolates.
aca, New York: Reexamination of the
nature and biological significance of
linear viroid molecules -Sequence of
the 5' end of linear PSTV molecules.
A.D. Branch, Rockefeller University,
New York, New York: Structure of
the viroid replication complex.
J. Semancik, University of California,
Riverside: Nuclear replication and
cellular pathology in CEV infection.
aca, New York: Comparison of four
satellite RNAs of CMV.
R.I.B. Francki, University of Adelaide,
Glen Osmond, South Australia: Sat-
ellite nature of some viroidlike RNAs.
R.H. Symons, University of Adelaide,
Australia: Comparative structure and
properties of virusoids.
ENHANCERS AND CONTROLLING ELEMENTS
April 3-April 6
SESSION 1 Papova Enhancers
P. Chambon, Faculte de Medecine de
Strasbourg, France: Upstream ele-
ments (72-bp and 21-bp repeats) of the
SV40 early promoter-In vivo and in
vitro studies.
P Gruss, University of Heidelberg,
Germany: Competition for cellular
factors required for the transcrip-
tional activation of enhancers.
T. Kadesch, Stanford University School
of Medicine, California: Transcrip-
SESSION 2 Promoters
G.L. Hager, National Cancer Institute,
Bethesda, Maryland: Glucocorticoid
regulatory sequence from MMTV -
A negative element?
K.R. Yamamoto, University of Califor-
nia, San Francisco: Fusions of a glu-
cocorticoid regulatory element to the
tk promoter region-Hormone-regu-
lated enhancement of promoter activ-
ity.
SESSION 3 Enhancers II
R. Kamen, Genetics Institute, Boston,
Massachusetts: Relationship between
the polyoma virus enhancer and the
cis-acting element required for vi-
ral DNA replication- Studies using
SV40/polyoma recombinants.
E. Linney, La Jolla Cancer Research
Foundation, California: Virus en-
hancing sequences for teratocarci-
noma cells.
M. Yaniv, Institut Pasteur, Paris,
France: Function of polyoma virus
enhancer in embryonal and differen-
tiated cells of the mouse.
SESSION 4 Promoters II
S. Beckendorf, University of Califor-
nia, Berkeley: Chromatin structure
and expression of a Drosophila glu
protein gene.
P.M. Bingham, State University of New
York, Stony Brook: Properties of pu-
tative enhancerlike elements at the
white locus of Drosophila.
L.P. Guarente, Massachusetts Institute
of Technology, Cambridge: Regula-
tion of the yeast iso-l-cytochrome c
SESSION 5 Special Systems
M. Fried, Imperial Cancer Research
Fund Laboratories, London, Eng-
land: Host sequences that enhance the
expression of adjacent DNA.
K. Calame, University of California,
Los Angeles: Regions in the mouse
immunoglobulin heavy-chain locus
that enhance transcription from the
SV40 early promoter.
tional position effects and enhance-
ment of the SV40 early promoter.
A. Nordheim, Massachusetts Institute of
Technology, Cambridge: Potential Z-
DNA in the SV40 enhancer region.
W. Schaffner, University of Zurich,
Switzerland: Transcriptional enhanc-
ers of viral and cellular origin.
M. Botchan, University of California,
Berkeley: Anatomy of the BPV acti-
vator and the relationship between
D.H. Hamer, National Institutes of
Health, Bethesda, Maryland: Distinct
promoter and regulatory sequences of
an inducible metallothionein gene.
B. Roizman, University of Chicago, Il-
linois: Identification of the regulatory
regions of alpha genes of HSV by
construction of a chimeric gene.
J. Nevins, Rockefeller University, New
J.A. Hassell, McGill University, Mon-
treal, Canada: Deletion mapping of
the polyoma virus early promoter-en-
hancer region.
I.M. Verma, The Salk Institute, San
Diego, California: Enhancer ele-
ments in murine LTR.
T.G. Wood, National Cancer Institute,
Bethesda, Maryland: Sequences re-
quired for the activation of the trans-
forming potential of a normal cellular
gene, c-mos.
B.H. Howard, National Institutes of
Health, Bethesda, Maryland: Corn-
gene by heme via an upstream acti-
vation site.
A.G. Hinnebusch, Massachusetts Insti-
tute of Technology, Cambridge: Re-
peated DNA sequences and regula-
tory genes that control amino acid
biosynthetic genes in yeast.
S. Mitrani-Rosenbaum, National Can-
cer Institute, Bethesda, Maryland:
Regulation of the human interferon
gene expression.
V.T. 0i, Stanford University School of
Medicine, California: Control of im-
munoglobulin gene expression in
transfected lymphoid cells.
S. Tonegawa, Massachusetts Institute of
Technology, Cambridge: Tissue-spe-
cific enhancer element in the major
intron of an immunoglobulin heavy-
chain gene.
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enhancers of transformation and ac-
tivators of transcription.
G. Khoury, National Cancer Institute,
Bethesda, Maryland: Specificity as-
sociated with viral enhancers.
M.R. Capecchi, University of Utah,
Salt Lake City: Location and function
of retroviral and SV40 sequences that
enhance biochemical transformation
after microinjection of DNA.
York, New York: Regulatory signals
in adenovirus-inducible promoter.
W. Dynan, University of California,
Berkeley: A promoter-specific tran-
scription factor that allows recogni-
tion of upstream sequence in early
SV40 promoter.
parison of enhancer functions in
SV40 and RSV.
T.E. Shenk, State University of New
York, Stony Brook: The Ad5 E1A
transcription unit contains an en-
hancerlike element.
P. Sassone-Corsi, Faculte de Medecine
de Strasbourg, France: An activator
element upstream from the Ad2 E1A
promoter.
K. Zinn, Harvard University, Cam-
bridge, Massachusetts: DNA se-
quences controlling expression of the
human 0-interferon gene.
H.R.B. Pelham, MRC Laboratory of
Molecular Biology, Cambridge, Eng-
land: Anatomy of stress-inducible
promoters.
A. Rich, Massachusetts Institute of
Technology, Cambridge: Nucleotide
sequences, Z-DNA formation, and
protein interactions.
M. Green, Harvard University, Cam-
bridge, Massachusetts: Activation of
human globin gene transcription by
cis- and trans-acting factors.
MECHANISMS OF PERCEPTION:
MARR MEMORIAL CONFERENCE
April 24-April 29
Participants
Allman, John, California Institute of
Technology, Pasadena
Bajcsy, Ruzena, Moore School of Elec-
trical Engineering, Philadelphia,
Pennsylvania
Baker, Curtis, Dalhousie University,
Halifax, Nova Scotia
Binford, Thomas, Stanford University,
California
Bobick, Aaron, Massachusetts Institute
of Technology, Cambridge
Braddick, Oliver J., University of Cam-
bridge, England
Brady, Michael, Massachusetts Institute
of Technology, Cambridge
Brown, Christopher M., University of
Rochester, New York
Bulthof, Heinrich, Max-Planck-Insti-
tut fiir Biologische Kybernetik, Tu-
bingen, Federal Republic of Germany
Chien, Y.T., National Science Founda-
tion, Washington, D.C.
Crick, Francis H.C., Salk Institute, San
Diego, California
Daugman, John, Harvard University,
Cambridge, Massachusetts
Dawson, Benjamin, Massachusetts In-
stitute of Technology, Cambridge
Fah le, Manfred, Eberhard-Karls-Uni-
versitat, Tubingen, Federal Republic
of Germany
Frisby, John, University of Sheffield,
England
Glaser, Donald A., University of Cali-
fornia, Berkeley
Grimson, Eric, Massachusetts Institute
of Technology, Cambridge
Hildreth, Ellen, Massachusetts Institute
of Technology, Cambridge
Hoffman, Donald, Massachusetts Insti-
tute of Technology, Cambridge
Kass, Michael, Massachusetts Institute
of Technology, Cambridge
Koch, Cristof, Massachusetts Institute
of Technology, Cambridge
Koenderink, J.J., Rijksuniversiteit
Utrecht, The Netherlands
Longuet-Higgins, Christopher H., Sus-
sex University, Brighton, England
Mayhew, John, University of Sheffield,
England
Mandelbrot, Benoit B., Thomas J. Wat-
son Research Center, IBM, Yorktown
Heights, New York
McGill, Michael, National Science
Foundation, Washington, D.C.
Mitchison, Graeme J., University of
Cambridge, England
Morgan, Michael J., University College
London, England
Nielsen, Kenneth R.K., Massachusetts
Institute of Technology, Cambridge
Nishihara, Keith H., Massachusetts In-
stitute of Technology, Cambridge
Poggio, Tomaso, Massachusetts Insti-
tute of Technology, Cambridge
Reichardt, Werner, Max-Planck-Insti-
tut ffir Biologische Kybernetik, Tu-
bingen, Federal Republic of Germany
Richards, Whitman, Massachusetts In-
stitute of Technology, Cambridge
Richter, Jacobi, Weizmann Institute of
Science, Rehovot, Israel
Rosenfeld, Azriel, University of Mary-
land, College Park
Rubin, John, Massachusetts Institute of
Technology, Cambridge
Scheuhammer, Joseph, Massachusetts
SLOAN JOURNALISTS' WORKSHOP:
NEW CONCEPTS IN MUTATION
August 5-August 7
SESSION 1 Genetic Origins
of Human Disease
J. Cairns, Harvard School of Public
Health, Boston, Massachusetts.
J.F. Crow, University of Wisconsin,
Madison.
SESSION 4 Mutation in Evolution
A.C. Wilson, University of California,
Berkeley.
SESSION 2 Origins of Genetic
Change
J.H. Miller, University of California,
Los Angeles.
M. Botchan, University of California,
Berkeley.
R.T. Schimke, Stanford University,
California.
SESSION 5 Approaches to Hu-
man Genetic Disease
C.T. Caskey, Baylor College of Medi-
cine, Houston, Texas.
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Institute of Technology, Cambridge
Segev, Idan, National Institutes of
Health, Bethesda, Maryland
Sejnowski, Terrence, Johns Hopkins
University, Baltimore, Maryland
Stevens, Kent, University of Oregon,
Eugene
Sutherland, Stuart N., Sussex Univer-
sity, Brighton, England
Terzopoulos, Demetri, Massachusetts
Institute of Technology, Cambridge
Thompson, William, University of
Minnesota, Minneapolis
Torre, Vincent, Universita di Genova,
Italy
Treisman, Anne, University of British
Columbia, Vancouver, Canada
Ullman, Shimon, Massachusetts Insti-
tute of Technology, Cambridge
Vaina, Lucia, Boston University, Mas-
sachusetts
Van Essen, David, California Institute
of Technology, Pasadena
Watt, R.J., University College London,
England
Westheimer, Gerald, University of Cal-
ifornia, Berkeley
Winston, Patrick, Massachusetts Insti-
tute of Technology, Cambridge
Witkin, Andrew, Fairchild Corpora-
tion, Palo Alto, California
Woodham, Robert J., University of
British Columbia, Vancouver, Canada
Yuille, A., Massachusetts Institute of
Technology, Cambridge
Zipser, David, University of California,
San Diego, La Jolla
SESSION 3 Engineering the
Mutation Process
D. Shortle, State University of New
York, Stony Brook.
M. Smith, University of British Colum-
bia, Vancouver, Canada.
MECHANISMS OF MUTAGENESIS
August 7-August 10
SESSION 1 Genomic Rearrangements
J. Cairns, Harvard School of Public
Health, Boston, Massachusetts.
M. Botchan, University of California,
Berkeley.
W.R. Engels, University of Wisconsin,
Madision.
G. Fink, Massachusetts Institute of
Technology, Cambridge.
T.D. Tlsty, Stanford University, Cal-
ifornia.
SESSION 2 Mutagenesis in Prokaryotes
J.H. Miller, University of California,
Los Angeles.
F Hutchinson, Yale University, New
Haven, Connecticut.
J.E. LeClerc, University of Rochester,
New York.
G.C. Walker, Massachusetts Institute of
Technology, Cambridge.
E. Eisenstadt, Harvard School of Pub-
lic Health, Boston, Massachusetts.
SESSION 3 Origins of Eukaryotic Mutation I
C.T. Caskey, Baylor College of Medi-
cine, Houston, Texas.
M. Calos, Stanford University, Cal-
ifornia.
D.F. Barker, University of Utah, Salt
Lake City.
R.J. Albertini, University of Vermont,
Burlington.
D. Martin, Jr., Genentech, Inc., South
San Francisco, California.
D. Patterson, Eleanor Roosevelt Insti-
tute for Cancer Research, Inc., Den-
SESSION 4 Origins of Eukaryotic Mutation II
J.F. Crow, University of Wisconsin,
Madison.
S.M. Weissman, Yale University, New
Haven, Connecticut.
F. Vogel, Ruprecht-Karls-Universitat,
SESSION 5 Directed Mutagenesis
M. Smith, University of British Colum-
bia, Vancouver, Canada.
D. Shortle, State University of New
York, Stony Brook.
Heidelberg, Federal Republic of
Germany.
L.S. Lerman, State University of New
York, Albany.
A.C. Wilson, University of California,
R.B. Wallace, City of Hope Research
Institute, Duarte, California.
M. Inouye, State University of New
York, Stony Brook.
R.T. Schimke, Stanford University,
California.
M. Wigler, Cold Spring Harbor Labo-
ratory, New York.
P.L. Foster, Harvard School of Public
Health, Boston, Massachusetts.
L.A. Loeb, University of Washington,
Seattle.
ver, Colorado.
F Sherman, University of Rochester,
New York.
L. Prakash, University of Rochester,
New York.
Berkeley.
T. Maniatis, Harvard University, Cam-
bridge, Massachusetts.
R.A. Flavell, Biogen Research Corpo-
ration, Cambridge, Massachusetts.
M. Grunstein, University of California,
Los Angeles.
THE ROLE OF GENETIC PREDISPOSITION
IN RESPONSES TO CHEMICAL EXPOSURE
October 2-October 5
INTRODUCTION
G.S. Omenn, University of Washing-
ton, Seattle: From pharmacogenetics
to ecogenetics.
W Kalow, University of Toronto, Can-
ada: A pharmacologist looks at phar-
macogenetics and ecogenetics.
SESSION 1 P-450 Systems
Chairperson: G.S. Omenn, University of Washington, Seattle
R.N. Hines, University of Nebraska,
Omaha: Regulation of expression of
cytochrome P-450.
M.J. Coon, University of Michigan,
Ann Arbor: P-450 - Multiplicity of
inducers, isozymes, and substrates.
H. Gelboin, National Institutes of
Health, Bethesda, Maryland: Pheno-
typing cytochrome P450 by mono-
clonal-antibody-directed enzyme in-
hibition and radioimmunoassay.
F.P. Guengerich, Vanderbilt University,
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Nashville, Tennessee: Purification
and characterization of a rat liver mi-
crosomal cytochrome P-450 involved
in debrisoquine 4-hydroxylation, a
prototype for genetic polymorphism
in drug metabolism.
SESSION 2 Drug and Carcinogen Metabolism
Chairperson: W.F. Bodmer, Imperial Cancer Research Fund Laboratories, London, England
D.S. Davies, University of London,
England: Studies of the substrate
specificity of human cytochrome P-
450.
J.R. Idle, University of London, Eng-
land: Lung cancer-Consequence of
habit and inheritance?
C. Von Bahr, Huddinge University Hos-
pital, Sweden: In vitro metabolism by
human liver in relation to poly-
morphic drug oxidation.
E.S. Vesell, Pennsylvania State Univer- R.E. Kouri, Microbiological Associ-
shy, Hershey: Impact of multiple dy- ates, Bethesda, Maryland: Variations
namically interacting genetic and en- in aryl hydrocarbon hydroxylase lev-
vironmental factors on methods to els in mitogen-activated human lym-
detect new polymorphisms of hepatic phocytes.
drug oxidation. W.F. Bodmer, Imperial Cancer Re-
search Fund Laboratories, London,
A.H. Conney, Hoffmann-La Roche, Inc., England: DNA polymorphisms in
Nutley, New Jersey: Variability in population and family studies -Ex-
chemical biotransformations in hu- amples from the HLA system.
man beings.
SESSION 3 Polymorphisms of Metabolizing Enzyme Systems
Chairperson: A.H. Conney, Hoffmann-La Roche, Inc., Nutley, New Jersey
S.P. Spielberg, Hospital for Sick Chil-
dren, Toronto, Canada: Pharmaco-
genetic susceptibility to toxic drug
metabolites in man.
B.N. La Du, Jr., University of Michi-
gan, Ann Arbor: Could the human
paraoxonase polymorphism account
for different responses to certain en-
vironmental chemicals?
A.G. Motulsky, University of Washing-
ton, Seattle: Biochemical genetics of
paraoxonase polymorphism.
E Oesch, University of Mainz, Federal
Republic of Germany: Variations in
epoxide hydrolase activities in human
liver and blood.
E. Beutler, Scripps Clinic and Research
Foundation, La Jolla, California:
SESSION 4 Oncogene Activation and DNA and Chromosomal Markers
Chairperson: J.E. Cleaver, University of California, San Francisco
R.A. Weinberg, Massachusetts Institute
of Technology, Cambridge: Onco-
genes and human carcinogenesis.
A. Pellicer, New York University, New
York: A chemical carcinogen acti-
vates in vivo a mouse c-ras oncogene.
A. Balmain, Beatson Institute for Can-
cer Research, Glasgow, Scotland:
Activation of oncogenes at stages of
chemical carcinogenesis in different
mouse strains.
C.C. Harris, National Cancer Institute,
Bethesda, Maryland: Carcinogenesis
studies using cultured human tissues
and cells.
T. Kakunaga, National Cancer Institute,
Bethesda, Maryland: Mutations as-
Sensitivity to drug-induced hemolytic
anemia in glucose-6-dehydrogenase
deficiency.
E.J. Calabrese, University of Massa-
chusetts, Amherst: Animal model for
blood hereditary disorders-Environ-
mental applications.
sociated with neoplastic transforma-
tion by chemical carcinogens.
J. Garrels, Cold Spring Harbor Labo-
ratory, New York: Use of two-dimen-
sional gel electrophoresis for detec-
tion of proteins indicating genetic
risk.
SESSION 5 Immunological and Molecular Genetic Approaches
Chairperson: H. Gelboin, National Institutes of Health, Bethesda, Maryland
B. Dupont, Memorial Sloan-Kettering specific for steroid-2l hydroxylation.
Cancer Center, New York, New York: H. Erlich, Cetus Corporation, Emery-
Disease susceptibility genes in the ville, California: HLA DNA poly-
HLA complex. morphisms -Use as genetic markers
P.C. White, Memorial-Sloan Kettering in control and disease populations.
Cancer Center, New York, New York: S. Wolff, University of California, San
Cloning and expression of cDNA en- Francisco: Use of sister chromatid
coding an adrenal cytochrome P-450 exchanges to determine possible ge-
SESSION 6 Population Correlations
Chairperson: C.C. Harris, National Cancer Institute, Bethesda, Maryland
F. Kueppers, Temple University,
Philadelphia: Effect of smoking
on the development of emphy-
sema in alpha-1 antitrypsin defi-
ciency.
netic predisposition in response to
chemical exposure.
M.-C. King, University of California,
Berkeley: Genetic and epidemiologic
approaches for detecting susceptibil-
ity in populations.
R.A. Cartwright, Yorkshire Regional P.G. Archer, University of Colorado,
Cancer Organisation, Leeds, Eng- Denver: Some statistical and meth-
land: Epidemiological studies on N- odological issues in cytogenetic
acetylation and C-center ring oxida- testing.
tion in neoplasia.
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COFFEE AND HEALTH
October 30-November 2
SESSION 1 The Coffee Product
Chairperson: R.G. Bost, General
G.E. Boecklin, National Coffee Asso-
ciation of USA, Inc., New York, New
York: Coffee-A social history.
A.E Beltrao, International Coffee Or-
ganisation, London, England: Coffee
in the world economy.
Foods Corporation, White Plains, New
W P. Clinton, General Foods Corpora-
tion, White Plains, New York: Chem-
istry of coffee.
S.N. Katz, General Foods Corporation,
Hoboken, New Jersey: Decaffeina-
tion of coffee.
SESSION 2 Coffee Mutagenesis -Experimental Approaches
Chairperson: L.W. Wattenberg, University of Minnesota, Minneapolis
T. Sugimura, National Cancer Center
Research Institute, Tokyo, Japan:
Mutagens in coffee-Background and
present knowledge of mutagens and
carcinogens produced by pyrolysis.
M. Nagao, National Cancer Center Re-
search Institute, Tokyo, Japan: Muta-
gens in coffee.
H.P. Wurzner, Nestle Products Techni-
cal Assistance Co. Ltd., Orbe, Switz-
erland: Preliminary findings of a car-
cinogen bioassay of coffee in mice.
H.-U. Aeschbacher, Nestle Products
Technical Assistance Co. Ltd., Orbe,
Switzerland: Risk evaluation of cof-
fee based on in vitro and in vivo mu-
York
R.G.K. Strobel, Procter & Gamble
Company, Ohio: Chemistry of instant
coffee.
A. Leviton, Harvard Medical School,
Boston, Massachusetts: Correlates of
coffee consumption.
tagenicity testing.
S. Takayama, Japanese Foundation for
Cancer Research, Tokyo: Long-term
carcinogenicity studies on caffeine,
instant coffee, and methylglyoxal in
rats.
SESSION 3 Coffee and Human Carcinogenesis I
Chairperson: T. Sugimura, National Cancer Center Research Institute, Tokyo, Japan
Pancreatic Cancer
B. MacMahon, Harvard School of Pub-
lic Health, Boston, Massachusetts:
Coffee and cancer of the pancreas -
A review.
Bladder and GI Tract Cancer
L. Gordis, Johns Hopkins School of
Hygiene and Public Health, Balti-
more, Maryland: Coffee and pan-
creatic cancer.
A.S. Morrison, Harvard School of Pub-
lic Health, Boston, Massachusetts:
Control of cigarette smoking in eval-
uating the association of coffee drink-
ing and bladder cancer.
L.W. Wattenberg, University of Min-
nesota, Minneapolis: Protective ef-
fects of coffee constituents on carci-
nogenesis in experimental animals.
SESSION 4 Coffee and Human Carcinogenesis II
Chairperson: R. Saracci, International Agency for Research on Cancer, Lyon, France
Ovarian Cancer
D. Trichopoulos, University of Athens
School of Medicine, Greece: A case-
control investigation of a possible as-
sociation between coffee consump-
tion and ovarian cancer in Greece.
S. Shapiro, Boston University School of
Medicine, Cambridge, Massachu-
setts: Ovarian cancer and coffee
drinking.
Breast Cancer and Fibrocystic Disease
V.L. Ernster, University of California,
San Francisco: Epidemiological stud-
ies of coffee and breast disease.
E Lubin, Chaim Sheba Medical Center,
Tel-Hashomer, Israel: Coffee and
methylxanthine in benign and malig-
nant breast disease.
L. Rosenberg, Boston University School
of Medicine, Cambridge, Massachu-
setts: Breast cancer and coffee drink-
ing.
E.M. Grossman, General Foods Cor-
poration, Tarrytown, New York: Caf-
feine and benign breast disease-A
proposed clinical trial.
SESSION 5 Physiological and Behavioral Effects
Chairperson: S.R. Tannenbaum, Massachusetts Institute of Technology, Cambridge
G.D. Friedman, The Permanente Med-
ical Group, Inc., Oakland, Califor-
nia: Coffee and coronary heart dis-
ease -Are there grounds for concern?
L. Welin, University of Gothenburg,
Sweden: Coffee, traditional risk fac-
tors, coronary heart disease, and
mortality.
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A. Sivak, Arthur D. Little, Inc., Cam-
bridge, Massachusetts: Chronic ex-
perimental animal studies with cof-
fee.
BIOLOGICAL IMAGING AND NUCLEAR MAGNETIC
RESONANCE (CONGRESSIONAL WORKSHOP)
December 2-December 4
INTRODUCTION
B. Chance, University of Pennsylvania, Philadelphia
OVERVIEW
P.C. Lauterbur, State University of New York, Stony Brook
SESSION 1
T. Brady, Massachusetts General Hos-
pital, Boston, Massachusetts: Mole-
cules in magnetic fields.
M. Ter-Pogossian, Washington Univer-
sity Medical School, St. Louis, Mis-
souri: Positron emission tomography.
SESSION 2
B. Chance, University of Pennsylvania,
Philadelphia: In vivo nuclear mag-
netic resonance.
C. Higgins, University of California,
San Francisco, Medical School: Pro-
ton imaging and computed tomogra-
phy.
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SESSION 3
T. Budinger, University of California,
Berkeley: Comparative and safety as-
pects.
P.C. Lauterbur, State University of New
York, Stony Brook, and B. Chance,
University of Pennsylvania, Philadel-
phia: Summary discussion.
Congressional redirect.
POSTGRADUATE COURSES
Participants and Seminars
THE CELLULAR AND MOLECULAR BIOLOGY
OF BEHAVIOR
Participants
Blum, Andrew S., B.A., Rockefeller University, New York,
New York
Bodnar, Deana A., B.S.E., University of Iowa, Iowa City
Earnest, Thomas N., M.A., Boston University, Massa-
chusetts
Floeter, Mary Kay, B.S., Washington University, St. Louis,
Missouri
Friedman, Alan M., A.B., Yale Medical School, New Ha-
ven, Connecticut
Goode, Marian I., B.A., Georgia Institute of Technology,
Atlanta
Hakim, Vincent, Attache de Recherche of the CNRS, Paris,
France
Indik, Jonathan H., M.D., University of Pennsylvania,
Philadelphia
Jones, Bradley R., B.S., Hopkins Marine Station, Pacific
Grove, Pennsylvania
LaMantia, Anthony-Samuel, B.A., Yale Medical School,
New Haven, Connecticut
McFarland, Jenny Lee, S.B., University of Washington,
Seattle
Mistler, Lisa A., S.B., University of California, San
Francisco
Morielli, Anthony D., B.S., University of California, Santa
Cruz
Reye, David N., B.S., University of Alberta, Edmonton,
Canada
Sakurai, Masaki, M.D., University of Tokyo, Japan
Schachter, Leah A., B.A., Yale University, New Haven,
Connecticut
Tamsky, Carolyn A., B.S., Arizona State University, Tempe
Wagner, Michael A., B.S., Institute for Cancer Research,
Philadelphia, Pennsylvania
Walsh, John, University of Texas, Houston
Williams, Heather, B.A., Rockefeller University, New York,
New York
Seminars
Axel, R., Columbia University. Introduction to the study of
gene regulation.
Goldberg, D., Columbia University. Regulation of transmit-
ter synthesis.
Scheller, R., Stanford University. Genes, peptides, and
behavior.
Truman, J., University of Washington. Hormones and
behavior.
Kupfermann, I., Columbia University. Motivation.
Wine, J., Stanford University. Nerve circuitry for simple
behavioral acts and their control.
Getting, P., University of Iowa. Rhythm generation in in-
vertebrate motor systems.
Thach, WT., Jr., Washington University. Cerebellar content
of posture and movement.
Fuchs, A., University of Washington. Adaptive regulation
in the oculomotor system.
Ghez, C., Columbia University. Voluntary movements in
mammals.
Suga, N., Washington University. Brain pathways for sound
processing in bats.
Heiligenberg, W, University of California, San Diego.
Electrolocation and electric communication in fish.
Ross, E., Southwestern Medical School. Language func-
tions in the human brain and their location.
Black, I., Cornell University. The role of neurotransmitters
in behavioral abnormalities.
MOLECULAR BIOLOGY OF PLANTS
Participants
Barnes, Wayne M., Ph.D., Washington University, St. Louis,
Missouri
Choi, Kyung-Hee, Ph.D., Albert Einstein College of Medi-
cine, Bronx, New York
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Curtis, Stephanie E., Ph.D., University of Chicago, Illinois
De Lorenzo, Giulia, Ph.D., Universita di Roma, Italy
Fox, Thomas D., Ph.D., Cornell University, Ithaca, New
York
Geste land, Raymond F, Ph.D., University of Utah, Salt
Lake City
Green, Pamela J., B.S., State University of New York, Stony
Brook
Haugli, Finn B., Ph.D., University of Troms6, Norway
Hombrecher, Gerd G., Ph.D., John Innes Institute, Nor-
wich, England
Kinlaw, Claire S., Ph.D., Rice University, Houston, Texas
Kuhlemeier, Cris, M.S., State University of Utrecht, The
Netherlands
Lemaux, Peggy G., Ph.D., Stanford University, California
Mackey, Catherine J., Ph.D., Pfizer, Inc., Groton,
Connecticut
Murphy, Caroline, Ph.D., University of Connecticut, Storrs
Tenning, Paul P., Max-Planck-Institut, Koln, Federal Re-
public of Germany
Van Den Elzen, Peter J., Ph.D., Advanced Genetic Sci-
ences, Inc., Berkeley, California
Seminars
Bidney, D., Advanced Genetic Sciences. The potato proto-
plast system and plant breeding.
Kemble, R., Kansas State University. Mitochondrial DNA
and male sterility.
Maliga, P., Washington University. Cell culture mutant se-
lection and protoplast fusion.
Long, S., Stanford University. Nitrogen fixation -Sym-
biosis.
Hanson, M., University of Virginia. Plant cell culture and
organelle genetics.
Van Montagu, M., Rijksuniversiteit Gent. Molecular biol-
ogy of crown gall disease.
Ausubel, E, Massachusetts General Hospital. Nitrogen fix-
ation -Enzymology and genetics.
Harada, J., University of California, Los Angeles. Regula-
tion of abundant genes during soybean embryogeny.
Dooner, H., Advanced Genetic Sciences. Maize controlling
elements.
Ellingboe, A., University of Wisconsin. Genetics of plant-
pathogen interactions.
Bogorad, L., Harvard University. Chloroplast molecular
biology.
Zaitlin, M., Cornell University. Plant viruses, viroids, vi-
rusoids, and satellites.
Miles, D., University of Missouri. Mutants in the photosyn-
thesis pathway.
Steinback, K., Advanced Genetic Sciences. Analysis of thy-
lakoid polypeptides and electron flow in photosynthesis.
Chau, N.H., Rockefeller University. Nuclear chloroplast in-
teractions and gene regulation.
Walbot, V., Stanford University. Developmental genetics of
maize.
Ho, D., University of Illinois. Hormone response mutants
of barley.
Dunsmuir, P., CSIRO. Chlorophyll ab binding protein.
NERVOUS SYSTEM OF THE LEECH
Participants
Davis, Robin L., B.S., M.A., Stanford University, California
Dietzel, Irmgard D., Ph.D., Max-Planck-Institut, Heidel-
berg, Federal Republic of Germany
Frederiksen, Kristen, M.S., Cold Spring Harbor Labora-
tory, New York
Friedman, Beth, Ph.D., Montreal General Hospital Re-
search Institute, Canada
Giraldez, Fernando, M.D., Ph.D., Physiological Labora-
tory, Cambridge, England
Kotak, Vibhakar C., Ph.D., Sardar Patel University, Kaira,
India
Loer, Curtis M., B.S., University of California, San Diego
Magill, Catherine, B.A., University of California, Berkeley
Sundin, Olof, Ph.D., Cold Spring Harbor Laboratory, New
York
Thompson, Stephen W.N., B.S., University of Glasgow,
Scotland
Seminars
Stent, G., University of California, Berkeley. Development
of leech nervous system.
Weisblat, D., University of California, Berkeley. Develop-
ment of leech nervous systems.
Friesen, 0., University of Virginia. Swimming.
Kristan, W, University of California, San Diego.
Swimming.
Hockfield, S., Cold Spring Harbor Laboratory. Monoclonal
antibodies for leech CNS.
MOLECULAR CLONING OF EUKARYOTIC GENES
Participants
Alter, Barbara J., M.S., University of Minnesota, Duluth
Buxser, Stephen E., Ph.D., University of Massachusetts
Medical School, Worcester
Carter, Richard, Ph.D., National Institutes of Health, Be-
thesda, Maryland
Chen, Jeff W, M.S., Johns Hopkins University Medical
School, Baltimore, Maryland
Griep, Anne E., B.A., University of Wisconsin, Madison
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Gurney, Mark E., Ph.D., University of Chicago, Illinois
Kimura, Shoji, Ph.D., Memorial Sloan-Kettering Cancer
Center, New York, New York
Leonard, Warren J., M.D., NCI, National Institutes of
Health, Bethesda, Maryland
Ponzetto-Zimmerman, Carola, Ph.D., Columbia University
College of Physicians & Surgeons, New York, New York
Riddle, Donald L., Ph.D., University of Missouri, Columbia
Roberts, Anita B., Ph.D., National Institutes of Health, Be-
thesda, Maryland
Roitman, Isaac, Ph.D., Universidad de Brasilia, Brazil
Samson, Leona, Ph.D., University of California, Berkeley
Sinangil, Faruk, Ph.D., University of Nebraska Medical
Center, Omaha
Tominaga, Akira, Ph.D., Harvard Medical School, Boston,
Massachusetts
Van Pel, Aline, Ludwig Institute, Brussels, Belgium
Seminars
Croce, C., Wistar Institute. Genetics of Burkitt's lymphoma.
Lacy, E., Columbia University. Gene transfer into mice.
Seed, B., Harvard University. Recovery and manipulation
of recombinant DNA in vivo.
Vande Woude, G., National Institutes of Health. Properties
of the mos oncogene locus in human and mouse genomes.
Scheller, R., Stanford University. The molecular genetic ba-
sis of simple behaviors.
Bender, W, Harvard University. Molecular genetics of the
bithorax complex in Drosophila.
Shortie, D., State University of New York, Stony Brook.
Directed mutagenesis.
Davis, M., Stanford University. Lymphocyte-specific gene
expression and cloning.
Sutcliff, J.G., Scripps Institute. Localizing the products of
brain-specific genes.
Fischer, S., State University of New York, Albany. DNA
sequence-specific separation in denaturing gradient gel
electrophoresis.
Fink, G., Massachusetts Institute of Technology. The con-
trol of recombination between repeated DNA elements.
Irwin, N., Harvard University. Expression of foreign genes
in E. con.
Hirsch, J., Harvard University. Reintroduction and expres-
sion of genes into Drosophila.
St. John, T., Stanford University. cDNA cloning in phage
and manipulation of insert material.
McKnight, S., Fred Hutchinson Cancer Research Center.
Regulation of cellular and viral TK enzyme expression.
Wigler, M., Cold Spring Harbor Laboratory. Human trans-
forming genes.
Ruley, E., Cold Spring Harbor Laboratory. Ela, c-myc.
Ward, D., Yale University. Biotin-labeled polynucleotides
as hybridization probes and affinity selection reagents.
Mulligan, R., Massachusetts Institute of Technology. New
vectors for gene transfer in the mammalian cell and the
intact animal.
Maniatis, T., Harvard University. Regulated expression of
eukaryotic genes.
GENETICS AND MOLECULAR BIOLOGY OF
CHLAMYDOMONAS
Participants
Adams, G.M.W., Louisiana State University, Baton Rouge
Aldrich, Jane, Ph.D., Standard Oil of Ohio, Cleveland
Ausich, Rodney L., Ph.D., Amoco Research Center, Naper-
ville, Illinois
Bartlett, Sue G., Louisiana State University, Baton Rouge
Bean, Barry, Ph.D., Lehigh University, Bethlehem,
Pennsylvania
Benedick, Michael J., Ph.D., DNAX Research Institute, Palo
Alto, California
Blair, Lindley C., Ph.D., University of California, Berkeley
Brunke, Karen, Ph.D., Institute for Cancer Research, Phil-
adelphia, Pennsylvania
Cox, John C., Ph.D., Martin Marietta Laboratories, Balti-
more, Maryland
Detmers, Patricia A., Ph.D., Albert Einstein College of
Medicine, Bronx, New York
Dutcher, Susan K., Ph.D., Rockefeller University New York,
New York
Forest, Charlene L., Ph.D., Brooklyn College, New York
Foster, Ken, Mt. Sinai School of Medicine, New York, New
York
Galloway, Ruth E., Washington University, St. Louis,
Missouri
Greenbaum, Elias, Ph.D., Oak Ridge National Laboratory,
Tennessee
Hicks, James, Ph.D., Cold Spring Harbor Laboratory, New
York
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Hodson, Robert, Ph.D., University of Delaware, Newark
Homan, Wieger L., Ph.D., University of Amsterdam, The
Netherlands
Hourcade, Dennis, Washington University, St. Louis,
Missouri
Howell, Stephen H., Ph.D., University of California, San
Diego, La Jolla
Huang, Bessie, Baylor College of Medicine, Houston, Texas
Jarvik, Jonathan, Carnegie Mellon University, Pittsburgh,
Pennsylvania
Lee, Robert W, Dalhousie University, Halifax, Nova Scotia
Lemieux, Claude, Ph.D., National Research Council, Ot-
tawa, Canada
Lewin, Ralph, Scripps Institute of Oceanography, La Jolla,
California
Matagne, Rene F., Laboratory of Molecular Genetics, Liege,
Belgium
Merlin, Ellis, Standard Oil of Ohio, Cleveland
Mets, Laurens, University of Chicago, Illinois
Morel, Nicole, Ph.D., Tufts University, Medford,
Massachusetts
Mosig, Gisela, Ph.D., Vanderbilt University, Nashville,
Tennessee
Muskavitch, Karen, Ph.D., Harvard University, Cam-
bridge, Massachusetts
Polley, David L., Ph.D., Wabash College, Crawfordsville,
Indiana
Rochaix, Jean-David, University of Geneva, Switzerland
Sager, Ruth, Sidney Farber Cancer Center, Boston,
Massachusetts
Schloss, Jeffrey, Yale University, New Haven, Connecticut
Segal, Rosalind, Rockefeller University, New York, New York
Sklar, Robert, Dana Farber Cancer Institute, Boston,
Massachusetts
Small, Gary D., Ph.D., University of South Dakota,
Vermillion
Surzycki, Stefan, University of Geneva, Switzerland
Togasaki, Robert, Indiana University, Bloomington, Indiana
Van Winkle-Swift, Karen, Ph.D., University of California,
San Diego
Wang, Wei-Yeh, University of Iowa, Iowa City
Weeks, Donald P., Ph.D., Zoecon Corporation, Palo Alto,
California
Weiss, Richard L., Ph.D., San Diego State University,
California
White, Frank F., Ph.D., University of Washington, Seattle
Wydrzyndki, Thomas, Ph.D., Amoco Research Center, Na-
perville, Illinois
Seminars
Sager, R., Sidney Farber Cancer Institute. Control of ma-
ternal inheritance of chloroplast DNA by methylation.
Mets, L., University of Chicago. Identification of the phys-
ical sites of genetic markers in the chloroplast genome.
Bartlett, S., Louisiana State University. Genetics of photo-
synthetic membranes.
Togasaki, R., Indiana University. Genetics of the dark re-
actions and ribulose bisphosphate carboxylase.
Wang, W-Y., University of Iowa. Genetic dissection of por-
phyrin biosynthesis.
Adams, G.M.W., Louisiana State University. Selection of
motility mutants.
Lee, R., Dalhousie University. Induction and selection of
chloroplast mutants/synchronized cultures and density
transfer experiments.
Lewin, R., Scripps Institute of Oceanography. The genus
Chlamydomonas.
The mating reaction.
Huang, B., Baylor College of Medicine. Genetic dissection
of flagellar axonemes.
Schloss, J., Yale University. Molecular genetics of tubulin.
Foster, K., Mt. Sinai School of Medicine. Phototaxis.
Howell, S., University of California, San Diego. Genetics
and molecular biology of the cell cycle.
Van Winkle-Swift, K., University of California, San Diego.
Mating type in the genus Chlamydomonas.
Matagne, R., University of Liege. Cell fusion.
Surzycki, S., Indiana University. In vitro transcription sys-
tems from Chlamydomonas.
Brunke, K., Institute for Cancer Research. Shared homol-
ogies in the 5' promoter regions of the coordinately reg-
ulated tubulin gene.
Rochaix, J.-D., University of Geneva. Transformation.
Hourcade, D., Washington University, St. Louis. Gene
transfer from bleomycin-treated Chlamydomonas.
Ausich, R., Amoco Research Center. Transformation of
Chlamydomonas using Agrobacterium tumefaciens con-
taining the T, plasmid.
MOLECULAR EMBRYOLOGY OF THE MOUSE
Participants
Chung, Su-yun, Ph.D., Princeton University, New Jersey
Crenshaw, E. Bryan III, S.B. University of California, San
Diego
Hanahan, Doug, Ph.D., Cold Spring Harbor Laboratory,
New York
Krangel, Michael, Ph.D., Cold Spring Harbor Laboratory,
New York
Lehrach, Hans, Ph.D., European Molecular Biology Lab-
oratory, Heidelberg, Federal Republic of Germany
Rassoulzadegan, Minoo, Ph.D., Centre de Biochimie, Nice,
France
Rigby, Peter, Ph.D., Imperial College, London, England
Schmidt, Azriel, Ph.D., National Institutes of Health, Be-
thesda, Maryland
Silver, Lee, Ph.D., Cold Spring Harbor Laboratory, New
York
Stubbs, Lisa, University of California, San Diego
Taniguchi, Tadatsugu, Ph.D., Cancer Institute, Tokyo, Japan
Yisraeli, Joel K., Hebrew University, Jerusalem, Israel
Seminars
McLaren, A., MRC Mammalian Development Unit. Ori-
gin, growth, and differentiation of germ cells.
. X inactivation.
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Pratt, H., University of Cambridge. Gene expression in
preimplantation embryos.
Chapman, V., Roswell Park Memorial Institute. X-
inactivation.
Stewart, T., Harvard Medical School. Chimeras with tera-
tocarcinoma cells.
McGrath, J., Wistar Institute. Nuclear transplantation with
mouse embryos.
Axelrod, H., Wistar Institute. Isolation of pluripotent cell
lines from mouse embryos.
Spradling, A., Carnegie Institution of Washington. Gene in-
sertion in Drosophila.
Angerer, R., University of Rochester. In situ hybridization
with sea urchin embryos.
Lo, C., University of Pennsylvania. Intercellular commu-
nication in early mouse embryos.
lontophoresis of DNA into mouse eggs.
Verma, I., Salk Institute. Oncogene expression in mouse
embryos.
Mulligan, R., Massachusetts Institute of Technology. Viral
vectors.
Jaenisch, R., Heinrich-Pette Institut. Introduction of retro-
viruses into the germ line.
Rigby, P., Imperial College, London. Transformation acti-
vators in embryonic genes.
Silver, L., Cold Spring Harbor Laboratory. The T complex
in mice.
SINGLE-CHANNEL RECORDING
Participants
Ashcroft, Frances M., Ph.D., University of Oxford, England
Assmann, Sarah M., B.A., Stanford University, California
Carrow, Grant M., Ph.D., Harvard University, Cambridge,
Massachusetts
Dawson, David C., Ph.D., University of Michigan Medical
School, Ann Arbor
Ebihara, Lisa, Ph.D., University of Colorado, Boulder
Jahr, Craig E., Ph.D., Harvard Medical School, Boston,
Massachusetts
Jalonen, Thula 0., M.S., University of Turku, Finland
Matthews, Hugh R., B.A., University of Cambridge,
England
McArdle, Joseph J., Ph.D., New Jersey Medical School,
West Orange
Robinson, Hugh P.C., B.A., Rockefeller University, New
York, New York
Seminars
Tank, D.W., Bell Laboratories. Patch-clamp procedures for
liposomes.
Steinbach, J.H., Salk Institute. Properties of acetylcholine
receptors in BC3H1 cells.
ADVANCED NEUROANATOMICAL METHODS
Participants
Catsicas, Stefano, B.S., Institute of Anatomy, Bugnon,
Switzerland
Chuong, Cheng-Ming, M.D., Rockefeller University, New
York, New York
Davidson, Robert M., M.S., State University of New York,
Buffalo
Hemmings, Hugh Carroll, Jr., B.S., Yale School of Medi-
cine, New Haven, Connecticut
Kennedy, Mary B., Ph.D., California Institute of Technol-
ogy, Pasadena
Leonard, Debra S., B.S., Purdue University, West Lafayette,
Indiana
LeTaillanter, Michel, Ph.D., University of Minnesota,
Minneapolis
Ronchi, Elettra, M.S., University of Rome, Italy
Vallury, Visalakshi, M.S., University of Illinois, Urbana
Wald, Steven L., M.D., University of Vermont, Burlington
Seminars
Raviola, E., Harvard University. Freeze fracture and related
techniques in the study of the retina.
McKay, R., Cold Spring Harbor Laboratory. Neuroimmu-
nology and hybridoma technology.
ADVANCED BACTERIAL GENETICS
Participants
Armengod, Maria-Eugenia, Ph.D., Instituto de Investiga-
ciones Citologicas, Valencia, Spain
Berberich, Mary Anne, Ph.D., National Institutes of Health,
Bethesda, Maryland
Boxer, David H., Ph.D., Dundee University, Scotland
Brownstein, Bernard H., Ph.D., Abbott Laboratories, North
Chicago, Illinois
Coulton, James W, Ph.D., McGill University, Montreal,
Canada
Eichinger, Daniel J., New York University Medical Center,
New York
Fekete, Thomas, M.D., University of Chicago, Illinois
Horn, Sherman, S.M., Ph.D., Johns Hopkins University,
Baltimore, Maryland
Levesque, Roger C., Ph.D., Massachusetts General Hospi-
tal, Boston
Marcotte, William R., Jr., B.S., University of Virginia,
Charlottesville
Ruether, James E., B.A, Sloan-Kettering Institute, New
York, New York
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Saunders, Roger, Ph.D., Chappaqua, New York
Shin, Hee-Sup, Ph.D., Sloan-Kettering Institute, New York,
New York
Warren, Fred D., B.S., University of Connecticut Health
Center, Farmington
Wolfe, Paul B., Ph.D., University of California, Los Angeles
Yakobson, Emanuel A., Ph.D., University of California, San
Diego
Seminars
Adhya, S., NCI, National Institutes of Health. Control of
the gal operon of E. coli.
Susskind, M.M., University of Massachusetts Medical
School. Changing the binding specificity of the repressor.
Schwartz, M., Institut Pasteur. Positive control in the mal-
tose regulation of E. coli.
Shuman, H., Columbia University. Use of gene fusions to
study membrane transport proteins.
Oliver, D., Genetics Institute. Mechanism of protein locali-
zation in E. coli.
Grindley, N., Yale University Medical School. Rearrange-
ments mediated by Tn903 and what they tell us about
transposition mechanisms.
Roth, J., University of Utah. Novel genetic approaches to
interesting biological problems.
Miller, C., Case Western Reserve University. Salmonella
genes regulated by growth phase.
MOLECULAR AND CELLULAR NEUROBIOLOGY
Participants
Akerblom, Ingrid E., B.S., University of California, San
Diego
Baetscher, Manfred W, University of Basel, Switzerland
Bhakoo, Kishore K., B.S., Institute of Neurology, London,
England
Bonini, Nancy M., A.B., University of Wisconsin, Madison
Chamberlain, Susan, B.S., University of Walk, Bristol,
England
Chun, Jerold J.M., B.A., Stanford Medical School,
California
DeVries, Steven H., B.S., University of Chicago, Illinois
Erondu, Ngozi E., B.S., California Institute of Technology,
Pasadena
Ge, Bang-lun, Ph.D., University of California, San
Francisco
Giovanni, Levi, Weizmann Institute, Rehovot, Israel
Grumet, Martin, Ph.D., Rockefeller University, New York,
New York
Holton, Thomas, Ph.D., California Institute of Technology,
Pasadena
Kuffer, Pierre, Institut de Physiologie, Lausanne,
Switzerland
Lindgren, Clark A., M.S., University of Wisconsin, Madison
Nef, Patrick, University of Geneva, Switzerland
Perkel, David J., Harvard University, Cambridge,
Massachusetts
Raghavan, K. Vijay, Ph.D., Tata Institute of Fundamental
Research, Bombay, India
Ring, George D., M.S., Hebrew University, Jerusalem,
Israel
Stiemer, Rainer Helmut, Institut for Neurobiologie, Federal
Republic of Germany
Made, Rebecca, B.S., Purdue University, West Lafayette,
Indiana
Waddell, Pamela J., B.S., University of Bristol, Scotland
Williams, Brenda P., University College London, England
Yaffa, Mizrachi, M.Sc., Weizmann Institute of Science, Re-
hovot, Israel
Zelingher, Julian, B.S., Hebrew University, Jerusalem,
Israel
Seminars
Lindstrom, J., Salk Institute. Acetylcholine receptor: Puri-
fication, structure of subunits, and reconstitution.
Merlie, J., Washington University, St. Louis. Regulation of
the acetylcholine receptor.
Lindstrom, J., Salk Institute. Myosthenia gravis.
Jan, Y.-N., University of California, San Francisco. Do
peptides act as neurotransmitters?
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. Differences between peptidergic transmissions and
classical transmission.
McKay, R., Cold Spring Harbor Laboratory. How genes
make brains.
Hockfield, S., Cold Spring Harbor Laboratory. Immuno-
logical probes of CNS structure.
Jan, Y.-N., University of California, San Francisco. P/M
hybrid dysgenesis and the cloning of the IC+ channel in
the shaker.
Basbaum, A., University of California, San Francisco.
Principles of immunocytochemistry.
. Substance P and pain.
. Endorphins.
Corey, D., Yale University. Voltage-dependent Ca conduct-
ance in photoreceptors.
Roberts, J., Columbia University. Use of recombinant DNA
technology to isolate neuroactive gene sequences.
Hume, R., Washington University, St. Louis. Neurotermi-
nals release acetylcholine before synapse formation.
Lewis, R., University of California, San Francisco. Patch
electrode recording from hair cells.
Scheller, R., Stanford University. Molecular basis of a
"simple" behavior in Aplysia.
. Neuroendocrine baf cells, cloning the ELH gene
family, in situ hybridization, immunofluorescence.
Heinemann, S., Salk Institute, Molecular cloning of the
acetylcholine receptors.
.
Structure and function of the acetylcholine
receptors.
Frank, E., Introduction to sensory-motor synapses in the
spinal cord.
. Mechanism of synaptic transmission at sensory-
motor synapses in the spinal cord.
. Development and plasticity of sensory-motor syn-
apses in the spinal cord.
Dionne, V., University of California, San Diego. From ace-
tylcholine receptors to olefaction.
Steinbach, J., Salk Institute. Developmental changes in
junctional acetylcholine receptors.
Van Essen, D., California Institute of Technology. Synapse
elimination at the neuromuscular junction.
Kehoe, J., Ecole Normale Superieure. Synaptic elimination
of synaptic conductance.
Erulkar, S., University of Pennsylvania. Single-channel
properties of the synaptically activated chloride channel
in Mollusca.
Bennett, M., Albert Einstein College of Medicine. Electri-
cal synapses and gap junctions: Morphology.
Brocks, J., California Institute of Technology. Glial growth
factor.
Jones, S., State University of New York, Stony Brook. M
currents of potassium in bullfrog autonomic ganglia.
Blaustein, M., University of Maryland. Hooked on angel
dust: K channels phencyclidine and behavior.
Black, I., Cornell University Medical College. Calecholam-
inergic synapse.
. Growth and development of calecholaminergic
systems.
. Peptide-calecholamin interactions.
. Neurotransmitter diseases in humans.
NEUROBIOLOGY OF HUMAN DISEASE
Participants
Allen, Donald, B.S., Rockefeller University, New York, New
York
Boone, Timothy, M.S., University of Texas, Houston
Boyle, Mary B., B.A., Yale University, New Haven,
Connecticut
Bredesen, Dale E., M.D., University of California, San
Francisco
Fitzpatrick, Susan, B.S., Cornell University, Ithaca, New
York
Greenamyre, Timothy, B.S., University of Michigan, Ann
Arbor
Halpain, Shelley, B.S., Rockefeller University, New York,
New York
Johnson, Eric, B.A., University of Pennsylvania,
Philadelphia
Kato, Ann, Ph.D., University of Geneva, Switzerland
Krause, James, Ph.D., State University of New York, Stony
Brook
Levi, Giovanni, M.S., Weizmann Institute, Rehovot, Israel
Levin, Leonard, B.A., Harvard Medical School, Boston,
Massachusetts
Lillien, Laura, B.A., University of Wisconsin, Madison
Lipkin, Walter, M.D., University of California, San
Francisco
Orloff, Gregory, B.A., Yale University, New Haven,
Connecticut
Patel, Urmi, Ph.D., National Institutes of Health, Bethesda,
Maryland
Ruggieri, Michael, B.A., University of Pennsylvania,
Philadelphia
Rutecki, Paul, M.D., Baylor College of Medicine, Waco,
Texas
Sapolsky, Robert, B.A., Rockefeller University, New York,
New York
Stewart, Kim, B.A., State University of New York, Stony
Brook
Wexler, Nancy, Ph.D., Hereditary Disease Foundation,
Beverly Hills, California
White, Jeffrey, Ph.D., State University of New York, Stony
Brook
Zaczek, Robert, B.S., Johns Hopkins University, Baltimore,
Maryland
Seminars
Coyle, J., Johns Hopkins University School of Medicine.
Degenerative diseases: Alzheimer's, Huntington's, and
experimental models.
Plum, F., Cornell University Medical College. Conscious-
ness, stupor, and coma.
Brady, R., National Institutes of Health. The lipidoses.
Barker, J., National Institutes of Health. Epilepsy.
Fields, H., University of California Medical School. Pain
syndromes and neuropeptides.
Jessell, T., Harvard Medical School. Pain syndromes and
neuropeptides.
Lindstrom, J., Salk Institute. Autoimmune disease -Myas-
thenia gravis.
Gajdusek, C., National Institutes of Health. Slow viruses
and the central nervous system.
Aguayo, A., McGill University, Montreal General Hospital.
Neural regeneration in the central and peripheral ner-
vous systems.
Gazzaniga, M., Cornell University Medical College. Cog-
nitive disorders and split brain function.
ADVANCED TECHNIQUES IN MOLECULAR CLONING
OF EUKARYOTIC GENES
Participants
Barber, Leslie, B.A., University of California, Los Angeles
Craik, Charles, University of California, San Francisco
Jacob, William, M.S., Brown University Providence, Rhode
Island
Kaczorek, Michel, Ph.D., Institut Pasteur, Paris, France
Kehry, Marilyn, Ph.D., University of Oregon, Eugene
Lenardo, Michael, M.D., University of Iowa, Iowa City
Mason, Philip, Ph.D., ICRF, London, England
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Osborne, Barbara, Ph.D., Amherst College, Massachusetts
Rice, Nancy, Ph.D., Frederick Cancer Research Facility,
Frederick, Maryland
Savage, Nancy, Ph.D., Bethesda Research Laboratories,
Maryland
Searls, David, Ph.D., Wistar Institute, Philadelphia,
Pennsylvania
Vincent, Karen, B.A., University of California, Berkeley
Seminars
Woods, D., Harvard Medical School. Cloning cDNA of
complement.
Seeburg, P., Genentech. Site-directed mutagenesis of the
human growth hormone gene.
Gallupi, G., Monsanto. Synthesis and use of oligonucleo-
tides.
Messing, J., University of Minnesota. M13 cloning and gene
structure.
Wallace, B., City of Hope. Hybridization with synthetic
DNA.
Tatchell, K., University of Pennsylvania. Use of oligonu-
cleotide linkers as mutagens.
ELECTROPHYSIOLOGICAL METHODS USED IN
ANALYZING THE MODE OF ACTION OF TRANSMITTERS
Participants
Acevedo, Larisa, B.A., University of California, Davis
Agmon, Ariel, M.S., Stanford University, California
Block, Melodye, M.S., University of California, Los
Angeles
Johansen, Jorgen, M.S., Cold Spring Harbor Laboratory,
New York
Lipscombe, Diane, B.S., University College London,
England
Mitchell, Clifford L., Ph.D., National Institute of Environ-
mental Health Sciences, Research Triangle Park,
Maryland
YEAST GENETICS
Participants
Boyd, Alan, Ph.D., The Leicester Biocentre, England
Driscoll, Robert, B.A., University of Utah, Salt Lake City
Dowhan, William, Ph.D., University of Texas, Houston
Ellwood, Marian Sue, Ph.D., University of Wisconsin,
Madison
Ford, Clark E, Ph.D., University of Virginia, Charlottesville
Hamer, Dean H., Ph.D., National Institutes of Health, Be-
thesda, Maryland
Howell, William M., Ph.D., University of Oregon, Eugene
Krisch, Henry M., Ph.D., University of Geneva, Switzerland
Lauquin, Guy J.-M., Ph.D., Centre d'Etudes Nucleaires,
Grenoble, France
Lindberg, Martin J., Ph.D., Biomedical Center, Uppsala,
Sweden
Meacock, Peter A., Ph.D., University of Leicester, England
Roulland-Dussoix, Daisy M., Ph.D., Institut Pasteur, Paris,
France
Seale, Ronald L., Ph.D., Scripps Clinic and Research Foun-
dation, La Jolla, California
Simons, Robert W, Ph.D., Harvard University, Cambridge,
Massachusetts
West, Robert W, Jr., Ph.D., Harvard University, Cam-
bridge, Massachusetts
Zonneveld, B.J.M., Ph.D., State University of Leiden, The
Netherlands
Seminars
Bloom, K., University of North Carolina. Topology of yeast
centromere DNA.
Warner, J., Albert Einstein College of Medicine. Ribosomal
protein genes and their regulation.
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Numman, Randy, B.S., University of Texas, Galveston
Rogawski, Michael, Ph.D., National Institutes of Health,
Bethesda, Maryland
Stansfeld, Catherine, M.S., University College, Cardiff
Wales
Swope, Sheridan, B.S., Harvard School of Public Health,
Cambridge, Massachusetts
Seminar
Adams, P, State University of New York, Stony Brook.
Slow and very slow postsynaptic currents.
Sternglanz, R., State University of New York, Stony Brook.
DNA topoisomerase yeast mutants.
Broach, J., State University of New York, Stony Brook.
Yeast plasmid 2u circle.
Szostak, J., Dana Farber Cancer Institute. Properties of tel-
omeres and artificial chromosomes.
Petes, T., University of Chicago. Recombination of re-
peated yeast genes.
Hereford, L., Dana Farber Cancer Institute. Regulation of
yeast histone gene expression.
Rosbash, M., Brandeis University. Splicing of mRNA in-
trons in yeast.
Botstein, D., Massachusetts Institute of Technology. Ge-
netics of actin and tubulin in yeast.
Smith, M., University of British Columbia. Site-directed
mutagenesis.
Grunstein, M., University of California, Los Angeles.
Deletion analysis of histone H2B genes.
Prakash, L., University of Rochester. RAD genes of yeast.
Klar, A. and Strathern, J., Cold Spring Harbor Laboratory.
Mechanism of recombination in mating-type switching.
Beach, D., Cold Spring Harbor Laboratory. Genetics in
Schizosaccharomyces pombe.
Fox, T., Cornell University. Interaction of mitochondrial and
nuclear genes.
IM M UNO G LO BULINS: M O LECULAR PROBES 
O F TH E NERVOUS SYSTEM
Wilson, D., University of Pennsylvania. Cell interaction in 
the immune system.
Sprent, J., University of Pennsylvania. MHC restriction.
Anderson, D., Columbia University College of Physicians 
& Surgeons. Acetylcholine receptor biosynthesis.
Weber, E., Stanford University. Immunological analysis of 
opioid peptides.
Lindstrom, J., Salk Institute. The immunobiology of the 
acetylcholine receptor.
Feramisco, J., Cold Spring Harbor Laboratory. The orga- 
nization of the cytoskeleton.
Matthew, W., Harvard Medical School. Immunological 
studies of neurite outgrowth.
Kelly, R., University of California, San Francisco. Synaptic 
vesicle structure and secretion mechanisms.
Hockfield, S., Cold Spring Harbor Laboratory. Cellular or- 
ganization in the mammalian CNS.
Willard, M., Washington University. The structure and 
function of the axon.
Harlow, E., Cold Spring Harbor Laboratory. Immunologi- 
cal analysis of SV40 T antigen.
Karten, H., State University of New York, Stony Brook. 
Antibodies as probes of defined neural circuits.
Participants
Bixby, John L., Ph.D., University of California, San 
Francisco
Borroni, Edilio, Max-Planck-Institut, Gottingen, Federal 
Republic of Germany
Caudy, Michael A., B.S., University of California, Berkeley
Chin, Gilbert, A.B., Harvard University, Cambridge, 
Massachusetts
Duguid, John R., Ph.D., University of California, San 
Francisco
Hishinuma, Akira, M.D., Columbia University, New York, 
New York
Hockfield, Susan, Ph.D., Cold Spring Harbor Laboratory, 
New York
Pirchio, Mario, M.D., Istituto di Neurofisiologia ״del CNR, 
Rome, Italy
Sarthy, P. Vijay, Ph.D., University of Washington, St. Louis, 
Missouri
Wagner, Michael A., B.S., Institute for Cancer Research, 
Philadelphia, Pennsylvania
Seminars
Poljak, R., Institut Pasteur. The three-dimensional structure 
of immunoglobulin.
Gefter, M., Massachusetts Institute of Technology. Idiotype 
regulation and the origin of antibody diversity.
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UNDERGRADUATE
RESEARCH
An important aspect of the summer program at the Laboratory is the participation of college undergraduate
students in active research projects under the supervision of full-time laboratory staff members. The program
was initiated in 1959. Since that year, 249 students have completed the course, and many have gone on to creative
careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental principles of
biology, (2) an increased awareness of major problem areas under investigation, (3) better understanding of the
physical and intellectual tools for modem research and the pertinence of this information to future training, and
(4) a personal acquaintance with research, research workers, and centers for study.
The following students, selected from a large number of applicants, took part in the program, which was
supported by J.M. Foundation, Burroughs Wellcome Fund, and Bayer Aspirin (Glen Brook Labs). They are listed
below with their Laboratory sponsors and topics of research.
Marvin Appel, Harvard University
Research Advisor: F. Daldal
Growth of anaerobes under normal atmospheric condi-
tions in medium reduced by E. coli membrane extracts.
Michael Cahn, Dartmouth College
Research Advisor: P. Thomas
Sequence analysis of human stress protein genes.
Brad Cookson, University of Utah
Research Advisor: M. Wig ler
Analysis of mutations altering expression of H-ras-1
genes.
Lillie Hsu, University of Michigan
Research Advisor: A.I. Bukhari
Vectors for shotgun cloning bacterial genes without re-
striction enzymes.
Kyu-Ho Lee, Massachusetts Institute of Technology
Research Advisor: F. Tamanoi
Use of M13 to express H-ras-1 T24 bladder carcinoma
p21 protein in E. coli.
Ramona Morfeld, Wheaton College
Research Advisors: J. Hicks, J. Ivy
Anti-Mar-A disrupter of the negative regulation of the
silent mating-type cassettes in Saccharomyces cerevisiae.
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Andrew Nathanson, University of Pennsylvania
Research Advisor: R. McKay
The molecular diversity of the embryonic nervous system
of the rat.
Michael Schor, Cornell University
Research Advisor: A.J.S. Klar
Search for a site-specific endonuclease gene in Schizo-
saccharomyces pombe.
Thomas Smart, Cornell University
Research Advisor: R. Malmberg
Cloning of the Nicotiana tabacum gene nitrate reduc-
tase through insertional mutagenesis of a modified
T-DNA fragment of Agrobacterium tumefaciens.
Laurie Smith, Princeton University
Research Advisor: A.I. Bukhari
Tn5 mutagenesis of the gin and mom genes of Mu.
Olney Fellow
Robert Dudley, Duke University
Research Advisor: R. McKay
The generation of antibodies to neural gene products by
means of cDNA clones.

SEMINARS
Cold Spring Harbor Seminars were initiated to provide a semiformal avenue for communication between the
various research groups at the Laboratory. They are particularly useful for research personnel who have joined
the Laboratory during the summer. The seminars also afford a necessary opportunity for the graduate students
and postgraduate staff to develop their skills in defending, organizing, and presenting their research. In addition
to those listed below, seminars were given by many others involved in research at this Laboratory.
1982-1983
September
Michael Smith, University of British Columbia, Vancou-
ver, Canada: Applications of synthetic oligonucleotides
in molecular biology in DNA sequence determination,
as probes, and site-directed mutagenesis.
Victoria Bautch, University of Illinois, Urbana: Organi-
zation and expression of Drosophila tropomyosin genes.
Mary Jane Madonna, University of Indiana, Blooming-
ton: Genetic and regulatory studies of the glt in Sal-
monella typhimurium.
Terrence Andreasen, University of Washington, St. Louis,
Missouri: Studies of calcium-regulated systems using
photoaffinity calmodulin probes.
October
Lindley Blair, University of California, Berkeley: Pro-
cessing and secretion of yeast sex factors.
Micholas Robakis, Roche Institute, Nutley, New Jersey:
DNA-directed in vitro synthesis of D1- and tripep-
tides -A novel system to study the regulation of the
expression of prokaryotic genes.
Robert Gerard, University of Miami, Florida: Genetic
analysis of nuclease-sensitive sites in SV40 chromatin.
Howard Fox, University of San Francisco Medical Cen-
ter, California: Molecular clones of the t complex.
Janet Tobian, Virginia Commonwealth University, Rich-
mond: Molecular cloning in the streptococci.
Toran Wadell, Karolinska Institut, Stockholm, Sweden:
Molecular epidemiology of adenoviruses.
Jeremy Thomer, University of California, Berkeley:
Polypeptide pheromone processing and secretion in
yeast.
November
Nick Hastie, Roswell Park Memorial Institute, Buffalo,
New York: The complexities of gene expression in the
mouse.
Amikam Cohen, Hebrew University, Jerusalem, Israel:
General plasmidic recombination -Role of bacterial
functions.
241
Mark Zoller, University of British Columbia, Vancouver,
Canada: Assays of gene function using site-directed
mutagenesis.
Michael Rabson, Yale University School of Medicine,
New Haven, Connecticut: Genome structures of non-
transforming Epstein-Barr virus variants.
George Cross, Rockefeller University, New York, New
York: Variant surface glycoproteins of Trypanosoma
bnicei -Structure and expression.
December
Susan Watts, University of Minnesota, Duluth: Transfor-
mation by rabbit and human papilloma viruses.
Timothy Donohue, University of Illinois at Urbana-
Champaign: Regulation of phospholipid biosynthesis in
Rhodopseudomonas sphaeroides.
Markku Kurkinen, Imperial Cancer Research Fund, Lon-
don, England: Basement membrane glycoproteins -
Latninin and type IV collagen.
John Northup, University of Texas at Dallas: Guanine nu-
cleotide regulatory component of adenylate cyclase.
Patrick Hallenbeck, University of California, Davis: Ni-
trogenase from the photosynthetic bacterium Rhodo-
pseudomonas capsulata -Purification and regulation of
activity.
Mike Freeling, University of California, Berkeley: Inser-
tion elements in maize-Structure and function of Rob-
ertson's mutator.
Lou Cantley, Harvard University, Cambridge, Massachu-
setts: The Na/K ATPase and its role in cellular
differentiation.
Ravi Dhar, National Institutes of Health, Bethesda, Mary-
land: Activation of the human bladder transforming
gene.
January
Robert Weiss, University of Washington, St. Louis, Mis-
souri: Ribosome frameshifting and mistranslation of the
genetic code.
Barbara Thalenfeld and Lenore Gardner, Enzo Biochem-
icals, New York, New York: Nonradioactive labeling of
DNA with biotin.
Richard Ogden, University of California, San Diego: In
vitro mutagenesis of yeast tRNA genes.
George Pavlakis, NCI, National Institutes of Health, Be-
thesda, Maryland: The regulation of genes in bovine
papilloma virus vectors.
Obaid Siddiqui, Tata Institute for Fundamental Research,
Bombay, India: Neurogenetics of olfaction in
Drosophila.
Larry Klobutcher, University of Colorado, Boulder: Ge-
nome rearrangement during macronuclear develop-
ment in ciliated protozoa.
Peter Walter, Rockefeller University, New York, New
York: Trans location of proteins across the endoplasmic
reticulum.
Douglas Youvan, University of California, Berkeley: "R"
site-directed transposon mutagenesis and isolation of
enhanced fluorescence mutants of Rhodopseudomonas
capsulata.
February
Diane Stassi, University of Syracuse, New York: The
cloning and control of expression of the maltosacchar-
omyces utilization gene ofStreptococcus pneumoniae.
Janet Lee, Imperial Cancer Research Fund, London,
England: Molecular analysis of HLA-D region genes.
Alex Rich, Massachusetts Institute of Technology, Cam-
bridge: Z-DNA and the replication of transcription.
Tim Baba, University of Texas, Dallas: Analysis of early
events in avian leukosis virus-induced lymphomas.
Jerry Lingrel, University of Cincinnati, Ohio: Different
evolutionary origins of the developmentally regulated
globin genes.
March
Michael Cole, St. Louis University, Missouri: Activation
ofmyc oncogene by chromosome translocation.
Dan Lundell, University of California, Berkeley: Struc-
ture of the phycombilisome.
Pat Higgins, University of Wyoming, Laramie: Bacteri-
ophage Mu transposition in vitro.
Pablo Sco lnick, University of Chicago, Illinois: Molecular
genetics of nitrogen fixation of Rhodopseudomonas
capsulata.
Michael Been, University of Washington, St. Louis, Mis-
souri: Specificity of eukaryotic type-1 topoisomerase on
native and single-stranded DNAs.
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Jesse Summers, Institute for Cancer Research, Philadel-
phia, Pennsylvania: Replication of hepatitis-B-like
viruses.
Mark Furth, Memorial Sloan-Kettering Cancer Center,
New York, New York: Expression of p32 ras in E. coli
and animal cells.
Bob Steinberg, University of Connecticut, Storrs: Fine-
structure analysis of mutations in the regulatory sub-
unit of cyclic AMP-dependent protein kinase.
Stephen Lam, Montana State University, Bozeman: The
use of transposon mutagenesis in genetic studies of
Pseudomonas syringae.
Graeme Laver, John Curtin School of Medical Research,
Birmingham, and Gillian Air, University of Alabama,
Birmingham: The structure and variation of antigenic
sites of influenza virus proteins.
Arnold Berk, University of California, Los Angeles:
Transcriptional control of adenovirus.
April
Mike Mackett, National Institutes of Health, Bethesda,
Maryland: Infectious vaccinia virus recombinants that
express foreign genes.
Clay Armstrong, University of Pennsylvania, Philadel-
phia: Gating currents-Or understanding sodium chan-
nels from its charge movements in the membrane.
Rolf Sternglanz, State University of New York, Stony
Brook: Identification and characterization of yeast DNA
topoisomerase mutants.
Joyce Hamlin, University of Virginia, Charlottesville:
Characterization of a mammalian chromosomal
replicon.
Richard Egel, Institute of Genetics, Copenhagen, Den-
mark: Pattern of mating-type switching in fission yeast.
May
Marilyn Kehry, University of Oregon, Eugene: Sensory
adaptation in bacterial chemotaxis.
Clyde Slaughter, University of Texas Health Sciences
Center, Dallas: Antibody diversity and idiotypes -
Studies of murine anti-arsonate antibodies.
Chuck Lent, Brown University, Providence, Rhode Is-
land: Serotonin and feeding behavior in the leech.
Michael Merchlinsky, Yale University School of Medi-
cine, New Haven, Connecticut: Studies with an infec-
tious molecular clone of the autonomous parvovirus
MVM.
NATURE STUDY
PROGRAM
The Nature Study Program gives elementary and high school students the opportunity to acquire a greater knowl-
edge and understanding of their environment. Through a series of specialized field courses, students can engage
in such introductory programs as Nature Detectives, Seashore Life, and Pebble Pups, as well as more advanced
programs such as Marine Biology, Nature Photography, and the Geology of Long Island.
During the summer of 1983 a new high of 475 students participated in the Nature Study Program. Most classes
were held outdoors, when weather permitted, or at the Uplands Farm Nature Preserve of the Long Island Chapter
of the Nature Conservancy. The Laboratory has equipped and maintains a darkroom and classroom/laboratories
at Uplands Farm. This facility is used as a base for the student's exploration of the local environment. Field
classes are held on Laboratory grounds, St. John's Preserve, Shu Swamp Preserve, Montauk Point State Park, the
Long Island Pine Barrens, Caumsett Park, and in other area parks.
In addition to the four-week courses, a series of one-day marine biology workshops was offered to students.
Studies on the marine ecology of L.I. Sound were conducted aboard the 66-foot schooner J.N. Carter chartered
from Schooner, Inc., of New Haven, Connecticut. Students were able to study the Sound chemically, physically,
and biologically using the ship's instrumentation. The three-day Adventure Education class took children on an
18-mile bike hike to Caumsett State Park, a six-mile canoe trip on the Nissequogue River, and a day of sailing on
the J.N. Carter.
PROGRAM DIRECTOR
Edward Tronolone, M.S., P.D., Science Curriculum Associate, East Williston Public Schools
INSTRUCTORS
Kathryn Bott, M.S., science teacher, Friends Academy
Ruth Burgess, B.A., naturalist, Nassau County BOCES
Michael Fricano, B.S., naturalist, Nassau County BOCES
Robert Jaeger, M.S., science teacher, Mineola High School
Eric Knuffke, M.S., science teacher, Mineola High School
Fred Maasch, M.S., science teacher, Islip High School
Bill Payoski, M.S., science instructor, Nassau Community College
Linda Payoski, B.A., naturalist, Nassau County BOCES
James Romanski, M.S., science teacher, Bay Shore High School
COURSES
Nature Bugs Seashore Life
Nature Detectives They Swim, Walk, and Crawl
Advanced Nature Study Geology of Long Island
Introduction to Ecology Marine Biology
Frogs, Flippers, and Fins Nature Photography
Pebble Pups Adventure Education
Bird Study Marine Biology Workshop
Fresh Water Life
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